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Abstract: Newly received calves that received antimicrobial treatment for bovine 
respiratory disease (BRD) were randomly assigned to 1 of 4 experimental ancillary 
therapy (ANC) groups: flunixin meglumine (NSAID), viral vaccination (VACC), vitamin 
C (VITC), or no ANC (NOAC). When contrasted with the average of NSAID, VACC, 
and VITC calves receiving NOAC tended to have heavier BW on d 56, greater ADG and 
DMI from first BRD treatment through d 28, greater DMI from d 28 through d 56, and 
had greater DMI from first BRD treatment through d 56 with mortalities and removals 
excluded (P = 0.06, P = 0.10, P = 0.08, P = 0.06, and P = 0.05 respectively). Overall 
morbidity and mortality attributed to BRD were 66.5% and 13.2% respectively. After the 
receiving period, calves were grouped by previous ANC treatment and the number of 
times treated for BRD (BRDX) and allocated to finishing pens. The BRDX experimental 
groups included: never treated for BRD (0X), treated 1 time (1X), 2 times (2X), or 3 or 4 
times (3/4X). Ultrasound estimates, BW, and visual appraisal were used to target a 
common compositional end point for each pen of cattle. No ANC group differences 
existed for any of variables analyzed (P ≥ 0.26). With increasing BRDX, days on feed 
and lung consolidation scores increased linearly (P ≤ 0.01), while hot carcass weight, 
dressing percentage, ribeye area, and the percentage of USDA Prime and Choice 
carcasses decreased linearly (P ≤ 0.03). An additional experiment examined the effects of 
copper (Cu), manganese (Mn), and zinc (Zn) supplementation on the clinical signs, 
immune response variables, and mineral status of calves following a bovine viral diarrhea 
virus (BVDV) and Mannheimia haemolytica (MH) immune challenge. Steers were 
randomly pairwise assigned to either a mineral supplemented (MIN) or control (CON) 
experimental treatments. There was a significant (P < 0.0001) time by treatment 
interaction observed for liver Cu levels. Time significantly impacted the concentrations 
of Cu, Mn, Fe, and Zn within the liver, Cu, Mn, and Zn within the muscle, and Cu, Fe, 
and Zn within the serum (P ≤ 0.05). Calves receiving MIN had greater liver Cu (P = 
0.0001) and Mn (P = 0.0075) concentrations compared to CON calves. In contrast, serum 
Cu and Fe concentrations were increased (P ≤ 0.05) in CON calves compared to MIN 
calves. The use of ANC does not appear to positively impact clinical health and could 
potentially be detrimental to receiving performance in severely immune challenged 
calves. Calves treated multiple times for BRD are able to reach similar compositional end 
points as untreated cohorts; however, it may not be possible for treated calves to achieve 
similar carcass traits. The supplementation of Cu, Mn, and Zn may impact the antibody 
response to a BVDV and MH immune challenge in calves. When Cu is supplemented to 
calves receiving a marginally Cu deficient diet, Cu status within the body can be altered. 
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CHAPTER I 
 
 
INTRODUCTION 
 
Bovine respiratory disease (BRD), also known as “shipping fever” or 
bronchopneumonia, is the most significant production problem confronting the feedlot 
industry. The BRD complex accounts for the majority of morbidity, mortality, and 
production losses occurring in feedlots. In a cross-sectional survey conducted by 
Woolums et al. (2005), BRD was implicated as the leading cause of morbidity and 
mortality in 561 feedlots in 21 states. Estimated annual economic losses due to BRD are 
approaching or exceeding $2 billion annually. Chirase and Greene (2001) estimated the 
annual economic losses due to morbidity, decreased feed efficiency, and treatment costs 
associated with BRD to be $800-900 million. Bovine respiratory disease is an extremely 
complex illness complicated by a multitude of stressors, viruses, and bacterial pathogens 
can potentially contribute to its onset (Duff and Galyean, 2007).  
The pathogenesis of BRD typically involves compromised respiratory immune 
mechanisms and a primary infection with one or more respiratory viruses. The viral 
infection and the calf's impaired immune response to the virus further compromise the 
immune system and allow for the colonization of lung tissues by bacteria (Hodgins et al., 
2002). Most of the pathogens associated with increased BRD incidence are well    
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documented in the literature. However, many of these pathogens are also frequently 
isolated from the respiratory tract of clinically healthy cattle. For example, the most 
common bacterial pathogen isolated from the respiratory tract of calves treated for BRD, 
and thus, the principal bacterial pathogen associated with BRD, is Mannheimia 
haemolytica (MH) (Whitley et al., 1992; Booker et al., 2008). However, as an 
opportunistic pathogen, MH is also frequently isolated from the respiratory tract of 
clinically healthy calves (Klima et al., 2014). 
The prevention and treatment of BRD continues to be a major concern for all of 
those within the feedlot industry. To aid in BRD prevention, most feedlots vaccinate 
cattle for bovine viral diarrhea virus (BVDV) (96.6 percent of feedlots), infectious bovine 
rhinotracheitis (IBR) virus (93.7 percent of feedlots), parainfluenza 3 (PI3) virus (85.1 
percent of feedlots), and bovine respiratory syncytial virus (BRSV) (89.5 percent of 
feedlots) (NAHMS, 2013). Treatment protocols for BRD vary greatly from feedlot to 
feedlot. However, the standard practice is to administer some class of injectable 
antimicrobial as the primary form of treatment when treating for suspected BRD in 
feedlot cattle. Nearly all feedlots (99.0 percent) used an injectable antimicrobial as the 
initial or primary treatment for BRD (NAHMS, 2013).  
It is also common to provide additional treatment, or ancillary therapy (ANC), 
along with the antimicrobial when treating for suspected BRD. The primary goal of ANC 
is to improve the response to a BRD challenge in calves treated with antimicrobials, not 
to replace antimicrobial treatment. This can be accomplished through a variety of 
mechanisms including: relieving the harmful effects of inflammation, blocking histamine 
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activity, or boosting immune system function to aid in the defense against infectious 
pathogens (Apley, 1994). 
Three large-scale surveys conducted since 1999 have provided substantial 
evidence as to the scope of ANC use in commercial feedlots. In 1999, USDA’s NAHMS 
surveyed feedlots in the top 12 cattle feeding states and noted that only 12.8% of these 
feedlots used a single antimicrobial for the treatment of BRD (NAHMS, 2001). More 
recently, a survey conducted by Terrell et al. (2011) reported that 48% of veterinarians 
recommended some form of ANC for the treatment of BRD. In 2011, USDA’s NAHMS 
surveyed feedlots with a capacity of 1,000 or more head in the top 12 cattle feeding states 
and reported that 55.9% of feedlots used a non-steroidal anti-inflammatory drug (NSAID) 
and 39.3% used a respiratory vaccine as a component of the initial BRD treatment 
program for some cattle (NAHMS, 2013). The most commonly used forms of ANC 
appearing in all surveys included: vitamin C, NSAID, antihistamines, direct-fed 
microbials (DFM), B vitamins, viral vaccines, and corticosteroids (NAHMS, 2001; 
Terrell et al., 2011; NAHMS, 2013). While these surveys provide evidence as to the 
scope of ANC use, there is limited published research on the efficacy of these ANCs.  
In addition to ANCs, the feedlot industry has investigated the use of nutritional 
additives as an additional method to decrease morbidity and mortality due to BRD, while 
simultaneously enhancing animal performance. One group of nutritional additives that 
has received consideration would be trace minerals (TM) due to their proposed positive 
impacts on immune function. The supplementation of TM has been demonstrated to alter 
immune function measurements and reduced morbidity associated with BRD in some 
cases (Galyean et al., 1999). The supplementation with TM including: copper (Cu), 
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manganese (Mn), and zinc (Zn) has become a normal management practice within the 
feedlot industry to promote maximum performance and immune function, and these TM 
are frequently included at levels in excess of published requirements in feedlot diets 
(Vasconcelos and Galyean, 2007).  
Research concerning TM supplementation has been extremely inconsistent. This 
inconsistency is especially evident when investigating ideal diet concentrations and TM 
forms or sources. However, in some instances organic mineral complexes have 
demonstrated more bioavailability than traditional inorganic mineral sources. This 
increased bioavailability is a result of the decreased likelihood of a chelated mineral 
complex becoming bound to another substance within the upper gastrointestinal tract and 
thus allowing the mineral to be more readily absorbed across the brush border of the 
small intestine. The increase in bioavailability of organic TM could allow for improved 
TM status within the animal in an immune challenge scenario such as a BRD event. 
However, this has not been demonstrated to date in the published research. 
In the last 40 years much knowledge of the pathogenesis of BRD has been 
acquired and advancements have been made in the production of vaccines and 
antimicrobials for the prevention and treatment of BRD. There are exponentially more 
commercially available respiratory vaccines and long lasting antimicrobials for BRD than 
in any time in previous history. However, the prevalence of BRD in feedlot cattle has not 
been significantly reduced. Data would indicate that no significant reduction in BRD 
incidence has occurred over the last 30 to 40 years (Gifford et al., 2012). These data 
suggest that current BRD prevention and treatment strategies have been ineffective in 
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reducing and controlling BRD, despite measurable improvements in commercially 
available vaccines and antimicrobials (Babcock et al., 2006). 
The objectives of the experiments presented in this dissertation were to: 1) 
Evaluate multiple ancillary therapies used in combination with an antimicrobial in newly 
received high-risk calves treated for bovine respiratory disease; 2) Evaluate the impact of 
bovine respiratory disease and ancillary therapy use during the receiving period on steer 
finishing performance, efficiency, carcass characteristics, and lung scores; 3) Evaluate 
the effects of chelated copper, manganese, and zinc supplementation on clinical signs, 
immune response variables, and mineral status in calves following natural exposure to 
bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica challenge. 
The ultimate goal of these experiments would be to expand upon the current knowledge 
regarding prevention and treatment of BRD and to improve upon the management of 
cattle subsequent to a BRD challenge to attempt to reduce the overall economic impact 
BRD to the feedlot industry. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
BOVINE RESPIRATORY DISEASE IN NEWLY RECEIVED CALVES 
Bovine respiratory disease (BRD) continues to be the most significant production 
problem confronting the feedlot industry. The BRD complex accounts for the majority of 
morbidity, mortality, and production losses occurring in feedlots. In a cross-sectional 
survey conducted by Woolums et al. (2005), BRD was implicated as the leading cause of 
morbidity and mortality in 561 feedlots in 21 states. In a review of feedlot data from 1994 
to 1999, an average of 12.6 head of cattle died for every 1,000 that were placed on feed 
(Loneragan et al., 2001). Loneragan et al. (2001) determined that BRD was responsible 
for 57.1% of the mortality that occurred. Edwards (1996) reported that approximately 
70% of all disease that occurred in Midwestern feedlots was attributed to BRD and with a 
10% morbidity rate, treatment costs alone would amount to $2 per head for all cattle 
marketed.  
Fulton et al. (2002a) observed that calves treated for BRD once returned $40.64 
less, calves treated for BRD twice returned $58.35 less, calves treated for BRD 3 or more 
times returned $291.93 less than calves that were not treated for BRD (Fulton et al.,
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2002a). Chirase and Greene (2001) estimated the annual economic losses due to 
morbidity, mortality, decreased feed efficiency, and treatment costs associated with BRD 
to be $800-900 million. More recent estimates of annual economic losses due to BRD in 
the U.S. are in excess of $1 billion dollars (Hodgins and Shewen, 2004; Griffin et al., 
2010; Powell, 2013).  
A major issue concerning the estimated incidence of BRD in feedlot cattle is how 
BRD is identified within the population. There is no standardized case definition for BRD 
making BRD difficult to define from clinical standpoint. Survey information and the 
available data would indicate that the clinical diagnosis of BRD is still done almost 
exclusively by subjective visual observation (Galyean et al., 1999). Due to the subjective 
nature of clinical diagnosis in feedlots, this can be a concern when attempting to quantify 
BRD. Even the most experienced veterinarians and pen riders will be ineffective at 
identifying all calves suffering from BRD in a commercial feedlot. As such, defining 
BRD incidence based on treatment records commonly underestimates the total effect of 
BRD. Gardner et al. (1999) reported that the presence of lung lesions at harvest was more 
highly correlated to decreased performance than animal treatment records. Steers with 
lung lesions present at harvest and active bronchial lymph nodes returned $73.78 less 
than steers without lung lesions (Gardner et al. 1999). Only 21% of this loss was 
attributed to treatment costs while 79% was due to lower hot carcass weights and poorer 
quality grades (Gardner et al. 1999). 
As a result, it would seem that retrospectively correlating the presence of lesions 
on the lungs of cattle at harvest may be a more valid indicator of overall respiratory 
disease incidence in cattle. In theory, the majority of cattle that previously suffered from 
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BRD would have lung lesions present at harvest. However, there are concerns with using 
this approach to quantify BRD incidence as well. While cattle were never treated for 
clinical signs of BRD have commonly demonstrated evidence of lung damage as 
expected, it has also been reported that cattle that were treated for clinical signs of BRD 
have lacked the presence of any pulmonary lesions (Wittum et al., 1996; Gardner et al., 
1999; Thompson et al., 2006; Schneider et al., 2009). Currently, there is not a perfect 
diagnostic tool to determine the exact incidence of BRD and thus determining the true 
production and economic losses due to BRD is extremely difficult. 
Bovine Respiratory Disease is an extremely complex illness complicated by a 
multitude of stressors, viruses, and bacterial pathogens that can potentially contribute to 
its onset (Duff and Galyean, 2007). The way cattle are marketed in the U.S. is inherently 
responsible for a variety of stressors. In the Southern Plains and Southeast U.S. calves are 
commonly removed directly from their dams and shipped to a livestock market for sale. 
At the livestock market, calves are commingled with many other animals of unknown 
disease and vaccination status. Calves are typically purchased and again commingled into 
large lots to be loaded on trucks for transportation. The calves are then transported long 
distances where they are potentially exposed to additional stressors such as exhaust 
fumes, extreme temperatures, dehydration, malnourishment, and exhaustion (Griffin et 
al., 2010).  
Other factors occurring prior to marketing cattle including prenatal nutrition, 
colostrum intake, previous nutrition of calves while still on the dam, cattle genetics, 
individual animal variation, and the previous health and vaccination history of both the 
herd and individual animals can interact with the marketing stressors to impact BRD 
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incidence (Duff and Galyean, 2007). Once calves arrive at the feedlot or are received into 
a stocker or backgrounding program, additional stressors then occur. These post-
marketing stressors include processing, (typically includes the administration of 
vaccinations and implants, and potentially includes dehorning and castration, additional 
sorting and commingling to form uniform pens, dusty pen environments, and the 
introduction to new feed and unfamiliar water sources. All of these serve to negatively 
affect the immune system at a time when the calf is likely going to be exposed to viral 
and bacterial respiratory pathogens. 
The pathogenesis of BRD typically involves compromised respiratory immune 
mechanisms and a primary infection with one or more respiratory viruses. The principal 
viral pathogens associated with BRD include: bovine herpesvirus 1 (BHV1) leading to 
infectious bovine rhinotracheitis (IBR), bovine viral diarrhea virus (BVDV), 
parainfluenza virus type 3 (PI3), bovine respiratory synctial virus (BRSV), and bovine 
respiratory corona virus (BCV) (Roth and Perino, 1998). The viral infection and the calf's 
impaired immune response to the virus further compromise the immune system and allow 
for the colonization of lung tissues by bacteria (Hodgins et al., 2002). Important bacterial 
pathogens connected to the increased incidence of BRD include: Mannheimia 
haemolytica (MH), Pasteurella multocida (PM), Histophilus somni (HS), and 
Mycoplasma bovis (MB) (Griffin et al., 2010).  
The pathogenesis of BRD can involve a variety of these viral or bacterial 
pathogens and identifying a true “cause” of BRD is often difficult if not impossible. To 
further complicate matters, many of these bacterial pathogens are also frequently isolated 
from the respiratory tract of clinically healthy cattle. For example, the most common 
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bacterial pathogen isolated from the respiratory tract of calves treated for BRD is M. 
haemolytica serotype 1 (Whitley et al., 1992; Booker et al., 2008). However, M. 
haemolytica is also frequently isolated from the respiratory tract of clinically healthy 
calves (Klima et al., 2014).  
The prevention and treatment of BRD, continues to be a major concern for the 
feedlot industry. To aid in BRD prevention, most feedlots vaccinate cattle for bovine 
viral diarrhea virus (BVDV) (96.6 percent of feedlots), infectious bovine rhinotracheitis 
(IBR) virus (93.7 percent of feedlots), parainfluenza 3 (PI3) virus (85.1 percent of 
feedlots), and bovine respiratory syncytial virus (BRSV) (89.5 percent of feedlots) 
(NAHMS, 2013). Treatment protocols for BRD vary greatly from feedlot to feedlot. 
However, the standard practice is to administer some class of injectable antimicrobial as 
the primary form of treatment when treating for suspected BRD in feedlot cattle. Nearly 
all feedlots (99.0 percent) used an injectable antimicrobial as the initial or primary 
treatment for BRD (NAHMS, 2013). 
 
Risk factors influencing BRD incidence 
The BRD complex is an extremely complicated illness that is elicited by a 
multitude of different risk factors or stressors, viruses, and bacterial pathogens (Duff and 
Galyean, 2007; Griffin et al., 2010). At its core, BRD is a viral and bacterial disease of 
the respiratory tract. However, a multitude of risk factors including various stressors can 
suppress the calf’s immune system, allowing for these viral and bacterial pathogens to 
rapidly multiply within the animal’s respiratory tract. Aich et al. (2009) defined these 
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stressors as “a psychologically perturbing condition occurring in response to adverse 
external influences capable of affecting physical health.” These risk factors or stressors 
can occur anytime after conception during the animal’s life. Some of these risk factors 
can be effectively managed at various phases of beef production, while others simply 
may not be avoidable and are inherently associated with the marketing of cattle and the 
current structure of the feedlot industry.  
These risk factors or stressors that can lead to increased BRD incidence can be 
subdivided into pre-marketing stressors, stressors associated with the cattle marketing 
process, and post-marketing stressors. While they occur at various degrees and at various 
production stages, these stressors can all cause a suppression of the calf’s immune 
system, allowing for subsequent pathogen infection and replication within the respiratory 
tract. The incidence of BRD is not only a feedlot concern. While BRD manifests itself in 
the stocker or feedlot segments of the beef industry, this is not where the problem is 
initiated.  
The origins of this problem are easily visible when looking at the population 
statistics of the cow calf production sector of the beef industry. There are 89.3 million 
head of beef cattle in the U.S. on 729,000 beef cow operations (NCBA, 2013). However 
the average cow herd size in the U.S. is only 44 head with 90% of cow herds having less 
than 100 head of cows (NCBA, 2013). The existence of so many cow calf operations and 
the small average size of these operations results in a huge variation in management and 
production practices prior to marketing. This substantial variation in pre-marketing 
production further complicates the stressors placed on calves through marketing channels 
and effects calf health post-marketing. Some major pre-marketing stress factors 
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impacting BRD incidence include: prenatal nutrition, colostrum intake, and previous 
nutrition of these calves while still on the dam, as well as individual cattle genetics and 
animal variation, and the previous health and vaccination history of the herd and 
individual animals (Duff and Galyean, 2007). 
Where pre-marketing stress is concerned, research has linked poor maternal 
nutrition during gestation to subsequent decreased calf performance and health (Funston 
et al. 2012). Previous research conducted by Corah et al. (1975) demonstrated that calves 
born to first-calf heifers receiving 65% of their required energy intake during the last 90 
days of gestation had increased morbidity and mortality rates compared to calves born to 
first-calf heifers receiving 100% of their required energy intake. Similarly, both 
Mulliniks et al. (2008) and Larson et al. (2009) stated that there was a reduction in the 
number of steers treated for BRD in the feedlot when cows were supplemented with 
additional protein compared to calves from non-protein supplemented dams. Other 
research has shown improvements in the number of live weaned calves, with no 
difference in the number of calves treated for BRD before weaning or in the feedlot 
(Stalker et al. 2006).  
Another pre-marketing stressor of concern is the quality and quantity of colostrum 
consumed by newborn calves. It is widely accepted that the passive transfer of 
immunoglobulins in colostrum is essential for optimal calf health with colostrum 
containing effectively all of the essential compounds of bovine cellular and humoral 
immune defense, including antibodies and important proteins. (Korhonen et al. 2000; 
Rauprich et al. 2000; Weaver et al. 2000; Stilwell and Carvalho, 2011). There are a 
multitude of factors, including the timing of colostrum ingestion in relation to birth, the 
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volume of colostrum ingested, the immunoglobulin concentration of the colostrum 
ingested, and the age of the dam, that can impact immunoglobulin absorption (Weaver et 
al. 2000). Wittum and Perina (1995) stated that calves demonstrating a failure of passive 
transfer (FPT) of immunoglobulins had an increased risk of neonatal and preweaning 
mortality in addition to an increased risk of preweaning morbidity compared to calves 
receiving an adequate passive transfer of immunoglobulins. In addition, calves 
experiencing FPT had decreased feedlot performance, with increased risks of mortality 
and respiratory morbidity when compared to those calves receiving adequate passive 
transfer (Wittum and Perina, 1995).  
Stilwell and Carvalho (2011) examined the clinical outcomes of calves with 
adequate transfer or FPT of immunoglobulins as diagnosed by a commercial 
Immunoglobulin G (IgG) kit. Out of the 97 calves included in the experiment, 60 calves 
(62%) had a positive test result (plasma IgG > 10 mg/mL), demonstrating protective IgG 
levels, while 37 (38%) had a negative test result (plasma IgG < 10 mg/mL), 
demonstrating FPT. Calves from the negative test group displayed a higher morbidity 
(56.8% vs. 16.7%, respectively) and mortality percentage (16.2% vs. 1.7%, respectively) 
compared to the positive test group (Stilwell and Carvalho, 2011). The number of 
antimicrobial treatments required for calves in each group was significantly different also 
with the positive test group requiring 19 antimicrobial treatments for 60 total animals and 
the negative test group requiring 38 antimicrobial treatments for 37 animals (Stilwell and 
Carvalho, 2011). 
In addition to prenatal nutrition and colostrum consumption, the nutrition of the 
calf prior to marketing can also impact the incidence of BRD. While the effects maternal 
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nutrition during gestation and colostrum consumption are fairly well researched, the 
effects of early postnatal nutrition and BRD incidence in beef cattle has not been well 
defined (Duff and Galyean, 2007). Nutrition affects many aspects of the immune system, 
including: development of lymph tissues, production of mucus, synthesis of 
immunologically active substances such as leukocytes, antibodies, and cytokines, cell 
proliferation, cellular signaling, activation, and movement, intercellular killing, and 
general immune system modulation (Cole, 1996). A major problem concerning when 
investigating the nutrition and health interaction in calves is that typically the nutritional 
background or nutrient status of calves used in BRD experiments is not known and 
impractical to obtain (Duff and Galyean, 2007). Duff and Galyean (2007) suggest that the 
large variation in nutritional status of calves could help explain the variation in response 
to nutritional supplements that exists in the literature. 
Montgomery et al. (2009) measured plasma glucose, lactate, and urea nitrogen 
(N) concentrations of 665 crossbred heifers at time of initial processing to determine the 
incidence of apparent BRD during receiving, and evaluate the effects of BRD on 
subsequent cattle performance and carcass characteristics. The authors found that at time 
of initial processing heifers that were eventually treated for apparent BRD had decreased 
plasma glucose and lactate, and increased plasma urea N concentrations as determined by 
linear contrasts (Montgomery et al., 2009). The interpretation of these results can be 
somewhat problematic as the changes in metabolites could be the result of an immune 
challenge that has already occurred, or the result of nutrient restriction predisposing the 
calves to an immune challenge. The authors suggested that both methods could be 
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responsible for the decrease in plasma glucose concentrations observed in heifers 
eventually treated for BRD (Montgomery et al., 2009). 
When considering the decrease in plasma glucose, Steiger et al. (1999) observed a 
biphasic response when heifers were infused bacterial lipopolysaccharides to simulate a 
gram-negative bacterial challenge with glucose concentrations increasing initially and 
then decreasing to concentrations below that of control saline-infused heifers. In addition, 
Kushibiki et al. (2000), observed a similar biphasic response for plasma glucose levels 
when injecting heifers with recombinant tumor necrosis factor-α (TNF-α). These 2 
studies would suggest that an immune challenge in cattle results in a period of increased 
plasma glucose levels followed by a period of decreased plasma glucose levels. In 
contrast, multiple studies have sighted decreased serum glucose levels when calves are in 
a fasted state. Galyean et al. (1981), Cole et al. (1988), and Schaefer et al. (1990) all 
reported decreased serum glucose concentrations in calves following a 24 to 36 hour fast. 
Montgomery et al. (2009) stated that the decreased plasma lactate concentrations 
observed in heifers treated for BRD might be a result of depleted glycogen stores due to 
extended fasting which could lead to decreased lactate production via glycogenolysis and 
anaerobic glycolysis. The authors proposed that the increased plasma urea N 
concentrations in heifers treated for BRD would suggests that those heifers were 
catabolic, and supported their previous statement regarding lactate levels and the 
possibility of decreased glycogen stores at initial processing. (Montgomery et al., 2009). 
Other factors such as genetics, breed type, and individual animal variation have 
been shown to impact BRD incidence. Snowder et al. (2005) aimed to characterize the 
genetic and environmental factors influencing BRD in cattle. Retrospective data from 9 
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purebred (Angus, Braunvieh, Charolais, Gelbvieh, Hereford, Limousin, Pinzgauer, Red 
Poll, and Simmental), 3 composite breeds (MARC I, MARC II, and MARC III), and a 
multiple F1 and 3-way crosses 20 year period were evaluated for the effects breed and 
heterozygosity on BRD incidence (Snowder et al., 2005). The highest incidence rates for 
BRD were observed in the Braunvieh (19%) and MARC I composites (17%), which 
contained ¹⁄₄ Braunvieh (Snowder et al., 2005). Snowder et al. (2005) suggested that the 
increased incidence of BRD in Braunvieh and Braunvieh composites may be confounded 
with the breed’s higher incidence of calving difficulty. The incidence of BRD ranged 
from 8 to 12% for all other breed groupings (Snowder et al., 2005). 
When evaluating mortality attributed to BRD, the highest mortality rates were 
observed in the Simmental (18%), MARC III (17%), and Red Poll (16%) breeds, while 
the lowest mortality rates were observed for Limousin (7%) and Braunvieh (9%) 
(Snowder et al., 2005). Interestingly, while Braunvieh cattle exhibited the greatest 
incidence of BRD, the mortality rate for Braunvieh cattle was much less than the overall 
average of 13% suggesting that while Braunvieh cattle are more susceptible to BRD 
infection, they were less sensitive to the disease once infected (Snowder et al., 2005). In 
contrast, the MARC III composite calves had relatively high mortality rates and the 
relatively low incidence rates (10%) suggesting that MARC III composites were more 
sensitive to the BRD, although more resistant to BRD infection (Snowder et al., 2005). 
Increased heterozygosity of calves resulted in a decreased incidence of BRD when 
compared to purebred cattle (Snowder et al., 2005). In addition, calves that were 
Continental × British crosses or tropical × British crosses had a lower incidence of BRD 
than calves that were strictly British × British crosses (Snowder et al., 2005). 
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In a second retrospective experiment, Snowder et al. (2006) examined the records 
from 18,112 calves representing the same 9 breeds and 3 composites over a 15-yr period 
(1987 to 2001), emphasizing that not all breeds were represented in all years. The authors 
noted that steers were more likely to experience BRD than heifers and cited the stress 
associated with castration prior to feedlot entry as a probable predisposing cause 
(Snowder et al., 2006). When the mean incidence was unadjusted for all breeds, the 
incidence of BRD was lowest for Angus (10.2%), with Charolais, Gelbvieh, and the 
MARC I and MARC III composite cattle also having lower unadjusted BRD incidences 
(Snowder et al., 2006). The unadjusted incidence of BRD was greatest for the Pinzgauer, 
Braunvieh, Simmental, and Limousin breeds (35, 34, 33, and 32%, respectively) 
(Snowder et al., 2006). 
When BRD incidence was adjusted via mixed model analyses, Snowder et al. 
(2006) indicated that Herefords were generally more susceptible to BRD infection than 
MARC I and MARC III composite breeds, with the composite breed types having similar 
susceptibility to BRD when compared to the other purebred breeds. The BRD attributed 
mortality was greatest for Red Poll calves (9%) compared to the average of all other 
breeds (4%) (Snowder et al., 2006). The greater mortality rate experienced by Red Poll 
calves suggests this breed may indeed be more sensitive to BRD infection than other 
breed types (Snowder et al., 2006). Interestingly, in this experiment Snowder et al. (2006) 
stated that there was no observed advantage for BRD resistance with increased 
heterozygosity when contrasting the composite breeds with the purebreds. 
The previous health program and vaccination history of a herd or individual 
animals can also impact BRD incidence. These practices along with other pre-marketing 
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management decisions can be grouped in to the broad category of “preconditioning.” 
Preconditioning can be thought of as a comprehensive management system that is 
designed to immunize calves against BRD related pathogens and to reduce or minimize 
the stressors that cattle potentially experience at the time of marketing (Cole, 1985). 
Preconditioning can be more specifically subdivided into 3 distinct categories: 
vaccination practices, surgical procedures, and feeding strategies (Cole, 1985). The 
preconditioning of calves is a longstanding practice, with the state of Iowa holding a 
preconditioned cattle sale in 1965 and Oklahoma State University holding the first 
national preconditioning seminar in 1967, and it is widely accepted by those in academia 
and industry that the preconditioning of calves is an effective tool for preventing or 
minimizing and managing BRD. Most feedlot operators believing that the 
preconditioning of cattle is beneficial in decreasing morbidity and mortality in calves 
weighing less than 318 kg (NAHMS, 2000).  
A major problem that surfaces when reviewing the literature is the determination 
of what exactly qualifies as preconditioning. Preconditioning is a broad term, and huge 
variations exist in the literature in the way the term is defined. In a review of 
preconditioning studies, Taylor et al. (2010b) found that some precondition experiments 
did not even offer explanation as to what constituted preconditioning. Lynch et al. (1997) 
determined calves to be preconditioned if they had simply received both viral and 
Pasteurella vaccination prior to weaning. While multiple experiments define calves that 
were vaccinated and weaned as preconditioned (Karren et al., 1987; Roeber et al., 2001; 
Macartney et al., 2003; Taylor et al., 2010b). However, Macartney et al. (2003) did not 
require that calves be trained to a feed bunk, while Karren et al. (1987) and Roeber et al. 
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(2001) required calves to be acclimated to feed bunks and water troughs. This variation 
among “preconditioning” studies makes it nearly impossible to compare results across 
studies and makes interpreting the effects of preconditioning difficult. 
While there is substantial variation in the interpretation of what constitutes 
preconditioning, there are several formalized preconditioning programs in existence 
today. Many states have developed programs to certify the preconditioning of calves. 
Two of the better known of these programs being the Texas A&M University Value 
Added Calf Program and the Oklahoma Quality Beef Network Vac-45 Program. These 
preconditioning programs have strict requirements that must be met. The requirements 
typically state that at a minimum: all bull calves be castrated and healed, all horned 
calves be dehorned and healed, all calves receive an approved vaccination regimen, all 
calves be weaned for at least 45 days prior to sale, and all calves be tagged with an 
official program identification tag (Avent et al., 2007).  
The preconditioning of calves has demonstrated a reduction in the incidence of 
BRD in calves as they move from the cow-calf phase to either the stocker or finishing 
phases of beef production (Thrift and Thrift, 2011). Roeber et al. (2001) observed the 
feedlot performance and carcass characteristics of calves purchased from 2 different 
certified preconditioning programs or directly from livestock markets. Morbidity rates of 
34.7%, 36.7%, and 77.3% were documented for cattle on the 2 certified preconditioning 
programs and livestock market calves, respectively (Roeber et al., 2001). Roeber et al. 
(2001) also reported mortality to be 1.1%, 1.1%, and 11.4% among the same 3 groups of 
calves. Step et al. (2008) observed vaccination and preconditioning in calves prior to 
shipment. The authors found that calves preconditioned for 45 days pre-shipping but not 
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vaccinated and calves both preconditioned 45 days and vaccinated had lower feedlot 
morbidity levels (5.9% and 9.5%, respectively), compared to calves marketed at weaning 
(35.1%) and calves assembled from a livestock market (41.9%) (Step et al., 2008). While 
feedlot mortality was not extremely high and did not differ significantly, the calves 
assembled from the livestock market and those marketed at weaning had mortality rates 
of 3.1% and 0.9% respectively, while the calves in both preconditioning treatments 
experienced 0.0% (Step et al., 2008). Richeson et al. (2012) observed ranch calves 
preconditioned for 61 days and auction market calves assembled at the time of purchase 
with and without exposure to a persistently infected bovine viral diarrhea virus (PI-
BVDV) pen mate. The authors stated that auction market calves had a 70.4% overall 
morbidity compared to 6.7% overall morbidity in preconditioned calves (Richeson et al., 
2012). 
The cattle marketing system in the U.S. is inherently responsible for a wide range 
of stressors. In the Southern Plains and Southeast U.S. it cannot be assumed that calves 
are preconditioned or even weaned prior to being shipped to a livestock market for sale. 
Upon arrival at the livestock market, calves are then commingled with many other 
animals of unknown disease and vaccination statuses. Once calves are purchased, they 
are again commingled to form lots to be loaded onto trucks. Once loaded, calves are 
frequently transported long distances and potentially exposed to exhaust fumes, extreme 
weather, and temperature fluctuations, or even resold through additional market channels. 
Dehydration, malnutrition, and exhaustion often occur as a result (Griffin et al., 2010).  
Whether or not a calf is formally weaned for a predetermined period of time or 
simply removed from its dam immediately prior to marketing, the physical separation of 
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a calf from its dam is invariably a source of stress. This stress resulting from the physical 
separation from the dam is demonstrated by increased vocalization and pacing by the calf 
(Newberry and Swanson, 2008). Physical separation has been shown to effect the 
physiological status of calves. Lay et al. (1998) subjected calves to restricted or ad 
libitum nursing after 21 days of age. The authors demonstrated that the restricted nursing 
calves had elevated heart rates and cortisol levels when compared to the ad libitum 
nursing calves prior to weaning (Lay et al., 1998). However, post weaning the ad libitum 
group had more calves vocalizing and tended to travel greater distances than the 
restricted group causing Lay et al. (1998) to propose that the ad libitum group 
experienced more stress post weaning. This observation led Lay et al. (1998) to suggest 
that the while the restricted calves were more stressed prior to weaning, the separation 
and restricted nursing potentially allowed for them to experience less stress post weaning.  
Hickey et al. (2003) randomly assigned calves to either a control or abruptly 
weaned treatment group and observed various physiological measures of stress and 
immune function. While the interpretation of results from this experiment are somewhat 
problematic due to complex variables and multiple interactions, the authors did 
emphasize some interesting results. There was an increase in the neutrophil to 
lymphocyte ratio that occurred after weaning (Hickey et al., 2003). The authors also 
stated that the abrupt weaning resulted in increased plasma cortisol and noradrenaline 
concentrations (Hickey et al., 2003). These changes were accompanied by decreased in 
vitro interferon-γ production in response to novel mitogen and antigen complexes after 
weaning (Hickey et al., 2003).  
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Arthington et al. (2008) allocated steers to 1 of 4 weaning management strategies: 
weaned on the day of shipping (control), allowed free-choice access to a concentrate feed 
prior to weaning and shipping (creep-fed), weaned and provided supplemental 
concentrate feed on pasture before shipping (preweaned), and weaned at 70 to 90 days of 
age and kept on pasture (early-weaned). Overall receiving ADG was greater for early-
weaned steers when compared to control steers (Arthington et al., 2008). During the first 
week after shipment, early-weaned steers consumed more concentrate and less hay when 
compared to control steers and preweaned steers and consumed more concentrate and a 
similar amount of hay when compared to creep-fed steers (Arthington et al., 2008). 
Arthington et al. (2008) also observed that plasma ceruloplasmin concentrations were less 
in control steers compared to early-weaned steers on day 0, but that plasma ceruloplasmin 
concentrations increased rapidly in the control calves over time causing them to be 
greater in control on day 15 and day 22. Steers that were creep-fed had greater plasma 
ceruloplasmin concentrations than preweaned steers on day 29 (Arthington et al., 2008). 
These results led the authors to suggest that early-weaned steers demonstrated improved 
performance in the feedlot compared to steers weaned directly before feedlot entry and 
that differences in preweaning strategies appeared to significantly affect the acute phase 
protein response in steers (Arthington et al., 2008). 
Boyles et al. (2007) researched the effects of weaning management strategies on 
the performance and health of calves during a 28 day feedlot receiving period. The 
authors evaluated: calves weaned at time of transport, calves weaned and confined in a 
dry lot for 30 days prior transport, and calves weaned 30 days before transport and 
allowed fence line contact with their dams (Boyles et al., 2007). Calves weaned at 
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transport and fence line weaned calves had increased ADG when compared to dry lot 
weaned calves (Boyles et al., 2007). Morbidity in the feedlot was decreased in fence line 
weaned calves (15%) when compared to calves weaned at transport and dry lot weaned 
calves (28% and 38% respectively) (Boyles et al., 2007). 
Other studies have demonstrated an impact of abrupt weaning on subsequent calf 
health and performance. Hodgson et al. (2005) found that weaning combined with 
immediate transport resulted in a failure to upregulate expression of interleukin-10 (IL-
10) and caused mortality attributed to BRD to be twice as high when compared to calves 
that were only subjected to transport and a bacterial challenge. Lynch et al. (2010) 
determined that abrupt weaning resulted in increased neutrophil counts and diminished 
phagocytic function in calves. Price et al. (2003) found that allowing fence line contact 
between beef calves and their dams at weaning reduced the negative effects of immediate 
separation on calf behavior and growth rate. 
The process of transporting calves to the livestock market and then to a 
subsequent destination results in calves being exposed to an additional social stress while 
simultaneously being exposed new or different isolates viral and bacterial pathogens. It is 
not uncommon for BRD to be referred to as “shipping fever” in the classical literature 
and by those outside of the scientific community today, and for many years transportation 
was considered the most common predisposing factor for BRD (Stanger et al., 2005; 
Taylor et al., 2010a). Transportation has been demonstrated to cause an increase in 
glucocorticoids within the blood and increased glucocorticoid levels have been linked to 
suppression of the immune system and increased susceptibility to disease (Stanger et al., 
2005; Aich et al., 2009). Cernicchiaro et al. (2012) reviewed retrospective data from 13 
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U.S. commercial feedlots on 16,590 head of cattle to determine the association between 
BW lost during transport (shrink) and subsequent health and performance in the feedlot. 
The median shrink experienced by all calves was 3.0% with a mean shrink of 2.4 %, 
while the mean cumulative BRD morbidity was 10.0% and the mean cumulative 
mortality was 1.3% (Cernicchiaro et al., 2012). Shrink was significantly associated with 
BRD morbidity, overall mortality, animal HCW and ADG (Cernicchiaro et al., 2012). 
These effects were also significantly impacted by gender, season, and arrival BW of the 
calf (Cernicchiaro et al., 2012). 
However, while almost every calf in the U.S. is transported at least 3 times prior 
to harvest, transportation does not appear to affect all cattle the same and the distance 
transported may have mixed effects. Ribble et al. (1995) conducted an experiment 
evaluating the effect of transportation on pneumonia and shrinkage in calves arriving at 
the feedlot. The authors reported that calves transported for 12 hours had higher 
morbidity rates than those calves transported for 24 hours (Ribble et al., 1995). Ribble et 
al. (1995) concluded that other stress factors such as sorting, loading, and time of transit 
are more strongly associated with the development of BRD than duration of 
transportation.  
Changes in the weather and temperature fluctuations have also been demonstrated 
to impact BRD incidence in calves. Classically, the highest incidence of BRD is observed 
during the fall (Kelly and Janzen, 1986; Loneragan et al., 2001 Taylor et al., 2010a). 
Traditionally calves born in the spring and summer are marketed through livestock 
markets and ultimately shipped to feedlots or stocker operations during the fall. This 
seasonality of marketing increases the number of newly received calves through livestock 
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markets which could potentially result in an increase in the time that calves spend in 
livestock markets, and could potentially cause delays in the loading, transport, and 
unloading processes. These changes can impact the length of time calves are exposed to 
inclement weather and temperature fluctuations at a time when they are experiencing 
stress, and more susceptible to disease. Wilson et al. (2012) examined the factors 
influencing subsequent receiving health and performance of 1361 head of “high-risk” 
steer and bull calves purchased at regional livestock markets received at a single facility 
in 2010 and 2011. Calves were received in either the spring or fall of the year and 
purchased by a single order buyer (Wilson et al., 2012). Calves received in the fall had 
lower ADG and increased morbidity and mortality attributed to BRD than calves received 
in the spring (Wilson et al., 2012). 
Cernicchiaro et al. (2012) reported that shrink had a greater effect on calves 
arriving during the fall months and that calves arriving during the fall also demonstrated a 
greater BRD morbidity risk. The authors suggested that the temperature fluctuations 
commonly observed during the fall and early spring could affect the health and 
performance of newly received cattle experiencing BW loss after transport (Cernicchiaro 
et al., 2012). In another experiment, Cernicchiaro et al. (2011) observed several weather 
factors during the first 45 days subsequent to arrival of calves at the feedlot. For this 
retrospective experiment, the population included 288,388 total head of cattle that arrived 
at 9 U. S. commercial feedlots between September and November in 2005 to 2007 
(Cernicchiaro et al., 2011). There were 24,947 cases of initial BRD that occurred within 
this population of cattle during these time periods (Cernicchiaro et al., 2011). The authors 
found that several weather factors including: maximum wind speed, mean wind chill 
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temperature, and temperature change in different lag periods were significantly 
associated with an increased BRD incidence (Cernicchiaro et al., 2011). However, 
Cernicchiaro et al. (2011) stated that the effects of these variables also depended on 
several cattle demographic factors including: month of arrival, BRD risk code, BW class, 
and cohort size. Though it has been accepted that sudden and extreme changes in weather 
and temperature predispose to calves to BRD, more research is needed to determine the 
true effect of these changes on BRD. 
After calves arrive at a feedlot or a stocker or backgrounding program, they are 
potentially exposed to even more stressors. These post-marketing stressors include 
processing, which typically consists of multiple vaccinations, treatment for internal and 
external parasites, and administration of growth promoting implants and may potentially 
include dehorning and castration. Additional sorting and commingling of calves occurs to 
fill pens in an attempt to make those pens more uniform. Calves are frequently exposed to 
dusty pen environments, and introduced to new feed and water sources. All of these 
stressors serve to further challenge the immune system at a time when the calf has been 
or is likely going to be exposed to multiple viral and bacterial pathogens. 
Common processing protocols subsequent to arrival at a feedlot or a stocker or 
backgrounding program include the administration of viral and clostridial vaccines. In the 
2011 Feedlot Survey, NAHMS (2013) stated that most feedlots vaccinated some cattle 
and that the most common vaccinations administered were those for the prevention of 
BRD. As a percentage of all feedlots, 96.6% vaccinated for BVDV, and 93.7% 
vaccinated for IBR, while 89.1% vaccinated for BRSV, and 85.1% vaccinated for PI3 
(NAHMS, 2013). NAHMS (2013) also stated that 84.4% of feedlots administered a 
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clostridial vaccine and roughly two thirds of feedlots vaccinated for the most common 
bacterial agents associated with respiratory disease: HS, MH, and PM.  
While vaccination is typically considered a preventative measure for reducing the 
incidence of BRD, it has hypothesized that vaccination at the time of arrival may actually 
be detrimental as calves are already stressed, have been exposed to pathogens, and 
perhaps are experiencing some level of immunosuppression (Perino and Hunsaker, 1997; 
Richeson et al., 2008). Most recent vaccine research has been focused on comparing 
different multivalent modified live vaccines composed of different antigen strains. In 
addition, most vaccine studies published in the literature do not include negative control 
(non-vaccinated) groups. As a result, it is extremely difficult to determine if vaccination 
at arrival aids in the prevention of BRD or if it actually may be detrimental. More 
research must be conducted in order to determine effective respiratory antigen 
immunization protocols for feedlot cattle. 
Richeson et al. (2008) examined the effects of arrival versus delayed viral 
vaccination on the subsequent health, performance, and serum IBR antibody titers of 
newly received calves. The authors found that ADG was greater (P ≤ 0.05) for delayed 
vaccinated calves throughout the experiment, while the time until first BRD treatment, 
total treatment cost, and mortality rates did not differ (Richeson et al., 2008). Richeson et 
al. (2008) stated that the morbidity rates for BRD were high for both calves vaccinated at 
arrival (71.5%) and delayed vaccinated calves (63.5%) and not statistically different. 
Positive IBR titer seroconversion was greater for delayed vaccinated calves (Richeson et 
al., 2008). The increase ADG and IBR antibody titers led the authors to conclude that 
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delaying vaccination by 14 days may result in a possible improvement in immune 
response (Richeson et al., 2008). 
In a second experiment, Richeson et al. (2009) examined the effects of arrival 
versus delayed clostridial or viral vaccination on the health, performance, BVDV titers, 
and immune response measures of newly received calves. The authors found that ADG 
and morbidity did not differ among the arrival or delayed vaccination treatments 
(Richeson et al., 2009). Richeson et al. (2009) noted that several differential white blood 
cell (WBC) measurements were greater when both the clostridial and viral vaccinations 
were delayed and that this could have been the result of an infection or due to differences 
in immune status. Richeson et al. (2009) concluded that timing of vaccination did not 
affect performance or health in high-risk newly received calves. 
Estrogenic, androgenic, and combination implants have been used extensively in 
beef production for many years. Steroidal implants have proven to be one of the best non-
nutritional management tools that beef producers can use to improve the performance and 
efficiency of calves. Implants work by releasing stimulants that act to increase the 
circulating levels of growth factors thus increasing the secretion of growth hormone and 
increasing lean tissue. Ultimately, steroid implants alter protein metabolism by increasing 
the rate protein synthesis and decreasing the rate of protein degradation. Because 
implants influence metabolism and nutrient partitioning within the body, immune 
function could be altered as a result (Nichols et al., 2002). If extra nutrients are 
partitioned for growth, at arrival when the immune system is compromised, implants 
could have an impact on the incidence of BRD. 
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Munson et al. (2012) examined the effects of delayed implanting on the health 
and performance of 1601 high-risk feedlot steers. Steers were either implanted with 
Revalor-XS (40 mg estradiol and 200 mg trenbolone acetate) at initial processing or 45 
days post processing (Munson et al., 2012). The authors found that delaying the time 
until initial implant tended to reduce morbidity (3.8% decrease) and reduced the 
percentage of animals that were required to be salvaged or realized (1.8% vs. 3.3%) 
(Munson et al., 2012). There were no effects of delayed implant administration on 
retreatment rates, mortality percentage, or lung lesions and adhesion at harvest (Munson 
et al., 2012). The authors concluded that delaying the timing of implanting did not greatly 
influence health or performance in calves at a high risk of developing BRD (Munson et 
al., 2012). 
Poe et al. (2103) conducted an experiment to determine the effects of viral 
vaccination timing with or without a growth implant on the health, performance, 
complete blood cell counts, and viral antibody titers in high-risk, newly received stocker 
calves. The percentage of calves treated for BRD and the days until first BRD 
antimicrobial treatment did not differ among implant treatments (Poe et al., 2103). Calf 
ADG was also unaffected by the administration of implants (Poe et al., 2103). The 
authors concluded that growth promoting implants administered on arrival to high-risk 
stocker calves did not impact health or performance, but noted that the morbidity rate was 
high with over 80% of calves requiring antimicrobial treatment (Poe et al., 2103). 
Dehorning or the “tipping” of horns is a common processing practice in beef 
production, and nearly all horned cattle entering a feedlot will be dehorned or have their 
horns tipped. Cattle that have been dehorned are safer to handle and present a lower 
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injury risk to other cattle, horses, and feedlot personnel (AVMA, 2012b). In addition to 
the safety concern, cattle with horns also take up additional bunk space in feedlot pens 
compared to polled cattle, causing intake and behavior concerns. While the dehorning of 
cattle is necessary from a safety and management perspective, the stress associated with 
dehorning is well documented. Both physiological and behavioral measurements have 
been used to evaluate the stress responses to dehorning. While individual responses vary, 
plasma cortisol concentrations increase rapidly after dehorning, and adrenaline 
(epinephrine) and noradrenaline (norepinephrine) concentrations have been demonstrated 
to increase after scoop dehorning young calves (AVMA, 2012b). While the dehorning of 
horned cattle is desirable, the stress and pain associated with dehorning could have an 
impact on the incidence of BRD. 
While the impacts of dehorning on stress and pain in calves is an area of 
increasing research, the impact of dehorning on BRD incidence has not been thoroughly 
examined. Martin et al. (1982) reviewed 3 years of data on 52,889 head of cattle to 
evaluate the factors associated with death loss and health costs in Ontario feedlot calves. 
The authors found that when dehorning greater than 30% of the animals within a group, 
dehorning had a negative impact on health and that dehorning was also associated with 
increased mortality rates (Martin et al., 1982). It should be noted however that dehorning 
was only recorded in this data set when greater than 30% of the animals within a group 
were dehorned (Martin et al., 1982). 
In the retrospective experiment by Wilson et al. (2012) examining the factors 
influencing subsequent receiving health and performance of high-risk calves, calves that 
were dehorned at initial processing had significantly lower ADG throughout the receiving 
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period. Calves that were dehorned also tended to receive a second antimicrobial treated 
more often than calves that were polled (Wilson et al., 2012). The authors found that first 
treatment morbidity and overall morbidity, while numerically greater for calves that were 
dehorned, was not significantly different (Wilson et al., 2012). These results led Wilson 
et al. (2012) to surmise that dehorning negatively impacted calf performance, but may or 
may not impact calf health. 
The castration of bull calves is a common processing practice in beef production, 
and nearly all bull calves entering a feedlot will be castrated shortly after arrival. The 
castration of bulls causes them to be safer to handle and presents a lower risk of injury to 
other cattle, horses, and feedlot personnel (AVMA, 2012a). Castration also improves 
carcass characteristics. Steers are less likely to be deemed “dark cutters” and produce 
higher quality grade, more marbled, and more tender carcasses when compared to bulls 
(AVMA, 2012a). There are several methods by which castration is achieved, but they can 
be broadly classified into 3 groups: physical, chemical, or hormonal (AVMA, 2012a). 
Physical castration methods can be subdivided into procedures involving surgical 
removal of the testes, or methods that irreparably damage the testicles and cause atrophy 
by interruption of the blood supply.  
In typical production settings, physical castration is the most common method of 
castration used. Coetzee et al. (2010) conducted a survey of 189 U.S. veterinarians to 
evaluate the prevalence of castration methods. The authors found that surgical castration 
with a scalpel (57%), followed by removal of the testicles by either manually twisting 
(44%), or through the use of an emasculator (36%) were the most frequently used 
surgical castration methods (Coetzee et al., 2010). The most common methods used to 
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incise the scrotum to conduct surgical castration included using a Newberry Knife (32%) 
or a conventional knife (14%) (Coetzee et al., 2010). For non-surgical castration methods, 
the use of elastrator rubber rings (44%), followed by generic banders (22%) were the 
most commonly used methods (Coetzee et al., 2010).  
While the castration of bulls is necessary from both a safety and meat quality 
perspective, the stress associated with castration has been well documented. All methods 
of physical castration cause physiological, neuroendocrine, and behavioral changes that 
are considered as indicators of pain and stress. Animals exhibit changes in behavior 
indicative of pain during the physical act of castration as well as after the castration 
procedure. Some of these behavioral responses include: struggling when restrained, 
kicking of the legs, tail swishing, foot stamping, head turning, restlessness, stiffened gait, 
reduction of normal social activity, increased lateral recumbency, abnormal standing 
posture, and reduced feed intake (AVMA, 2012a). While individual responses may vary 
dependent on castration method, research has consistently demonstrated increases in 
plasma cortisol concentrations after castration (AVMA, 2012a). 
Research has repeatedly demonstrated that castration upon arrival to the feedlot 
impacts subsequent BRD incidence. When examining the effects of metaphylactic 
antimicrobial administration on the behavior of feedlot calves, Daniels et al. (2000) 
reported that calves castrated on arrival had a 92% greater incidence of morbidity 
compared with those calves that had been castrated before entering the feedlot. In 
addition, calves castrated on arrival had increased mortality compared to previously 
castrated calves (3.5% vs. 0% respectively) (Daniels et al., 2000). Daniels et al. (2000) 
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also reported that previously castrated calves had ADG more than twice that of calves 
castrated on arrival during a 21 day evaluation period.  
Massey et al. (2011) reviewed records from 11 receiving experiments consisting 
of 3,380 head of calves that took place between 2006 and 2008. Sixty-five percent of all 
calves arrived as bulls and all bulls were surgically castrated (Massey et al., 2011). 
Massey et al. (2011) stated that only 28% of calves required antimicrobial treatment for 
BRD, but it should be noted that all calves received metaphylactic antimicrobial 
treatment. Calves arriving as steers had a greater probability of never being treated for 
BRD compared to calves arriving as bulls (90.8% vs. 87.9% respectively) (Massey et al., 
2011). There was a greater probability that calves arriving as bulls would require multiple 
BRD treatments (2.4% vs. 1.8%). (Massey et al., 2011). Massy et al. (2011) also noted a 
difference in ADG, with calves castrated before arrival gaining 1.55 kg/day and calves 
arriving as bulls gaining 1.32 kg/day. 
Wilson et al. (2011) reviewed the effect of castration methods on the subsequent 
health and performance of 390 head (266 bulls and 124 steers) of high-risk commingled 
calves purchased from livestock markets in a 3 state area. Bulls were randomly assigned 
to 1 of 2 experimental treatments: surgical castration using a Newberry Knife to incise 
the scrotum, followed by castration by emasculation or non-surgical castration using a 
Callicrate Bander® (Wilson et al., 2011). The authors found that calves that arrived at the 
feedlot as bulls had greater first treatment rates, greater retreatment rates, and greater 
total morbidity than calves that arrived as steers independent of castration method 
(Wilson et al., 2011). Calves that arrived as bulls also had higher mortality than calves 
that arrived as steers (Wilson et al., 2011). When considering castration method, Wilson 
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et al. (2011) noted that surgically castrated bulls had greater first treatment rates and 
greater total morbidity than bulls that were non-surgically castrated. Steers had improved 
performance compared to calves that arrived as bulls independent of castration method, 
and there was no difference in performance between the two castration methods (Wilson 
et al., 2011). 
Coetzee et al. (2012) examined the effects of oral meloxicam administration on 
the subsequent health and performance of steers relative to bulls that were castrated upon 
arrival to the feedlot. The calves were divided by castration status at arrival (145 bulls 
and 113 steers) and randomly assigned to receive either a lactose placebo or oral 
meloxicam 24 hours prior to processing (Coetzee et al., 2012). All calves received 
metaphylactic antimicrobial treatment at processing (Coetzee et al., 2012). The 
percentage of calves “pulled” was significantly greater for calves that were castrated at 
arrival compared to calves arriving as steers (Coetzee et al., 2012). In addition calves that 
were castrated at arrival tended to have higher overall morbidity and a greater incidence 
of BRD (Coetzee et al., 2012). Coetzee et al. (2012) reported that castration reduced 
ADG and G:F from days 1 to 14, but that by day 28 no effects in performance were 
apparent. The oral administration of meloxicam did impact the health of castrated calves. 
Bull calves that received meloxicam prior to castration had reduced pen-level first pull 
rates and reduced BRD morbidity rates (Coetzee et al., 2012). 
While it is understood that BRD is ultimately a viral and bacterial disease of the 
respiratory tract, the BRD complex is a complicated illness that is prompted by multiple 
risk factors or stressors. These stressors can occur at any time during a calf’s life to 
impact BRD incidence and can be divided into pre-marketing stressors, stressors 
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associated with the cattle marketing process, and post-marketing stressors for ease of 
examination. These stressors act to reduce the calf’s immune system, allowing for viral 
and bacterial pathogens to rapidly multiply within the calf’s respiratory tract. Some of 
these risk factors can be effectively managed, while others simply are unavoidable and 
are inherently associated with the cattle marketing and structure of the feedlot industry. 
 
Pathogens associated with BRD incidence 
While a multitude of risk factors can suppress the calf’s immune system, the 
development of clinical BRD commonly consists of a primary infection with one or more 
respiratory viruses. The principal viral pathogens associated with BRD include: bovine 
herpesvirus 1 (BHV1) leading to infectious bovine rhinotracheitis (IBR), bovine viral 
diarrhea virus (BVDV), parainfluenza virus type 3 (PI3), bovine respiratory synctial virus 
(BRSV), bovine adenoviruses (BAdV), and bovine corona virus (BCV) (Roth and Perino, 
1998; Fulton et al., 2011). The initial viral infection combined with the calf's previously 
compromised immune system allows for the rapid colonization of lung tissues by bacteria 
(Hodgins et al., 2002). Important bacterial pathogens associated with increased incidence 
of BRD include: Mannheimia haemolytica (MH) (formerly Pasteurella haemolytica), 
Pasteurella multocida (PM), Histophilus somni (HS), and Mycoplasma species (primarily 
Mycoplasma bovis) (MB) (Griffin et al., 2010; Fulton et al., 2011). Many of these 
bacterial pathogens are frequently isolated from the respiratory tract of clinically healthy 
cattle. For example, the most common bacterial pathogen isolated from the respiratory 
tract of calves treated for BRD is MH serotype A1 (Whitley et al., 1992; Booker et al., 
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2008; Griffin et al., 2010). However, MH is also frequently isolated from the respiratory 
tract of clinically healthy calves (Klima et al., 2014; Griffin et al., 2010).  
Bovine herpesvirus 1 (BHV1) is the etiological agent responsible for IBR and is 
in the alpha herpesvirus subfamily that can cause diseases of the respiratory tract, fetal 
infections and abortions, reproductive tract diseases in both males and females, and 
severe neonatal disease (Fulton et al., 2009). There are 3 BHV-1 subtypes (BHV1.1, 
BHV-1.2a, and BHV-1.2b) classified by antigenic and genomic differences (Fulton et al., 
2009). In addition, another BHV has been identified in cattle that impacts the central 
nervous system (Fulton et al., 2009). Viral infection resulting from BHV1 has been 
associated with a variety of clinical conditions that result from infection of the genitals, 
respiratory tract, or digestive tract (Hodgins et al., 2002). A dormant infection with 
BHV1 can exist in the trigeminal ganglia and stress may cause a reactivation of the virus 
complete with clinical signs and viral shedding (Cusack et al., 2003). Clinical signs range 
from serous, hyperemic, and edematous membranes, to mucopurulent exudate with focal 
necrosis, to pseudomembranous inflammation in severe cases (Cusack et al., 2003). The 
replication of BHV1 occurs within mucosal cells, the submucosa, and connective tissue 
bordering the tracheal rings (Cusack et al., 2003).  
It has been suggested that BHV1 may set in motion the destruction of the 
respiratory epithelium via the cessation of ciliary activity resulting in loss of function of 
the mucociliary escalator (Cusack et al., 2003). A secondary respiratory infection then 
may occur due to the inhalation of the exudates combined with the failure to remove 
particulates and bacteria from the lungs (Cusack et al., 2003). Necropsies and field 
observations would support this as a high percentage of cattle diagnosed with BRD and 
37 
 
identifiable IBR have a cranioventral lobar distribution of lesions resembling inhalation 
pneumonia (Cusack et al., 2003). In addition, BHV1 can cause extreme 
bronchoconstriction which results in trapping of secretions in the lower airways, 
impairing lung defense mechanisms and favoring increased bacterial growth (Cusack et 
al., 2003). Ultimately, infection by BHV1 has been implicated as a cause of 
immunosuppression that increases the susceptibility to secondary bacterial infections 
resulting in severe pneumonia (Cusack et al., 2003). This immunosuppression may occur 
through reductions in neutrophil migration, decreased cell-mediated cytotoxicity, 
diminished mitogen responses of peripheral blood lymphocytes, and impaired functional 
activities of alveolar macrophages (Cusack et al., 2003). 
Bovine viral diarrhea virus (BVDV) is probably the most researched of all of the 
viral pathogens associated with BRD with decades of research concerning BVDV 
prevalence and pathogenesis having been previously conducted (Hodgins et al., 2002; 
Ridpath, 2010). However, the role of BVDV in the pathogenesis of BRD has been is still 
under intense debate primarily due to a lack of evidence implicating BVDV as a primary 
BRD pathogen (Cusack et al., 2003). More specifically the uncertainty of BVDV’s role in 
BRD pathogenesis is a result of the difficulty associated with the determination of total 
impact of acute, uncomplicated BVDV infections, the high incidence of BRD in 
persistently infected BVDV animals (PI-BVDV), and the unknown impact of 
immunosuppression that accompanies acute BVDV infections and predisposes animals to 
secondary infections, and the impact of increased virulence of pathogens involved in co-
infections (Ridpath, 2010). Holland (2009) stated that recent research concerning viral 
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pathogens involved in field cases of BRD has centered on BVDV with the primary 
concern being calves that are PI-BVDV. 
Regardless of the lack of understanding and agreement on BVDV’s exact role in 
the pathogenesis of BRD, it has been reported that BVDV is the virus most commonly 
isolated from pneumonic lungs of cattle (Hodgins et al., 2002). The term BVDV 
encompasses a heterogeneous group of viruses that belong to 2 different species or 
genotypes, BVDV1 and BVDV2, within the pestivirus genus of the Flavivirus family 
(Ridpath, 2010). In addition, BVDV is classified by biotype as cytopathic or non-
cytopathic based on the presence or absence of visible cytopathic effects in infected cell 
cultures (Fulton et al. 2002b). Within genotype, BVDV has been further subdivided into 
subtypes 1a and 1b on the basis of polymerase chain reaction (PCR) and nucleic acid 
sequencing (Fulton et al. 2002b). In the U.S. the prevalent subtypes include: BVDV1a, 
BVDV1b, and BVDV2a and in multiple studies, BVDV1b has been the predominant 
BVDV subtype isolated from calves diagnosed with BRD (Fulton et al. 2002a; Fulton et 
al. 2002b). 
It is suspected that BVDV may facilitate colonization of the lungs by other 
pathogens (Cusack et al., 2003). Experimental infection of immune-competent, 
seronegative calves with BVDV has been shown to induce primary BRD in the absence 
of concurrent infection with other BRD pathogens (Cusack et al., 2003). Fulton et al. 
(2002a; 2002b) stated that BVDV has been associated with clinical signs and lesions of 
characteristic of BRD and that the involvement of BVDV in the pathogenesis of BRD has 
been demonstrated through experimental infections, virus isolation, the identification of 
BVDV antigen in lesions and other respiratory tract samples from calves, and the 
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demonstration of active infection through seroconversions in groups of cattle with BRD. 
This evidence would suggest a primary role for BVDV in the pathogenesis of BRD 
despite debate within the published research. 
The immunosuppressive effect demonstrated through acute BVDV infection may 
be facilitated by an initial hyperplasia of the germinal centers of lymphoid tissues 
followed by subsequent lymphoid depletion (Cusack et al., 2003). In addition, BVDV has 
been shown to impair the production of humoral antibodies, reduce monocyte 
chemotaxis, and weaken the myeloperoxidase antibacterial system in polymorphonuclear 
leukocytes (Cusack et al., 2003). Through these mechanisms there is a potential for 
increased colonization of the lungs by other pathogens causing increased aggravation to 
pulmonary tissues. The cytopathic effects of BVDV in the respiratory tract cause acute 
catarrhal inflammation within the nasal cavity and trachea, and have been shown to cause 
focal intralobular interstitial pneumonia (Cusack et al., 2003). The evidence suggests that 
BVDV may increase BRD incidence by means of immunosuppression and should be 
considered a primary respiratory pathogen (Fulton et al. 2002b; Cusack et al., 2003). 
Parainfluenza virus type 3 (PI3) has been associated with both acute and chronic 
pneumonia in cattle and an infection with PI3 is often simultaneous with a BHV1 or 
BVDV infection. (Hodgins et al., 2002). The replication of PI3 occurs within epithelial 
cells of both the upper and lower respiratory tract (Cusack et al., 2003). However, despite 
replication throughout, the damage to respiratory tissues primarily occurs in the lower 
respiratory tract causing bronchitis, bronchiolitis and alveolitis (Cusack et al., 2003). In 
the case of acute PI3 viral infections, there is proliferation and necrosis of the bronchiolar 
epithelium and extensive damage to the cilia and the ciliated cells in small bronchi and 
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bronchioli (Cusack et al., 2003). The PI3 virus infects alveolar macrophages and thus 
impairs innate pulmonary defenses (Cusack et al., 2003). The infection of alveolar 
macrophages by PI3 has been associated with a decreased ability to kill invading bacteria, 
including inhibition of phagosome-lysosome fusion, and enhanced production of 
arachidonic acid metabolites which may inhibit other phagocyte functions (Hodgins et 
al., 2002). Ultimately, cattle can be subjected to a secondary bacterial pneumonia as a 
result of impaired mucociliary escalator function and depressed cellular immune 
responses (Cusack et al., 2003). 
Bovine respiratory syncytial virus (BRSV) has been recognized as an important 
viral pathogen in the incidence of BRD and has been demonstrated to act together with 
various bacterial pathogens to cause pneumonia in cattle (Hodgins et al., 2002). In the 
U.S., BRSV has commonly been identified in outbreaks of clinical BRD (Cusack et al., 
2003). Similar to the other major respiratory viruses, BRSV infection results in 
destruction of the ciliated respiratory epithelium and the infection of macrophages within 
the alveoli to reduce local cellular immunity (Cusack et al., 2003). It is presumed that 
BRSV also negatively impacts the function of neutrophils and lymphocytes (Hodgins et 
al., 2002). Both ciliated and non-ciliated epithelial cells in the respiratory tract can be 
effected by BRSV infection, causing necrotizing bronchiolitis and interstitial pneumonia 
(Hodgins et al., 2002). The prevention of pulmonary clearance through the destruction of 
the ciliated epithelium causes cattle to succumb to secondary bacterial infections (Cusack 
et al., 2003).  
Bovine adenovirus (BAdV) is encountered throughout the world in cattle 
populations and 10 serotypes of BAdV have been identified (Hodgins et al., 2002). Viral 
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infections of BAdV in cattle are well documented, but as with BVDV, the role of BAdV 
in the pathogenesis of clinical BRD remains controversial (Hodgins et al., 2002). The 
controversy is primarily due to the fact that while adenoviruses have been occasionally 
isolated from the respiratory tracts of calves with pneumonia, it is much more common to 
isolate BAdV from clinically healthy cattle (Hodgins et al., 2002). In contrast to what is 
observed in cattle, adenovirus infection is very common in sheep, and the isolation of 
adenovirus from diseased animals occurs frequently (Hodgins et al., 2002). Some 
serologic experiments provide support for a role of BAdV in the incidence of BRD, while 
other experiments do not (Hodgins et al., 2002). In an experiment examining the effects 
of BAdV type 1 on alveolar macrophages a decrease in the expression of Fc receptors 
was observed along with a decrease in the ability to phagocytize and kill Candida krusei 
were noted in vitro (Hodgins et al., 2002). While it has been suggested that BAdV has a 
role in BRD pathogenesis, there is simply not enough information available in the 
published literature to support this hypothesis.  
Bovine corona virus (BCV) has received increased attention from researchers in 
recent years as BRD continues to be a persistent problem despite the widespread use of 
vaccines for BHV-1 (IBR), BVDV, PI3, and BRSV (Fulton et al., 2011). Active BCV 
infections are routinely identified through viral isolations from nasal swabs and 
seroconversions in cattle with BRD and in healthy cattle in numerous studies (Fulton et 
al., 2011). The virus has also been positively identified in pneumonic lungs, often found 
in combination with other pathogens (Fulton et al., 2011). Previous research has 
demonstrated the presence or absence BCV antibodies can be used as a predictor of 
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antimicrobial treatment in the feedlot, and that BCV can be found in the nasal secretions 
of calves upon arrival to the feedlot (Fulton et al., 2011).  
Necropsy findings of cattle infected with BCV include the presence of epithelial 
lesions in the turbinates, trachea, and lungs, along with occasional interstitial pneumonia 
(Fulton et al., 2011). Laboratory experiments have suggested multiple mechanisms as to 
how BCV may cause a decrease resistance against bacterial pathogens (Hodgins et al., 
2002). Isolates of BCV from respiratory tracts with acetylesterase activity capable of 
releasing acetate from the normal glycocalyx lining have been discovered and it is 
thought that this modification of the glycocalyx could increase the adhesion of MH and 
PM to host cells in the lower respiratory tract (Hodgins et al., 2002). The M and E 
structural proteins of BCV have been demonstrated to induce interferon alpha (IFN-α) 
synthesis by peripheral blood mononuclear cells (Hodgins et al., 2002). Cytokines such 
as IFN-α have proinflammatory properties and could induce the infiltration of neutrophils 
into the lung (Hodgins et al., 2002). The role of BCV in the pathogenesis of BRD is not 
fully understood, and is an area of emerging research. While BCV should not currently be 
considered to have a significant impact on BRD incidence due to a lack of evidence 
implicating BCV as a primary BRD pathogen, more research needs to be conducted to 
increase knowledge of BCV pathogenesis.  
Mannheimia haemolytica (MH) (formerly Pasteurella haemolytica), is a small 
gram-negative, nonmotile, facultative anaerobe that exists as a non-spore-forming rod or 
coccobacillus belonging to the Pasteurellaceae family. There are 12 capsular serotypes of 
MH based on the original P. haemolytica serotype assignments of A1, A2, A5, A6, A7, 
A8, A9, A12, A13, A14, A16, and A17.5 (Griffin et al., 2010). Commonly, MH exists as 
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part of the normal bacterial flora within the upper respiratory tract of healthy calves, and 
can be found in the nasopharynx and tonsillar crypts (Griffin et al., 2010). While MH 
serotypes A1 and A2 are known to colonize the upper respiratory tract of healthy calves, 
serotype A2 is the predominate serotype isolated from clinically normal appearing cattle 
(Griffin et al., 2010). It has been suggested that MH exists in a commensal relationship 
with the host animal until conditions within the animal change resulting from a stressor or 
coinfection (Hodgins and Shewen, 2004; Griffin et al., 2010). However, once this initial 
commensal relationship is disrupted, MH serotype A1 quickly becomes the predominate 
organism isolated (Hodgins and Shewen, 2004; Griffin et al., 2010). With great 
repeatability, the most common bacterial pathogen isolated from the respiratory tract of 
calves treated for BRD is MH serotype A1, and this serotype has been shown to be 
responsible for characteristic BRD infection in calves (Whitley et al., 1992; Hodgins and 
Shewen, 2004; Booker et al., 2008; Griffin et al., 2010). 
Once MH has been established within the lung, the resulting tissue damage is a 
result of multiple virulence factors associated with MH pathogenesis. These virulence 
factors include: a capsule used for adherence and invasion, outer membrane proteins that 
induce immune responses, adhesions used for further colonization, neuraminidase that 
decreases the viscosity of mucus, a lipopolysaccharide (LPS) complex that causes 
hemorrhaging, edema, hypoxemia, and inflammation, a leukotoxin (LKT) responsible for 
lysis of leukocytes and platelets, and a quorum-sensing system that is believed to regulate 
expression of these virulence factors (Hodgins et al., 2002; Griffin et al., 2010). The 
extracellular fractions of MH can kill bovine neutrophils (Cusack et al., 2003). The 
presence of lipopolysaccharide endotoxin in the outer membranes is involved in lung 
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damage. The endotoxin demonstrated a multitude of toxic effects including the initiation 
of complement and coagulation cascades (Cusack et al., 2003). These cascades result in 
increased vascular permeability and coagulation which results in the accumulation of 
inflammatory cells, edema and both fibrin deposition within the lung (Cusack et al., 
2003). The endotoxin serves to activate granulocytes and macrophages that help protect 
against the invading bacteria, but that also lead to increased tissue damage and 
inflammation (Cusack et al., 2003).  
M. haemolytica also produces a specific LKT that is active against phagocytes 
and impairs phagocytosis and kills macrophages (Cusack et al., 2003). The LKT of MH 
is a member of the RTX toxins family and is a pore-forming, calcium-dependent 
cytolysin with specificity for leukocytes and platelets (Hodgins et al., 2002). Low 
concentrations of this LKT serve to activate neutrophils and induce the apoptosis of 
leukocytes (Hodgins et al., 2002). Apoptosis of leukocytes would effectively limit the 
initial inflammatory response, allowing for MH to further colonize and replicate within 
the lung (Hodgins et al., 2002). This LKT has demonstrated the ability to suppress the 
respiratory burst of leukocytes, encourage the degranulation of lysosomes, and inhibit 
phagocytosis and the killing of invading bacteria (Hodgins et al., 2002). All of these LKT 
activities would improve the ability of MH to rapidly colonize and establish within the 
lung. 
Similar to MH, Pasteurella multocida (PM) is also a small gram-negative, 
nonmotile, facultative anaerobe that exists as a non-spore-forming coccobacillus 
belonging to the Pasteurellaceae family. There are 5 capsular serotypes (A-F) and 16 
somatic serotypes (1-16) for PM (Griffin et al., 2010). Also similar to MH, PM can be 
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isolated from healthy calves and is presumed to exist in a commensal relationship with 
the host animal in some form until additional predisposing factors resulting from a 
stressor or coinfection occur (Hodgins and Shewen, 2004; Griffin et al., 2010). Once this 
commensal relationship is disrupted then PM can quickly colonize and establish within 
the lung (Hodgins and Shewen, 2004; Griffin et al., 2010). Serotype A3 is the most 
commonly isolated PM serotype in confirmed BRD cases (Griffin et al., 2010).  
Much less is known about the virulence factors of PM compared to those of MH. 
However, virulence factors are assumed to be similar between the 2 organisms. As 
demonstrated with MH, PM can also impact neutrophil defenses within the lung. The 
capsular fraction of PM has been demonstrated to inhibit neutrophil function (Cusack et 
al., 2003). In addition, PM attracts phagocytes to affected regions of the lungs and 
destroys them via the production of toxins (Cusack et al., 2003). As such, most of the 
damage associated with PM is also due to pulmonary inflammation (Cusack et al., 2003). 
While PM is similar to MH in both structure and function, the 2 bacteria do not 
necessarily impact calves in the same manner. It has been demonstrated that PM impacts 
younger calves, and PM is most commonly isolated from younger animals (Hodgins et 
al., 2002; Step et al., 2005). In addition, PM is considered to be less virulent than MH 
(Hodgins et al., 2002; Step et al., 2005). In experimental challenge studies, it has taken 
higher levels of PM to produce primary pneumonia (Hodgins et al., 2002). Interestingly, 
microbiologists are reporting PM more frequently in fatal BRD cases from feedlots 
(Griffin et al., 2010). This is somewhat contradictory to decades of previous research 
implicating MH as the principle bacterial pathogen associated with fatal BRD (Griffin et 
al., 2010). One potential reasons for this change in the frequency of isolation of PM 
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compared to MH could be a result of younger cattle being placed on feed in feedlots 
(Griffin et al., 2010). 
As with the other bacteria associated with BRD previously discussed, Histophilus 
somni (HS) (formerly Haemophilus somnus) is another small, commensal, gram-negative, 
nonmotile, facultative anaerobe that exists as a non-spore-forming coccobacillus 
belonging to the Pasteurellaceae family that resides in the respiratory tract of calves. 
Similar to MH and PM, HS has a lipooligosaccharide endotoxin in the outer membrane of 
its cell wall (Cusack et al., 2003). This endotoxin causes lesions like those produced by 
the lipopolysaccharide of MH and PM, but also results in vasculitis and necrosis (Cusack 
et al., 2003). The endotoxin produced by HS can also cause damage to endothelial cells, 
alveolar macrophages, and neutrophils (Cusack et al., 2003). In addition to similiarities 
with MH and PM, HS also produces a histamine and an exopolysaccharide that play an 
important role in the pathogenesis (Griffin et al., 2010). In most cases, BRD attributed to 
HS is considered to be more subacute or chronic than that caused by infection by either 
MH or PM (Hodgins et al., 2002). Clinically, BRD caused by HS is not distinguishable 
from that caused by the other BRD bacterial pathogens discussed (Griffin et al., 2010). 
Mycoplasma species comprise some of the simplest self-replicating life forms and 
include over 100 different species. Most Mycoplasma species are facultative anaerobes 
and have unique membranes rather than traditional cell walls found in other bacterial 
BRD pathogens. Multiple Mycoplasma species including Mycoplasma bovis (MB) have 
been associated with BRD in feedlot cattle, and the isolation of multiple species of 
mycoplasmas from pneumonic lungs has been noted in some experiments (Hodgins et al., 
2002). Mycoplasma species can alter phagocytic function by preventing the activation of 
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macrophages by other stimuli (Hodgins et al., 2002). In in vitro studies, the killing of 
Escherichia coli by bovine neutrophils has been inhibited by the products of Mycoplasma 
species (Hodgins et al., 2002). Certain species of mycoplasma demonstrate mitogenic 
activity for lymphocytes, and peptides of some mycoplasma species have been shown to 
impact T cells (Hodgins et al., 2002). Mycoplasma species are not greatly understood and 
limited information exists about them in the scientific literature. 
Of all the Mycoplasma species, MB is perhaps the most researched and 
understood. However, the role of MB in disease pathogenesis in young calves is much 
better understood than it is in stocker or feedlot cattle (Griffin et al., 2010). The exact role 
of MB in BRD pathogenesis is heavily debated as the data defining the relationship of 
MB to BRD incidence is not as conclusive as it is for other bacterial BRD pathogens 
(Griffin et al., 2010). However, MB is more widely accepted as a culprit of chronic 
bronchopneumonia with caseous and possibly coagulative necrosis and is often 
characterized by a persistent infection that seems unresponsive to many antibiotics 
(Caswell and Archambault, 2007). Through serology, the movement of MB through 
herds has been traced, and when naïve cattle are exposed to cattle infected with MB, The 
pathogen can be found in the naïve cattle within a day (Griffin et al., 2010). Once MB has 
become established within the respiratory tract, it may persist for the life of the animal in 
a commensal relationship.  
The virulence factors related to MB are associated with 5 variable surface 
lipoproteins (VSP): VSP-A, VSP-B, VSP-C, VSP-F, and VSP-O (Caswell and 
Archambault, 2007; Griffin et al., 2010). These VSP have various roles in the 
development of disease including: evasion of host animal’s antibody response, 
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colonization of mucosal surfaces, adhesion to cells, and suppression of lymphocyte 
blastogenesis and cytokine secretion (Caswell and Archambault, 2007). In addition, other 
surface proteins aside from VSP have been shown to facilitate the adhesion of MB to host 
cells (Caswell and Archambault, 2007). Other virulence factors exhibited by MB include: 
the production of a polysaccharide toxin and other polysaccharides, the formation of 
hydrogen peroxide, heat shock protein responses, and the formation of biofilm (Caswell 
and Archambault, 2007). 
A synergistic effect has been observed involving MB and MH with a more severe 
disease response occurring when MB infected calves are challenged with MH compared 
to when calves not infected with MB are challenged with MH (Griffin et al., 2010). The 
presence of lung lesions associated with MB infection range from mild lesions 
consolidated to cranioventral areas to chronic caseonecrotic bronchopneumonia and 4 
main patterns of lung lesions have been observed: caseonecrotic bronchopneumonia, 
bronchopneumonia with foci of coagulation necrosis, suppurative bronchopneumonia 
without necrosis, and chronic bronchopneumonia with abscessation (Caswell and 
Archambault, 2007; Griffin et al., 2010). Some clinical signs that may suggest the 
presence of a MB infection are: lameness, chronic sickness, and the failure to respond to 
antimicrobial treatment, but these signs are not specific to only MB cases (Caswell and 
Archambault, 2007). The clinical signs of MB infected calves with BRD are usually not 
distinguishable from other BRD causes (Caswell and Archambault, 2007). 
While a multitude of risk factors can potentially increase the risk of BRD, the 
development of clinical BRD is ultimately a result of infection by viral and bacterial 
pathogens. Frequently pathogenesis occurs through a primary infection by one or 
49 
 
multiple respiratory viruses. The principal infection combined with the calf's previously 
compromised immune system allows for the rapid colonization and replication within 
lung tissues by commensal bacteria. This bacterial infection causes inflammation and 
severe immune responses to occur within the lung tissue leading to the clinical signs 
associated with BRD. 
 
Management of newly received calves with a high risk of BRD incidence 
Given the complex nature of BRD and the multitude of risk factors, viruses, and 
bacteria involved in BRD pathogenesis, special management considerations should be 
provided to calves at high risk of developing BRD. The risk factors or stressors that cause 
calves to be considered at a high risk of developing BRD can occur any time after 
conception in the calf’s life, and while some of these risk factors can be effectively 
managed at early stages of production, others simply are unavoidable and inherently 
associated with the cattle marketing system in the U.S. In the Southern Plains and 
Southeast U.S. it cannot be assumed that calves marketed through typical auction markets 
have even been weaned prior to being marketed. Through marketing channels calves are 
commingled with many other animals of unknown disease and vaccination statuses. After 
being sold, calves are loaded on trucks and frequently transported long distances where 
they are potentially exposed to exhaust fumes, extreme weather, and temperature 
fluctuations. While variation in classification of risk levels exists within the industry, 
upon arrival to the feedlot, calves are generally placed into 1 of 2 risk categories: high-
risk or low-risk (Edwards, 1996). 
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High-risk calves characteristically are younger lighter-weight calves, have not 
been weaned prior to being marketed, have been assembled from multiple lots of cattle at 
multiple livestock markets, have potentially been transported long distances, have 
unknown disease and vaccination histories, may not have been dehorned or castrated, and 
are highly stressed upon arrival to the feedlot. High-risk calves are typically suffering 
from dehydration, malnourishment, and exhaustion at the time of arrival (Griffin et al., 
2010). Low-risk calves customarily are older or heavier-weight calves, have been weaned 
prior to marketing and possibly been enrolled into a recognized preconditioning program, 
come from one or very few sources, arrive with some vaccination or health history, and 
appear to be less stressed upon arrival to the feedlot. Sanderson et al. (2008) reviewed 
risk factors associated with BRD in U.S. feedlots and found that cattle arriving in mixed-
gender groups, cattle arriving from multiple sources, and cattle transported longer 
distances were associated with an increased risk for developing initial BRD, while cattle 
entering the feedlot at heavier body weights were associated with decreased risk of initial 
BRD. Wilson et al. (2012) observed that calves that were castrated after arrival to the 
feedlot had lower ADG and higher first treatment rates for BRD than calves that arrived 
as steers and that calves that were dehorned after arrival to the feedlot had lower ADG 
than calves that were polled.  
Given the array of factors that can dictate the risk level of incoming calves 
arriving at a feedlot, calves are classified into high-risk or low-risk categories simply 
based on if they were preconditioned or not. This allows for a simpler classification of 
risk levels and eliminates unnecessary confusion as to what constitutes high-risk or low-
risk. Regardless of how preconditioning is defined, the preconditioning of calves has 
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proven to reduce the incidence of BRD in calves as they enter the feedlot (Thrift and 
Thrift, 2011). Multiple studies have demonstrated various benefits of preconditioning 
(NAHMS, 2000; Roeber et al., 2001; Step et al., 2008; Thrift and Thrift, 2011; Richeson 
et al., 2012).  
The vaccination of clinically healthy, unstressed cattle has shown to be effective 
in reducing BRD and achieving an optimal vaccine response dependent on providing an 
efficacious vaccine to an immunocompetent calf (Edwards et al., 2010). As a result of the 
proven efficacy of vaccines in healthy cattle, the majority of cattle are vaccinated shortly 
after arrival to the feedlot to help manage BRD pathogens (NAHMS, 2013). Occasionally 
low-risk calves that arrive at the feedlot with a known vaccination history are not re-
vaccinated. As a percentage of all feedlots, 96.6% vaccinated for BVDV, and 93.7% 
vaccinated for IBR, while 89.1% vaccinated for BRSV, and 85.1% vaccinated for PI3 
(NAHMS, 2013). NAHMS (2013) also stated approximately 2 out of 3 feedlots 
vaccinated for the most common bacterial agents associated with respiratory disease: HS, 
MH, and PM.  
While the vaccination for respiratory viruses, and to some extent bacterial 
pathogens upon arrival to the feedlot is widespread, there is little scientific evidence to 
support this management practice (Edwards et al., 2010; Taylor et al., 2010b). Some 
epidemiologic studies have suggested that the vaccination for respiratory viruses actually 
leads to increased BRD incidence (Taylor et al., 2010b). It could be interpreted that this 
data is somewhat confounded, as high-risk calves are more likely to be vaccinated for 
respiratory viruses. Regardless, there is little justification in the literature for the 
vaccination of high-risk calves at arrival.  
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A probable reason for the lack of efficacy of respiratory vaccines in high-risk 
calves is due to the timing of vaccine administration. Calves under a great deal of stress 
are unlikely to mount an optimal immune response to the vaccine. Few studies have 
evaluated the effects of delayed vaccination of high-risk calves, and the results of those 
studies have been inconsistent. Initial research by Richeson et al. (2008) indicated that 
delaying vaccination by 14 days may result in a possible improvement in immune 
response. Conversely in a second experiment, Richeson et al. (2009) determined that 
timing of vaccination did not affect performance or health in high-risk newly received 
calves. In addition to vaccine timing, the complicated nature of BRD pathogens and the 
increased susceptibility of the high-risk calves to these pathogens may also negatively 
influence vaccine efficacy (Taylor et al., 2010b). 
The involvement of multiple bacterial pathogens in combination with the 
increased risk of BRD incidence observed in high-risk calves may justify the mass 
antimicrobial treatment of high-risk populations. This prophylactic mass antimicrobial 
treatment, known as metaphylaxis, has consistently been found to economically and 
efficiently reduce BRD related morbidity in high-risk calves (Duff and Galyean, 2007; 
Edwards et al., 2010; Taylor et al., 2010b). Metaphylaxis can be administered via 3 
methods: parenterally by subcutaneous, intramuscular, or intravenous injection, through 
the feed, or in the water (Taylor et al., 2010b). Most commonly, metaphylaxis occurs in 
the form of an injectable antimicrobial that is administered subcutaneously. While 
including an antimicrobial in the feed or water in the face of a BRD outbreak could be 
advantageous, achieving adequate feed or water intake is often a major concern. Calves 
must have adequate intakes to ensure proper dosage of antimicrobials and the feed and 
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water intakes of high-risk calves are often depressed for up to a week or more. Currently, 
the physical injection of antimicrobials is the only way to ensure that calves receive the 
appropriate dose of antimicrobial. 
Metaphylaxis is the instrument most commonly used by feedlot managers and 
veterinarians to reduce the occurrence of BRD in newly received high-risk feedlot cattle 
(NAHMS, 2013). As a percentage of all feedlots, 59.3% treated at least some cattle 
metaphylactically upon arrival. This percentage resulted in approximately 1 in 5 cattle 
placed on feed (21.3%) being metaphylactically treated (NAHMS, 2013). For calves 
placed on feed weighing less than 317.5 kg, 92.6% of feedlots with a capacity of 8,000 or 
more head used metaphylaxis (NAHMS, 2013). This resulted in approximately 2 in 5 
calves weighing less than 317.5 kg at arrival (39.2%) receiving metaphylactic treatment 
for BRD (NAHMS, 2013). The 3 most commonly used antimicrobials used for 
metaphylaxis were tilmicosin (57.6 percent of feedlots), tulathromycin (45.3 percent), 
and ceftiofur (39.7 percent) (NAHMS, 2013). Tulathromycin was more commonly used 
for metaphylactic treatment in cattle weighing less than 317.5 kg at placement compared 
to cattle weighing more than 317.5 kg at placement (NAHMS, 2013).  
Classical metaphylactic work by Lofgreen (1983a) demonstrated that the 
combination of long-acting oxytetracycline and a sustained-release sulfadimethoxine, 
decreased BRD-related morbidity from 63.3% in non-medicated control calves to 7.1% in 
metaphylactically treated calves. Numerous additional studies have demonstrated the 
effectiveness of tilmicosin, tulathromycin, ceftiofur crystalline free acid, and florfenicol 
in decreasing BRD related morbidity in newly received, high-risk calves (Duff and 
Galyean, 2007; Edwards et al., 2010; Taylor et al., 2010b). Interestingly, the 
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administration of antimicrobials prior to shipping does not appear to be any more 
effective than administering antimicrobials upon or subsequent to arrival (Edwards et al., 
2010; Taylor et al., 2010b). The exact preventative mode of action of metaphylaxis is still 
unknown, but MH has been shown to be greatly affected by metaphylactic administration 
programs (Duff and Galyean, 2007). Studies by Frank and Duff (2000) and Frank et al. 
(2002) reported that both tilmicosin and florfenicol inhibited the colonization of MH 
within the nasopharynx of cattle (Duff and Galyean, 2007). 
The nutritional management of high-risk calves subsequent to feedlot arrival has 
far-reaching implications on the function of the immune system including: development 
of lymph tissues, production of mucus, synthesis of immunologically active cells such as 
leukocytes, antibodies, and cytokines, cell proliferation, cellular signaling, activation, and 
movement, intercellular killing, and general immune system modulation (Cole, 1996). A 
major concern with the nutritional management of high-risk calves is that the nutritional 
background or nutrient status of calves arriving at the feedlot is often unknown and 
impractical to obtain (Duff and Galyean, 2007). However, it is known that high-risk 
calves typically suffer from dehydration, malnourishment, and exhaustion upon arrival to 
the feedlot (Griffin et al., 2010). When reviewing the literature, a great deal of variation 
in responses to nutritional supplementation is observed in experiments involving high-
risk calves. Duff and Galyean (2007) suggest that this variation is partially due to 
variations in the nutritional status of calves at arrival. 
Another major problem in the nutritional management of high-risk calves is 
simply achieving adequate dry matter intake (DMI) to meet calves’ nutrient requirements. 
High-risk calves have altered eating patterns when compared with unstressed cohorts 
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(Galyean et al., 1999). The DMI of high-risk calves is extremely variable, and many 
calves do not achieve adequate DMI for the first couple of weeks on feed. Hutcheson and 
Cole (1986) stated that DMI for newly received calves ranged from 0.5% to 1.5% of 
body weight and that the majority of morbid calves do not consume any feed for the first 
2 days in the feedlot. Approximately 4 out 5 (83.4%) morbid calves were consuming feed 
by the end of the first week in the feedlot (Hutcheson and Cole, 1986). The irregular 
intake of high-risk calves makes the formulation of receiving diets incredibly 
challenging.   
The first inclination when formulating receiving diets would likely be to increase 
the nutrient density of the diet to compensate for the reduced DMI of high-risk calves. 
Multiple researchers have demonstrated that the voluntary DMI of lower energy diets 
containing higher levels of roughage is less than that for higher energy diets in newly 
received high-risk calves (Galyean et al., 1999). When newly received stressed calves 
were given a choice among feed mixes varying in concentrate levels, the calves selected 
diets that contained 72% concentrate during the first week in the feedlot (Lofgreen, 
1983b). As a result of altered DMI patterns and the increased energy density of higher 
concentrate diets, the performance by newly received high-risk calves is typically greater 
with higher-concentrate (60% concentrate or greater) receiving rations (Galyean et al., 
1999). 
While increased energy density receiving diets have been shown to improve the 
performance of high-risk calves, these diets are not without negative aspects. One such 
negative aspect of feeding high concentrate receiving rations is an increase in BRD 
morbidity and an increase in the severity of BRD events. Lofgreen (1983b) reported 
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morbidity rates of 47%, 49%, and 57%, respectively when steam-flaked milo-based 
receiving diets with concentrate levels of 25%, 50%, and 75% were fed to lightweight, 
high-risk cattle. Rivera et al. (2005) reviewed dietary roughage and concentrate levels in 
multiple studies conducted at the Clayton Livestock Research Center. The diets in this 
review ranged from all hay diets to 75% concentrate rations (Rivera et al., 2005). 
Morbidity attributed to BRD decreased slightly as roughage concentration in the diet 
increased (Rivera et al., 2005).  
The economic analysis conducted by Rivera et al. (2005) indicated that the 
decrease in morbidity observed in calves consuming diets with higher roughage 
concentrations would not compensate for the production losses due to decreased ADG on 
these same diets. It is also a possibility that the increased morbidity rates observed in 
calves consuming higher concentrate receiving diets include calves that are misdiagnosed 
due to the similarity of clinical signs of BRD and subclinical ruminal acidosis. The 
adaptation of calves to receiving and finishing diets has been associated with 
inflammatory and acute-phase responses and clinical behavior resulting from digestive 
upsets associated with dietary adaptation can mimic BRD morbidity behavior (Ametaj et 
al., 2009; Tizard, 2008). 
Dietary protein concentration has also been shown to impact BRD incidence in 
newly received calves. Similar to what is observed with increasing energy or concentrate 
level, increasing crude protein concentrations in receiving diets seems to increase BRD 
incidence, but simultaneously increase ADG and DMI (Galyean et al., 1999). In a review 
of 15 studies, the relationship between BRD morbidity and crude protein level in the 
receiving diet was evaluated (Galyean et al., 1999). The regression analysis revealed that 
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BRD morbidity rates tended to increase with increasing CP level, but that the 
performance by calves fed higher crude protein diets was equal to or greater than the 
performance of calves fed lower crude protein diets (Galyean et al., 1999). The authors 
suggested that this contradictory response could be attributed to 3 possible scenarios: the 
inaccurate diagnosis of BRD, the sick calves fed higher crude protein diets had increased 
performance compared to sick calves fed lower crude protein diets, or the healthy calves 
consuming higher crude protein diets had increased performance compared to healthy 
calves fed lower crude protein diets (Galyean et al., 1999). Multiple researchers have 
suggested that additional research is needed to determine the effects of dietary crude 
protein level on the health and performance of high-risk calves. 
The inclusion of minerals and vitamins and the supplementation of minerals and 
vitamins in excess of published requirements in receiving diets for high-risk calves to aid 
in immune function has received much consideration. Multiple TM including cobalt (Co), 
copper (Cu), manganese (Mn), selenium (SE), and zinc (Zn) can affect immune function, 
but the effects of TM supplementation on performance and immune function in challenge 
models and field studies are inconsistent (Duff and Galyean, 2007). Much of the recent 
research involving TM supplementation has focused on the comparison of organic or 
inorganic TM supplementation. Antioxidant vitamins including vitamin C and vitamin E 
have also been shown to influence immune function, but again the results from challenge 
studies and field experiments in calves are inconsistent at best. Duff and Galyean (2007) 
suggested that adding vitamin E to receiving diets at pharmacological levels (greater than 
1000 IU per day) appeared to decrease BRD morbidity. The supplementation of vitamin 
58 
 
A and B vitamins in receiving diets above requirements has not been justified (Duff and 
Galyean, 2007). 
Another concern with managing high-risk calves would be the increased time and 
labor required to properly care for them. In feedlots, cattle are “pulled” by trained pen 
riders when they are deemed to be sick almost entirely based on subjective criteria 
(Galyean et al., 1999). This subjective evaluation will use some criteria based system 
such as the DART™ system (Pharmacia Upjohn Animal Health, Kalamazoo, MI). In the 
DART™ system, the pen riders will assign a calf a numerical severity score based on the 
clinical signs and the severity of those signs. This system is commonly used with 
modifications as described by Step et al. (2008). The subjective criteria for pulling calves 
used in the DART™ system consist of depression, abnormal appetite, and respiratory 
signs.  
Signs of depression can include but are not limited to: depressed attitude, lowered 
head, glazed or sunken eyes, slow or restricted movement, arched back, difficulty 
standing or walking, knuckling of joints or dragging toes when walking, and stumbling. 
Signs of abnormal appetite can include: an animal that is completely off feed, an animal 
eating less than expected or eating extremely slow, a lack of gut fill or gaunt appearance, 
and obvious body weight loss. Respiratory signs include: labored breathing, extended 
head and neck (in an attempt to breathe), and audible noise when breathing. A major 
problem exists in that all of these clinical signs can be very subtle and are entirely 
subjective to the observation by the pen rider. A substantial amount of art and skill is 
required to determine which cattle should be pulled and evaluated for BRD treatment. 
Skilled and trained pen riders are increasingly difficult to find and it is difficult to train 
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personnel in these skills. Multiple studies have demonstrated that more animals had lung 
lesions present at slaughter than were treated for BRD, and commonly calves that were 
never treated had lung lesions present at slaughter (Wittum et al., 1996; Bryant et al., 
1999; Gardner et al., 1999; Thompson et al., 2006). These results would indicate that 
current methods feedlots employ to diagnose and treat calves for BRD are inadequate at 
detecting calves potentially requiring treatment for BRD. 
In a recent survey of feedlot consulting veterinarians, Terrell et al. (2011) 
investigated labor recommendations for pen riders and doctors for high-risk calves. When 
asked the number of times per day they recommend that pen riders check high-risk 
calves, 17.4% recommended checking them once daily, 71.4% recommend checking 
them twice daily, and 4.4% recommended checking 3 times a day (Terrell et al., 2011). 
Terrell et al. (2011) also asked the consultants questions about the recommended number 
of employees required to adequately handle the pulling and treatment of both high-risk 
and low-risk calves. (Figure 2-2). Veterinarians recommended that a trained pen rider 
could tend to 2,739 head of high-risk calves and responses ranged from a minimum of 
1,000 head to a maximum of 5,000 head per pen rider (Terrell et al., 2011). The same 
veterinarians recommended that this trained pen rider tend to 5,591 head of low-risk 
calves (Terrell et al., 2011). The consultants also recommended that a feedlot doctor 
could attend to 7,083 head of high-risk calves or 15,972 head of low-risk calves (Terrell 
et al., 2011). Based on these results, it can be determined that consulting feedlot 
veterinarians feel that high-risk calves require twice the labor and personnel of low-risk 
calves for adequate BRD detection and treatment. 
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High-risk calves typically are believed to be younger, have not been weaned, have 
been assembled from multiple lots at multiple livestock markets, and appear to be highly 
stressed upon arrival to the feedlot. As a result, high-risk calves require substantially 
more labor and management than low-risk calves. The successful management of these 
calves requires a team effort from everyone involved the feedlot operations, especially 
the nutritionist, veterinarian, and pen riders. With proper management, high-risk calves 
can be successfully fed, but without proper management, the loss due to increased 
morbidity and mortality can be exponentially increased. 
 
Impact of BRD incidence on cattle performance and feedlot economics 
The incidence of BRD is the most significant production problem facing the 
feedlot industry and accounts for the majority of morbidity, mortality, and economic 
losses that occur in feedlots. In a cross-sectional survey conducted by Woolums et al. 
(2005), BRD was implicated as the leading cause of morbidity and mortality in 561 
feedlots in 21 states. Morbidity attributed to BRD accounts for approximately 75% of 
total morbidity in feedlot cattle (Edwards, 1996).  In addition, mortality attributed to 
BRD accounts for 36 to 80% of total mortality in feedlot cattle (Vogel and Parrott, 1994; 
Edwards, 1996; Smith, 1998; Chirase and Greene, 2001).  
In the 2011 feedlot survey, NAHMS (2013) stated that nearly all feedlots (96.9%) 
had at least some cattle that were affected by BRD. Across all cattle, BRD was the most 
common illness affecting 16.2 percent of cattle placed on feed (NAHMS, 2013). Feedlots 
in the central region (Colorado, Kansas, Nebraska, Oklahoma, and Texas) had twice as 
61 
 
many cattle affected with BRD compared to feedlots in the rest of the U.S. (NAHMS, 
2013). NAHMS (2013) reported that the average cost of treatment for BRD in all feedlots 
was $23.60. In addition to treatment costs, there are other costs and increased labor 
involved in caring for calves treated for BRD. The majority of feedlots provided bunk 
hay (95.5%), extra bunk space (88.5%), extra water tank space (86.8%), wind breaks 
(73.5%), additional bedding (70.7), and shade (65.0%), to calves treated for BRD 
(NAHMS, 2013). After initial treatment and labor expenses, additional economic losses 
occur due to retreatments, mortalities, and chronic BRD cases. For cattle treated for BRD 
that weighed less than 317.5 kg at placement, 14.9% required an additional antimicrobial 
treatment, 4.0% died, and an additional 2.3% were realized as chronics (NAHMS, 2013). 
Additional economic losses result from the decreased performance of calves 
treated for BRD. Most published research regarding BRD incidence and animal 
performance have been conducted retrospectively. In most situations, BRD incidence 
results in decreased ADG and final BW (Smith, 1998; Gardner et al., 1999; Thompson et 
al., 2006; Schneider et al., 2009). Over the course of a 28 day receiving period, Smith 
(1996) reported that ADG was decreased by 0.23 kg, and Bateman et al. (1990) reported 
that ADG was decreased by 0.14 kg less for calves that became sick. Similiarly in a 90 
day feeding experiment, calves suffering from a single episode of BRD had 0.18 kg lower 
ADG than those calves not treated, and calves treated 2 or more times had 0.33 kg lower 
ADG (Morck et al., 1993).  
Erickson et al. (2011) reviewed commercial data on 978 lots (276,116 head of 
cattle) from 2 feedlots in Canada to evaluate impact of BRD incidence on animal 
performance. Lots of cattle were categorized by the percentage of the lot treated for BRD 
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and then analyzed for linear and quadratic effects as BRD incidence increased (Erickson 
et al., 2011). As more cattle within a pen got sick, DMI decreased linearly and the 
decrease in DMI was about 0.41 kg less for cattle with 30% or greater incidence of BRD 
compared to lots with 5% or less incidence of BRD (Erickson et al., 2011). Similarly, as 
BRD incidence increased, ADG decreased linearly with about a 0.07 kg decrease in ADG 
for lots where 30% or more of cattle were treated compared to those lots 5% or less 
incidence of BRD (Erickson et al., 2011). The authors stated that while the impact of 
BRD incidence on G:F was significant, the effects were sporadic and no clear impact of 
BRD incidence on G:F was observed (Erickson et al., 2011). 
Although the treatment costs, labor costs, and production losses attributable to the 
treatment of BRD are substantial, the economic impacts of BRD on carcass merit and 
meat quality are also significant. McNeill et al. (1996) reported that “healthy” steers had 
greater ADG and 12% more U.S. Choice carcasses than cattle identified as “sick” at some 
point during the feeding period. Gardner et al. (1999) showed that the net return for steers 
without lung lesions was $20.03 more than for steers with lung lesions even with non-
active lymph nodes. Treatment costs accounted for 25% of this decrease in net return 
while the remaining 75% decrease in return was due to decreased carcass value (9.4% 
more USDA Standard carcasses and 3.9% decrease in carcass weight). In addition, when 
compared to steers without lung lesions, steers with lesions and active lymph nodes had 
$73.78 less net return of which 21% was due to treatment costs and the remaining 79% 
was due to lower carcass weight (8.4% less) and decreased quality grade (24.7% more 
USDA Standard carcasses).  
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As BRD treatments increase, carcass values and net returns per animal can 
exponentially decrease. Brooks et al. (2011) examined the economic impact of the 
number of BRD treatments received by heifers. Heifers treated once for BRD actually 
returned $10.12 per head more than those heifers never treated (Brooks et al., 2011). 
However heifers treated twice, 3 times, or deemed chronics returned $11.08, $72.01, and 
$143.28 less per head than those heifers never treated (Brooks et al., 2011). Schneider et 
al. (2009) found similar results upon reviewing the records from 5,976 animals fed in 
Midwestern feedlots to examine the economic impact of increasing BRD treatments. 
Schneider et al. (2009) observed that decreases in animal performance and carcass merit 
were associated with a decreases of $23.23, $30.15, and $54.01 in carcass value for cattle 
treated for BRD once, twice, or 3 or more times respectively when compared to cattle 
never treated for BRD. 
Chirase and Greene (2001) estimated the annual economic losses due to 
morbidity, decreased feed efficiency, and treatment costs associated with BRD to be 
$800-900 million. This is the estimate often cited in the introduction of BRD articles, but 
it was published almost 15 years ago. Other recent estimates indicate that the economic 
impact to be in excess of $2 billion (Powell, 2013). The problems with these estimates is 
that they do not include losses of carcass value or the amount of money spent by the 
feedlot industry on BRD prevention. When considering the total costs to the feedlot 
industry including losses in carcass value and what is spent on the prevention of BRD, 
the true cost of BRD may be well in excess of $5 billion. 
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USE OF ANCILLARY THERAPY IN CALVES TREATED FOR BRD 
While the scientific community has gained considerable knowledge about BRD 
pathogenesis and many advancements have been made in vaccine and antimicrobial 
production in recent years, the prevalence of BRD in feedlot cattle has not significantly 
been reduced. In fact, published data would indicate that no significant reduction in the 
prevalence of BRD has occurred over the last 30 to 40 years (Gifford et al., 2012). It 
could be argued that these data suggest current BRD prevention and treatment strategies 
are ineffective in reducing and controlling BRD, despite the wealth of BRD research and 
measurable improvements in commercially available vaccines and antimicrobials 
(Babcock et al., 2006). As such, other therapies and treatments have been investigated 
and employed by the feedlot industry in an attempt to improve the clinical response and 
general outcomes in calves treated for BRD. 
It has become increasingly common to provide an additional form of treatment, or 
ANC, along with an antimicrobial when treating for suspected BRD. In this case the 
primary goal of ANC is to improve the calf’s response to a BRD challenge, not to replace 
antimicrobial treatment. Ultimately, the aim of ANC is to typically focus on the calf or 
the calf’s clinical signs rather than the invading pathogens which would be the case with 
antimicrobials. Vaccines would be one of the few exceptions, in that they are meant to 
provide pathogen specific antibody responses. The improvement in the calf’s response to 
BRD can be accomplished through a variety of mechanisms. These mechanisms can be 
divided into 3 broad classes: relieving the harmful effects of inflammation, blocking 
histamine activity, or boosting immune system function to aid in the defense of infectious 
pathogens (Apley, 1994). When considering these mechanisms, multiple ANCs can fall 
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into each class. Anti-inflammatory drugs commonly used for ANC in calves would 
include corticosteroids and NSAID. Those ANCs with histamine blocking activity would 
be commonly referred to as antihistamines. Most of the remaining ANCs would fall into 
the immuno-modulating category, which would include vitamins, minerals, DFM, and 
vaccines. 
Most of the information available concerning ANC use in feedlots comes from 
extensive surveys of veterinarians or feedlot operators. From the survey data, the same 
list of the most commonly used ANCs occurs with great repeatability, while the 
frequency of use for a specific ANC varies some over time and among the different 
surveys. Across all surveys the most commonly used forms of ANC include: 
antihistamines, B vitamins, corticosteroids, DFM, NSAID, viral vaccines, and vitamin C 
(NAHMS, 2001; Terrell et al., 2011; NAHMS, 2013). While these surveys provide 
evidence as to the scope and frequency of ANC use in feedlots, they provide no 
information on the modes of action of ANCs or evidence as to the efficacy of ANC use. 
Very few reviews of ANC use in cattle treated for BRD have been conducted, and there 
is very limited published research concerning the efficacy of ANC use. The results that 
do appear in the published literature concerning ANCs and BRD are highly inconsistent.  
 
Justification for ANC use: Proposed modes of action and immune system modulation 
While it has become increasingly common to provide ANC along with an 
antimicrobial when treating calves for suspected BRD, the justification of this practice is 
not necessarily supported by the current literature. Ultimately the use of ANC is a 
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function of a real or perceived improvement to a BRD challenge in calves. These 
mechanisms for this improvement in response can be divided into 3 broad classes: 
relieving inflammation, blocking histamine activity, or boosting immune system function 
(Apley, 1994). Multiple ANCs can make up each class, with the majority of ANCs falling 
into the immunomodulating category. 
The majority of anti-inflammatory drugs target arachidonic acid-derived 
eicosanoids and inhibit their synthesis (Apley, 1994). Eicosanoids include leukotrienes, 
thromboxane A2, and prostaglandins and can cause a wide variety of physiological 
changes within the body including: bronchodilation and broncho-constriction, changes in 
renal blood flow, inhibition of B-cell differentiation, and the proliferation of T-cells 
(Apley, 1994). Trauma, toxins, or chemical insult can activate phospholipase A2, which 
causes the release of arachidonic acid from cell membranes. The arachidonic acid is then 
synthesized into eicosanoids by lipoxygenase or cyclooxygenase (Apley, 1994). Anti-
inflammatory drugs frequently used for ANC in calves would include corticosteroids and 
NSAID. 
Corticosteroids prevent the synthesis of eicosanoids through membrane 
stabilization and by synthesizing lipocortin, which inhibits phospholipase A2 (Apley, 
1994). In addition to relieving the effects of inflammation, corticosteroids can also have 
adverse effects on the immune system. Corticosteroids inhibit interleukin-1 (IL-1) and 
interleukin-2 (IL-2) production, prevent macrophage migration, interfere with interferon 
gamma (IFN-γ) function, and inhibit neutrophil activity (Apley, 1994). While 
corticosteroids can successfully relieve the effects of inflammation, it would seem that 
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the immunosuppressive effects of corticosteroids could potentially outweigh any 
potential benefits of the reduced inflammation. 
While NSAID also prevent the synthesis of eicosanoids, they accomplish this 
inhibition through different mechanisms. In the case of NSAID the synthesis is prevented 
through the inhibition cyclooxygenase (Apley, 1994). It has also been demonstrated that 
NSAID relieve inflammation through both central and peripheral mechanisms (Apley, 
1994). Two of the commonly used NSAID in cattle are acetylsalicylic acid and flunixin 
meglumine. The NSAID flunixin meglumine has been shown to reduce rectal 
temperatures and decrease lung consolidation in multiple studies (Apley, 1994; Francoz 
et al., 2012). While it could be argued that the benefits of NSAID may be important from 
an animal welfare perspective, it is difficult to determine the economic benefits for the 
use of NSAID based on inconsistent results in the performance and clinical health of 
calves given NSAID (Francoz et al., 2012). 
Antihistamines work by reducing histamine, which is a chemical released from 
mast cells in response to a stimulation by antigens of cellular insult (Apley, 1994). 
Histamine causes bronchoconstriction, vasodilation, and increased capillary permeability 
through the activation of H1 and potentially H2 receptors (Apley, 1994). Antihistamines 
reduce histamine production through the blocking of the H1 receptors through 
competitive antagonism (Apley, 1994). There has been very little research conducted to 
evaluate the effects of antihistamines as ANC for BRD. Antihistamines have not been 
demonstrated as effective in treating asthma as it is believed that the bronchoconstriction 
is caused by leukotrienes rather than histamine (Apley, 1994). If this is the case in calves 
with BRD as well, antihistamines would likely have no effect in relieving 
68 
 
bronchoconstriction. When critically evaluating the use of antihistamines as an ANC, the 
short duration of efficacy (6 to 12 hours), rapid elimination from the body, and lack of 
published research concerning antihistamines should be considered.   
The final class of ANCs are those in the immuno-modulating category which 
attempt to boost immune system function to aid in the defense of infectious pathogens. 
This class would include DFM, TM, vaccines, and vitamins. The modes of action for the 
ANCs in this class are extremely varied and mostly unproven. There has been very little 
research conducted on immuno-modulators and the work that has been published is 
inconsistent. However, there are multiple ANCs in this class that are used with great 
frequency in commercial feedlots.  
The use of DFM has been well received by feedlot operators as DFM are simply a 
source of live, naturally occurring microorganisms (Yoon and Stern, 1995). The concept 
of feeding a DFM to cattle is based on the presumption of potential benefits on 
gastrointestinal health which would include the establishment of more desirable 
microflora and prevention of the establishment of pathogenic organisms via competitive 
exclusion (Krehbiel et al., 2003). Potential beneficial responses observed when feeding 
DFM to cattle include: increased ADG and improved G:F in feedlot cattle, improved 
health and increased immunity in young calves, decreased potential for ruminal acidosis, 
increased propionate concentrations within the rumen, and altered rumen microflora 
populations (Krehbiel et al., 2003; Guillen, 2009). While there is a considerable amount 
of evidence demonstrating the effectiveness of DFM on cattle performance, the results 
have been somewhat inconsistent (Krehbiel et al., 2003). In addition, there is very limited 
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research on the effects of DFM on cattle health in general and even less on the use of 
DFM as an ANC. 
Another group of the immuno-modulators that has received consideration are TM. 
This is due the proposed impacts of TM on immune function. The supplementation of 
TM has been demonstrated to alter immune function measurements and reduced 
morbidity associated with BRD in some cases (Galyean et al., 1999). The 
supplementation with TM including: Cu, Mn, and Zn has become a normal management 
practice within the feedlot industry to promote maximum performance and OPTIMAL 
immune function, and these TM are frequently included at levels in excess of published 
requirements in feedlot diets (Vasconcelos and Galyean, 2007). However, the published 
research concerning TM supplementation at levels greater than published requirements or 
as an ANC is lacking and has been extremely inconsistent. 
A third group of the immuno-modulators would be vaccines. Vaccines attempt to 
increase immunity to pathogens by increasing antibody titers within the body and 
initiating a similar immunological response to that of natural exposure to an antigen. 
Vaccines can be thought of as tools to prime the immune system prior to insult with a 
viral pathogen by eliciting both specific and non-specific effects on cellular and humoral 
immunity. Most previous vaccine research in cattle has focused on comparing different 
multivalent modified live vaccines and many published vaccine studies do not include a 
negative control. As a result, it is extremely difficult to determine if vaccination at arrival 
truly aids in prevention of BRD or if it actually may be detrimental to calves as some 
studies suggest. Data examining the use of vaccines as an ANC for BRD are not available 
at the current time. 
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The final group of immuno-modulating ANCs would include vitamins. Water 
soluble B vitamins and vitamin C have been shown to be critical to immune system 
function. Specifically the pyridoxine (B6), folic acid (B9), pantothenic acid (B5), and 
ascorbate (vitamin C) have been shown to have roles in immune function, and the 
requirements of these water soluble vitamins are increased substantially by stress 
(Dubeski et al., 1996). Pantothenic acid and ascorbate have been shown to be required for 
glucocorticoid synthesis in nonruminants and pyridoxine is an important regulator of 
glucocorticoid function (Dubeski et al., 1996). In addition the supplementation of 
ascorbate and pyridoxine has demonstrated improvement in cortisol-induced 
immunosuppression human subjects and laboratory animals (Dubeski et al., 1996).  
Ascorbate occurS in higher concentrations in leukocytes than other tissues and 
these levels are decreased by viral infections or stress (Apley, 1994). In addition, 
interferon production, lymphocyte proliferation, and antigen clearance are all effected by 
ascorbate concentrations within the body (Apley, 1994). In a clinical experiment 
evaluating the effects of ascorbate on neutrophil function in steers, supplemental vitamin 
C resulted in increased neutrophil oxidative metabolism and tended to increase the ability 
of neutrophils to phagocytize S. aureus (Apley, 1994). As observed with the other 
immuno-modulating ANCs, the published research supporting the use of vitamins as an 
ANC for BRD is lacking and has been inconsistent. 
Some of the most comprehensive reviews of ANC for BRD have been conducted 
by Dr. Mike Apley. In his most recent review presented at the CVC in Kansas City in 
2010, Dr. Apley chose to focus on the published data concerning the use of steroidal anti-
inflammatory drugs and NSAID as an ANC for BRD. In this review, the author cites 
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multiple studies that demonstrate that NSAID have some beneficial effect as an ANC 
with the most typical response being a reduction in rectal temperature in calves treated 
with an NSAID (Apley, 2010). Other clinical responses to NSAID were inconsistent 
(Apley, 2010). Apley (2010) concluded that there was no published data at the current 
time that supported the use of antihistamines, B vitamins, DFM, vaccines, or vitamin C as 
ANCs for BRD. 
 
Prevalence of ANC use in feedlots 
There has not been justification in the published research for the use of many if 
not all ANCs in the treatment of BRD, and the published research that supports the use of 
ANC is lacking and produced inconsistent results. However, it is still very common to 
provide ANC, along with an antimicrobial when treating calves for suspected BRD in 
feedlots. The best evidence of the prevalence of ANC use in feedlots is found in large-
scale surveys of consulting veterinarians and feedlot operators. There are 3 large-scale 
surveys that have been conducted since 1999 that provided substantial evidence as to the 
scope of ANC use in commercial feedlots.  
In 1999, USDA’s NAHMS surveyed feedlots in the top 12 cattle feeding states. 
The feedlots represented 84.9% of all U.S. feedlots at the time and controlled 96.1% of 
U.S. cattle on feed on January 1, 2000, in feedlots with a 1,000-head-or-more capacity 
(NAHMS, 2001). The survey noted that only 12.8% of these feedlots used a single 
antimicrobial for the treatment of BRD, and that the use of 2, 3, or 5 products in 
combination for BRD treatment was more common than using a single antimicrobial 
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(NAHMS, 2001). The survey found that the most frequent forms of ANC used in 1,000 
head or greater capacity feedlots were: respiratory vaccines, NSAID, antihistamines, B 
vitamins, a single dose DFM, electrolytes and fluids, corticosteroids, and vitamin C, 
respectively (NAHMS, 2001).  
More recently, Terrell et al. (2011) conducted a survey of 23 feedlot consulting 
veterinarians that represented approximately 34% of all cattle on feed in the U.S. The 
authors reported that 48% of veterinarians recommended some form of ANC for the 
treatment of BRD (Terrell et al., 2011). The most common ANCs recommended by the 
consulting veterinarians were: vitamin C, NSAID, antihistamines, a single dose DFM, B 
vitamins, viral vaccines, and corticosteroids, respectively (Terrell et al., 2011). When 
considering the prevalence of individual ANCs, vitamin C was recommended twice as 
often as any of the ANCs (Terrell et al., 2011). 
 Also in 2011, USDA’s NAHMS again surveyed feedlots with a capacity of 1,000 
or more head in the top 12 cattle feeding states and found that 55.9% of feedlots used 
NSAID and 39.3% used a respiratory vaccine as a component of the initial BRD 
treatment program for some cattle (NAHMS, 2013). The survey found that the most 
frequent forms of ANC used in 1,000 head or greater capacity feedlots were: NSAID, 
respiratory vaccines, corticosteroids, a single dose DFM, B vitamins, antihistamines, 
electrolytes and fluids, and vitamin C, respectively (NAHMS, 2013). When looking at the 
percentage of cattle receiving specific ANCs as a component of initial BRD treatment, 
48.5% of cattle received a respiratory vaccine and 34.1% received vitamin C (NAHMS, 
2013). The most frequent forms of ANC given on a percentage of cattle basis were: 
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respiratory vaccines, vitamin C, NSAID, corticosteroids, electrolytes and fluids, a single 
dose DFM, B vitamins, and antihistamines, respectively (NAHMS, 2013). 
Regardless of the survey, the most commonly used forms of ANC have not 
changed greatly in recent years. However, the prevalence of use of individual ANCs does 
vary from survey to survey over time. In addition, differences in ANC use are observed if 
the use of ANC is estimated by evaluating the percent of feedlots or consultants using or 
recommending a specific ANC or by evaluating the total percent of cattle receiving a 
respective ANC. Irrespective of the survey, the most commonly used forms of ANC 
included: antihistamines, B vitamins, corticosteroids, DFM, electrolytes and fluids, 
NSAID, viral vaccines, and vitamin C, in no particular order (NAHMS, 2001; Terrell et 
al., 2011; NAHMS, 2013). These surveys provide a great deal of evidence as to the scope 
of ANC use feedlots, but no evidence as to the efficacy of these ANCs.  
 
Effects of ANC use on the immune status and clinical health of calves 
While the use of ANC may not be justified by results within the literature, 
providing ANC along with an antimicrobial when treating calves for BRD is still 
incredibly popular with veterinarians and feedlot managers. NAHMS (2013) cited 
respiratory vaccines, vitamin C, NSAID as the 3 most frequent forms of ANC given to 
cattle treated for BRD on a percentage of cattle basis. When reviewing the published 
research concerning the use of these 3 ANCs in calves treated for BRD, it becomes 
obvious that this area of research is deficient and produced very inconsistent results at 
present. There is limited published research concerning the effectiveness of various forms 
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of ANC and no published research comparing multiple commonly administered ANCs 
within a single experiment or across similar groups of calves.  
The vaccination of healthy calves for respiratory viral pathogens is important for 
preventing BRD and maintaining optimal calf health. However, there is little justification 
for the vaccination of high-risk calves at arrival to the feedlot even though it is a 
widespread and accepted management practice (Edwards et al., 2010; Taylor et al., 
2010b). Some epidemiologic studies have actually suggested that the vaccinating of 
calves upon arrival to the feedlot for respiratory viruses actually leads to increased BRD 
incidence (Taylor et al., 2010b). In addition, most published vaccine research has focused 
on comparing different multivalent vaccines and the majority of vaccine studies do not 
include a non-vaccinated negative control. As a result, it is extremely difficult to 
determine if vaccination at arrival aids in the prevention of BRD or if it actually may be a 
detrimental to calves. Currently, to the author’s knowledge, there are no published studies 
examining the use of vaccines as an ANC for BRD. This is extremely surprising given 
that NAHMS (2013) reported that a respiratory vaccine was used as a component of the 
initial BRD treatment program in 39.3% of feedlots, and that 48.5% of cattle received a 
respiratory vaccine as part of initial BRD treatment. 
Cusack et al. (2005) examined the physiological effects and performance of 
feeding additional vitamin E and ruminally-protected vitamin C in cattle challenged with 
BHV1. Angus and Angus crossbred heifer calves were randomly allocated 4 
experimental diets in a 2x2 factorial arrangement (Cusack et al., 2005). The diets fed by 
Cusack et al. (2005) provided either 15 or 185 IU of vitamin E per kg of DM, with or 
without 3.7 g of ruminally-protected vitamin C per kg of DM. The feeding of ruminally-
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protected vitamin C did not result in greater mean plasma ascorbate concentrations, but 
did result in lower mean total superoxide dismutase concentration in the blood. The 
feeding ruminally-protected vitamin C did not significantly impact DMI, ADG, or G:F 
(Cusack et al., 2005). There were interactions between vitamin E and vitamin C leading 
the authors to conclude that vitamin C may exert physiological effects without increasing 
plasma concentrations of ascorbate (Cusack et al., 2005). Cusack et al. (2005) also stated 
that the feeding of ruminally-protected vitamin C might have caused more significant 
effects on the performance and physiological effects of challenged calves had virus 
challenge been more severe. 
In another experiment, Cusack et al. (2005) examined the effects of injectable 
vitamin C given at the time of BRD treatment on subsequent cattle health. At the time of 
BRD treatment, 176 head cattle were alternately administered injectable vitamin C (5 g 
per head) or not injected (Cusack et al., 2005). Fewer of the cattle injected with vitamin C 
at the time of BRD treatment died later in the experiment compared to those cattle that 
were not injected (11% vs. 23%, respectively) (Cusack et al., 2005). This finding led the 
authors to conclude that mortality rate in cattle with BRD may be reduced by 
administering injectable vitamin C at the time of antimicrobial administration.  
Urban-Chmiel et al. (2011) evaluated the effects of vitamin E and vitamin C on 
the development of inflammation processes and selected defense mechanisms against 
MH-induced infections. Simmental calves were assigned to 3 treatments and received 
subcutaneous injections of vitamin E (750 IU), vitamin C (2.5 g per head), or no vitamin 
injection (Urban-Chmiel et al., 2011). Calves receiving either of the vitamin injections 
demonstrated a difference in the sensitivity of leukocytes to the cytotoxic effect of LKT 
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when compared to the control group (Urban-Chmiel et al., 2011). There were no 
differences observed in the percentage of cells sensitive to LKT between the calves 
receiving vitamin E and those receiving vitamin C (Urban-Chmiel et al., 2011). The 
authors concluded that both vitamin E and vitamin C exerted a protective effect on 
leukocytes aiding in the defense against MH virulence factors when administered by 
injection (Urban-Chmiel et al., 2011). Urban-Chmiel et al. (2011) also suggested that 
these vitamins can be used to support the treatment of BRD in cattle following transport. 
Hellwig et al. (2000) examined the use of the NSAID flunixin meglumine as an 
ANC for BRD in stocker calves purchased from local livestock auctions. Calves with 
clinical signs of BRD were randomly assigned either a flunixin meglumine and tilmicosin 
phosphate treated group or tilmicosin phosphate only treatment group (Hellwig et al., 
2000). The calves receiving tilmicosin phosphate and flunixin meglumine had a higher 
percentage of treatment successes (88% vs. 61%) and a lower combined percentage of 
treatment failures and BRD relapses (5% vs. 38%) than those calves receiving only 
tilmicosin phosphate (Hellwig et al., 2000). In addition, Hellwig et al. (2000) found that 
the treatment cost for calves receiving the combination of the NSAID and antimicrobial 
tended to be less than the treatment cost for calves receiving the antimicrobial alone. Calf 
ADG was not different among experimental treatments (Hellwig et al., 2000). Based on 
the clinical results, Hellwig et al. (2000) concluded that the flunixin meglumine 
tilmicosin phosphate combination was more successful for treating BRD than tilmicosin 
phosphate alone. 
Abundant research and some of the most comprehensive reviews of the use of 
ANC for BRD have been conducted by Dr. Mike Apley. In a recent review of the 
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research concerning ANC use presented in 2010, Dr. Apley also chose to focus on the 
published data concerning the use of anti-inflammatory drugs as an ANC for BRD. In 
this review, multiple studies that demonstrate that NSAID have some beneficial effect as 
an ANC are cited with the most typical response observed being a reduction in rectal 
temperature in calves treated with an NSAID (Apley, 2010). Apley (2010) determined 
that other clinical responses to NSAID as an ANC were inconsistent. In regard to the use 
of other ANCs, Apley (2010) concluded that no data published at the current time 
supported the use of vaccines, vitamin C, or other ANCs for BRD. 
Francoz et al. (2012) performed an exhaustive search of the data and then 
conducted a comprehensive review of the literature concerning the use of ANC for BRD. 
In order to be included in the review, experiments must have involved the treatment of 
naturally occurring BRD with antimicrobials and with and without at least 1 ANC. As a 
result, experimental models, BRD prevention studies, studies evaluating an ANC without 
a control group, or studies including different antimicrobials in the treatment groups were 
not included. These stipulations resulted in only 15 articles meeting the criteria (Francoz 
et al., 2012). Of those experiments, 14 dealt with anti-inflammatory drugs (12 NSAID 
experiments, 1 steroidal anti-inflammatory drug experiment, and 1 experiment containing 
both a steroidal anti-inflammatory drug and NSAID) and 1 dealt with immune-
modulators (Francoz et al., 2012). 
In reviewing the data related to the use of NSAID as an ANC to BRD, the authors 
concluded that NSAID caused a more rapid decrease in rectal temperature of calves, but 
did not have any benefit clinical signs, mortality, or calf performance (Francoz et al., 
2012). The authors also mentioned that published data were somewhat lacking and too 
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inconsistent to conclude NSAID used for ANC have any effect on animal performance or 
mortality (Francoz et al., 2012). The reviewers also suggested that NSAID have the 
potential to decrease lung lesions at slaughter, but lung consolidation was only evaluated 
in 2 of the studies (Francoz et al., 2012). It can be argued that reduction in rectal 
temperature and the potential to reduced lung lesions resulting from NSAID 
administration may be important from an animal welfare perspective (Francoz et al., 
2012). However, it is extremely difficult to justify the economics of NSAID use based on 
inconsistent improvements in clinical signs and the lack of performance benefit seen in 
calves (Francoz et al., 2012). As a result of only 1 additional ANC experiment being 
evaluated outside of the anti-inflammatory drug experiments, the authors concluded that 
there was no published data at the current time that supported the use of vaccines, vitamin 
C, or other ANCs for BRD (Francoz et al., 2012). 
The use of NSAID as an ANC for BRD has been researched more than the use of 
any other ANC. In addition, NSAID seem to provide the most consistent response of all 
of the ANCs that have been examined. The use of vaccines as an ANC for BRD has been 
not been researched to date, even though the practice is widespread. While there are some 
experiments that suggest vitamin C has other immuno-modulating capabilities as an 
ANC, the published research supporting the use of vitamins as an ANC for BRD is 
somewhat deficient and has proven inconsistent to date. While there is potentially some 
justification for the use of NSAID as an ANC from an animal welfare perspective, no 
clinical experiments justifying the use of NSAID as an ANC from an economical or 
animal performance perspective exist currently. 
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TRACE MINERAL SUPPLEMENTATION FOR FEEDLOT CATTLE 
In addition to ANCs, the feedlot industry has investigated the use of nutritional 
additives in an attempt to improve the response of calves treated for BRD. One such 
group of nutritional additives that has received much consideration would be TM. 
Although TM make up less than 0.01% of the total mass of an organism and are required 
in extremely small amounts within the diet, many TM are essential for proper growth, 
development, and immune function.  Trace mineral requirements are not well defined, 
and deficiencies are difficult to isolate due to the inconspicuousness of deficiency signs 
and the complex interactions that exist within mineral metabolism.  
The supplementation of TM has been demonstrated to alter immune function 
measurements and reduce morbidity associated with BRD in some cases (Galyean et al., 
1999). However, other experiments have shown no improvements in performance or 
health variables from the supplementation of TM. Overall, TM research has been very 
inconsistent when investigating the ideal concentrations and sources of TM 
supplementation needed for optimum results. Organic mineral complexes have been 
shown to be more bioavailable than traditional inorganic mineral sources in some cases. 
This increased bioavailability is a result of chelated mineral complexes being less likely 
bound to other substances within the upper gastrointestinal tract and thus allowing the 
mineral to be more readily absorbed across the brush border of the small intestine. The 
increased bioavailability of organic TM could potentially allow for improved TM status 
within the animal in an immune challenge scenario such as a BRD event. 
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The supplementation of TM including Cu, Mn, and Zn has been a common 
management practice within the feedlot industry for many years and often times these 
TM are frequently included at levels in excess of published requirements in feedlot diets 
(Vasconcelos and Galyean, 2007). The primary resource cited for TM supplementation 
within feedlot diets would be the NRC (2000) Nutrient Requirements of Beef Cattle. 
Some of the most relevant information available concerning TM in feedlots comes from 
the published surveys of consulting feedlot nutritionists. From the survey data, the 
average and most common TM concentrations in feedlot diets are gleaned. While the 
dietary concentration of specific TM varies some over time as a result of the use of 
different feed ingredients and increased research, the overall supplement of specific TM 
has been relatively consistent in recent years.  
With respect to actual TM inclusion practices in feedlot diets, 29 consulting 
feedlot nutritionists indicated recommended concentrations of TM typically 1 to 2 times 
the NRC (2000) recommendations for beef cattle (Vasconcelos and Galyean, 2007). 
Interestingly, the average concentrations of TM recommended by the nutritionists in 2007 
survey were greater than the concentration of the same TM reported in the previous 
Galyean and Gleghorn (2001) survey. The supplementation of TM at levels exceeding 
published nutrient requirements perhaps reflects a goal to err on the side of caution in 
ration formulation, thus providing a safety factor for both the consulting nutritionist and 
the feedlot operator (Vasconcelos and Galyean, 2007). Another possible explanation 
would be that consulting nutritionists supplement TM exceeding published nutrient 
requirements in order to compensate for a potential depressed TM status of calves 
entering the feedlot. 
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Justification for Cu, Mn, and Zn supplementation: Proposed immune system 
modulation 
While the supplementation of TM is not a new management practice, it is 
becoming increasingly common to include selective TM such as Cu, Mn, and Zn in 
feedlot diets at levels that exceed published nutrient requirements (Vasconcelos and 
Galyean, 2007). While these TM make up very small percentage of a calf’s body mass 
and are required in extremely small amounts within the diet, it has been well established 
that certain TM are essential for overall performance and immune function. In addition to 
general health and immune function mechanisms, the supplementation of TM has been 
demonstrated to alter specific immune function measurements and reduce morbidity 
associated with BRD in some cases (Galyean et al., 1999). However, other experiments 
have demonstrated no improvements in performance or health variables from the 
supplementation of TM. The role of TM in immune function, combined with the 
unknown TM status of newly received calves may serve as an explanation for increased 
TM inclusion in feedlot diets even though justification of the practice is not necessarily 
supported by the literature. 
Copper is important for hemoglobin formation and iron (Fe) absorption, plays and 
role in bone and connective tissue metabolism, and is necessary for adequate immune 
function. Copper serves as an essential component of enzymes including lysyl oxidase, 
cytochrome oxidase, superoxide dismutase, ceruloplasmin, and tyrosinase. In human 
medicine, Cu has demonstrated a key role in the development and maintenance of a 
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healthy immune system. Multiple experiments have established that Cu status within the 
body alters several aspects of neutrophil, monocyte, and T-cell function (Wintergerst et 
al., 2007). The Cu-containing enzyme superoxide dismutase, which functions in the 
antioxidant defense against reactive oxygen species, is essential in the disproportionation 
reaction that converts the superoxide anion to oxygen and hydrogen peroxide 
(Wintergerst et al., 2007). This disproportionation reaction diminishes damage to lipids, 
proteins, and DNA (Wintergerst et al., 2007). Published data demonstrating the effects of 
Cu on the immune response are somewhat limited. This is partially a result of a reduced 
ability to accurately measure marginal to moderate Cu deficiency in humans due to a lack 
of specific biomarkers and the fact that Cu status is maintained over a wide range of 
dietary Cu intakes (Wintergerst et al., 2007). 
Manganese plays an important role in growth, bone development, muscular 
coordination, and carbohydrate and lipid metabolism. Manganese serves as an essential 
component of enzymes including pyruvate carboxylase, arginase, superoxide dismutase, 
and others. When laser ablation inductively coupled plasma mass spectrometry was used 
to categorize metal distribution within tissue sections, it was revealed that tissue 
abscesses caused by Staphylococcus aureus were virtually devoid of detectable Mn 
(Kehl-Fie and Skaar, 2010). However Kehl-Fie and Skaar (2010) reported that there were 
extremely high levels of Mn in the surrounding healthy tissue. While all of the factors 
responsible for the sequestering Mn are unknown, the lack of Mn within the abscess 
seems to represent an employed strategy to help control infection (Kehl-Fie and Skaar, 
2010). These results along with additional data involved in the protein mediated transport 
of Mn suggest a role for extracellular manganese binding and intracellular manganese 
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transport in the defense against bacterial infection (Kehl-Fie and Skaar, 2010). In 
addition, the antioxidant enzyme manganese superoxide dismutase functions in the 
antioxidant defense against oxidative stress similar to Cu-containing superoxide 
dismutase. Published data demonstrating the effects of Mn on the immune response are 
more limited that either Zn or Cu. Limited data would suggest that toxic levels of Mn 
may actually impair immune function. 
Zinc is important for bone and skin development, is an essential component of a 
number of important metabolic enzymes for protein and carbohydrate metabolism, and is 
necessary for adequate immune function. In addition, enzymes that require Zn are 
involved in protein, nucleic acid, and carbohydrate metabolism as well as enzymes 
associated with immune function. The many immune-related functions of Zn are well 
documented within human medicine. In vitro and in vivo studies have demonstrated the 
antioxidant activity of Zn as a cofactor of superoxide dismutase, through the binding and 
stabilization of protein thiols (Wintergerst et al., 2007). In addition, Zn is involved in the 
defense against oxidative stress caused by reactive oxygen species produced by activated 
macrophages (Wintergerst et al., 2007). The thymic hormone thymulin, which requires 
Zn as cofactor, induces multiple T-cell markers, and encourages T-cell function 
(Wintergerst et al., 2007). Cytokine release by peripheral blood mononuclear cells is also 
controlled by Zn (Wintergerst et al., 2007). 
Ho et al. (2003) stated that a Zn deficiency in human lung fibroblasts has resulted 
in induced oxidative stress and increased DNA damage and p53 protein expression. This 
caused subsequent reduced antioxidant defense and diminished DNA repair mechanisms, 
which resulted in the lung fibroblasts becoming susceptible to oxidative DNA damage 
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(Ho et al., 2003). A Zn deficiency also impairs macrophage functions (phagocytosis, 
intracellular killing activity), neutrophil functions (chemotaxis, generation of the 
oxidative burst), and natural killer cell activity (Ibs and Rink, 2003). Deficiency of Zn 
can also cause an imbalance in helper T cell functions. In a Zn deficiency experiment the 
Th2 cytokine production response was not affected while the Th1 cytokine response was 
decreased (Wintergerst et al., 2007). Wintergerst et al. (2007) also stated that a deficiency 
of Zn has resulted in decreased serum thymulin activity, decreased recruitment of T-naïve 
cells, and a reduction in precursors of cytolytic T cells. 
The TM Cu, Mn, and Zn have been demonstrated to play a role in immune 
function in both human and animal experiments. There is infinitely more research 
concerning the supplementation of TM and their relation to immune function in human 
medicine. In human medicine and lab animal models the published data demonstrating 
the effects of Cu on the immune response are more limited than those of Zn, and data 
demonstrating the effects of Mn on the immune response are more limited still. However, 
there is sufficient evidence in both the classical and recent literature to substantiate the 
role of Cu and Zn in immune function. The role of Mn in immune function is still not 
well defined. In addition, the research concerning the additional supplementation of TM 
to feedlot cattle has been very inconsistent. As such, the use of TM as an ANC or the 
feeding of TM in excess of published requirements when calves are not in a state of 
deficiency has not demonstrated consistent positive results. 
 
Typical Cu, Mn, and Zn supplementation strategies in feedlots 
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There is some justification in the published research for role of TM in immune 
function. However, the published research concerning the supplementation of Cu, Mn, or 
Zn at levels greater than published requirements or as an ANC is lacking and has 
produced inconsistent results. As such, there is likely no justification for overfeeding of 
these TM or for the use of these TM as an ANC at the current time. Regardless, the 
supplementation of TM including: Cu, Mn, and Zn has become a normal management 
practice within the feedlot industry for many years primarily to avoid unwanted 
deficiencies and promote maximum animal performance.  
Both consulting nutritionists and academic researchers cite the NRC (2000) 
Nutrient Requirements of Beef Cattle as the primary resource when formulating TM 
supplementation levels in feedlot diets. For growing and finishing cattle, TM 
requirements reported in the NRC (2000) are 10 mg/kg for Cu, 20 mg/kg for Mn, and 30 
mg/kg for Zn. Interestingly, these TM are frequently included in commercial feedlot diets 
at levels in excess of published requirements (Vasconcelos and Galyean, 2007). The best 
evidence available for the prevalence of TM supplementation and typical dietary TM 
levels in feedlots is found in large-scale surveys of consulting feedlot nutritionists. Two 
large-scale surveys conducted since 2000 provide substantial evidence of TM inclusion 
levels in commercial feedlots.  
In 2000, Galyean and Gleghorn (2001) surveyed consulting feedlot nutritionists 
representing practices in all of the major cattle feeding areas of the U.S. including the 
Midwest, High Plains, and Southwest. The survey reported the mean and mode TM 
inclusion levels in both receiving and finishing feedlot diets (Galyean and Gleghorn, 
2001). The mean inclusion level for Cu in receiving diets was 20.42 mg/kg with 20 
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mg/kg being the most recommended inclusion level for Cu (Galyean and Gleghorn, 
2001). For Mn, the mean inclusion level in receiving rations was 49.33 mg/kg with 50 
mg/kg of Mn being the concentration recommended by the most consulting nutritionists 
(Galyean and Gleghorn, 2001). In regards to Zn, consulting nutritionists included a mean 
concentration of 94.06 mg/kg in receiving diets with 150 mg/kg of Zn being the most 
recommended concentration (Galyean and Gleghorn, 2001).  
Interestingly, all 3 TM were included in receiving diets at average concentrations 
of 2 to 3 times greater than published TM nutrient requirements. This increased 
supplementation of TM relative to published nutrient requirements perhaps reflects a goal 
to err on the side of caution in ration formulation, thus providing a safety factor for both 
the consulting nutritionist and the feedlot operator (Vasconcelos and Galyean, 2007). 
Another possible explanation could be that consulting nutritionists choose to supplement 
TM at 2 to 3 times the published nutrient requirements in order to compensate for low 
DMI intakes of calves during the beginning of the receiving period or to compensate for a 
potential depressed TM status of calves entering the feedlot. Finally, the supplementation 
of these TM in excess of published requirements could result from the ability of Cu, Zn, 
and Mn to alter immune function measurements and reduced morbidity associated with 
BRD in some cases (Galyean et al., 1999). 
The mean Cu inclusion level in finishing rations was 14.75 mg/kg with 20 mg/kg 
being the most recommended Cu inclusion level (Galyean and Gleghorn, 2001). In the 
case of Mn, the mean inclusion level in finishing diets was 38.28 mg/kg with 40 mg/kg of 
Mn being the concentration recommended by the most consulting nutritionists (Galyean 
and Gleghorn, 2001). Regarding Zn, consulting nutritionists included a mean 
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concentration of 74.03 mg/kg in finishing rations with 50 mg/kg being the most 
recommended Zn concentration (Galyean and Gleghorn, 2001). The same trend observed 
with the receiving diets was also observed in the finishing diets. All 3 TM were included 
in finishing rations at average concentrations that were greater than published TM 
nutrient requirements. However, the average concentrations of the 3 TM included in 
finishing diets were approximately 75% of those included in the receiving diets. This 
decrease in over formulation as cattle are transitioned from receiving diets to finishing 
diets suggests that the increased TM supplementation observed in receiving diets is not 
simply a reflection of the goal to err on the side of caution in ration formulation. Rather it 
is also a likely a function of consulting nutritionists attempting to compensate for low 
DMI intakes of calves during the beginning of the receiving period, a potential depressed 
TM status of calves entering the feedlot, or a perceived benefit to immune function 
measurements and reduced BRD associated morbidity.  
Vasconcelos and Galyean (2007) surveyed consulting feedlot nutritionists 
representing practices in Texas, Kansas, and Oklahoma (46.43% of respondents); Iowa, 
Nebraska, Colorado, and South Dakota (31.25% of respondents); Washington and Idaho 
(8.93% of respondents); Arizona and California (6.25% of respondents); and other states 
(7.14% of respondents). The 29 respondents represented more than 18 million head of 
cattle on feed per year or slightly more than 69% of the cattle on feed in the U.S. annually 
based on USDA estimates (Vasconcelos and Galyean, 2007). In this survey the mean and 
mode TM inclusion levels were reported for finishing feedlot diets only (Vasconcelos and 
Galyean, 2007). In 2007, the mean Cu inclusion level in finishing rations was 17.61 
mg/kg with 20 mg/kg being the most recommended Cu inclusion level (Galyean and 
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Gleghorn, 2001). For Mn, the mean inclusion level in finishing diets was 47.86 mg/kg 
with 50 mg/kg of Mn being the concentration most commonly recommended by 
consulting nutritionists (Galyean and Gleghorn, 2001). For Zn, consulting nutritionists 
included a mean concentration of 92.95 mg/kg in finishing rations with 100 mg/kg being 
the most recommended Zn concentration (Galyean and Gleghorn, 2001). 
The same trend in the 2000 survey was observed in the 2007 survey with all 3 TM 
being included finishing rations at average concentrations greater than current published 
TM nutrient requirements. Interestingly, the recommended concentrations of Cu, Mn, and 
Zn in the 2007 survey were higher than the recommended concentration of Cu, Mn, and 
Zn reported by consulting nutritionists in the 2000 survey. The TM concentrations 
recommended for finishing diets in the 2007 survey nearly exactly match recommended 
TM concentrations of receiving diets in the 2000 survey. This resulted in an 
approximately 25% increase in the concentration of Cu, Mn, and Zn in finishing rations 
from 2000 to 2007.  
From the surveys, it is apparent the supplementation of TM has increased in 
recent years. It is also clear that Cu, Mn, and Zn are frequently included in commercial 
feedlot diets at levels 2 to 3 times greater than the published requirements for these TM 
(Vasconcelos and Galyean, 2007). It would be interesting to know the TM inclusion 
levels in receiving diets in 2007. Because Vasconcelos and Galyean (2007) did not report 
receiving diet information, it is unknown if TM inclusion levels increased in receiving 
rations at the same rate from 2000 to 2007. It is possible the concentration of Cu, Mn, and 
Zn in finishing rations in 2007 was increased to mimic the concentration of TM seen in 
2000 receiving diets while the concentration of TM in receiving diets in 2007 remained 
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relatively constant. It would also be helpful to have a more recent survey to see if the 
trend for increased TM supplementation in feedlot diets has continued or if it has 
plateaued since 2007. 
 
Effects of Cu, Mn, and Zn supplementation on the immune status and clinical health 
of calves 
The supplementation of TM including Cu, Mn, and Zn has been a longstanding 
management practice within the feedlot industry primarily to avoid unwanted deficiencies 
and promote maximum animal performance. In addition, there is some evidence 
suggesting these TM play a role in the improving the clinical health the immune function 
calves. However, the published research concerning the supplementation of Cu, Mn, or 
Zn at levels greater than published requirements or as an ANC is somewhat lacking and 
has produced inconsistent results to date. Regardless, the inclusion of these 3 TM in 
feedlot diets at concentrations 2 to 3 times greater than published requirements is still 
incredibly popular with feedlot nutritionists. The role of TM in immune function, 
combined with the unknown TM status of newly received calves and expected depressed 
DMI early in the receiving period may serve as a possible explanation for increased TM 
inclusion even though justification of the practice is not necessarily supported by the 
published literature.  
Much of the available literature concerning Cu supplementation comes from 
classical Cu deficiency studies. Stabel et al. (1993) fed Holstein steers a semi-purified 
diet containing only 1.5 mg of Cu/kg and supplemented with no Cu or 10 mg of Cu/kg 
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for 5 months and then challenged with IBR followed by MH. Serum ceruloplasmin and 
plasma Cu were both significantly higher in Cu supplemented calves and increased after 
the MH challenge (Stabel et al., 1993). In addition, Cu concentrations were higher in all 
tissues for Cu supplemented calves (Stabel et al., 1993). Serum immunoglobulin M 
tended to be higher in Cu supplemented calves and increased for all calves after the IBR 
challenge (Stabel et al., 1993). Stabel et al. (1993) observed significantly higher serum 
IBR antibody titers in the calves that received no Cu supplementation. In contrast, 
antigen-specific antibodies to MH tended to be higher in Cu supplemented calves on day 
21 post challenge (Stabel et al., 1993). The supplementation of Cu did not affect the 
blastogenic response of lymphocytes and phytohemagglutinin-stimulated blastogenesis 
was higher in both treatments after the IBR challenge. 
Arthington et al. (1996) examined the effects of dietary Cu depletion and 
subsequent repletion on acute-phase protein concentrations, superoxide dismutase 
activity, leukocyte numbers, and lymphocyte proliferation in Hereford x Angus crossbred 
heifers. Heifers were assigned to either a control experimental treatment or a Cu deficient 
experimental treatment (Arthington et al., 1996). The Cu deficiency was induced in the 
Cu deficient heifers through the addition of sulfur at 0.3% of the diet and Molybdenum 
(Mo) to achieve a Mo:Cu ratio of 2.5:1 (Arthington et al., 1996). Arthington et al. (1996) 
fed the control heifers the basal diet (6.2 mg/kg Cu) with additional CuSO4 to bring the 
total Cu level to at least 8 mg/kg of Cu. All dietary treatments were delivered for 129 
days followed by inoculation with BHV1 (Arthington et al., 1996).  
To ensure adequate Cu stores before viral challenge the control heifers were given 
an injection of cupric glycinate on day 100 and on the day of BHV1 challenge the Mo 
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supplemented heifers had liver Cu levels of 23.2 mg/kg and the control heifers had liver 
Cu levels of 90.1 mg/kg (Arthington et al., 1996). Arthington et al. (1996) noted that 
ceruloplasmin was increased by 48 hours post challenge in the control heifers, but was 
not increased in the Mo supplemented heifers. Neutrophils were increased on day 129 for 
the Mo supplemented Cu deficient heifers (Arthington et al., 1996). Plasma fibrinogen 
was increased by 48 hours after challenge in Mo-supplemented heifers (Arthington et al., 
1996). In addition, erythrocyte superoxide dismutase activity was less for Mo 
supplemented heifers on d 129. The lymphocyte proliferative response to 
phytohemagglutinin was greater for Mo supplemented heifers post BHV1 challenge. 
Sharma et al. (2005) examined Cu status and immune function in Cu deficient 
heifers supplemented with mineral mixture containing Cu sulfate (CuSO4) or the same 
mineral mixture with salt replacing the CuSO4. Sharma et al. (2005) observed a 
significant improvement in serum ceruloplasmin after 30 days and a significant 
improvement in monoamine oxidase and liver cytochrome oxidase after 60 days on the 
experimental treatments for the Cu supplemented animals. In addition, Cu supplemented 
heifers demonstrated significant improvements in hemoglobin levels, total leukocyte 
counts, and total erythrocyte counts compared to heifers not receiving Cu 
supplementation after 30 days on their respected treatments (Sharma et al., 2005). When 
evaluating the effects of Cu supplementation on immune function, Sharma et al. (2005) 
detected that the phagocytic activity of neutrophils against Candida albicans was 
significantly improved for those heifers supplemented with CuSO4 after 60 days of 
treatment. Significant improvements in superoxide dismutase activity in RBC, WBC, and 
whole blood were observed for Cu supplemented heifers. 
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The supplementation of Cu or adequate dietary Cu inclusion has demonstrated 
positive effects on immune function in cases of natural or induced Cu deficiencies in 
many other experiments. Xin et al. (1991) demonstrated that Cu status affected the 
distribution of Cu within tissues and affected Cu related enzyme activities as well as 
bactericidal function of neutrophils. Gengelbach et al. (1997) observed superoxide 
dismutase activity was higher for control or Cu supplemented calves compared to Mo 
supplemented calves, and that bactericidal activity of neutrophils from Cu supplemented 
calves tended to be higher than that of Mo supplemented calves. After an IBR and MH 
challenge, the Cu supplemented calves had higher levels of plasma tumor necrosis factor 
than MO supplemented calves at weaning and tended to have higher plasma tumor 
necrosis factor than MO supplemented calves 5 days after IBR inoculation (Gengelbach 
et al., 1997).  
When additional Cu is added to diets that are not Cu deficient, there seems to be 
little to no effect on immune function. Stress events such as shipping or disease 
challenges have been shown to impact Cu status within the body (Orr et al., 1990; 
Nockels et al., 1993). However, this change in Cu status is generally fairly short lived, 
and does not translate to noticeable changes is immune function or performance. Many 
experiments have shown no improvements in performance or health variables from the 
supplementation of additional Cu in excess of animal requirements. Multiple studies have 
looked at the effect of Cu source on clinical health and immune response of calves, and 
found no relevant differences between organic or inorganic Cu sources (Stanton et al., 
2001; Salyer et al., 2004). In one experiment the source of both Cu and Zn affected the 
humoral immune response to an ovalbumin vaccine although the effects of TM source 
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were not consistent for the 2 minerals (Salyer et al., 2004). Overall, the research 
involving Cu supplementation has been very inconsistent except when a true dietary Cu 
deficiency exists. 
The available data concerning the impact of Mn supplementation on health and 
immune function is scarce, except in experiments were Mn was given in combination 
with 2 or more other TM. Only 1 experiment was found evaluating clinical health or 
immune function involving Mn and 1 other TM. In this experiment, Chirase and Greene 
(2001) observed the effects of organic and inorganic Mn and Zn supplementation. 
Chirase and Greene (2001) examined different dietary sources of Mn and Zn that were 
administered beginning with the fetal stage on the subsequent immune response of transit 
stressed and virus challenged calves. The treatments supplied 40 mg/kg of Mn and 50 
mg/kg of Zn as either through an organic mineral source (Mn and Zn methionine) or 
through an inorganic mineral source (Mn and Zn oxide) (Chirase and Greene, 2001). A 
negative control treatment was not included in the experiment. 
After weaning, calves were shipped to the feedlot and remained on their 
respective treatments (Chirase and Greene, 2001). During a 28 day receiving period, 
steers fed organic Mn and Zn had higher DMI and improved gain compared to steers fed 
inorganic Mn and Zn (Chirase and Greene, 2001). After this 28 day period, Chirase and 
Greene (2001) challenged the calves with IBR. During the challenge phase, steers fed Mn 
and Zn methionine had 20.4% higher DMI than the steers fed Mn and Zn oxide (Chirase 
and Greene, 2001). The steers fed organic Mn and Zn also had lower rectal temperatures 
and retained more weight than those fed inorganic Mn and Zn (Chirase and Greene, 
2001). Chirase and Greene (2001) stated that these data indicated organic Mn and Zn 
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lessened the effects of transit stress and IBR infection of calves better than inorganic Mn 
and Zn. While this experiment does provide some evidence that the feeding of organic 
mineral sources may be beneficial, it demonstrates little about a specific role of Mn in the 
clinical health or immune function of calves. It does not determine if the positive effects 
seen from organic TM supplementation are a result of feeding Mn, Zn, or the 
combination. There is not enough published research to confirm a role for Mn in the 
health and immune function of calves at present. 
Published data regarding the impact of Zn supplementation on the health and 
immune function of calves is less prevalent than that for Cu supplementation, but more 
prevalent than that for Mn supplementation. However, similar to what was observed for 
Mn, it is uncommon to find this research were Zn was the only TM examined, and in 
most experiments Zn was given in combination with other TM. It has been documented 
that stressful events such as transport or a disease challenge have been shown to impact 
Zn status within the body (Orr et al., 1990; Nockels et al., 1993). It has also been shown 
that organic or inorganic sources of Zn source do not relevantly affect the clinical health 
or immune response of calves in multiple studies (Nockels et al., 1993; Stanton et al., 
2001; Salyer et al., 2004). In contrast, Chirase and Greene (2001) suggested that organic 
Zn and Mn lessened the effects of transit stress and IBR infection of calves better than 
inorganic Zn and Mn. In addition, Salyer et al. (2004) did note that the source of Zn or 
Cu affected the humoral immune response to an ovalbumin vaccine although the effects 
of TM source were not consistent for the 2 minerals (Salyer et al., 2004). 
Similar to what is observed for Cu, when supplemental Zn is added to diets that 
are not Zn deficient, there seem to negligible effects on immune function. While stressful 
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events have been shown to impact Zn status, this change in is generally short lived. In 
addition, multiple experiments have shown no improvements in performance or health 
variables resulting from Zn supplementation in excess of animal requirements and found 
no relevant differences between organic or inorganic Zn sources. In summary the 
research concerning Zn supplementation in calves has been very inconsistent to date 
except when a true dietary Zn deficiency exists. 
Varied immune and clinical health responses have been observed in studies where 
a combination of Cu, Mn, and Zn or a combination of 4 or more TM have been 
administered to calves. George et al. (1997) examined the effects of Co, Cu, Mn, and Zn 
sources and amounts on the performance and immune function of stressed heifers. Calves 
were assigned to 3 experimental treatments consisting of inorganic TM at concentrations 
of 7 mg/kg Co, 37 mg/kg Cu, 58 mg/kg Mn, and 106 mg/kg Zn, organic TM at 
isoelemental concentrations, or organic TM supplemented at 3 times this concentration 
for the first 14 days after transport then supplemented at the isoelemental concentrations 
for the remainder of the experiment (George et al., 1997). There were no differences 
observed among the treatments for performance variables over the 42 d experiment 
(George et al., 1997). Calf secondary PI3 antibody titer responses at days 14 and 28 post 
vaccination, skin swelling responses at 21 days post transport and at 12, 24, and 48 hours 
post intradermal phytohemagglutinin antigen injection were better for calves receiving 
organic TM at 3 times the initial concentration than the other organic or inorganic 
isoelemental groups (George et al., 1997). In addition, when calves were fed increased 
organic TM for the first 14 days they experienced a 17.2% reduction in BRD incidence 
when compared to the other organic or inorganic isoelemental groups (George et al., 
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1997). Calves receiving organic TM demonstrated improved antibody titer responses to 
IBR vaccination at days 14 and 28 compared to calves receiving inorganic TM at the 
same concentration (George et al., 1997). The authors concluded that feeding elevated 
organic TM early in the receiving period resulted in significant improvements in primary 
and secondary humoral, and cell-mediated immunity in stressed heifer calves (George et 
al., 1997). 
Rhoads et al. (2003) examined the effects of concentration and source of TM on 
the performance, immunity, mineral and lipid metabolism, and carcass characteristics of 
steers. The TM treatments administered consisted of Co, Cu, Mn, and Zn administered at 
different levels from different sources, and the treatments changed from the receiving 
period to the finishing period (Rhoads et al., 2003). Due to the treatment structure, there 
is little value in direct comparisons between the treatments. However, some information 
can be gleaned from the lack of differences observed to such varied treatments. For 
example, the antibody titer response to IBR was not different among any of the 
treatments suggesting that neither TM source nor concentration impacted the response to 
a viral challenge. The authors concluded that overall results indicated that TM 
concentration and source had minimal effects on performance and immunity (Rhoads et 
al., 2003). 
Kegley et al. (2012) also compared organic Co, Cu, Mn, and Zn to inorganic Co, 
Cu, Mn, and Zn supplementation in livestock auction purchased stressed beef calves. The 
calves that were supplemented with organic TM had heavier final BW and ADG 
compared to the calves that were supplemented with inorganic TM (Kegley et al., 2012). 
In addition, calves that were supplemented with organic Co, Cu, Mn, and Zn tended to 
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receive a second treatment for BRD less often (Kegley et al., 2012). The source of TM 
also impacted antibody response. When allowing for calves that arrived with antibody 
titers to IBR, the naïve calves receiving organic TM had lower antibody responses to IBR 
vaccination (Kegley et al., 2012). Although IBR antibody titers were increased for the 
calves supplemented with inorganic minerals, the fewer calves requiring a second 
antimicrobial for BRD and improved performance for the calves supplemented with 
organic TM would suggest an advantage for organic TM supplementation. 
Arthington and Havenga (2011) and Richeson and Kegley (2011) both examined 
the effects of a single injection of trace minerals on the health and performance of calves. 
Arthington and Havenga (2011) used only 2 treatments, either a subcutaneous injection 
of a TM solution containing 15 mg/mL of Cu, 10 mg/mL of Mn, 5 mg/mL of Se, and 40 
mg/mL of Zn or a saline-injected negative control. Richeson and Kegley (2011) used 3 
treatments: a subcutaneous injection of a TM solution containing 10 mg/mL of Cu, 20 
mg/mL of Mn, 5 mg/mL of Se, and 20 mg/mL of Zn, a subcutaneous injection of a TM 
solution containing 16 mg/mL of Cu, 10 mg/mL of Mn, 5 mg/mL of Se, and 48 mg/mL 
of Zn, or negative control treatment. Arthington and Havenga (2011) discovered that 
calves receiving injectable TM at the time of vaccination experienced greater neutralizing 
antibody titers to BHV1 on days 14, 30, and 60 when compared with receiving a saline 
injection. The results demonstrated that injectable TM do not negatively impact the 
humoral immune response and may enhance the production of neutralizing antibodies to 
BHV1 in naïve beef calves (Arthington and Havenga, 2011). 
Richeson and Kegley (2011) noted that ADG was greater for calves that received 
either of the injectable TM treatments compared to the control calves, but the ADG was 
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not different between the 2 injectable TM treatments. In addition, G:F was improved for 
both of the injectable TM treatments (Richeson and Kegley, 2011). The calves 
administered the TM solution containing 10 mg/mL of Cu, 20 mg/mL of Mn, 5 mg/mL of 
Se, and 20 mg/mL of Zn had a reduced incidence of BRD when compared to the control 
calves, with the other TM solution being intermediate (Richeson and Kegley, 2011). The 
average antimicrobial treatment cost was greater for the control calves than for either of 
the injectable TM treatments (Richeson and Kegley, 2011). These results lead Richeson 
and Kegley (2011) to conclude that the administration of injectable TM to highly stressed 
calves at initial processing can result in improved performance, reduced BRD morbidity, 
and antimicrobial treatment cost. 
The supplementation of TM to beef cattle has been researched for many decades. 
Traditional TM research in beef cattle focused on supplementation in situations of 
existing or induced TM deficiencies. This research has demonstrated a role for individual 
TM in health and immune function. However, the supplementation of individual TM in 
diets that are not deficient in TM seems to have little to no effect on the clinical health 
and immune function of calves. Recent research has focused on the supplementation of 
multiple TM at once and the comparison of organic and inorganic TM sources. The 
results from this research are somewhat inconsistent and difficult to interpret. When 4 
TM are fed or injected in combination, it is impossible to determine the impact of 
individual TM on reported results. In addition, the concentrations of TM making up the 
treatments in these studies are often not isoelemental making direct comparisons invalid. 
While there are some experiments that suggest TM do in fact positively impact the health 
and immune function of calves when supplemented at levels in excess of published 
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requirements or used as an ANC, the published research supporting this practice is 
somewhat deficient and has ultimately proven inconsistent to date.  
 
SUMMARY AND CONCLUSIONS FROM THE LITERATURE 
Bovine respiratory disease is still the most significant production problem 
confronting the feedlot industry, accounting for the majority of morbidity, mortality, and 
production losses that occur in feedlots. Estimated annual economic losses due to BRD 
are approaching or exceeding of $2 billion annually. However, the true cost to the feedlot 
industry when losses in carcass value and the amount of money spent on the prevention 
of BRD are included may be well in excess of $5 billion. Published data would indicate 
that no significant reduction in the prevalence of BRD has occurred over the last 30 to 40 
years (Gifford et al., 2012). This suggests that current BRD prevention and treatment 
strategies are ineffective in reducing and controlling BRD, despite the wealth of BRD 
research and measurable improvements in commercially available vaccines and 
antimicrobials (Babcock et al., 2006). 
Bovine Respiratory Disease is an extremely complicated illness and a multitude 
of risk factors, viruses, and bacterial pathogens can potentially contribute to its onset 
(Duff and Galyean, 2007). The prevention and treatment of BRD continues to be a major 
concern for all of those within the feedlot industry. The standard practice is to administer 
some class of injectable antimicrobial as the primary form of treatment when treating for 
suspected BRD in feedlot cattle. Nearly all feedlots (99.0 percent) used an injectable 
antimicrobial as the initial or primary treatment for BRD (NAHMS, 2013). However, it is 
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also common to provide additional treatment, or ANC, along with the antimicrobial when 
treating calves for BRD.  
The primary goal of ANC would be to improve the response to a BRD challenge 
in calves treated with antimicrobials, not to replace antimicrobial treatment. There are 
some experiments that suggest vitamin C has immuno-modulating capabilities as an 
ANC, but the published research supporting the use of vitamins as an ANC for BRD is 
somewhat lacking and has proven inconsistent. The use of NSAID as an ANC for BRD 
has been researched more than the use of any other ANC and NSAID seem to provide the 
most consistent response of all of the ANCs that have been examined. There is 
potentially some justification for the use of NSAID as an ANC from an animal welfare 
perspective, but no clinical experiments justify the use of NSAID from an economical or 
animal performance perspective. In reviews of ANC research, multiple authors have 
concluded that there is no published data to support the use of vaccines, vitamin C, or 
other ANCs for BRD (Apley, 2010; Francoz et al., 2012). 
In addition to ANC, the feedlot industry has investigated the use of other 
nutritional additives as a method to decrease morbidity and mortality due to BRD, while 
simultaneously enhancing animal performance. The supplementation of TM has been 
demonstrated to alter immune function measurements and reduced morbidity associated 
with BRD in some cases (Galyean et al., 1999). The supplementation with TM including: 
Cu, Mn, and Zn has become a standard management practice within the feedlot industry 
to promote maximum performance and immune function, and these trace minerals are 
frequently included at levels in excess of published requirements in feedlot diets 
(Vasconcelos and Galyean, 2007).  
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However, research concerning TM supplementation has been extremely 
inconsistent. Classical research has demonstrated a role for individual TM in health and 
immune function in the face of a TM deficiency. However, the supplementation of TM in 
diets that are not deficient in TM seems to have negligible effects on the clinical health 
and immune function of calves. More recent research has focused on the supplementation 
of multiple TM and the comparison of organic and inorganic TM sources. These results 
have been somewhat inconsistent and difficult to interpret. While some experiments that 
suggest TM do in fact positively impact the health and immune function of calves when 
supplemented at levels in excess of published requirements or used as an ANC, the 
published research supporting this practice is somewhat deficient and has ultimately 
proven inconsistent. 
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CHAPTER III 
 
 
EVALUATION OF MULTIPLE ANCILLARY THERAPIES USED IN 
COMBINATION WITH AN ANTIMICROBIAL IN NEWLY RECEIVED HIGH-RISK 
CALVES TREATED FOR BOVINE RESPIRATORY DISEASE 
 
ABSTRACT 
Ancillary therapy (ANC) is commonly provided in conjunction with an antimicrobial 
when treating calves for suspected bovine respiratory disease (BRD). This experiment 
evaluated the effects of 3 ANC in combination with an antimicrobial in high-risk calves 
treated for BRD. Newly received crossbred steers (n = 516; initial BW = 217 ± 20 kg) 
were monitored by trained personnel for clinical signs of BRD. Calves that met 
antimicrobial treatment criteria (n = 320) were then randomly assigned to 1 of 4 
experimental ANC: intravenous flunixin meglumine injection (NSAID), intranasal viral 
vaccination (VACC), intramuscular vitamin C injection (VITC), or no ANC (NOAC). 
Steers receiving VACC tended (P = 0.10) to require a second BRD treatment less 
frequently than steers receiving NSAID or NOAC. Calves receiving NSAID or VITC 
tended (P = 0.09) to require a third BRD treatment less often than calves receiving 
NOAC. Of calves treated 3 times for BRD, those receiving NOAC had lower (P = 0.05) 
severity scores than those receiving VACC or VITC and heavier (P = 0.02) BW than 
those receiving NSAID, VACC, or VITC at the time of third treatment. Between the 
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second and third BRD treatments, calves receiving NOAC also had greater (P = 0.03) 
ADG than those receiving VACC or VITC and tended (P = 0.06) to have greater ADG 
than those receiving NSAID. Calves receiving NOAC tended (P = 0.07) to have heavier 
BW on d 28 than NSAID, VACC, or VITC with mortalities and removals excluded. 
There was no difference in rectal temperature among the experimental ANC. When 
contrasted with the average of NSAID, VACC, and VITC with mortalities and removals 
excluded, calves receiving NOAC tended to have heavier BW on d 56 (P = 0.06), greater 
ADG (P = 0.10) and DMI (P = 0.08) from first BRD treatment through d 28, greater DMI 
from d 28 through d 56 (P = 0.06), and had greater DMI from first BRD treatment 
through d 56 (P = 0.05). After the receiving period, a subset of calves (n = 126) were 
allocated to finishing pens to evaluate the effects ANC administration on finishing 
performance, carcass characteristics, and lung scores. No ANC treatment differences 
were observed for any of the variables analyzed in the finishing experiment (P ≥ 0.26). 
Responses observed to the 3 ANC used in these experiments were negligible. The use of 
NSAID, VACC, and VITC do not appear to positively impact clinical health and could 
potentially be detrimental to performance during the receiving period in high-risk 
exposed calves. 
 
Key Words: ancillary therapy, bovine respiratory disease, flunixin meglumine, high-risk 
calves, viral vaccine, vitamin C 
 
INTRODUCTION 
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Bovine respiratory disease (BRD) is the most significant production problem for 
the feedlot industry, accounting for the majority of morbidity, mortality, and decreased 
production in feedlots with estimated annual economic losses in excess of $2 billion 
(Powell, 2013). The standard protocol when treating for suspected BRD in feedlot cattle 
is to administer an injectable antimicrobial. However, it is also common for veterinarians 
to prescribe an additional treatment, or ancillary therapy (ANC), along with the 
antimicrobial. The goal of ANC is to improve the response to a BRD challenge in calves 
treated with antimicrobials, not to replace antimicrobial treatment. This can be 
accomplished by relieving the harmful effects of inflammation, blocking histamine 
activity, or boosting immune system function to aid in the defense against infectious 
pathogens (Apley, 1994). 
In 1999, USDA’s NAHMS surveyed feedlots in the top 12 cattle feeding states 
and noted that only 12.8% of these feedlots used a single antimicrobial for the treatment 
of BRD (NAHMS, 2001). More recently, a survey conducted by Terrell et al. (2011) 
reported that 48% of veterinarians recommended some form of ANC for the treatment of 
BRD. After this experiment was conducted, NAHMS (2013) released an updated survey 
detailing additional ANC use in feedlots. The most common forms of ANC listed in the 
surveys included: antihistamines, B vitamins, corticosteroids, direct-fed microbials 
(DFM), non-steroidal anti-inflammatory drugs (NSAID), viral vaccines, and vitamin C 
(NAHMS, 2001; Terrell et al., 2011; NAHMS, 2013). While these surveys provide 
evidence as to the scope of ANC use, there is limited published research on the efficacy 
of these ANC. The objective of this experiment was to evaluate the effects of 3 of the 
most common ANC used in combination with an antimicrobial on the performance, 
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health, and immune response variables of newly received high-risk calves treated for 
clinical bovine respiratory disease. 
 
MATERIALS AND METHODS 
All procedures for the present experiment were approved by the Oklahoma State 
University Institutional Animal Care and Use Committee (Animal Care and Use Protocol 
AG-12-11). 
 
Cattle description and initial processing 
Over the course of 1 week, 516 crossbred steers and bulls (BW at arrival = 217 ± 
20 kg) were purchased at livestock auctions throughout Oklahoma and transported 
(average distance = 135 km) to the Willard Sparks Beef Research Center at Oklahoma 
State University. Upon arrival at the feed yard, calves were individually weighed and 
visually inspected for noticeable deformities or abnormalities. Hide color, horn status, 
and sex was recorded and an uniquely numbered ear tag was placed in the left ear of each 
calf. Calves were then commingled into holding pens, given ad libitum access to prairie 
hay and water, and allowed to rest 24 to 48 hours prior to initial processing. 
At processing, a blood sample (9 mL) was collected via jugular venipuncture for 
subsequent serum analysis (Corvac™ Serum Separator Tube, Tyco Healthcare Group LP, 
Mansfield MA). Initial processing consisted of vaccination for Infectious Bovine 
Rhinotracheitis (IBR) virus, Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2, 
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Parainfluenza 3 (PI3) virus, and Bovine Respiratory Syncytial Virus (BRSV; BRD 
Shield; Novartis, Greensboro, NC), Clostridium chauvoei, Clostridium septicum, 
Clostridium novyi, Clostridium sordellii and Clostridium perfringens Types C and D 
(Caliber 7; Boehringer-Ingelheim, St. Joseph, MO), and treatment for the control of 
internal and external parasites (Ivomec Plus; Merial, Duluth, GA). Individual BW were 
obtained, bulls (n = 355) were surgically castrated by incising the scrotum with a 
Newberry castrating knife followed by emasculation by a single individual. Any calves 
with horns (n = 57) had their horns tipped with a Keystone dehorner. 
 
Receiving phase pen management and diet 
After processing, groups of calves were gate cut and returned to receiving pens 
where they received ad libitum access to a common receiving ration and water. Receiving 
pens were 12.2 × 30.5 m soil-surfaced open-air pens with 12.2 m concrete bunk at the 
front of each pen. A 76 L concrete water tank (Model J 360-F; Johnson Concrete, 
Hastings, NE) was shared between 2 pens and was cleaned 3 times per week throughout 
the experiment. The common wet corn gluten feed based receiving ration was formulated 
to meet or exceed NRC (2000) nutrient requirements (Table 1). The ration was fed to all 
cattle twice daily at 0700 h and 1300 h in a 274-12B Roto-Mix Forage Express mixer 
wagon (Roto-Mix, Dodge City, KS) to the nearest 0.45 kg of that day’s feed call. Long 
stem prairie hay was fed at 0.454 kg per head per d for 5 d. Ration samples were 
collected once per week and dried in a forced air oven for 48 h at 60ºC to determine DM. 
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Ration samples were composited gravimetrically and analyzed at a commercial 
laboratory (Servi-Tech Inc., Dodge City, KS) for nutrient composition (Table 1). 
 
Assessment for clinical signs of BRD and antimicrobial administration 
Calves remained in the receiving pens and were allocated to an experimental 
ANC only after they were identified as demonstrating subjective clinical signs of BRD, 
met treatment criteria, and were administered an antimicrobial. During the receiving 
period, calves were visually monitored twice daily by trained evaluators throughout the 
experiment for clinical signs characteristic of BRD. The evaluation employed criteria 
based on the DART™ system (Pharmacia Upjohn Animal Health, Kalamazoo, MI) with 
some modifications as described by Step et al. (2008). The subjective criteria used for 
pulling calves consisted of depression, abnormal appetite, and respiratory signs. Signs of 
depression included but were not limited to: depressed attitude, lowered head, glazed or 
sunken eyes, slow or restricted movement, arched back, difficulty standing or walking, 
knuckling of joints or dragging toes when walking, and stumbling. Signs of abnormal 
appetite included: an animal that was completely off feed, an animal eating less than 
expected or eating extremely slow, a lack of gut fill or gaunt appearance, and obvious 
body weight loss. Respiratory signs included: labored breathing, extended head and neck 
(in an attempt to breathe), and audible noise when breathing. The evaluators assigned a 
calf a severity score from 0 to 4 based on the clinical signs and the severity of those 
signs. 
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A score of 0 was assigned for a clinically normal appearing calf. A score of 1 was 
assigned for mild clinical signs, 2 for moderate clinical signs, 3 for severe clinical signs, 
and 4 for a moribund animal. For a calf to be assigned a score of 4, the calf was unable to 
rise, or had extreme difficulty standing, walking, or breathing. These animals required 
immediate assistance. The objective criteria used to determine if antimicrobial treatment 
was necessary was rectal temperature. All calves assigned a severity score of 1 to 4 were 
taken to the processing chute for rectal temperature measurement (GL M-500, GLA 
Agricultural Electronics, San Luis Obispo, CA). Any animal that was pulled with a 
severity score of 1 or 2, and had a rectal temperature of 40°C or greater received an 
antimicrobial according to label instructions. If a calf was pulled with a severity score of 
1 or 2 and had a rectal temperature of less than 40°C, no antimicrobial treatment was 
administered, and the calf was returned to its receiving pen after evaluation. Any animal 
with a severe clinical signs (severity score = 3 or 4), received an antimicrobial according 
to label instructions regardless of rectal temperature. In extreme cases the antimicrobial 
may have been administered in the home pen if the calf was deemed unable to make the 
walk to the working facility. 
Prior to antimicrobial administration, an accurate BW was obtained to calculate 
the appropriate dosage and a blood sample was collected (Corvac™ Serum Separator 
Tube, Tyco Healthcare Group LP, Mansfield MA). Antimicrobial doses were calculated 
by rounding the calf’s current BW up to the nearest 11.3 kg. All antimicrobials were 
administered subcutaneously per manufacturer’s label directions following Beef Quality 
Assurance Guidelines (NCBA, 2001). The first antimicrobial treatment was administered 
on the left side of the animal, and subsequent injections were given on alternating sides of 
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the animal. The severity score, temperature, BW, and antimicrobial dosage administered 
(or no treatment administered) was recorded for every calf that was pulled for exhibiting 
clinical signs of BRD. A maximum of 4 antimicrobial treatments were administered 
during the experiment. 
The first time antimicrobial treatment criteria were met, gamithromycin 150 
mg/mL (Zactran; Merial, Duluth, GA) was administered at the rate of 1 mL/24.9 kg of 
BW. A moratorium was observed after gamithromycin administration before a second 
antimicrobial treatment could be administered. This moratorium was 240 h for calves 
with a severity score of 1 or 2, and 96 h for calves with a severity score of 3 or 4. If 
antimicrobial treatment criteria were met a second time, florfenicol 300 mg/mL (Nuflor; 
Intervet/Schering-Plough, Desoto, KS) was administered at the rate of 1 ml/7.56 kg of 
BW. After florfenicol administration, a 96 h moratorium was observed before a third 
antimicrobial treatment could be administered regardless of severity score. If 
antimicrobial treatment criteria were met a third time, ceftiofur crystalline free acid 200 
mg/mL (Excede; Pfizer, New York City, NY) was administered at the rate of 1 ml/30.2 
kg of BW. After ceftiofur crystalline free acid administration, a 168 h moratorium was 
observed before a fourth antimicrobial treatment could be administered regardless of 
severity score. If antimicrobial treatment criteria were met a fourth time, a second dose of 
ceftiofur crystalline free acid was administered as described above. 
 
Allocation to experimental ANC treatments and ANC administration 
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Once a calf was “pulled” for suspected BRD, met the treatment criteria described, 
and received an antimicrobial, it was then randomly assigned to 1 of 4 ANC treatments. 
The 4 ANC treatments consisted of: an intravenous flunixin meglumine injection 
(NSAID), an intranasal viral vaccination (VACC), an intramuscular vitamin C injection 
(VITC), or no ANC (NOAC). The VITC experimental ANC treatment consisted of 10 
mL per calf of Vita-Jec® C (Aspen; Liberty, MO) containing 250 mg of sodium ascorbate 
per mL injected intramuscularly. The NSAID experimental ANC treatment consisted of 2 
mL per 45.4 kg of BW of Suppressor® (RXVeterinary; Westlake, TX) containing 50 mg 
of flunixin per mL injected intravenously. The VACC experimental ANC treatment 
consisted of 2 mL per calf of Inforce 3® (Zoetis; Florham Park, NJ) viral respiratory 
vaccine containing IBR-PI3-BRSV isolates administered intranasally. The NOAC 
experimental treatment consisted of no experimental ANC, and only an antimicrobial 
injection was administered at the time of BRD treatment. Calves received their respective 
experimental ANC at all subsequent BRD treatments. 
After calves were administered their experimental ANC, they were allocated to a 
new home pen that previously had been randomly assigned to their respective ANC 
group. The calves remained in these pens for the duration of the experiment with the 
exception of mortalities and removals. These pens had the same dimensions and pen 
structure of those receiving pens previously described. A group of 4 pens (1 per ANC 
group) remained open until 80 head of calves (20 per experimental ANC) were allocated 
to those pens. The average length of time it took to fill a group of pens was 3 d and half 
the pens on the experiment were filled in 2 d. The date when a group of pens were closed 
was determined to be d 0 for that group of 4 pens.  
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Receiving phase data collection, calculations and statistical analysis 
A shrunk BW was obtained for all animals upon arrival. Unshrunk BW were 
obtained at the time of initial BRD treatment and all subsequent BRD treatments. Interim 
BW were determined for all animals by weighing all pens and individual animals on d 28 
and 56 after pens were closed. Body weights obtained at the time of BRD treatments and 
on d 28 and 56 are presented with a calculated 2% shrink. Individual BW and DOF were 
used to calculate individual ADG. Individual BW and ADG values were averaged within 
a pen to obtain pen means. Actual head days within a pen and total feed consumption 
were used to calculate DMI. Average DMI and ADG for the pen were used to calculate 
G:F. 
Data were analyzed using the MIXED procedure of SAS 9.3 (SAS Institute Inc., 
Cary, NC) with pen serving as the experimental unit. Contrasts were performed for the 
main effects and for the average of the 3 experimental ANC treatments (NSAID, VACC, 
and VITC) vs. the control (NOAC). Results were considered significantly different where 
P ≤ 0.05. Tendencies are discussed where 0.05 > P ≤ 0.10. Data were analyzed with 
mortalities and removals included (deads in) and with mortalities and removals excluded 
(deads out). For the deads out analysis, the feed consumptions for mortalities and off 
experiment calves were removed from the pen at a calculated maintenance intake level. 
The NRC (2000) equation NEm = 0.077 Mcal/EBW0.75 and ration NEm concentration 
were used to calculate maintenance DMI.  
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Finishing phase cattle management 
After the receiving period, calves remained in their home pens and received ad 
libitum access to the common receiving ration (Table 1) and water for 2 to 3 additional 
weeks. After this additional period, (average total DOF = 86) a subset of 126 calves were 
allocated to a finishing experiment. Body weight at arrival was not different for the 
subpopulation of calves used for the finishing experiment (P = 0.70). For the finishing 
experiment, all previous experimental ANC were maintained, but calves were also 
allocated by the number of antimicrobial treatments administered during the receiving 
period for a separate experiment. This resulted in 6 pens or replications of each ANC 
treatment (2 pens of calves that received 1 antimicrobial treatment, 2 pens of calves that 
received 2 antimicrobial treatments, and 2 pens of calves that received 3 or 4 
antimicrobial treatments). After the respective experiments were completed, the data 
were analyzed for interactions between the experimental ANC treatments and the number 
of antimicrobials administered. The lack of significant interactions allowed for the 
integrity of both experiments to be maintained.  
Prior to allocation to finishing pens, all steers were administered 200 mg 
trenbolone acetate (TBA) and 40 mg estradiol (Revalor XS; Merck Animal Health, 
Summit, NJ) in the caudal aspect of the right ear per manufacturer’s directions. The goal 
was to harvest all calves at a common physiological end point regardless of DOF, while 
still maintaining the integrity of the pen and shipping truck load lots. This was 
accomplished through the use of the ultrasound estimates, BW, and visual appraisal. 
Calves were harvested in 2 groups (DOF = 166 or 197). For the last 28 DOF, all steers 
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were fed ractopamine hydrochloride (Optaflexx 45; Elanco Animal Health, Indianapolis, 
IN) at 300 mg•steer-1•d-1. 
 
Finishing phase pen management and diet 
Finishing pens were 4.57 × 15.24 m in area with a 4.57 m long concrete bunk at 
the front of the pen. The pens contained a 4.57 × 4.42 m concrete pad with the remainder 
of the pen being soil surfaced. The pens were under partial cover, with the bunk and pad 
being covered by an overhang. A 76 L concrete water tank (Model J 360-F; Johnson 
Concrete, Hastings, NE) was shared between 2 pens and was cleaned 3 times per week 
throughout the experiment.  
The common finishing ration was formulated to meet or exceed NRC (2000) 
nutrient requirements (Table 2). Adaptation to the finishing diet was accomplished using 
a two-ration blend method where each day the percentage of finishing diet delivered was 
increased by approximately 4.6% DM and the percentage of receiving diet (Table 1) 
delivered was decreased by approximately 4.6% DM until only the finishing diet was 
being fed. Following adaptation, the finishing ration was fed to all cattle twice daily at 
0700 h and 1300 h in a 274-12B Roto-Mix Forage Express mixer wagon (Roto-Mix, 
Dodge City, KS) to the nearest 0.45 kg of that day’s feed call. Ration samples were 
collected once per week, and dried in a forced air oven for 48 h at 60º centigrade to 
determine dry matter. Ration samples were composited gravimetrically and analyzed at a 
commercial laboratory (Servi-Tech Inc., Dodge City, KS) for nutrient composition (Table 
2). 
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Finishing phase data collection, calculations and statistical analysis 
Unshrunk BW were obtained at the time of allocation to finishing pens and at 
approximately 45 d intervals thereafter. All BW were shrunk a calculated 4%. Individual 
BW and ADG values were averaged within a pen to obtain pen mean BW and ADG. 
Ultrasound estimates were taken at 91 and 138 DOF. Carcass data along with lung 
consolidation and lung adhesion scores were obtained at the harvest facility by trained 
personnel from West Texas A&M University. Data were analyzed using the MIXED 
procedure of SAS 9.3 (SAS Institute Inc., Cary, NC) with pen serving as the experimental 
unit. Initially data were analyzed for an interaction between experimental ANC and the 
number of antimicrobials administered. Only one interaction existed (marbling score) for 
all variables analyzed. Due to the lack of significant interactions, the integrity of the 
experiment was able to be maintained, and data were subsequently analyzed on the basis 
of ANC only. Results were considered significantly different where (P ≤ 0.05). 
Tendencies are discussed where (0.05 > P ≤ 0.10). Contrasts were performed for the main 
effects and for the average of the 3 experimental ANC (NSAID, VACC, and VITC) vs. 
the control (NOAC). Data were analyzed with mortalities (4; 3 digestive and 1 BRD) 
included in the analysis (deads in). One NOAC calf, 1 VACC calf, and 2 VITC calves 
died during the experiment. Due to calves being harvested at varying DOF, harvest group 
was included in the model statement for the analysis of marbling number and the 
percentage of USDA Prime and Choice carcasses. 
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RESULTS 
Receiving phase calf performance within BRD treatment intervals 
Calf performance within BRD treatment intervals is presented in Table 3. The 
BW of calves at the time of the initial BRD treatment was not different between the 4 
experimental ANC (P = 0.75). There was also no difference (P = 0.75) in the BW of 
calves among ANC groups at the time of second antimicrobial administration for BRD. 
Between the first and second BRD treatments, calves on all experimental ANC 
treatments lost an average of 0.71 kg per d, but there was no difference among ANC (P = 
0.92).  
By the time calves received a third antimicrobial treatment for BRD, those calves 
receiving NOAC had significantly heavier BWs compared to the other 3 ANC groups (P 
= 0.02). This was a result of the calves receiving NOAC gaining 0.06 kg per d between 
the second and third BRD treatments, while the calves receiving NSAID, VACC, and 
VITC lost an average of 1.81 kg during the same interval. The ADG of the NOAC calves 
was significantly greater than the ADG for VACC and VITC calves and tended to be 
greater than the ADG for NSAID calves during this time period (P = 0.03). There were 
no differences (P = 0.94) in BW among ANC by the time a fourth antimicrobial was 
administered. In addition, ADG between the third and fourth BRD antimicrobial 
treatments and the overall ADG between the first and fourth BRD antimicrobial 
treatments was not different between ANC groups (P = 0.95 and P = 0.78, respectively). 
When the average of the 3 experimental ANC (NSAID, VACC, and VITC) was 
contrasted against NOAC, BW at the time of the third BRD treatment, and the ADG 
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between the second and third BRD treatments were greater for calves receiving NOAC as 
expected based on the mean separations with the overall model (P ≤ 0.01). 
 
Retreatment percentages and BRD retreatment intervals 
The data for BRD retreatment percentages and the length of time between BRD 
treatments are also presented in Table 3. Calves that received VACC tended to require a 
second antimicrobial treatment for BRD less frequently than calves receiving either 
NOAC or NSAID (P = 0.10). However, when comparing ANC means, there was no 
difference between calves receiving VACC or VITC and VITC was also not different 
from NOAC or NSAID (P ≥ 0.17). Calves that received NSAID or VITC tended to 
require a third antimicrobial treatment for BRD less often than calves receiving NOAC 
(P = 0.09). When comparing individual ANC means, NSAID was not different from 
VACC or VITC and NOAC was not different from VACC (P ≥ 0.13). When the average 
of NSAID, VACC, and VITC was contrasted against NOAC, calves receiving NOAC did 
receive a third antimicrobial treatment more often (P = 0.04). There were no significant 
differences between ANC for the length of time until the first, second, third, or fourth 
BRD antimicrobial treatments (P ≥ 0.21). However, it should be noted that calves 
receiving NOAC received both their third and fourth BRD treatments at numerically 
greater days after arrival. This numerical difference resulted in a significant increase (P = 
0.05) in the length of time until the third BRD treatment when the average of the 3 
experimental ANC was contrasted against NOAC. 
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Subjective clinical severity scores and rectal temperatures 
The data for subjective clinical severity scores and rectal temperatures at the time 
of BRD treatment are contained in Table 4. There was a tendency (P = 0.10) for calves 
receiving VACC to have lower clinical severity scores than calves receiving NOAC or 
VITC at the time of initial BRD treatment. Clinical severity scores for calves receiving 
NSAID were not different from any other ANC at the time of initial BRD treatment (P > 
0.10). At the time of the second antimicrobial treatment, there were no differences (P = 
0.27) in clinical severity scores among ANC groups. At the time of the third BRD 
treatment, calves receiving NOAC had lower (P = 0.05) clinical severity scores than 
calves receiving VACC or VITC, while the severity scores of calves receiving NSAID 
were not different (P > 0.10) from any of the other ANC. Upon receiving a fourth 
antimicrobial treatment, there was again no difference among any of the ANC groups (P 
= 0.79). There were no differences in rectal temperatures among any of the ANC at any 
BRD treatment event throughout the experiment (P ≥ 0.21).  
 
Removals and mortality attributed to BRD 
Data concerning mortality attributed to BRD and removal of calves from the 
experiment are reported in Table 4 as well. There were no differences (P = 0.55) in the 
mortality percentages among the ANC groups, while the calves receiving NOAC did 
exhibit numerically decreased mortality compared to the other ANC groups. There were 
also no differences in removals among the ANC groups (P = 0.13). However, when the 
average of the 3 ANC was contrasted against the NOAC group, calves receiving NOAC 
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were removed from the experiment at a greater rate (P = 0.05). The numerical decrease in 
mortality and increase in removals for calves receiving NOAC resulted in no difference 
(P = 0.98) in the combined percentage of calves that were not able to complete the 
experiment due to BRD-related mortality or removal from the home pen as a result of 
lameness or the inability to compete.  
 
Receiving phase performance with mortalities and removals included 
The performance data including mortalities and removals (deads in data) is 
included in Table 5. No differences (P ≥ 0.23) existed between any of the individual 
ANC for any of the performance or efficiency data when evaluated on a deads in basis. 
However, when the average of NSAID, VACC, and VITC was contrasted against NOAC, 
there was a tendency (P ≤ 0.07) for calves receiving NOAC to have heavier BW on d 28 
and d 56 of the experiment. There was also a tendency (P = 0.07) for NOAC calves to 
have greater DMI from d 28 to d 56 when compared to the average of the other 3 ANC. 
 
Receiving phase performance with mortalities and removals excluded 
The performance data with mortalities and removals excluded (deads out data) is 
found in Table 6. When the mortalities and removals were excluded from the analysis, 
there was a tendency (P = 0.07) for calves receiving NOAC to have heavier BW on d 28. 
When the average of NSAID, VACC, and VITC was contrasted against NOAC, the same 
tendencies observed in the deads in data for calves receiving NOAC to have heavier BW 
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(P = 0.06) on d 56 and greater DMI (P = 0.06) from d 28 to d 56 were observed in the 
deads out data. In addition, calves receiving NOAC tended to have greater ADG (P = 
0.10) and DMI (P = 0.08) from the time of the first BRD treatment to d 28 when 
comparing NOAC to the 3 other ANC. Finally, when contrasting the average of NSAID, 
VACC, and VITC against NOAC, calves that received NOAC had greater DMI (P = 
0.05) over the length of the receiving period. 
 
Finishing performance, efficiency, lung scores, and carcass characteristics 
No ANC differences were observed in the overall model for any of the variables 
analyzed in the finishing experiment (P ≥ 0.26). When average of the NSAID, VACC, 
and VITC was contrasted against NOAC, a tendency was observed for improved 
efficiency over a single interval. During the first 45 d of the finishing period, calves 
receiving NOAC demonstrated improved G:F. No other differences were observed for 
performance or efficiency during finishing for the contrast of the 3 ANC versus NOAC. 
There were also no differences observed in ultrasound measurements, lung scores, or 
carcass characteristics among any of the ANC (P ≥ 0.26). This was also true for the 
contrast of the 3 ANC versus NOAC (P ≥ 0.14). 
 
DISCUSSION 
The goal of ANC administration is to focus on the overall health of the calf or 
improving the calf’s clinical signs rather than treating the invading pathogens responsible 
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for the illness as would be the case with antimicrobials. The use of vaccines as an ANC 
would be one of the few exceptions, in that they attempt boost the immune system by 
providing a pathogen-specific antibody response. The improvement in the calf’s response 
resulting from ANC administration can be theoretically accomplished through a variety 
of mechanisms and these mechanisms can subsequently be divided into 3 broad classes. 
The 3 classes of ANC can potentially impact overall calf health or calf’s clinical signs by: 
relieving the harmful effects of inflammation, reducing histamine activity, or improving 
immune system function to aid in the defense against BRD pathogens (Apley, 1994).  
The objective of this experiment was to evaluate the effects of 3 of the most 
commonly used ANC that also had significantly different intended effects and modes of 
action in combination with an antimicrobial within a common population of newly 
received, high-risk calves that were treated for BRD. It has been established that there is 
widespread use of ANC within the feedlot industry through surveys conducted by 
NAHMS (2001), Terrell et al. (2011), and NAHMS (2013). However, there is limited 
published research concerning the effectiveness of the various forms of ANC and there is 
no published research to the author’s knowledge comparing multiple commonly 
administered ANC within a single experiment or across similar groups of calves. 
According to the most recent survey detailing ANC use conducted by NAHMS (2013), 
the 3 ANC used in this experiment were the 3 most frequent forms of ANC given on a 
percentage of cattle treated basis in commercial feedlots.  
In addition to comparing multiple ANC within a single experiment across a 
similar group of calves, the present experiment aimed to observe the effects of ANC in a 
group of newly-received, high-risk calves originating from multiple livestock auctions. If 
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only a small incidence of BRD occurs within the experiment, any observed responses to 
the ANC could be viewed as less valid. The calves in this experiment experienced a 
significant natural immune challenge resulting in a first treatment morbidity of 66.5% 
and mortality attributed to BRD of 13.2% when considering the initial population of 516 
head. The final goal of the experiment was to make sure that calves were experiencing a 
natural BRD challenge prior to receiving an ANC. In the present experiment, only calves 
that met antimicrobial treatment criteria were enrolled in the experiment to ensure that 
the effects observed were only evaluated in morbid calves. 
It is difficult to compare the results of this experiment to others published in the 
literature. When reviewing the published research concerning the use of these 3 specific 
ANC in calves treated for BRD, it becomes obvious that this area of research is deficient 
and has produced very inconsistent results to date. Much of the research that exists 
consists of the evaluation of a single ANC. These studies may or may not include a 
negative control, and they are often conducted on a small number of animals and not well 
replicated. The use of NSAID as an ANC for BRD have been researched to a greater 
extent than the use of any of the other ANC and NSAID seem to provide the most 
consistent response of all the ANC that have been examined. There are a couple recent 
reviews concerning the use of ANC that bear mentioning. These ANC reviews essentially 
become reviews of anti-inflammatory drugs and more specifically NSAID due to the lack 
of published controlled field experiments for other ANC. 
The responses observed to the 3 ANC used in this experiment were largely 
negligible. For all of the variables measured, positive responses to ANC administration 
were only observed on 2 occasions during the receiving period. The first being that calves 
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receiving VACC tended to require a second antimicrobial treatment for BRD less 
frequently than calves receiving NOAC. The second being that calves receiving either 
NSAID or VITC tended to require a third BRD treatment less often when compared to 
calves receiving NOAC. The tendencies for improvements in BRD treatment percentages 
in the case of these 2 variables could potentially be the result of numerical differences in 
the intervals between BRD treatments, the intervals from arrival to mortality, and the 
intervals from first BRD treatment to mortality between the experimental treatments.  
There were no differences in the time intervals for calves receiving from 1 to 4 
antimicrobial treatments for BRD existed among the individual ANC groups. However, 
when the average of the 3 experimental ANC was contrasted against NOAC, a significant 
increase in the length of time until the third antimicrobial was administered was observed 
for calves receiving NOAC. In addition, calves that received the 3 experimental ANC all 
received their final BRD treatment in numerically fewer days than calves receiving 
NOAC. Of calves that suffered BRD attributed mortality, the calves receiving NOAC 
lived numerically longer from the time of arrival and lived at least 4 d longer after 
receiving their initial BRD treatment than any of the other ANC.  
Calves receiving NSAID were treated for BRD the final time 3 d sooner than 
calves receiving NOAC. In addition, calves that suffered mortality that had received 
NSAID did on average 19 d after receiving an initial BRD treatment and 25 d after 
arrival. This was numerically less than the 23 d after receiving a BRD treatment and 26 d 
after arrival for calves receiving NOAC. Calves receiving VACC received their final 
BRD treatment an average of 6 d sooner than calves receiving NOAC and VACC calves 
that died, did so an average of 15 d after receiving their first antimicrobial treatment 21 d 
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after arrival. Calves that received VITC were treated for BRD the final time an average of 
5 d sooner than calves receiving NOAC and VITC calves that died, did so an average of 
19 d after receiving their first antimicrobial treatment 25 d after arrival. These numerical 
differences in intervals between BRD treatments, intervals from arrival to mortality, and 
intervals from first BRD treatment to mortality may have simply caused for calves on the 
NOAC treatment to receive numerically more antimicrobials over certain treatment 
intervals. Total antimicrobials administered were not different among ANC groups and 
ranged from 137 to 150. 
For many of the variables measured, calves receiving NOAC demonstrated 
statistically or numerically positive responses in relation to the other ANC. This was 
especially true when average of the NSAID, VACC, and VITC was contrasted against 
NOAC. Regardless of one’s opinion of ANC use, the improvements observed in cattle 
receiving NOAC were somewhat surprising. Some of these advantages for NOAC are of 
clinical importance, while others may serve to simply advocate that there is little 
justification for ANC use in high-risk calves suffering from an extreme natural immune 
challenge.  
Calves receiving NOAC had heavier BW at the time of third BRD treatment and 
improved ADG between the second and third BRD treatments compared to the other 
ANC. These differences must be critically evaluated as calves receiving NOAC received 
their third BRD treatment approximately a week after calves receiving NSAID, VACC, 
or VITC received their third BRD treatment. As a result, it would be expected that the 
calves receiving NOAC would weigh more at this time. However, the fact that calves 
receiving NOAC actually gained BW between the second and third BRD treatments, 
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while the calves receiving the other 3 ANC all lost BW during the same BRD treatment 
interval should not be disregarded. In addition, the subjective clinical scores at the time of 
third BRD treatment were significantly lower for calves receiving NOAC compared to 
calves receiving VACC or VITC. While this is a subjective measurement, it suggests that 
calves receiving NOAC exhibited less visible depression and had improved appetites and 
respiratory signs at this time compared to the other ANC. 
The importance of the results previously discussed and the perceived 
improvement in calves receiving NOAC could certainly be argued. This argument can be 
made with variables that are not measured over equal intervals for all ANC or with 
variables that are by nature subjective. In order to circumvent this, performance and 
efficiency were also measured across fixed intervals that were the same for all pens and 
ANC. These data were also presented both with mortalities and removals included and 
mortalities and removals excluded due to the numerical differences in intervals from the 
time of initial BRD treatment until mortality previously discussed among the ANC. The 
results of these data provide perhaps the most compelling evidence in favor of NOAC 
compared to the other 3 ANC. When mortalities and removals were included in the 
analysis, there are no differences between any of the individual ANC for any of the 
performance and efficiency data when evaluated. However, when the average of NSAID, 
VACC, and VITC was contrasted against NOAC, there was a tendency for calves 
receiving NOAC to have heavier BW on d 28 and d 56 of the experiment greater DMI 
from d 28 to d 56. 
When mortalities and removals were excluded in the analysis the results favoring 
the use of NOAC compared to the other 3 ANC were magnified. This difference resulted 
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primarily from removing any of the differences in intervals from the time of initial BRD 
treatment until mortality previously discussed. Only calves that received an ANC and 
completed the 56 d receiving experiment were included in this analysis. With the 
mortalities and removals excluded, the calves receiving NOAC tended to have heavier 
BW on d 28 in the overall model. When the average of the 3 ANC was contrasted against 
NOAC, the same tendencies observed in the deads in data for calves receiving NOAC to 
have heavier BW on d 56 and greater DMI from d 28 to d 56 were still observed. In 
addition calves receiving NOAC tended to have greater ADG and DMI from the time of 
the first BRD treatment to d 28 and had greater DMI over the length of the entire 
experiment when compared to the 3 other ANC.  
The expectation would be that any performance differences observed in the 56 d 
receiving period would likely disappear by the time calves were fed for an additional 166 
or 197 d. It would be also expected that any ANC treatment administered within 30 d of 
arrival would not significantly impact finishing performance or carcass characteristics. 
This was the case and at the end of the finishing period, no ANC differences were 
observed in the overall model for any of variables analyzed. When average of the 
NSAID, VACC, and VITC was contrasted against NOAC for the finishing data, only 1 
tendency was observed for a single 45 d interval with calves receiving NOAC 
demonstrating improved G:F for the first 45 d of the finishing period. There were no 
other differences observed for performance, efficiency, ultrasound measurements, lung 
scores, or carcass characteristics for the 3 ANC contrasted against NOAC. 
When reviewing the published research concerning the use of these 3 specific 
ANC in calves treated for BRD, very few controlled well-replicated studies are found 
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except in the case of NSAID. There are also a few good review papers concerning ANC 
in calves treated for BRD. A recent review of the research concerning ANC conducted by 
Apley (2010) chose to focus on the published data concerning the use of anti-
inflammatory drugs as an ANC for BRD. In this review, multiple studies that 
demonstrated some beneficial effect of NSAID as an ANC are cited with the most typical 
response observed being a reduction in rectal temperature in calves treated with an 
NSAID (Apley, 2010). Apley (2010) determined that other clinical responses to NSAID 
as an ANC in the research were inconsistent.  
Francoz et al. (2012) also conducted a comprehensive review of the literature 
concerning ANC use. For an experiment to be included in the review, the experiment 
must have involved the treatment of naturally occurring BRD with antimicrobials and 
with and without at least 1 ANC. As a result of this criteria, experimental models, BRD 
prevention studies, studies evaluating an ANC without a control group, or studies 
including different antimicrobials within the treatment groups were not included. When 
studies not meeting these stipulations were removed from consideration, it resulted in 
only 15 articles meeting the criteria (Francoz et al., 2012). Of those 15 experiments, 14 
dealt with anti-inflammatory drugs (12 NSAID experiments, 1 steroidal anti-
inflammatory drug experiment, and 1 experiment containing both a steroidal anti-
inflammatory drug and NSAID) and 1 dealt with immune-modulators (Francoz et al., 
2012).  
Upon reviewing the data related to the use of NSAID as an ANC to BRD, the 
authors concluded that NSAID caused a more rapid decrease in rectal temperature of 
calves, but did not in any way benefit clinical signs, mortality, or calf performance 
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(Francoz et al., 2012). The authors did mention that published data were lacking and too 
inconsistent to conclusively determine the effects on calf performance or mortality when 
NSAID were used as an ANC for BRD (Francoz et al., 2012). Francoz et al. (2012) 
suggested that NSAID have the potential to decrease lung lesions at slaughter, but noted 
that lung consolidation was only evaluated in 2 of the studies (Francoz et al., 2012). 
Based on the results of this review, it could be argued that the reduction in rectal 
temperature and the potential to reduced lung lesions resulting from NSAID 
administration may be important from an animal welfare perspective (Francoz et al., 
2012). However, it would be extremely difficult to justify the economics of NSAID use 
based on inconsistent improvements in clinical signs and the lack of performance benefits 
seen in calves receiving a NSAID as ANC for BRD (Francoz et al., 2012).  
When reviewing individual research experiments concerning ANC use for calves 
with BRD, several studies using NSAID were found. Within this literature, the most 
consistent response observed when a NSAID is used as an ANC for BRD calves is a 
more rapid reduction in rectal temperature after NSAID administration. However this 
response is often short-lived and typically there is no difference in rectal temperature 
when measured at the end of the evaluation period. Many of these studies involving the 
use of NSAID such as the one conducted by Hellwig et al. (2000) examine the use of a 
single NSAID antimicrobial combination as an ANC for BRD calves. Hellwig et al. 
(2000) randomly assigned calves with clinical signs of BRD either a flunixin meglumine 
and tilmicosin phosphate treatment group or tilmicosin phosphate only treatment group. 
The calves receiving the tilmicosin phosphate and flunixin meglumine combination had a 
higher percentage of treatment successes (88% vs. 61%) and a lower combined 
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percentage of treatment failures and BRD relapses (5% vs. 38%) than those calves 
receiving only tilmicosin phosphate (Hellwig et al., 2000). In addition, Hellwig et al. 
(2000) found that the treatment cost for calves receiving the combination of the NSAID 
and antimicrobial tended to be less than the treatment cost for calves receiving the 
antimicrobial alone. Hellwig et al. (2000) did not mention or report rectal temperate 
changes for calves in this experiment. However, based on the clinical results, Hellwig et 
al. (2000) concluded that the flunixin meglumine tilmicosin phosphate combination was 
more successful for treating BRD than tilmicosin phosphate alone. 
When reviewing the published data, the most consistent response to NSAID 
administration is a more rapid decrease in the rectal temperature of calves compared to a 
control or other treatments. In the current experiment, the administration of NSAID as an 
ANC did not decrease the rectal temperature of calves at subsequent BRD. Granted, 
rectal temperature was only measured in calves that met treatment criteria at the time of 
BRD treatment. It is quite possible that calves receiving NSAID could have demonstrated 
improvements in the reduction of rectal temperature if rectal temperature was obtained a 
few hours after NSAID administration. This experiment attempted to mimic commercial 
production settings as much as possible and pulling multiple calves up at short intervals 
to obtain hourly rectal temperatures was not a priority of the current experiment. That is 
not to say that changes in rectal temperature were unimportant in the current experiment, 
but rather the concern was with prolonged or sustained changes in rectal temperature over 
the course of time. It should also be noted, however, that the interval between BRD 
treatments was relatively short for many calves, and this was especially the case with the 
first and second BRD treatments. As such, if calves receiving NSAID demonstrated any 
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prolonged improvement in rectal temperatures it could have been detected and this was 
not the case. 
It has also been suggested in the research that NSAID have the potential to 
decrease lung lesions at harvest in treated calves. Our data did not support these findings. 
In the present experiment, the administration of NSAID as an ANC did not reduce lung 
consolidation or adhesion at harvest. Calves receiving NSAID actually had numerically 
increased lung consolidation compared to calves receiving NOAC. Conversely, calves 
receiving NSAID had a slight numerical decrease in lung adhesion scores when 
compared to calves receiving NOAC.  
In regard to the use of other ANC, reviewers have not observed reasons to justify 
their use. In the review conducted by Apley (2010), the author concluded that no data 
published at the current time supported the use of vaccines, vitamin C, or other ANC for 
BRD. Similar to Apley (2010), Francoz et al. (2012) concluded that there was no 
published data that currently supported the use of vaccines, vitamin C, or other ANC for 
BRD. This was primarily a result of Francoz et al. (2012) only being able to evaluate 1 
additional ANC experiment outside of the anti-inflammatory drug experiments included 
in the review.  
When reviewing the research, no experiment utilizing VACC as an ANC for BRD 
was found. This is extremely surprising given that NAHMS (2013) reported that a 
respiratory vaccine was used as a component of the initial BRD treatment program in 
39.3% of feedlots, and that 48.5% of cattle received a respiratory vaccine as part of initial 
BRD treatment. It is well established that the vaccination of healthy calves for respiratory 
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pathogens is important for preventing BRD and maintaining optimal calf health. 
However, there is little justification for the vaccination of high-risk calves at arrival to the 
feedlot even though it is a widespread and accepted management practice (Edwards et al., 
2010; Taylor et al., 2010). Some epidemiologic studies have actually suggested that the 
vaccinating of calves upon arrival to the feedlot for respiratory viruses actually leads to 
increased BRD incidence (Taylor et al., 2010). This data is somewhat confounded as 
preconditioned low-risk calves would be less likely to be vaccinated on arrival. As a 
result the increased BRD incidence observed in calves vaccinated upon arrival to the 
feedlot is not necessarily a causal response. In addition, most published vaccine research 
has focused on comparing different multivalent vaccines and the majority of vaccine 
studies do not include a non-vaccinated negative control. As a result, it is extremely 
difficult to determine if vaccination of high-risk calves at or shortly after arrival aids in 
the prevention of BRD or if it actually may be a detrimental. 
Because no published research was found evaluating the use of VACC as an ANC 
for BRD, comparisons to the data in the present experiment are not possible. It is 
interesting to note that while not significant, calves that died after receiving VACC in the 
current experiment did so numerically sooner than any other ANC treatment. This was 
true regardless if the interval was measured from the time of arrival to the feedlot, or 
from the time of the first BRD treatment. This ultimately resulted in the VACC group 
receiving the fewest total antimicrobial treatments (137 doses) for BRD. However, this 
was only 8 to 13 total antimicrobial treatments less than the other 3 ANC groups. 
When reviewing individual research experiments concerning ANC use for calves 
with BRD, a few experiments utilizing VITC as an ANC for BRD were found. In an 
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experiment conducted by Cusack et al. (2005), the authors examined the effects of 
injectable vitamin C given at the time of BRD treatment on subsequent cattle health. At 
the time of BRD antimicrobial treatment, 176 cattle were alternately administered 
injectable vitamin C (5 g per head) or not injected (Cusack et al., 2005). Fewer of the 
cattle injected with vitamin C at the time of BRD treatment died later in the experiment 
compared to those cattle that were not injected (11% vs. 23%, respectively; Cusack et al., 
2005). The results led the authors to conclude that mortality rate in cattle with BRD may 
be decreased by administering injectable vitamin C at the time of antimicrobial 
administration. 
Urban-Chmiel et al. (2011) evaluated the effects of vitamin E and vitamin C on 
the development of inflammation processes and selected defense mechanisms against 
MH-induced infections. Calves were assigned to 3 treatments and received subcutaneous 
injections of vitamin E (750 IU), vitamin C (2.5 g per head), or no vitamin injection 
(Urban-Chmiel et al., 2011). Calves receiving either of the vitamin injections 
demonstrated a difference in the sensitivity of leukocytes to the cytotoxic effect of LKT 
when compared to the control group (Urban-Chmiel et al., 2011). There were no 
differences observed in the percentage of cells sensitive to LKT between the calves 
receiving vitamin E and those receiving vitamin C (Urban-Chmiel et al., 2011). The 
authors concluded that both vitamin E and vitamin C exerted a protective effect on 
leukocytes aiding in the defense against MH virulence factors when administered by 
injection (Urban-Chmiel et al., 2011). Urban-Chmiel et al. (2011) also suggested that 
these vitamins can be used to support the treatment of BRD in cattle following transport. 
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In the current experiment, VITC had no major effects on morbidity or mortality. 
In fact calves administered VITC had numerically higher mortality and combined 
mortality and removals when compared to NOAC. While leukocyte sensitivity was not 
measured in the current experiment as with Urban-Chmiel et al. (2011), there was no 
evidence to support the use of VITC as an ANC for BRD as those authors suggested. 
Calves that died after receiving VITC in the current experiment did so at the same time 
interval as calves receiving NSAID, but numerically sooner than calves receiving NOAC. 
This was true regardless if the interval was measured from the time of arrival to the 
feedlot or from the time of the first BRD treatment. 
 
Conclusions 
There is widespread use of ANC for BRD in commercial feedlots as evidenced by 
multiple published surveys. The goal of ANC therapy is to improve the response to a 
BRD challenge in calves treated with antimicrobials, and there is potential justification 
for ANC use based on the modes of actions of various ANC. However, published 
research has yet to prove that ANC other than NSAID are effective in commercial 
settings in response to a natural BRD challenge. While NSAID have demonstrated the 
ability to reduce rectal temperatures in treated calves, the response is usually short-lived 
and not evident at the end of the evaluation period. It has also been suggested that 
NSAID reduce lung consolidation at harvest, but this has only been demonstrated in a 
few experiments. For all of the variables measured in the current experiment, positive 
responses to ANC administration were only observed on 2 occasions during the receiving 
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period. However, there were numerous positive responses to NOAC administration 
observed for multiple variables in the receiving period. The lack of positive responses 
observed to the 3 ANC used in this experiment combined with the improvements 
observed in calves receiving NOAC lead us to conclude that the use of NSAID, VACC, 
and VITC as an ANC for BRD does not appear to be warranted because NSAID, VACC, 
and VITC do not appear to positively impact clinical health of calves treated for BRD. In 
addition, this experiment suggests that ANC use could potentially be detrimental to calf 
performance during the receiving period if administered to calves experiencing a severe 
natural immune challenge. 
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Table 3-1. Composition of common receiving diet1 
Ingredient (%)1  
Wet corn gluten feed2  48.8 
Grain sorghum hay  30.0 
Dry-rolled corn  15.0 
Dry supplement B-2733  5.2 
Nutrient Composition1,4   
NEm, Mcal/kg  1.69 
NEg, Mcal/kg  1.07 
TDN, %  71.60 
Crude protein, %  17.40 
Crude fat, %  1.90 
NDF, %  39.90 
ADF, %  21.40 
Calcium, %  0.68 
Phosphorus, %  0.67 
Magnesium, %  0.36 
Potassium, %  1.15 
Sulfur, %  0.27 
1All values are presented on a DM basis. 
2Sweet Bran® (Cargill; Dalhart, Texas).  
3Dry supplement B-273 was formulated to contain 
(% DM basis): 38.46% ground corn, 30.36% 
limestone, 21.04% wheat midds, 6.92% urea, 1.03% 
magnesium oxide, 0.618% zinc sulfate, 0.38% salt, 
0.119% copper sulfate, 0.116% manganese oxide, 
0.05% selenium premix (contained 0.6% Se), 
0.311% vitamin A (30,000 IU/g), 0.085% vitamin E 
(500 IU/g), 0.317% Rumensin 90 (Elanco Animal 
Health; Indianapolis, IN), and 0.195% Tylan 40 
(Elanco Animal Health; Indianapolis, IN). 
4Feed samples were analyzed for nutrient 
composition by an independent laboratory (Servi-
Tech Laboratories; Dodge City, KS). 
  
160 
 
Table 3-2. Composition of common finishing diet1 
Ingredient (%)1  
Dry-rolled corn  48.14 
Wet corn gluten feed2  15.00 
Dried distillers grains plus solubles   15.00 
Prairie hay  9.00 
Liquid supplement3  6.54 
Dry supplement B-2734  3.12 
Dry supplement B-2835  3.20 
Nutrient Composition1,6   
NEm, Mcal/kg  2.23 
NEg, Mcal/kg  1.54 
TDN, %  89.55 
Crude protein, %  18.85 
Crude fat, %  5.00 
NDF, %  22.35 
ADF, %  10.40 
Calcium, %  0.96 
Phosphorus, %  0.52 
Magnesium, %  0.28 
Potassium, %  1.03 
Sulfur, %  0.31 
1All values are presented on a DM basis. 
2Sweet Bran® (Cargill; Dalhart, Texas). 
3Synergy 19-14 (Westway Feed Products; New Orleans, LA). 
4Dry supplement B-273 was formulated to contain (% DM 
basis): 38.46% ground corn, 30.36% limestone, 21.04% wheat 
midds, 6.92% urea, 1.03% magnesium oxide, 0.618% zinc 
sulfate, 0.38% salt, 0.119% copper sulfate, 0.116% manganese 
oxide, 0.05% selenium premix (contained 0.6% Se), 0.311% 
vitamin A (30,000 IU/g), 0.085% vitamin E (500 IU/g), 0.317% 
Rumensin 90 (Elanco Animal Health; Indianapolis, IN), and 
0.195% Tylan 40 (Elanco Animal Health; Indianapolis, IN). 
5Dry supplement B-283 was formulated to contain (% DM 
basis): 40.47% limestone, 36.26% ground corn, 19.73% wheat 
midds, 2.47% salt, 0.312% zinc sulfate, 0.071% copper sulfate, 
0.064% manganese oxide, 0.029% selenium premix (contained 
0.6% Se), 0.202% vitamin A (30,000 IU/g), 0.056% vitamin E 
(500 IU/g), 0.207% Rumensin 90 (Elanco Animal Health; 
Indianapolis, IN), and 0.127% Tylan 40 (Elanco Animal Health; 
Indianapolis, IN). 
6Feed samples were analyzed for nutrient composition by an 
independent laboratory (Servi-Tech Laboratories; Dodge City, 
KS). 
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Table 3-3. The effects of ancillary therapies used in combination with an antimicrobial on performance 
between bovine respiratory disease treatments, retreatment percentages, and retreatment intervals  
 Experimental ancillary treatment1  P-value2 
     Pooled Overall Ancillary 
Variable NOAC NSAID VACC VITC SEM P-value vs. NOAC 
Vvs. 
Treatment BW3, kg        
1st treatment  214 213 211 212 2.60 0.75 0.38 
2nd treatment  217 208 212 210 7.14 0.49 0.17 
3rd treatment  221a 198b 195b 198b 8.05 0.02 <0.01 
4th treatment  188 181 185 190 12.9 0.94 0.84 
Average daily gain4, kg        
1st to 2nd  -0.50 -0.74 -0.68 -0.91 0.60 0.92 0.58 
2nd to 3rd 0.06ay -1.36abz -2.10b -1.60b 0.55 0.03 0.01 
3rd to 4th  -0.52 -0.34 -0.65 -0.76 0.65 0.95 0.93 
1st to 4th  -0.86 -0.85 -1.17 -1.18 0.39 0.78 0.57 
Retreatments5, %        
2nd treatment 48.8a 51.3a 37.5b 43.8ab 10.9 0.10 0.30 
3rd treatment 55.4y 39.0z 49.4yz 40.7z 12.3 0.09 0.04 
4th treatment 24.4 25.7 36.5 50.7 16.3 0.44 0.37 
3rd treatment of 1st 30.0 25.0 21.3 22.5 9.18 0.26 0.08 
4th treatment of 1st 8.75 8.75 12.5 15.0 5.42 0.50 0.41 
Time to treatment6, d        
1st treatment 7.60 7.36 7.39 7.36 1.34 0.78 0.33 
2nd treatment 11.6 9.35 11.3 8.53 2.38 0.70 0.47 
3rd treatment 20.4 13.2 14.3 13.3 2.74 0.21 0.05 
4th treatment 25.4 22.5 19.2 20.6 4.04 0.65 0.29 
1Experimental ancillary therapy (ANC) treatments administered at each bovine 
respiratory disease (BRD) treatment: NOAC = antimicrobial only, no ANC; NSAID = 
intravenous flunixin meglumine injection; VACC = revaccination with an intranasal viral 
vaccine; VITC = intramuscular vitamin C injection. 
2P-values are included for the overall F-test and the contrast of NOAC vs. the combined 
average of the NSAID, VACC, and VITC. Within a row means with different 
superscripts (a,b,c) differ (P ≤ 0.05) and means with different superscripts (x,y,z) tend to 
differ (P ≤ 0.10). 
3Treatment BW was the BW in kg with a calculated 2% shrink at the time of BRD 
treatment. 
4Treatment ADG was calculated from the shrunk (2%) BW in kg and individual DOF 
between the BRD treatments. 
5Retreatment percentages were calculated by taking the number of calves treated for BRD 
divided by the number of calves treated for BRD the previous time in the case of 2nd 
treatment, 3rd treatment, and 4th treatment, or by taking the number of calves treated for 
BRD divided by the number of calves treated for BRD initially in the case of 3rd 
treatment of 1st and 4th treatment of 1st. 
6Average length of time in days from arrival until the BRD treatment. 
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Table 3-4. The effects of ancillary therapies used in combination with an antimicrobial on clinical 
severity scores, rectal temperatures, and mortalities and removals  
 Experimental ancillary treatment1  P-value2 
     Pooled Overall Ancillary 
Variable NOAC NSAID VACC VITC SEM P-value vs. NOAC 
Vvs. 
Severity score3         
1st treatment 1.14y 1.13abyz 1.04bz 1.18a 0.04 0.10 0.55 
2nd treatment 2.43 2.88 2.43 2.68 0.29 0.27 0.28 
3rd treatment 2.43a 2.92ab 3.24b 3.14b 0.20 0.05 0.01 
4th treatment 2.94 3.17 3.20 3.06 0.23 0.79 0.41 
Rectal temperature4, °C        
1st treatment 40.7 40.7 40.8 40.8 0.07 0.21 0.19 
2nd treatment 40.4 40.3 40.5 40.3 0.16 0.80 0.94 
3rd treatment 40.0 39.7 40.0 39.8 0.36 0.83 0.49 
4th treatment 39.4 39.5 39.0 39.0 0.35 0.56 0.47 
Off experiment, %        
Mortality 16.3 22.5 20.0 22.5 8.86 0.55 0.20 
Removals5 6.25 0.00 3.75 1.25 1.80 0.13 0.05 
Combined off 
experiment6 
22.5 22.5 23.8 23.8 9.67 0.98 0.82 
1Experimental ancillary therapy (ANC) treatments administered at each bovine 
respiratory disease (BRD) treatment: NOAC = antimicrobial only, no ANC; NSAID = 
intravenous flunixin meglumine injection; VACC = revaccination with an intranasal viral 
vaccine; VITC = intramuscular vitamin C injection. 
2P-values are included for the overall F-test and the contrast of NOAC vs. the combined 
average of the NSAID, VACC, and VITC. Within a row means with different 
superscripts (a,b,c) differ (P ≤ 0.05) and means with different superscripts (x,y,z) tend to 
differ (P ≤ 0.10).  
3Subjective clinical severity score (1 = mild clinical signs, 2 = moderate clinical signs, 3 
= severe clinical signs, and 4 = extreme clinical signs or a moribund animal) assigned by 
trained personnel. For a calf to be assigned a clinical severity score of 4, the calf was not 
be able to rise, or had extreme difficulty standing, walking, or breathing.  
4Rectal temperature in degrees Celsius at the time of BRD treatment. 
5Percentage of calves removed from the experiment due to lameness or the inability to 
compete in the home pen (includes surviving chronic BRD cases).  
6Combined percentage of mortalities and removals for the experiment. 
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Table 3-5. The effects of ancillary therapies used in combination with an antimicrobial on receiving 
performance with mortalities and removals included 
 Experimental ancillary treatment1  P-value2 
     Pooled Overall Ancillary 
Variable NOAC NSAID VACC VITC SEM P-value vs. NOAC 
Vvs. 
Body weight3, kg        
1st treatment  214 213 211 212 2.60 0.75 0.38 
d 28  250 243 244 244 3.36 0.26 0.07 
d 56  288 279 280 280 4.03 0.25 0.06 
Average daily gain4, kg        
1st treatment – d 28 1.19 1.03 1.15 1.04 0.09 0.40 0.21 
d 28 – d 56 1.25 1.20 1.27 1.22 0.07 0.93 0.85 
1st treatment – d 56 1.27 1.16 1.21 1.17 0.06 0.47 0.17 
Dry matter intake5, kg        
1st treatment – d 28 5.04 4.57 4.80 4.82 0.54 0.40 0.17 
d 28 – d 56 7.95 7.29 7.58 7.48 0.24 0.23 0.07 
1st treatment – d 56 6.34 5.77 6.04 6.05 0.41 0.32 0.13 
Gain:Feed6        
1st treatment – d 28 0.238 0.232 0.246 0.219 0.02 0.72 0.79 
d 28 – d 56 0.157 0.165 0.167 0.164 0.01 0.75 0.32 
1st treatment – d 56 0.200 0.205 0.202 0.196 0.01 0.93 0.95 
1Experimental ancillary therapy (ANC) treatments administered at each bovine 
respiratory disease (BRD) treatment: NOAC = antimicrobial only, no ANC; NSAID = 
intravenous flunixin meglumine injection; VACC = revaccination with an intranasal viral 
vaccine; VITC = intramuscular vitamin C injection. 
2P-values are included for the overall F-test and the contrast of NOAC vs. the combined 
average of the NSAID, VACC, and VITC. Within a row means with different 
superscripts (a,b,c) differ (P ≤ 0.05) and means with different superscripts (x,y,z) tend to 
differ (P ≤ 0.10).  
3Treatment BW was the BW in kg with a calculated 2% shrink. 
4Treatment ADG was calculated from the shrunk (2%) BW in kg and DOF between the 
time periods. 
5Treatment DMI was calculated by taking DMI in kg for a pen for the period shown 
divided by the actual number of head days within each pen including mortalities and 
removals (deads in).  
6Treatment G:F was calculated by taking the pen ADG in kg divided by the pen average 
DMI in kg for the time periods. 
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Table 3-6. The effects of ancillary therapies used in combination with an antimicrobial on receiving 
performance with mortalities and removals excluded 
 Experimental ancillary treatment1  P-value2 
     Pooled Overall Ancillary 
Variable NOAC NSAID VACC VITC SEM P-value vs. NOAC 
Vvs. 
Body weight3, kg        
1st treatment  216 212 213 213 2.91 0.73 0.31 
d 28  253a 245b 245b 246b 2.80 0.07 0.01 
d 56  288 279 281 280 4.03 0.25 0.06 
Average daily gain4, kg        
1st treatment – d 28 1.28 1.12 1.15 1.12 0.08 0.39 0.10 
d 28 – d 56 1.25 1.20 1.27 1.22 0.07 0.93 0.85 
1st treatment – d 56 1.27 1.16 1.21 1.17 0.06 0.47 0.17 
Dry matter intake5, kg        
1st treatment – d 28 5.43 4.76 5.04 5.14 0.46 0.19 0.08 
d 28 – d 56 8.05 7.37 7.58 7.66 0.22 0.21 0.06 
1st treatment – d 56 6.70 6.03 6.28 6.37 0.31 0.15 0.05 
Gain:Feed6        
1st treatment – d 28 0.238 0.245 0.233 0.220 0.02 0.81 0.81 
d 28 – d 56 0.155 0.164 0.167 0.160 0.01 0.69 0.33 
1st treatment – d 56 0.189 0.194 0.193 0.185 0.01 0.87 0.84 
1Experimental ancillary therapy (ANC) treatments administered at each bovine 
respiratory disease (BRD) treatment: NOAC = antimicrobial only, no ancillary therapy; 
NSAID = intravenous flunixin meglumine injection; VACC = revaccination with an 
intranasal viral vaccine; VITC = intramuscular vitamin C injection. 
2P-values are included for the overall F-test and the contrast of NOAC vs. the combined 
average of the NSAID, VACC, and VITC. Within a row means with different 
superscripts (a,b,c) differ (P ≤ 0.05) and means with different superscripts (x,y,z) tend to 
differ (P ≤ 0.10).  
3Treatment BW was the BW in kg with a calculated 2% shrink. 
4Treatment ADG was calculated from the shrunk (2%) BW in kg and DOF between the 
time periods. 
5Treatment DMI was calculated by taking DMI in kg for a pen for the period shown 
divided by the actual number of head days within each pen excluding mortalities and 
removals (deads out). Mortalities and removals were backed out of the pen at a calculated 
maintenance DMI (NEm= 0.077 Mcal/EBW0.75). 
6Treatment G:F was calculated by taking the pen ADG in kg divided by the pen average 
DMI in kg for the time periods. 
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Table 3-7. The effects of ancillary therapies used in combination with an antimicrobial on 
subsequent finishing performance and efficiency of crossbred steers  
 Experimental ancillary treatment1  P-value2 
     Pooled Overall Ancillary 
Variable NOAC NSAID VACC VITC SEM P-value vs. NOAC 
Days on feed3, d 182 182 192 182 6.54 0.61 0.65 
Body weight4, kg        
Initial  292 288 281 287 12.7 0.95 0.67 
d 45  372 367 359 363 13.8 0.92 0.59 
d 91  440 432 423 424 12.4 0.73 0.34 
d 138  503 498 489 494 11.5 0.85 0.51 
Final 563 560 562 560 7.09 0.99 0.83 
Average daily gain5, kg        
Initial - d 45  1.81 1.76 1.73 1.69 0.06 0.52 0.22 
d 46 - d 91 1.44 1.41 1.39 1.32 0.08 0.75 0.51 
d 92 - d 138  1.33 1.41 1.42 1.50 0.06 0.34 0.14 
d 139 - final  1.44 1.54 1.38 1.57 0.11 0.60 0.63 
Initial - final 1.49 1.51 1.47 1.51 0.04 0.91 0.88 
Dry matter intake6, kg        
Initial - d 45  8.57 8.65 8.73 8.58 0.23 0.96 0.77 
d 46 - d 91 9.71 9.75 10.1 10.1 0.33 0.73 0.47 
d 92 - d 138  10.1 9.78 10.2 10.5 0.31 0.48 0.86 
d 139 - final  10.2 9.87 9.91 10.4 0.30 0.60 0.65 
Initial - final 9.63 9.49 9.74 9.82 0.23 0.76 0.84 
Gain:feed7        
Initial - d 45  0.212 0.203 0.198 0.197 0.01 0.26 0.07 
d 46 - d 91 0.149 0.145 0.139 0.130 0.01 0.31 0.22 
d 92 - d 138  0.132 0.145 0.140 0.144 0.01 0.49 0.16 
d 139 - final  0.140 0.155 0.140 0.151 0.01 0.54 0.40 
Initial - final 0.155 0.159 0.151 0.154 <0.01 0.61 0.98 
1Experimental ancillary therapy (ANC) treatments administered at each bovine 
respiratory disease (BRD) treatment: NOAC = antimicrobial only, no ancillary therapy; 
NSAID = intravenous flunixin meglumine injection; VACC = revaccination with an 
intranasal viral vaccine; VITC = intramuscular vitamin C injection. 
2P-values are included for the overall F-test and the contrast of NOAC vs. the average of 
the NSAID, VACC, and VITC. Within a row means with different superscripts (a,b,c) 
differ (P ≤ 0.05) and means with different superscripts (x,y,z) tend to differ (P ≤ 0.10).  
3Average of days on feed (DOF) for all pens within an experimental treatment. 
4Treatment BW was the BW in kg with a calculated 4% shrink. 
5Treatment ADG was calculated from the shrunk (4%) BW in kg and DOF between the 
time periods. 
6Treatment DMI was calculated by taking DMI in kg for a pen for the period shown 
divided by the actual number of head days within each pen. 
7Treatment G:F was calculated by taking the pen ADG in kg divided by the pen average 
DMI in kg for the time periods. 
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Table 3-8. The effects of ancillary therapies used in combination with an antimicrobial on 
ultrasound estimates, lung scores, and carcass characteristics of crossbred steers  
 Experimental ancillary treatment1  P-value2 
     Pooled Overall Ancillary 
Variable NOAC NSAID VACC VITC SEM P-value vs. NOAC 
Ultrasound estimates3        
d 91 REA, cm2 80.3 79.2 75.1 78.4 2.51 0.50 0.36 
d 91 12th-rib fat, cm 0.81 0.76 0.81 0.75 0.05 0.74 0.53 
d 91 IMF 4.21 4.15 4.50 4.14 0.18 0.47 0.81 
d 138 REA, cm2 87.6 87.4 82.2 86.7 2.20 0.29 0.40 
d 138 12th-rib fat, cm 0.92 0.90 0.93 0.91 0.07 0.99 0.98 
d 138 IMF 4.46 4.18 4.55 4.16 0.19 0.41 0.47 
Lung scores4        
Consolidation5  0.61 1.03 1.07 0.72 0.19 0.26 0.14 
Adhesion6  0.80 0.69 0.89 0.89 0.18 0.84 0.91 
HCW, kg 363 360 361 359 5.42 0.95 0.64 
Dressing percentage 64.5 64.2 64.3 64.1 0.35 0.82 0.40 
REA, cm2 92.3 90.9 89.3 90.2 2.12 0.79 0.39 
12th-rib fat, cm 1.34 1.26 1.46 1.32 0.11 0.59 0.94 
KPH fat, % 1.99 2.00 2.05 2.08 0.08 0.85 0.60 
Marbling score7 407 415 443 418 20.2 0.61 0.42 
Prime and choice8, % 42.8 56.1 65.1 41.7 11.5 0.41 0.37 
Yield grade 2.68 2.63 2.95 2.75 0.20 0.68 0.67 
Liver Score9 0.56 0.33 0.36 0.50 0.31 0.94 0.65 
1Experimental ancillary therapy (ANC) treatments administered at each bovine 
respiratory disease (BRD) treatment: NOAC = antimicrobial only, no ancillary therapy; 
NSAID = intravenous flunixin meglumine injection; VACC = revaccination with an 
intranasal viral vaccine; VITC = intramuscular vitamin C injection. 
2P-values are included for the overall F-test and the contrast of NOAC vs. the average of 
the NSAID, VACC, and VITC. Within a row means with different superscripts (a,b,c) 
differ (P ≤ 0.05) and means with different superscripts (x,y,z) tend to differ (P ≤ 0.10).  
3Ultrasound estimates of rib eye area (REA), 12th-rib fat thickness, and intramuscular fat 
were taken on d 91 and d 138 by Chad Gordon of Ultrasound Technologies. 
4Lung scores were obtained by trained personnel from West Texas A&M University. 
5Lung consolidation: 0 = clinically normal, healthy lung with < 5% consolidation of lung 
tissue, 1 = ± 5% consolidation of lung tissue or mycoplasma like lesion, 2 = > 5%, but < 
50% consolidation of lung tissue, missing lung, or mycoplasma like lesion, 3 = > 50% 
consolidation of lung tissue, missing lung, or mycoplasma like lesion.  
6Lung adhesion: 0 = clinically normal, healthy lung, 1 = minor threadlike fibrous 
adhesion, 2 = extensive fibrous adhesion. 
7Rib eye area. 
8Marbling scores: 400 = Small00, 500 = Modest00. 
9Pecentage of calves having prime or choice carcasses within each pen. 
10Liver Score: 0 = no abscesses, 1 = A-, 2 = A, 3 = A+, 4 = telangiectasis, 5 = distoma 
(fluke damage), and 6 = fecal contamination.  
167 
 
CHAPTER IV 
 
 
IMPACT OF BOVINE RESPIRATORY DISEASE DURING THE RECEIVING 
PERIOD ON STEER FINISHING PERFORMANCE, EFFICIENCY, CARCASS 
CHARACTERISTICS, AND LUNG SCORES 
 
ABSTRACT 
Bovine respiratory disease (BRD), also known as “shipping fever” or bronchopneumonia, 
is the most significant production problem for the feedlot industry, accounting for the 
majority of morbidity, mortality, decreased production, and economic losses in feedlots. 
The objective of this experiment was to evaluate the effect of BRD incidence during the 
receiving period on subsequent finishing performance, efficiency, carcass characteristics, 
and lung scores of feedlot steers. Prior to the initiation of this experiment, some calves 
were enrolled in an experiment evaluating ancillary therapy use. During the receiving 
period, crossbred steers (n = 516; initial BW = 217 ± 20 kg) were monitored daily by 
trained personnel for clinical signs of BRD. Overall morbidity and mortality attributed to 
BRD were 66.5% and 13.2% respectively. After the receiving period, a subset of calves 
(n = 174) were grouped by previous experimental treatment and the number of times 
treated for BRD (BRDX) and allocated to finishing pens. The BRDX experimental 
groups included: never treated for BRD (0X), treated 1 time (1X), 2 times (2X), or 3 or 4 
times (3/4X). Arrival BW did not differ among calves utilized in this experiment 
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(P = 0.17). However, BRDX during the receiving period decreased calf performance, 
resulting in BW of 324, 316, 285, and 260 kg for 0X, 1X, 2X, and 3/4X, respectively, at 
the start of the finishing phase (P < 0.001). Ultrasound estimates, BW, and visual 
appraisal were used to target a common compositional end point based on 12th rib fat 
thickness (average days on feed; DOF = 182) for each pen of cattle. There was no 
difference (P ≥ 0.83) in 12th rib fat thickness among BRDX at harvest. Data were 
analyzed using the MIXED procedure of SAS with pen (n = 32; 8 per BRDX group) 
serving as the experimental unit. The lack of significant interactions between BRDX and 
previous experimental ancillary therapy treatments allowed for the integrity of both 
experiments to be maintained. With increasing BRDX, DOF and lung consolidation 
scores increased linearly (P ≤ 0.003), while HCW, dressing percentage, rib eye area 
(REA), and the percentage of USDA Prime and Choice carcasses decreased linearly (P ≤ 
0.03). These results suggest that with additional DOF, calves treated multiple times for 
BRD are able to reach similar compositional end points as their untreated cohorts; 
however, it may not be possible for these calves to ever reach the same quality and yield 
potential. 
 
Key Words: bovine respiratory disease, carcass characteristics, finishing performance, 
high-risk calves, lung scores. 
 
INTRODUCTION 
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Bovine respiratory disease (BRD) is a complex illness and a multitude of 
stressors, viruses, and bacterial pathogens can potentially contribute to its onset (Duff and 
Galyean, 2007). Development of clinical BRD frequently occurs via a primary infection 
with 1 or more respiratory viruses. The initial viral infection combined with a 
compromised immune system then allows for the rapid colonization of bacteria within the 
lungs (Hodgins et al., 2002). The BRD complex accounts for the majority of morbidity, 
mortality, decreased production, and economic losses in feedlots. 
Woolums et al. (2005) implicated BRD as the leading cause of morbidity and 
mortality in 561 feedlots in 21 states. Morbidity attributed to BRD can account for 
approximately 75% of total morbidity, and mortality attributed to BRD accounts for 36 to 
80% of total mortality in feedlot cattle (Vogel and Parrott, 1994; Edwards, 1996; Smith, 
1998; Chirase and Greene, 2001). In a 2011 survey, NAHMS (2013) stated nearly all 
feedlots (96.9%) had cattle that were affected by BRD and that BRD was the most 
common illness in feedlots affecting 16.2% of cattle placed on feed. Economic losses 
from BRD result from antimicrobial treatments, increased labor, mortalities, chronic 
BRD cases, and decreased performance of calves treated for BRD. Powell (2013) 
estimated annual economic losses resulting from BRD to be in excess of $2 billion.  
In an experiment with a slightly different treatment structure, Holland et al. 
(2010) examined the effects of previous BRD incidence in heifers. The authors suggested 
that when calves were harvested at a common endpoints, animals requiring multiple 
antimicrobial treatments for BRD were able to produce carcasses with similar value to 
untreated animals given additional days on feed (DOF). The objective of this experiment 
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was to evaluate the impact of BRD incidence during the receiving period on subsequent 
finishing performance, efficiency, carcass characteristics, and lung scores of steers. 
 
MATERIALS AND METHODS 
All procedures for the present experiment were approved by the Oklahoma State 
University Institutional Animal Care and Use Committee (Animal Care and Use Protocol 
AG-12-11). 
 
Cattle and receiving period 
Over the course of 1 week, 516 crossbred steers and bulls (BW at arrival = 217 ± 
20 kg) were purchased at livestock auctions throughout Oklahoma and transported 
(average distance = 135 km) to the Willard Sparks Beef Research Center (WSBRC) at 
Oklahoma State University. Upon arrival at the feed yard, calves were individually 
weighed and visually inspected for noticeable deformities. Hide color, horn status, and 
sex were recorded and an uniquely numbered ear tag was placed in the left ear of each 
calf. Calves were then commingled into receiving pens, given ad libitum access to prairie 
hay and water, and allowed to rest 24 to 48 hours prior to initial processing. 
Initial processing consisted of vaccination for protection against Infectious 
Bovine Rhinotracheitis (IBR) virus, Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2, 
Parainfluenza 3 (PI3) virus, and Bovine Respiratory Syncytial Virus (BRSV; BRD 
Shield; Novartis, Greensboro, NC), Clostridium chauvoei, Clostridium septicum, 
171 
 
Clostridium novyi, Clostridium sordellii and Clostridium perfringens Types C and D 
(Caliber 7; Boehringer-Ingelheim, St. Joseph, MO), and treatment for the control of 
internal and external parasites (Ivomec Plus; Merial, Duluth, GA). Individual BW were 
obtained, bulls (n = 355) were surgically castrated by incising the scrotum with a 
Newberry castrating knife, then by emasculation by a single individual, and all horns (n = 
57) were tipped with a Keystone dehorner. 
 
Assessment for clinical signs of BRD and antimicrobial administration 
During the receiving period, calves were visually monitored twice daily by trained 
evaluators throughout the experiment for clinical signs characteristic of BRD. The 
evaluation employed criteria based on the DART™ system (Pharmacia Upjohn Animal 
Health, Kalamazoo, MI) with some modifications as described by Step et al. (2008). The 
subjective criteria utilized for pulling calves consisted of depression, abnormal appetite, 
and respiratory signs. Signs of depression observed included but were not limited to: 
depressed attitude, lowered head, glazed or sunken eyes, slow or restricted movement, 
arched back, difficulty standing or walking, knuckling of joints or dragging toes when 
walking, and stumbling. Signs of abnormal appetite included: an animal that was 
completely off feed, an animal eating less than expected or eating extremely slow, a lack 
of gut fill or gaunt appearance, and obvious body weight loss. Respiratory signs included: 
labored breathing, extended head and neck (in an attempt to breathe), and audible noise 
when breathing. The evaluators assigned a calf a severity score from 0 to 4 based on the 
clinical signs and the severity of those signs. 
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A score of 0 was assigned for a clinically normal appearing calf. A score of 1 was 
assigned for mild clinical signs, 2 for moderate clinical signs, 3 for severe clinical signs, 
and 4 for a moribund animal. For a calf to be assigned a score of 4, the calf was not be 
able to rise, or had extreme difficulty standing, walking, or breathing. These animals 
required immediate assistance. The objective criteria used to determine if antimicrobial 
treatment was necessary was rectal temperature. All calves assigned a severity score of 1 
to 4 were taken to the processing chute for rectal temperature measurement (GL M-500, 
GLA Agricultural Electronics, San Luis Obispo, CA). Any animal that was pulled with a 
severity score of 1 or 2, and had a rectal temperature of 40°C or greater received an 
antimicrobial according to label instructions. If a calf was pulled with a severity score of 
1 or 2 and had a rectal temperature of less than 40°C, no antimicrobial treatment was 
administered, and the calf was returned to its receiving pen after evaluation. Any animal 
with a severe clinical signs (severity score = 3 or 4), received an antimicrobial according 
to label instructions regardless of rectal temperature. In extreme cases the antimicrobial 
may have been administered in the home pen if the calf was deemed unable to make the 
walk to the working facility. 
Prior to antimicrobial administration, an accurate BW was obtained to calculate 
the appropriate dosage and a blood sample was collected (Corvac™ Serum Separator 
Tube, Tyco Healthcare Group LP, Mansfield MA). Antimicrobial doses were calculated 
by rounding the calf’s current BW up to the nearest 11.3 kg. All antimicrobials were 
administered subcutaneously per manufacturer’s label directions following Beef Quality 
Assurance Guidelines (NCBA, 2001). The first antimicrobial treatment was administered 
on the left side of the animal, and subsequent injections were given on alternating sides of 
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the animal. The severity score, temperature, BW, and antimicrobial dosage administered 
(or no treatment administered) was recorded for every calf that was pulled for exhibiting 
clinical signs of BRD. A maximum of 4 antimicrobial treatments were administered 
during the experiment. 
The first time antimicrobial treatment criteria were met, gamithromycin 150 
mg/mL (Zactran; Merial, Duluth, GA) was administered at the rate of 1 mL/24.9 kg of 
BW. A moratorium was observed after gamithromycin administration before a second 
antimicrobial treatment could be administered. This moratorium was 240 h for calves 
with a severity score of 1 or 2, and 96 h for calves with a severity score of 3 or 4. If 
antimicrobial treatment criteria were met a second time, florfenicol 300 mg/mL (Nuflor; 
Intervet/Schering-Plough, Desoto, KS) was administered at the rate of 1 ml/7.56 kg of 
BW. After florfenicol administration, a 96 h moratorium was observed before a third 
antimicrobial treatment could be administered regardless of severity score. If 
antimicrobial treatment criteria were met a third time, ceftiofur crystalline free acid 200 
mg/mL (Excede; Pfizer, New York City, NY) was administered at the rate of 1 ml/30.2 
kg of BW. After ceftiofur crystalline free acid administration, a 168 h moratorium was 
observed before a fourth antimicrobial treatment could be administered regardless of 
severity score. If antimicrobial treatment criteria were met a fourth time, a second dose of 
ceftiofur crystalline free acid was administered as described above. Once a calf was 
“pulled” for suspected BRD, met the treatment criteria, and received an antimicrobial, it 
was then randomly assigned to 1 of 4 ancillary therapy treatments. The 4 ancillary 
therapy treatments consisted of: an intravenous flunixin meglumine injection, an 
intranasal viral vaccination, an intramuscular vitamin C injection, or no ancillary therapy.  
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Finishing phase cattle management 
After the receiving period, calves remained in their home pens and received ad 
libitum access to a common receiving ration (Table 1) and water for 2 to 3 additional 
weeks. After this additional period (average total DOF = 86), a subset of 174 calves were 
allocated to a finishing experiment. This subset included 126 head of calves that were 
treated for BRD from the receiving ancillary therapy experiment and an additional 48 
head of calves that were not treated for BRD during the receiving period. Body weight at 
arrival was not different for the subpopulation of calves used for the finishing experiment 
(P = 0.17). For the finishing experiment, all previous experimental ANC were 
maintained, but calves were allocated by the number of times treated for BRD (BRDX). 
The BRDX experimental groups included: never treated for BRD (0X), treated 1 time 
(1X), 2 times (2X), or 3 or 4 times (3/4X). Data were analyzed for interactions between 
ANC and number of BRD treatments administered. Only one interaction existed 
(marbling score) for all variables analyzed. Due to the lack of significant interactions, the 
integrity of the experiment was able to be maintained, and data were subsequently 
analyzed on the basis of BRDX only.  
Prior to allocation to finishing pens, all steers were administered 200 mg 
trenbolone acetate (TBA) and 40 mg estradiol (Revalor XS; Merck Animal Health, 
Summit, NJ). The ultimate goal was to harvest all calves at a common compositional end 
point with an emphasis on achieving a 12th rib fat thickness of at 1.27 cm regardless of 
DOF, while still maintaining the integrity of the pen and shipping truck load lots. This 
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was accomplished through the use of the ultrasound estimates, BW, and visual appraisal. 
Calves were harvested in 2 groups (DOF = 166 or 197). For the last 28 DOF, all steers 
were fed ractopamine hydrochloride (Optaflexx 45; Elanco Animal Health, Indianapolis, 
IN) at 300.75 mg•steer-1•d-1. 
 
Finishing phase pen management and diet 
Finishing pens were 4.57 × 15.24 m in area with a 4.57 m long concrete bunk at 
the front of the pen. The pens contained a 4.57 × 4.42 m concrete pad with the remainder 
of the pen being soil surfaced. The pens were under partial cover, with the bunk and pad 
being covered by an overhang. A 76 L concrete water tank (Model J 360-F; Johnson 
Concrete, Hastings, NE) was shared between 2 pens and was cleaned 3 times per week 
throughout the experiment.  
The common finishing ration was formulated to meet or exceed NRC (2000) 
nutrient requirements (Table 2). Adaptation to the finishing diet was accomplished using 
a two-ration blend method where each day the percentage of finishing diet delivered was 
increased by approximately 4.6% DM and the percentage of receiving diet (Table 1) 
delivered was decreased by approximately 4.6% DM until only the finishing diet was 
being fed. Following adaptation, the finishing ration was fed to all cattle twice daily at 
0700 h and 1300 h in a 274-12B Roto-Mix Forage Express mixer wagon (Roto-Mix, 
Dodge City, KS) to the nearest 0.45 kg of that day’s feed call. Ration samples were 
collected once per week, and dried in a forced air oven for 48 h at 60ºC to determine DM. 
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Ration samples were composited gravimetrically and analyzed at a commercial 
laboratory (Servi-Tech Inc., Dodge City, KS) for nutrient composition (Table 2). 
 
Finishing phase data collection, calculations and statistical analysis 
Unshrunk BW were obtained at the time of allocation to finishing pens and at 
approximately 45 d intervals thereafter. All BW were shrunk a calculated 4%. Individual 
BW and ADG values were averaged within a pen to obtain pen mean BW and ADG. 
Ultrasound estimates were taken at 91 and 138 DOF. Carcass data, lung consolidation 
scores, and lung adhesion scores were obtained by trained personnel from West Texas 
A&M University at harvest. Lung consolidation and lung adhesion scores were converted 
to a numeric scale and individual values were averaged within a pen to obtain pen mean 
lung scores. Lung consolidation scores consisted of: 0 = clinically normal, healthy lung 
with < 5% consolidation of lung tissue, 1 = ± 5% consolidation of lung tissue or 
mycoplasma-like lesion, 2 = > 5%, but < 50% consolidation of lung tissue, missing lung, 
or mycoplasma-like lesion, 3 = > 50% consolidation of lung tissue, missing lung, or 
mycoplasma like-lesion. Lung adhesion scores consisted of: 0 = clinically normal, 
healthy lung, 1 = minor threadlike fibrous adhesion, 2 = extensive fibrous adhesion.  
Data were analyzed using the MIXED procedure of SAS 9.3 (SAS Institute Inc., 
Cary, NC) with pen serving as the experimental unit. Contrasts were performed for the 
linear and quadratic effects of BRDX. Contrasts were not considered unless the overall 
model was significant (P ≤ 0.05) or tended to be significant (0.05 > P ≤ 0.10). Data were 
analyzed with mortalities (4; 3 digestive and 1 BRD) included in the analysis (deads in). 
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One calf from the 2X group and 3 calves from the 3/4X group died during the 
experiment. Due to circumstances beyond our control, the calves harvested at 197 DOF 
experienced a longer chill time at the plant prior to grading. Due to calves being 
harvested at varying DOF and there being a difference in chill time prior to grading 
between the harvest groups, harvest group was included in the model statement for the 
analysis of carcass quality parameters. 
 
Carcass value and economic analysis 
 The average base price on the premium grid at the time of harvest was $199.87 
per 45.4 kg. This base price was then adjusted for any individual premiums or discounts 
based on the carcass data and then multiplied by the individual HCW for each animal to 
calculate a carcass value for each calf. This carcass value represents the actual value of 
the calf at the time of harvest. After carcass values were calculated for each BRDX 
group, the actual cost of antimicrobials used in the experiment was subtracted from each 
respective BRDX group. For 3/4X, the average of 3 or 4 antimicrobials was used. Next 
additional labor and other expenses were accounted for at an assumed cost of $7.25 per 
antimicrobial administered. Yardage was then adjusted based on actual DOF for a pen 
and a yardage cost of $0.40 steer-1•d-1. Finally, feed cost was also adjusted based on 
actual DMI for a pen and a ration cost of $301.85 per 907.2 kg on a DM basis. These 
adjustments resulted in what is termed as total calf value. Total calf value would be the 
carcass value adjusted for actual costs resulting from BRD treatment including: the 
purchase price of antimicrobials, increased labor costs associated with treatment and care, 
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adjustments in yardage costs based on variations in DOF, and adjustments in feed costs 
based on variations in DOF. 
 
RESULTS 
Finishing performance and efficiency 
 The performance and efficiency data is shown in Table 3. Arrival BW prior to the 
receiving experiment did not differ among calves utilized in this experiment (P = 0.17) 
for BRDX. However, the incidence of BRDX during the receiving period did impact calf 
ADG during this period. As a result, there was a linear decrease (P < 0.001) in initial BW 
at the start of the finishing phase resulting in initial BW of 324, 316, 285, and 260 kg for 
0X, 1X, 2X, and 3/4X, respectively. Interval BW obtained on d 45, d 91, and d 138 all 
exhibited the same linear decrease (P < 0.001) as BRDX increased. The difference in BW 
among the BRDX groups decreased throughout the finishing period, resulting in final 
BW difference of only 16 kg between 0X and 3/4X compared to the initial BW difference 
of 64 kg between the same 2 BRDX groups. However, there was still a linear decrease (P 
= 0.01) in the final BW taken prior to harvest for increasing BRDX. 
 During the first 45 d of the finishing period, there was no difference (P = 0.68) in 
ADG among the BRDX groups. Conversely, from d 46 to d 91 and from d 92 to 138 
there was a linear increase (P ≤ 0.002) in ADG as BRDX increased. From d 139 to the 
end of the experiment, this difference in ADG was no longer present (P = 0.40). However 
when ADG was calculated for the entire finishing period, a linear increase (P = 0.05) in 
ADG was observed as BRDX increased.  
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There was also a linear increase (P = 0.004) in DMI observed from the start of the 
finishing period until d 45 as BRDX increased. There was a tendency for DMI to be 
different from d 92 through d 138, however no linear or quadratic trend (P ≥ 0.12) could 
be determined to separate the DMI of heifers, regardless of BRDX group. No other 
differences in DMI (P ≥ 0.49) were detected among the BRDX groups. When DMI was 
evaluated as a percentage of average BW, a significant linear increase (P ≤ 0.005) was 
observed for all intervals as well for the entire finishing period. There was a tendency for 
a quadratic effect from d 92 through d 138 of the experiment for DMI as a percentage of 
average BW.  
 Gain:feed was not different (P = 0.20) among BRDX during the first 45 d of the 
finishing period. However, the improvement in ADG with increasing BRDX from d 46 to 
d 91 and from d 92 to 138 combined with similar DMI among BRDX groups during these 
same intervals resulted in linear improvements (P ≤ 0.01) in G:F over the next 2 
intervals. From d 139 to the end of the experiment, this difference in G:F was no longer 
present (P = 0.26). In addition, overall G:F was not significantly different (P = 0.22) 
among BRDX groups. 
 
Common compositional end point projections and days on feed 
 On d 91, ultrasound estimates (Table 4) indicated that there was a significant 
linear decrease (P < 0.001) in rib eye area (REA) and that intramuscular fat tended (P = 
0.10) to decrease linearly (linear, P = 0.06) as the number of BRD treatments increased. 
By d 138, there was still a linear decrease (P = 0.01) in REA as BRDX increased, but 
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there was no longer a difference (P = 0.32) in intramuscular fat according to ultrasound. 
The 12th rib fat thickness of calves was not different (P ≥ 0.21) among BRDX groups at 
d 91 or d 138 according to ultrasound estimates. Based on the ultrasound estimates, the 
average BW and ADG of calves within each pen, and visual appraisal, an individual 
harvest date was projected for each pen. Logistics dictated that calves would need to be 
shipped in groups large enough to evenly fill trucks and also allow for efficient carcass 
data collection. Ultimately, the pens were fairly easily separated into early and late 
harvest groups by their individual predicted harvest dates and all pens were able to be 
harvested in 2 groups (DOF = 166 or 197). Days on feed (Table 3) did increase linearly 
(P = 0.002) as BRDX increased. At harvest, there were no differences (P = 0.83) in 
compositional maturity based on 12th rib fat thickness among any of the BRDX groups. 
There was actually a numerical increase in 12th rib fat thickness observed for 2X and 
3/4X calves compared to 0X.  
  
Carcass characteristics and lung consolidation and adhesion scores 
 Hot carcass weight followed the same pattern as final BW with increasing BRDX 
resulting in a linear decrease (P ≤ 0.001) in HCW. In addition to the decrease in HCW 
due to differences in BW, there was also linear decrease (P ≤ 0.001) in dressing 
percentage which further impacted HCW. Rib eye area also decreased in a linear fashion 
(P = 0.03) when BRDX increased. However, when REA was evaluated as a percentage of 
HCW no differences were observed among the BRDX groups (P = 0.52). There tended 
(P = 0.06) to be a linear decrease in the percentage of USDA Prime and Choice carcasses 
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(linear, P = 0.03) as the number of BRD treatments increased. No differences (P ≥ 0.26) 
for 12th rib fat thickness, kidney pelvic and heart fat, marbling score, USDA Yield 
Grade, or liver score were observed among the BRDX groups. Lung consolidation 
increased linearly (P ≤ 0.01) as BRDX increased. Conversely, there were no differences 
(P = 0.47) in lung adhesion among BRDX groups with calves receiving 1 BRD treatment 
having the numerically highest adhesion scores.  
 
Carcass value and economic analysis 
 The average carcass price per 45.4 kg was not different (P = 0.25) among BRDX 
groups and ranged from $197.99 to $200.41. However, decreases in BW and dressing 
percentage as BRDX increased resulted in larger differences in total carcass value as 
BRDX increased. Calves never treated for BRD had an average carcass value of 
$1,643.80, while 1X, 2X, and 3/4X groups returned $1,612.67, $1,589.01, and $1,540.46, 
respectively resulting in a linear decrease (P = 0.001) in total carcass value. When total 
calf value was calculated by adjusting for the cost of antimicrobials, increased labor, and 
variation in yardage and feed consumption due to differences in DOF, the differences in 
value among BRDX groups became more magnified. The total calf value for 0X 
remained the same, while 1X, 2X, and 3/4X groups had total calf values of $1,605.93, 
$1,476.91, and $1,413.35, respectively (linear P < 0.0001). These differences in total calf 
value resulted in losses of $37.87, $166.89, and $230.46 for 1X, 2X, and 3/4X, 
respectively when compared to 0X. The greatest single economic loss experienced by all 
calves that were treated for BRD was a loss of carcass value at the time of harvest.  
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DISCUSSION 
The overall morbidity (66.5%) and mortality (13.2%) attributed to BRD within 
this experiment fell within the range of expected morbidity and mortality rates for high-
risk steers and bulls of similar backgrounds at our facility. In other recent experiments 
conducted at the WSBRC utilizing high-risk, livestock auction-sourced steers and bulls 
purchased during the fall total morbidity has ranged from 31.4% to 68.0%. Mortality 
attributed to clinical BRD in these same experiments ranged from 1.49% to 13.9%. These 
morbidity and mortality percentages would be supported by surveys and reviews within 
the literature. In a survey conducted by Woolums et al. (2005), the authors implicated 
BRD as the leading cause of morbidity and mortality in 561 feedlots in 21 states. 
Edwards (1996) estimated that BRD accounts for approximately 75% of total morbidity 
in feedlot cattle.  Mortality attributed to BRD has been estimated to account for between 
36 to 80% of total mortality in feedlot cattle depending on the source (Vogel and Parrott, 
1994; Edwards, 1996; Smith, 1998; Chirase and Greene, 2001). From a 2011 survey, 
NAHMS (2013) identified that nearly all feedlots (96.9%) had cattle affected by BRD 
and that BRD was also the most common illness in feedlots affecting 16.2% of cattle 
placed on feed. In addition, it was reported that feedlots in the central region (Colorado, 
Kansas, Nebraska, Oklahoma, and Texas) had twice as many cattle affected with BRD 
compared to feedlots in the rest of the U.S. (NAHMS, 2013). It should also be noted that 
this average includes all cattle received into feedlots, not only high-risk calves as in the 
case of the current experiment. 
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An advantage to the increased morbidity and numbers of animals requiring 
multiple treatments was that it afforded the ability for replication of BRD treatment 
groups within a finishing experiment. This particular set of calves provided an excellent 
opportunity to examine our objectives. The primary objective of this experiment was to 
evaluate the effect of BRD incidence during the receiving period on subsequent finishing 
performance, efficiency, carcass characteristics, and lung scores of feedlot steers. In our 
opinion, to accurately determine the effects of BRD incidence all calves must be allowed 
to reach their quality and yield potential regardless of the number of BRD treatments 
received. Obviously, this cannot be accomplished by feeding all calves to equal days on 
feed, so our second objective was to attempt to harvest each pen of calves at a common 
compositional end point. Our target was to harvest all pens when calves within that pen 
reached a 12th rib fat thickness of 1.27 cm. This goal was successfully achieved through 
the use of ultrasound estimates, BW projections, and visual appraisal, as all BRDX 
groups were harvested between 1.28 and 1.40 cm of 12th rib fat. Finally, this experiment 
aimed to quantify the actual economic losses due to increasing BRDX for a specific 
group of cattle under recent market conditions.  
Calves were enrolled in a 56 day receiving experiment once they received an 
initial BRD treatment. After the receiving period, calves remained in their receiving pens 
for an additional 2 to 3 additional weeks (average total DOF = 86). This time frame 
attempted to ensure that all BRD treatments, including up to 4 antimicrobial treatments 
when necessary, would occur prior to the finishing period. This approach would also be 
supported by the literature. Thompson et al. (2006) reported that 87% of all BRD 
treatments had occurred within 35 d of arrival, and Babcock et al. (2009) stated that 74% 
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of morbidity occurred during the first 42 d on feed. There was 1 calf from the 3/4X group 
that did require BRD treatment after the initiation of the finishing experiment. This calf 
ultimately died and the death was attributed to BRD.  
This experiment was very similar to one conducted by Holland et al. (2010). The 
major differences between that experiment and the present experiment being sex and the 
treatment structure of BRDX. In the experiment by Holland et al. (2010), heifers were 
used. In the present experiment, all calves used arrived as steers or bulls. Also, Holland et 
al. (2010) classified BRD treatment groups (BRDX) as: never treated for BRD (0X), 
treated for BRD 1 time (1X), treated for BRD 2 times (2X), treated for BRD 3 times 
(3X), or chronically ill (CI). In the present experiment, up to 4 antimicrobials were 
administered, and calves receiving 3 or 4 antimicrobials were combined into one BRDX 
group. There were several calves in the 3/4X group in the present experiment that could 
have been classified as CI according to the classification provided by Holland et al. 
(2010). To be classified as CI by Holland et al. (2010), a calf must have been 
administered 3 antimicrobial treatments and at least 48 h had to have passed after the last 
antimicrobial was given. In addition, the calf must have been enrolled in the experiment 
for longer than 21 d and have experienced a net loss of BW over the most recent 21-d 
period. Finally a calf must have been assigned a clinical severity score of 3 or 4 on the 
day of classification.  
By assembling the BRDX groups the way we did in the present experiment, we 
were able to provide greater replication of calves experiencing a severe natural BRD 
challenge and receiving multiple antimicrobial treatments. This treatment structure 
allowed us to have 8 pens per BRDX, even though we had fewer steers in some of the 
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pens receiving multiple BRD treatments. With the treatment structure employed by 
Holland et al. (2010), there were only 2 pens of CI animals, while there were at least 6 
pens of heifers for the other BRDX groups. If Holland et al. (2010) had more CI heifers 
in their experiment and combined them with the 3X group, the treatment structures would 
be essentially the same between the 2 experiments. Waggoner et al. (2007) reported the 
mean DOF for cattle that were never treated to be 193 d, for cattle treated 1 time to be 
200 d, and for cattle treated 2 or more times to be 212 d. The 19 d difference in DOF 
between healthy calves and those treated 2 or more reported by Waggoner et al. (2007) is 
consistent the difference in DOF for the same groups of calves within the present 
experiment. In this experiment, calves in the 2X and 3/4X groups required an additional 
17 DOF on average. 
Holland et al. (2010) also used a similar combination of ultrasound estimates, calf 
performance, and visual appraisal to target a common compositional end point (an 
average 12th rib fat thickness of 1.27 cm) for all heifers. There were 3 harvest dates 
(DOF = 152, 174, and 189) used by Holland et al. (2010) compared to 2 harvest dates in 
the present experiment. In their experiment heifers treated 0X, 1X, and 2X were all 
harvested at the same average DOF, while heifers in the 3X and CI groups were on feed 
for an average of 19 and 26 more days, respectively. In the present experiment, all BRDX 
groups were harvested at different average DOF (Holland et al., 2010).  
Arrival BW prior to initiation of the receiving phase did not differ among the 
BRDX groups (10 kg difference between 0X and 3/4X) in the present experiment. 
However, increasing BRDX during the receiving period decreased calf ADG, resulting in 
a linear decrease in BW at the start of the finishing phase (64 kg difference between 0X 
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and 3/4X). These results are in agreement with Holland et al. (2010) where arrival BW 
was also not different among BRDX groups. Similarly Gardner et al. (1999) and 
Waggoner et al. (2007) also demonstrated that arrival BW was not different between 
cattle that were never treated for BRD and cattle that required antimicrobial treatment for 
clinical signs of BRD. In addition, Holland et al. (2010) observed a linear decrease in BW 
as BRDX increased at the start of the finishing phase resulting from a linear decrease in 
ADG during the receiving period. This linear decrease in BW during the receiving period 
associated with increasing BRDX is also supported by data from other experiments 
(Gardner et al., 1999; Thompson et al., 2006; Schneider et al., 2009). 
The depression in ADG observed in the present experiment was consistent with 
other results in the published literature. During the pre-finishing period (average DOF = 
86), steers in 1X, 2X, and 3/4X groups in the present experiment had decreases in ADG 
of 6.7%, 32.9%, and 52.4%, respectively when compared to 0X. This was similar to the 
decreases in ADG reported by Holland et al. (2010) who reported a 59% decrease in 
ADG for heifers in the 3X group. It should be noted that this was over a 63 d period, and 
an improvement in ADG would be expected for those heifers from d 63 to d 86. This 
initial loss of ADG during the pre-finishing period in the current experiment resulted in a 
7.4% decrease in ADG for calves in the 3/4X group compared to the 0X group from the 
time of arrival to harvest. This result was similar to the overall decrease in ADG from 
arrival to harvest reported by Holland et al. (2010) who stated that heifers receiving 3 
antimicrobial treatments had a decrease in ADG of 8.7% during this time. 
After the decrease in ADG during the pre-finishing period observed for morbid 
steers, a compensatory gain response was observed for those calves during the finishing 
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period. The interval improvements in ADG for treated calves resulted in improved 
overall ADG during the finishing phase for calves treated for BRD. These results are in 
contrast to those reported by Holland et al. (2010) who reported no difference in overall 
finishing period ADG. Similar to those results reported by Holland et al. (2010), 
Thompson et al. (2006) observed a decrease in ADG during the first 35 d on feed for 
morbid animals, but no difference in ADG from d 35 until slaughter. Although a 
compensatory gain response was observed during the finishing phase in the present 
experiment, it is important to note that steers treated for BRD were not able to fully 
compensate in regards to BW even with additional DOF.  
Holland et al. (2010) reported no linear differences in the final BW of heifers for 
the 0X, 1X, 2X, and 3X groups. This was in contrast to the results of the present 
experiment where there was still a linear decrease in the final BW present just prior to 
harvest as BRDX increased. However, it is interesting to note that when contrasting 3X 
heifers with CI heifers, there was a significant decrease in final BW for CI heifers 
(Holland et al., 2010). The differing results observed in the final BW of these 2 
experiments could simply be the result of how the BRDX groups were structured for 
those calves receiving 3 or more antimicrobial treatments that suffered from an extreme 
BRD challenge.  
Experiments by Roeber et al. (2001) and Waggoner et al. (2007) evaluated 
animals in 2 separate Ranch to Rail programs where animals were also slaughtered on a 
market ready basis. Similar to the findings of Holland et al. (2010), final BW was not 
different among animals administered varying antimicrobial treatments. However Roeber 
et al. (2001) and Waggoner et al. (2007) did both find a numerical decrease (8 and 18 kg, 
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respectively) in final BW for calves requiring 2 or more antimicrobial treatments. In a 
review of individual carcass characteristics of 33,073 steers fed in commercial pens 
linked to previous BRD treatments, Erickson et al. (2011) reported a significant linear 
decrease in final BW among steers as BRDX increased.  
Much of the data investigating the effects of BRD on feedlot cattle performance 
results from correlating individual cattle performance to treatment records on a 
retrospective basis. This retrospective approach has also been conducted using the 
presence of lung lesions or lung scores at harvest. Finally, other experiments have simply 
evaluated the performance of a pen or lot of cattle with high incidence of BRD. These 
experiments provide good evidence of performance of treated cattle on a large 
commercial scale. However, none of these methods are ideal, as they either cannot 
account for DMI and efficiency measures, or they simply lump non-treated and cattle 
receiving differing numbers of BRD treatments within a pen or lot together to determine 
intake and efficiency of the pen or lot.  
The treatment structure of the present experiment allowed for the measurement of 
DMI of feedlot cattle that had required different numbers of antimicrobial treatments for 
BRD during the receiving period. Obviously without knowing which calves would 
eventually require treatment, we were not able to measure intake during the receiving 
period, but previous data would suggest that the morbid calves in our experiment were 
likely consuming less feed than healthy animals during this time. It is likely that much of 
the decrease in pre-finishing ADG observed in the current experiment by calves that 
required antimicrobial treatment for BRD could be the result of less frequent visits to the 
feed bunk and decreased DMI by these calves. Because all calves in the present 
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experiment received the same diets during both the receiving and finishing phases, 
differences in performance resulting from nutrition would only be related to differences 
in DMI by morbid animals. 
High-risk calves have been shown to have altered eating patterns when compared 
with unstressed cohorts (Galyean et al., 1999). In addition, the DMI of high-risk calves is 
extremely variable, and many calves do not achieve adequate DMI for the first couple of 
weeks on feed. Hutcheson and Cole (1986) stated that DMI for newly received calves 
ranged from 0.5% to 1.5% of body weight and that the majority of morbid calves do not 
consume any feed for the first 2 days in the feedlot. It was also reported that 
approximately only 4 out 5 (83.4%) morbid calves were consuming feed by the end of the 
first week in the feedlot (Hutcheson and Cole, 1986). These results can cause sick calves 
to have only 58%, 68%, and 88% of the DMI compared to healthy animals during the 
first, fourth, and eighth weeks after arrival in the feedlot (Hutcheson and Cole, 1986).  
There was a linear decrease in DMI as BRDX increased for the first 45 d of the 
present experiment. However, no other trends were observed for the remainder of the 
experiment and overall DMI was not different among BRDX groups. These results would 
be similar to those reported by Holland et al. (2010) who noted a linear decrease in DMI 
during the first 65 DOF. However, when DMI was evaluated as a percentage of mean 
BW in the present experiment, a linear increase was observed for all intervals as well for 
the entire finishing period. This increase in DMI as a percentage of BW would serve as 
additional evidence of the attempted compensation for lost performance that occurred 
during the receiving period among treated calves. Holland et al. (2010) reported a linear 
improvement or tendency linear for improvement in DMI as a percentage of BW over 2 
190 
 
intervals, but no difference in DMI as a percentage of BW over the length of the 
experiment.  
In the present experiment there was no difference in G:F among BRDX during the 
first 45 d of the finishing period. However, the improvement in ADG with increasing 
BRDX from d 46 to d 91 and from d 92 to 138 combined with similar DMI among 
BRDX groups during these same intervals resulted in linear improvements in G:F over 
these 2 intervals. From d 139 to finish, calves in the 2X and 3/4X groups became 
numerically less efficient resulting in overall G:F not being significantly different among 
the BRDX groups. This result was in contrast to the efficiency data reported by Holland 
et al. (2010) who noted a linear increase in overall G:F for increasing BRDX. 
The ultimate goal of the present experiment was to harvest all calves at a common 
compositional end point regardless of DOF. Due to the desired collection of carcass data 
and lung scores at harvest combined with the distance to the harvest facility from 
WSBRC, logistical concerns compelled us to harvest calves in as few harvest groups as 
possible while maintaining our goal to harvest all calves at a common compositional end 
point. By using a combination of animal performance, ultrasound estimates, and visual 
appraisal we were able to project an ideal individual harvest date for each pen. After this 
was accomplished, pens were fairly easily separated into early and late harvest groups by 
their individual predicted harvest dates and all pens were able to be harvested in 2 groups. 
Based on the measure of 12th rib fat thickness as well as overall carcass fat 
evidenced through KPH percentage and USDA Yield Grades, we were successful at 
harvesting all steers at the same compositional end point. Only a 0.12 cm difference the 
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12th-rib fat thickness was observed between steers across BRDX treatment groups. Cattle 
in the 3/4X group were finished to the greatest numerical fat thickness and was actually a 
numerical increase in 12th rib fat thickness observed for both 2X and 3/4X calves 
compared to 0X. By ensuring that calves treated multiple times for BRD had slightly 
numerically higher fat thickness, we were confident that these calves were given ample 
time to reach their quality and yield potential. These results were similar to those 
described by Holland et al. (2010) who also reported no differences in 12th-rib fat and 
overall carcass fatness, except for in the CI heifers. 
In the present experiment, HCW followed the same pattern as final BW with 
increasing BRDX resulting in a linear decrease in HCW. In addition to the decrease in 
HCW due to final BW, there was also linear decrease in dressing percentage which 
caused a further decrease in HCW. This was in contrast to the data reported by Holland et 
al. (2010) who noted no linear differences in HCW or dressing percentage. The results 
reported by Roeber et al. (2001) support the findings of the present experiment. Roeber et 
al. (2001) reported that there was a significant decrease in both HCW and dressing 
percentage for calves receiving 2 or more antimicrobial treatments. In the review of 
commercial data by Erickson et al. (2011), a significant linear decrease in HCW was 
observed among steers as BRDX increased.  
In the present experiment REA also decreased in a linear fashion when BRDX 
increased. These results were also in contrast to those described by Holland et al. (2010) 
who reported no differences in the REA of heifers with increasing BRDX. Roeber et al. 
(2001) and Waggoner et al. (2007) also reported no significant decrease in REA with 
increasing BRD treatments however both did find a numerical decreases in the REA of 
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calves requiring 2 or more antimicrobial treatments. Erickson et al. (2011), reported 
significant linear decrease in the REA of steers in commercial feedlots as BRDX 
increased. When REA was examined as a percentage of HCW in the present experiment, 
no differences existed among BRDX groups. This would suggest the reduction in REA 
observed in the present experiment is primarily the result of decreased HCW as BRDX 
increases. 
In addition quality grade seemed to be negatively impacted in the current 
experiment as there also tended to be a linear decrease in the percentage of USDA Prime 
and Choice carcasses as the number of BRD treatments increased. Again these findings 
were different than those of Holland et al. (2010), who reported no difference in the 
percentages USDA Choice or Select carcasses among the BRD treatment groups. No 
differences for kidney pelvic and heart (KPH) fat, marbling score, USDA Yield Grade, or 
liver score were observed among the BRDX groups in the present experiment. These 
results are similar to those described by Holland et al. (2010). Holland et al. (2010) 
reported a tendency for a linear decrease in marbling score as the number of BRD 
treatments increased. In the present experiment there was a numerical decrease in 
marbling score as BRDX increased, but this difference of 45 units from Small06 to 
Small51 was not statistically significant.  
The results for a decrease in quality grade and a numerical decrease in marbling 
score in the present experiment are similar to those reported elsewhere in the literature. 
Schneider et al. (2009) reported that 16% fewer calves that were treated for BRD graded 
USDA Choice compared to non-treated calves. Roeber et al. (2001) reported that there 
was a significant decrease in marbling score for calves receiving 2 or more antimicrobial 
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treatments. In a review of commercial data, Erickson et al. (2011) reported significant 
linear decreases in both marbling score and the percentage of USDA Choice carcasses of 
steers as antimicrobial treatments for BRD increased. However the impacts of BRD 
treatment on quality grade and marbling score have proved to be somewhat inconsistent. 
Waggoner et al. (2007) and Garcia et al. (2010) reported no decrease in marbling score 
for cattle requiring BRD treatment. Garcia et al. (2010) observed a tendency for treated 
cattle derived from sires of 7 Bos taurus breeds to have a decreased percentage of USDA 
Choice carcasses. Interestingly, Garcia et al. (2010) observed no difference in the 
percentage of USDA Choice carcasses for treated cattle derived from sires of tropically 
adapted Bos taurus and Bos indicus-influenced breeds.  
In the present experiment, lung consolidation scores increased linearly as BRDX 
increased. Conversely, there were no differences in lung adhesion scores among BRDX 
groups. Calves receiving 1 BRD treatment actually had the numerically highest lung 
adhesion scores in the current experiment. In the experiment by Holland et al. (2010), a 
slightly different lung scoring system was utilized as described by Bryant et al. (1999). In 
their experiment, the presence and severity of lung lesions (score = 0, 1, 2, or 3) were 
evaluated along with a simple presence or absence of interlobular adhesions or missing 
lobes indicating thoracic adhesions (score = 0 or 1) (Holland et al., 2010). There were no 
significant differences in any of the lung score data presented by Holland et al. (2010).  
In theory, the majority of cattle that previously suffered from BRD would have 
lung lesions present at harvest. Wittum et al. (1996) and Bryant et al. (1999) previously 
indicated that the presence of pulmonary lesions was a better predictor than treatment 
records for losses in ADG resulting from BRD. One reason for this finding would be that 
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cattle that were never treated for clinical signs of BRD have commonly demonstrated 
evidence of lung damage at harvest. However using the presence of lung lesions at 
harvest as a predictor of previous BRD incidence is not without fault, as it has also been 
reported that cattle that have be treated for clinical signs of BRD have lacked the 
presence of any detectable pulmonary lesions at harvest (Wittum et al., 1996; Gardner et 
al., 1999; Thompson et al., 2006; Schneider et al., 2009). Holland et al. (2010) argued 
that even though the lung lesion data were not different between the BRD treatment 
groups in their experiment, that the differences in preconditioning phase performance, 
combined with increased haptoglobin concentrations and rectal temperatures in treated 
heifers indicated that the BRD treatments administered were related to an active 
infection. Currently, there is no perfect diagnostic tool to determine the exact incidence 
of BRD in feedlot cattle and thus determining the true production and economic losses 
due to BRD is extremely difficult. However, we would agree with the assessment 
Holland et al. (2010) that measuring finishing performance, carcass characteristics, and 
ultimately economic losses due to BRD based on antimicrobial treatment for the clinical 
signs of BRD is appropriate and accurate.  
It has been well documented that as BRD treatments increase, carcass values and 
overall net return per animal can exponentially decrease. Waggoner et al. (2007) reported 
the mean loss in total value for cattle that were treated 1 time to be $28.52, and the mean 
loss in total value for cattle for cattle treated 2 or more times to be $172.67. Schneider et 
al. (2009) reviewed the records from 5,976 animals fed in Midwestern feedlots and 
reported similar results for the economic impact of 1 BRD treatment. However, the 
economic loss resulting from multiple antimicrobial treatments was not as severe 
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according to Schneider et al. (2009). The authors observed that decreases in animal 
performance and carcass merit were associated with a decrease of $23.23, $30.15, and 
$54.01 in carcass value for cattle treated for BRD once, twice, or 3 or more times 
respectively when compared to cattle never treated for BRD (Schneider et al., 2009). 
Brooks et al. (2011) examined the economic impact of BRD treatments for the heifers in 
the experiment conducted by Holland et al. (2010). Interestingly, heifers treated once for 
BRD actually returned $10.12 per head more than those heifers never treated (Brooks et 
al., 2011). However heifers treated 2 times, 3 times, or deemed chronically ill returned 
$11.08, $72.01, and $143.28 less per head than those heifers never treated (Brooks et al., 
2011).  
In the current experiment those calves never treated for BRD had an average 
carcass value of $1,643.80, while 1X, 2X, and 3/4X groups had average carcass values of 
$1,612.67, $1,589.01, and $1,540.46, respectively. When a total calf value was calculated 
by adjusting for the cost of antimicrobials, increased labor, and variation in yardage and 
feed consumption due to differences in DOF, these differences in value were increased. 
The total calf value for 0X remained $1,643.80, while 1X, 2X, and 3/4X groups had total 
calf values of $1,605.93, $1,476.91, and $1,413.35, respectively. These differences in 
total calf value resulted in economic losses of $37.87, $166.89, and $230.46 for 1X, 2X, 
and 3/4X, respectively when compared to 0X. The greatest single economic loss for all 
calves that were treated for BRD was due a loss of carcass value at the time of harvest. 
The second greatest economic loss for 1X calves was due to antimicrobial cost. In 
addition, calves in the 1X group received a positive adjustment for yardage and feed cost 
due to a numerical decrease in DOF resulting from a numerical improvement in 
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performance compared to calves in the 0X group. The second greatest economic loss for 
2X and 3/4X calves was due to increased feed cost resulting from increased DOF.  
These economic values obviously change and those presented in this experiment 
are specific to this lot of cattle, and the prices and market conditions at the time they were 
marketed. These values are dependent on the price of cattle at the time of harvest, the 
choice select spread, and grid premiums and discounts. In addition, the cost of inputs 
greatly impacts the total value of the calf at harvest. The average cost of antimicrobial 
treatment administered in this experiment was $13.73. However, NAHMS (2013) 
reported that the average cost of antimicrobial treatment for BRD in all feedlots was 
$23.60. Regardless of how the economic data presented is viewed, to accurately estimate 
the total economic losses resulting from BRD our opinion is that calves treated for BRD 
should be allowed additional DOF in order reach similar compositional end points 
compared to untreated cohorts. In addition, our opinion is that all costs associated with 
BRD treatment and the additional DOF including: antimicrobial treatment costs, 
additional labor, additional yardage, and additional feed consumption should be 
considered.  
 
Conclusions 
The calves in this experiment experienced a significant natural immune challenge 
resulting in a first treatment morbidity of 66.5% and mortality attributed to BRD of 
13.2% for the initial lot of 516 calves. The incidence of clinical BRD prior to the 
finishing phase resulted in decreased BW and ADG. However, after allocating calves by 
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previous BRD treatments prior to finishing, a compensatory gain response was observed 
as those calves previously treated for BRD attempted to compensate for lost performance 
that occurred during the receiving period. Although a compensatory gain response was 
observed during the finishing phase, it is important to note that steers treated for BRD 
were not able to fully compensate in regards to BW even with additional DOF.  
The steers in this experiment were able to be successfully harvested at a common 
compositional end point through the use of ultrasound estimates, BW projections, and 
visual appraisal. At harvest, all BRDX groups exhibited 1.28 and 1.40 cm of 12th rib fat. 
To achieve this, DOF had to increase linearly as BRDX increased. Increasing BRDX 
resulted in a linear increase in the consolidation of lung tissue, while lung adhesion 
scores were not adversely affected BRDX. When slaughtered at a common endpoint, 
REA and the percentage of USDA Prime and Choice carcasses were negatively impacted 
by increasing BRDX; however, the differences in base carcass price per 45.4 kg were 
minimal among the experimental BRDX treatments. The most significant economic 
losses were an effect of losses in carcass value primarily due to HCW losses resulting 
from decreased final BW and dressing percentages as BRDX increased. After the initial 
loss in carcass value due to BRD, the next most significant economic losses were a result 
of the additional feed cost and the antimicrobial treatment cost.  
With additional DOF calves treated multiple times for BRD can reach the same 
compositional end point as untreated cohorts; however, these calves will likely never 
reach the same quality and yield potential and consequently carcass value. The overall net 
return of calves treated for BRD is further decreased due the costs associated with BRD 
treatment and the additional DOF including: antimicrobial treatment costs, labor, 
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yardage, and feed consumption. Therefore, the economic losses of calves requiring 
multiple antimicrobial treatments for BRD can be minimalized with additional DOF, but 
not eliminated. In this experiment, the incidence of clinical BRD resulted in a 2.3%, 
10.2%, and 14.0% decrease in the total value of calves at harvest for calves treated once, 
twice, and 3 or 4 times, respectively.  
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Table 4-1. Composition of common receiving diet1 
Ingredient (%)1  
Wet corn gluten feed2  48.8 
Grain sorghum hay  30.0 
Dry-rolled corn  15.0 
Dry supplement B-2733  5.2 
Nutrient Composition1,4   
NEm, Mcal/kg  1.69 
NEg, Mcal/kg  1.07 
TDN, %  71.60 
Crude protein, %  17.40 
Crude fat, %  1.90 
NDF, %  39.90 
ADF, %  21.40 
Calcium, %  0.68 
Phosphorus, %  0.67 
Magnesium, %  0.36 
Potassium, %  1.15 
Sulfur, %  0.27 
1All values are presented on a DM basis. 
2Sweet Bran® (Cargill; Dalhart, Texas).  
3Dry supplement B-273 was formulated to contain (% 
DM basis): 38.46% ground corn, 30.36% limestone, 
21.04% wheat midds, 6.92% urea, 1.03% magnesium 
oxide, 0.618% zinc sulfate, 0.38% salt, 0.119% copper 
sulfate, 0.116% manganese oxide, 0.05% selenium 
premix (contained 0.6% Se), 0.311% vitamin A 
(30,000 IU/g), 0.085% vitamin E (500 IU/g), 0.317% 
Rumensin 90 (Elanco Animal Health; Indianapolis, 
IN), and 0.195% Tylan 40 (Elanco Animal Health; 
Indianapolis, IN). 
4Feed samples were analyzed for nutrient composition 
by an independent laboratory (Servi-Tech 
Laboratories; Dodge City, KS). 
204 
 
Table 4-2. Composition of common finishing diet1 
Ingredient (%)1  
Dry-rolled corn  48.14 
Wet corn gluten feed2  15.00 
Dried distillers grains plus solubles   15.00 
Prairie hay  9.00 
Liquid supplement3  6.54 
Dry supplement B-2734  3.12 
Dry supplement B-2835  3.20 
Nutrient Composition1,6   
NEm, Mcal/kg  2.23 
NEg, Mcal/kg  1.54 
TDN, %  89.55 
Crude protein, %  18.85 
Crude fat, %  5.00 
NDF, %  22.35 
ADF, %  10.40 
Calcium, %  0.96 
Phosphorus, %  0.52 
Magnesium, %  0.28 
Potassium, %  1.03 
Sulfur, %  0.31 
1All values are presented on a DM basis. 
2Sweet Bran® (Cargill; Dalhart, Texas). 
3Synergy 19-14 (Westway Feed Products; New Orleans, LA). 
4Dry supplement B-273 was formulated to contain (% DM basis): 
38.46% ground corn, 30.36% limestone, 21.04% wheat midds, 
6.92% urea, 1.03% magnesium oxide, 0.618% zinc sulfate, 0.38% 
salt, 0.119% copper sulfate, 0.116% manganese oxide, 0.05% 
selenium premix (contained 0.6% Se), 0.311% vitamin A (30,000 
IU/g), 0.085% vitamin E (500 IU/g), 0.317% Rumensin 90 
(Elanco Animal Health; Indianapolis, IN), and 0.195% Tylan 40 
(Elanco Animal Health; Indianapolis, IN). 
5Dry supplement B-283 was formulated to contain (% DM basis): 
40.47% limestone, 36.26% ground corn, 19.73% wheat midds, 
2.47% salt, 0.312% zinc sulfate, 0.071% copper sulfate, 0.064% 
manganese oxide, 0.029% selenium premix (contained 0.6% Se), 
0.202% vitamin A (30,000 IU/g), 0.056% vitamin E (500 IU/g), 
0.207% Rumensin 90 (Elanco Animal Health; Indianapolis, IN), 
and 0.127% Tylan 40 (Elanco Animal Health; Indianapolis, IN). 
6Feed samples were analyzed for nutrient composition by an 
independent laboratory (Servi-Tech Laboratories; Dodge City, 
KS).
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Table 4-3. Effect of 0, 1, 2, or 3 or 4 antimicrobial treatments for bovine respiratory disease (BRD) during 
the receiving period on subsequent finishing performance and efficiency of steers  
 Antimicrobials administered1  P-value2 
     Pooled Overall Linear Quadratic 
Variable 0X 1X 2X 3/4X SEM P-value Contrast Contrast 
Days on feed3, d 174 170 193 189 4.51 0.002 0.002 1.00 
Animal BW4, kg         
Initial  324 316 285 260 5.98 <0.001 <0.001 0.18 
d 45  402 395 364 336 6.71 <0.001 <0.001 0.12 
d 91  459 456 425 408 7.20 <0.001 <0.001 0.34 
d 138  517 522 486 480 6.65 <0.001 <0.001 0.41 
Final 568 572 560 552 4.89 0.04 0.01 0.25 
Average daily gain5, kg         
Initial - d 45  1.74 1.76 1.78 1.70 0.05 0.68 0.66 0.29 
d 46 - d 91 1.23 1.33 1.31 1.53 0.05 0.005 0.002 0.28 
d 92 - d 138  1.23 1.41 1.30 1.53 0.04 <0.001 <0.001 0.53 
d 139 - final  1.50 1.60 1.39 1.46 0.09 0.40 0.40 0.85 
Initial - final 1.41 1.51 1.43 1.54 0.03 0.02 0.05 0.83 
Dry matter intake6, kg         
Initial - d 45  8.94 8.95 8.60 8.35 0.15 0.02 0.004 0.38 
d 46 - d 91 9.83 10.0 9.70 10.0 0.26 0.78 0.86 0.85 
d 92 - d 138  9.81 10.1 9.68 10.5 0.24 0.07 0.12 0.27 
d 139 - final  9.74 10.1 9.89 10.3 0.26 0.49 0.26 0.97 
Initial - final 9.56 9.78 9.47 9.75 0.18 0.57 0.75 0.86 
Dry matter intake7, % of BW         
Initial - d 45  2.46 2.52 2.65 2.80 0.03 <0.001 <0.001 0.16 
d 46 - d 91 2.29 2.36 2.46 2.69 0.06 <0.001 <0.001 0.18 
d 92 - d 138  2.01 2.07 2.13 2.37 0.05 <0.001 <0.001 0.06 
d 139 - final  1.80 1.85 1.89 1.99 0.04 0.04 0.005 0.66 
Initial - final 2.14 2.21 2.24 2.40 0.04 <0.001 <0.001 0.17 
Gain:feed8         
Initial - d 45  0.194 0.196 0.207 0.204 <0.01 0.20 0.06 0.64 
d 46 - d 91 0.126 0.133 0.136 0.154 0.01 0.01 0.002 0.36 
d 92 - d 138  0.126 0.139 0.135 0.146 <0.01 0.05 0.01 0.83 
d 139 - final  0.155 0.158 0.140 0.142 0.01 0.26 0.11 0.94 
Initial - final 0.148 0.154 0.151 0.158 <0.01 0.22 0.09 0.93 
1Number of times treated for BRD (BRDX): never treated for BRD (0X), treated once for BRD (1X), 
treated twice for BRD (2X), or treated 3 or 4 times for BRD (3/4X). 
2P-values are included for the overall F-test and the linear and quadratic contrast for the number of 
times treated for BRD.  
3Average of days on feed (DOF) for all pens within an experimental treatment. 
4Treatment BW was the BW in kg with a calculated 4% shrink. 
5Treatment ADG was calculated from the shrunk (4%) BW in kg and DOF between the time periods. 
6Treatment DMI was calculated by taking DMI in kg for a pen for the period shown divided by the 
actual number of head days within each pen. 
7(DMI/Average BW for the time period) × 100. 
8Treatment G:F was calculated by taking the pen ADG in kg divided by the pen average DMI in kg for 
the time periods.
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Table 4-4. Effect of 0, 1, 2, or 3 or 4 antimicrobial treatments for bovine respiratory disease (BRD) 
during the receiving period on lung consolidation and adhesion and carcass characteristics of steers  
 Antimicrobials administered1  P-value2 
     Pooled Overall Linear Quadratic 
Variable 0X 1X 2X 3/4X SEM P-value Contrast Contrast 
Ultrasound estimates3         
d 91 REA, cm2 81.3 84.1 77.0 73.7 1.49 <0.001 <0.001 0.05 
d 91 12th-rib fat, cm 0.82 0.82 0.81 0.72 0.04 0.21 0.08 0.25 
d 91 IMF 4.55 4.29 4.42 4.04 0.15 0.10 0.04 0.70 
d 138 REA, cm2 88.9 89.6 84.6 83.8 1.71 0.05 0.01 0.65 
d 138 12th-rib fat, cm 0.94 0.93 0.91 0.91 0.05 0.95 0.60 0.99 
d 138 IMF 4.60 4.28 4.49 4.24 0.15 0.32 0.22 0.83 
Lung scores4         
Consolidation5  0.38 0.54 1.06 0.97 0.16 0.01 0.003 0.42 
Adhesion6  0.73 0.96 0.67 0.83 0.14 0.47 0.99 0.81 
HCW, kg 372 369 360 353 3.66 0.004 <0.001 0.63 
Dressing percentage 65.5 64.6 64.2 64.0 0.27 0.003 <0.001 0.23 
REA7, cm2 91.8 93.9 90.8 87.3 1.56 0.05 0.03 0.09 
REA8, % of BW 24.7 25.4 25.3 24.7 0.44 0.52 0.97 0.15 
12th-rib fat, cm 1.33 1.28 1.36 1.40 0.09 0.83 0.49 0.63 
KPH fat, % 2.17 2.01 2.08 2.00 0.06 0.26 0.16 0.55 
Marbling score9 451 428 426 406 16.7 0.29 0.10 0.91 
Prime and choice10, % 70.3 56.5 60.2 36.2 9.15 0.06 0.03 0.54 
Yield grade 2.81 2.60 2.75 2.91 0.16 0.59 0.53 0.26 
Liver score11 0.67 0.23 0.63 0.46 0.27 0.65 0.86 0.61 
1Number of times treated for BRD (BRDX): never treated for BRD (0X), treated once for BRD 
(1X), treated twice for BRD (2X), or treated 3 or 4 times for BRD (3/4X). 
2P-values are included for the overall F-test and the linear and quadratic contrast for the number of 
times treated for BRD.   
3Ultrasound estimates of rib eye area (REA), 12th-rib fat thickness, and intramuscular fat were 
taken on d 91 and d 138 by Chad Gordon of Ultrasound Technologies. 
4Lung scores were obtained by trained personnel from West Texas A&M University. 
5Lung consolidation: 0 = clinically normal, healthy lung with < 5% consolidation of lung tissue, 1 
= ± 5% consolidation of lung tissue or mycoplasma like lesion, 2 = > 5%, but < 50% consolidation 
of lung tissue, missing lung, or mycoplasma like lesion, 3 = > 50% consolidation of lung tissue, 
missing lung, or mycoplasma like lesion.  
6Lung adhesion: 0 = clinically normal, healthy lung, 1 = minor threadlike fibrous adhesion, 2 = 
extensive fibrous adhesion. 
7Rib eye area. 
8(REA/HCW) × 100. 
9Marbling scores: 400 = Small00, 500 = Modest00. 
10Pecentage of calves having prime or choice carcasses within each pen. 
11Liver Score: 0 = no abscesses, 1 = A-, 2 = A, 3 = A+, 4 = telangiectasis, 5 = distoma (fluke 
damage), and 6 = fecal contamination. 
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Table 4-5. Effect of 0, 1, 2, or 3 or 4 antimicrobial treatments for bovine respiratory disease (BRD) during the receiving period on 
carcass value at harvest and feedlot economics  
 Antimicrobials administered1  P-value2 
  Pooled Overall Linear Quadratic 
Variable 0X 1X 2X 3/4X SEM P-value Contrast Contrast 
Final shrunk body weight, kg 568 572 560 552 4.89 0.04 0.01 0.25 
Dressing percentage 65.5 64.6 64.2 64.0 0.27 0.003 <0.001 0.23 
Hot carcass weight, kg 372 369 360 353 3.66 0.004 <0.001 0.63 
Actual carcass price2, $/45.4 kg 200.41 198.24 201.01 197.99 1.27 0.25 0.43 0.74 
Total carcass value3, $ 1,643.80 1,612.67 1,589.01 1,540.46 20.6 0.01 0.001 0.68 
Carcass value difference from previous BRDX, $ 0.00 -31.13 -23.66 -48.55 18.0 0.31 0.10 0.86 
Carcass value difference from 0X, $ 0.00 -31.13 -54.79 -103.34 18.0 0.003 <0.001 0.63 
Antimicrobial cost4, $ 0.00 -14.40 -29.60 -46.97 0.00 <0.001 <0.001 <0.001 
Additional labor cost5, $ 0.00 -7.25 -14.50 -25.38 0.00 <0.001 <0.001 <0.001 
Additional yardage cost6, $ 0.00 1.55 -7.75 -6.20 1.49 <0.001 <0.001 1.00 
Additional feed cost7, $ 0.00 13.36 -60.25 -48.56 12.0 <0.001 <0.001 0.94 
Total calf value8, $ 1,643.80 1,605.93 1,476.91 1,413.35 23.2 <0.001 <0.001 0.58 
Total calf value difference from previous BRDX, $ 0.00 -37.87 -129.02 -63.57 20.9 0.002 0.006 0.02 
Total calf value difference from 0X, $ 0.00 -37.87 -166.89 -230.46 20.9 <0.001 <0.001 0.54 
1Number of times treated for BRD (BRDX): never treated for BRD (0X), treated once for BRD (1X), treated twice for BRD (2X), 
or treated 3 or 4 times for BRD (3/4X). 
2Pen averages of actual carcass base prices. The base carcass price on the grid was $199.87 per 45.4 kg.   
3Base carcass price multiplied by HCW. 
4Actual cost of antimicrobial treatment. For 3/4X, the antimicrobial cost was averaged for those calves that received 3 or 4 
antimicrobials. 
5An estimate of $7.25 per antimicrobial treatment was assumed to cover the cost of labor, and any additional costs related to BRD 
treatment. 
6Actual yardage based on pen DOF relative to 0X. Yardage was $0.40 steer-1•d-1. 
7Actual feed cost based on pen DMI and pen DOF relative to 0X. The ration cost $301.85 per 907.2 kg on a DM basis. 
8Total carcass value adjusted for additional costs associated with antimicrobial treatment, labor, yardage, and feed consumption. 
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CHAPTER V 
 
 
EFFECT OF COPPER, MANGANESE, AND ZINC SUPPLEMENTATION ON THE 
PERFORMANCE, CLINICAL SIGNS, AND MINERAL STATUS OF CALVES 
FOLLOWING EXPOSURE TO BOVINE VIRAL DIARRHEA VIRUS TYPE 1B AND 
SUBSEQUENT MANNHEIMIA HAEMOLYTICA INFECTION 
 
ABSTRACT 
Trace mineral (TM) supplementation has been demonstrated to alter immune function 
and reduce morbidity associated with BRD in some cases (Galyean et al., 1999). The 
objective of this experiment was to determine the influence of dietary copper (Cu), 
manganese (Mn), and zinc (Zn) supplementation on the performance, clinical signs, and 
mineral balance of calves following a bovine viral diarrhea virus (BVDV) and 
Mannheimia haemolytica (MH) immune challenge. Steers (n = 16; BW = 225 ± 20 kg) 
from a single ranch were processed, weaned, and randomly pairwise assigned to either 
the mineral supplemented (MIN) or control (CON) experimental treatments. The MIN 
calves received 150 mg of Cu, 130 mg of Mn, and 320 mg of Zn daily while the CON 
calves received the basal diet with no additional Cu, Mn, or Zn supplementation. The 
basal diet contained sufficient Mn and Zn, but inadequate Cu based on NRC (2000) 
published nutrient requirements. After 46 d on the experimental treatments, all calves 
were naturally exposed to heifer persistently infected (PI) with BVDV type 1b for 4 d and 
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then subsequently intratracheally challenged with MH. Data were analyzed using the 
GLIMMIX procedure of SAS with sampling time serving as a repeated measure and calf 
serving as the experimental unit. The immune challenge was validated via increased 
BVDV antibody titers, MH whole cell (WC) and leukotoxin (LKT) antibody titers, rectal 
temperatures (TEMP), and subjective clinical scores (CS). Calf performance (P ≥ 0.48) 
was not affected by mineral supplementation. Mineral supplementation also did not 
impact the CS or TEMP of calves (P ≥ 0.53). There was a significant (P < 0.001) time by 
treatment interaction observed for liver Cu levels. Time significantly impacted the 
concentrations of Cu, Mn, Zn, and Fe within the liver, Cu, Mn, and Zn within the muscle 
and Cu, Zn, and Fe within the serum (P ≤ 0.03). Calves receiving MIN had greater (P < 
0.01) liver Cu and Mn concentrations compared to CON calves. In contrast, serum Cu 
and Fe concentrations were increased (P ≤ 0.05) in CON calves compared to MIN calves. 
Mineral supplementation did not impact mineral levels within the muscle (P ≥ 0.38). The 
supplementation of Cu, Mn, and Zn can potentially impact TM status in response to an 
immune challenge in calves. When Cu is supplemented to calves receiving a marginally 
Cu deficient diet, Cu status within the body can be altered. 
 
Key Words: bovine respiratory disease, bovine viral diarrhea virus, immune challenge, 
Mannheimia haemolytica, mineral supplementation 
 
 
INTRODUCTION 
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Bovine respiratory disease (BRD) is the most significant production problem for 
the feedlot industry, accounting for the majority of morbidity, mortality, and decreased 
production in feedlots with estimated annual economic losses in excess of $2 billion 
(Powell, 2013). The supplementation of trace minerals (TM) has been demonstrated to 
alter immune function and reduce morbidity associated with BRD in some cases 
(Galyean et al., 1999).  However, other experiments have shown no improvements in 
performance or health variables from the supplementation of TM.  
Overall, TM research has been very inconsistent when investigating the ideal 
concentrations and sources of TM supplementation needed for optimum results. The 
supplementation of TM including Cu, Mn, and Zn has been a common management 
practice within the feedlot industry for many years and often times these TM are included 
at levels in excess of published requirements (Vasconcelos and Galyean, 2007). The role 
of TM in immune function, combined with the unknown TM status of newly received 
calves may explain the increased TM inclusion in feedlot diets despite the inconsistent 
responses in the literature.  
Organic mineral complexes have been shown to be more bioavailable than 
traditional inorganic mineral sources. This increase in bioavailability is a result of 
chelated mineral complexes being less likely bound to other substances within the upper 
gastrointestinal tract and thus allowing the mineral to be more readily absorbed across the 
brush border of the small intestine. The increased bioavailability of organic TM could 
potentially allow for improved TM status within the animal in an immune challenge 
scenario such as a BRD event. The objective of this experiment was to determine if 
copper (Cu), manganese (Mn), and zinc (Zn) supplementation effected the performance, 
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clinical signs, and mineral balance of calves following a BVDV and MH immune 
challenge. 
 
MATERIALS AND METHODS 
All procedures for the present experiment were approved by the Oklahoma State 
University Institutional Animal Care and Use Committee (Animal Care and Use Protocol 
AG-12-5). 
 
Cattle description and initial processing 
An Angus-based commercial cow herd was identified as a potential source to 
supply calves for this experiment. An initial pool of 18 bull calves were selected from a 
single pasture. Eighty days prior to the initiation of the experiment, all bull calves were 
tagged with an individually numbered tag, given an initial vaccination for clostridial 
pathogens (Covexin 8; Merck Animal Health, Summit, NJ), and surgically castrated at 
the ranch of origin. Blood samples were collected and analyzed as described by Burciaga-
Robles et al. (2010) to ensure calves were seronegative to the pathogens to be used in the 
challenge portion of this experiment. On 24 d prior to initiation of the experiment, a 
second blood sample collected and analyzed to confirm steers remained seronegative to 
the pathogens to be used in the challenge portion of this experiment. Ear notches were 
also obtained and tested via immunohistochemistry (IHC) by a commercial diagnostic lab 
to ensure no calves were persistently infected (PI) with BVDV.  
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Eleven days prior to the experiment, calves received a second vaccination for 
clostridial pathogens (Covexin 8; Merck Animal Health, Summit, NJ), were vaccinated 
for viral pathogens excluding BVDV (Inforce; Zoetis, Florham Park, NJ), received a 
vaccine for infectious bovine keratoconjunctivitis (IBK) (Autogenous Bacterin; Newport 
Laboratories, Worthington, MN), and were treated for the control of internal and external 
parasites (Ivermax Plus; Norbrook Laboratories, Lenexa, KS). Calves also received a 
prophylactic dose of tilmicosin phosphate (300 mg per mL) administered at the rate of 
1.5 mL per 45.4 kg of BW (Micotil; Elanco Animal Health, Indianapolis, IN) and a fly 
tag (Corathon; Bayer, Shawnee Mission, KS). After processing, all steers were 
transported 97 km to the Animal Science Equine Center at Oklahoma State University. 
This facility was chosen to prevent exposure of the recently weaned calves to any other 
cattle at the other University research facilities. Calves remained at the Equine Center for 
a 6 d weaning period. 
 
Challenge model and facility management 
Five days prior to initiation the experiment, the steers were gathered and 
transported 6 km to the Nutrition and Physiology Research Center (NPRC) at Oklahoma 
State University. Calves were weighed, and BW in combination with initial antibody 
titers were used to allocate 16 steers to experimental treatments. Calves were then placed 
in metabolic stanchions with headlocks for a 5 d adaptation period. Each stanchion had 
an individual automatic water bowl and each calf was provided with an individual feed 
trough. Calves were placed in metabolic stanchions prior to the experiment to allow for 
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adaption of calves to the stanchions and automatic water bowls. Metabolic stanchions 
were only used during this experiment during the adaptation period (5 d) and the intense 
sampling period (d 0 through d 7).  
After the adaptation period, the experiment was initiated. All time will be 
referenced in relation to the MH challenge as d 0. All calves were randomly assigned 
individual 3.05 × 3.66 m slatted floor pens on d -46. Each pen had access to 2 automatic 
water bowls and each calf was provided with an individual feed bunk. Calves remained in 
these individual pens for the first 42 d of the experiment.  
The BVDV and MH challenge model described by Burciaga-Robles et al. (2010) 
was utilized in this experiment with slight modifications. Pre BVDV challenge samples 
were collected on d -4. After this sampling, all calves were comingled in a common 
pasture for 4 d with an animal previously confirmed as being PI positive with BVDV1b 
via IHC and genotyping as described by Fulton et al. (2006). During this time, all animals 
shared a single common water tank, and were fed together in 3 portable 3 m feed bunks.  
On d 0, calves were gathered and placed in the metabolic stanchions. Pre-MH 
challenge sampling took place at h 0. Immediately after h 0 sampling, all steers received 
10 mL of a solution containing 6 × 109 CFU of MH serotype 1 that was reconstituted and 
grown prior to the challenge as described by Mosier et al. (1998). The MH was delivered 
via intratracheal bronchoalveolar lavage by a licensed veterinarian as described by 
Dowling et al. (2002), with slight modifications. Briefly, steers were restrained and a 
broncheoalveolar lavage tube (Bivona Medical Technology, Gary, IN) was gently 
inserted into the ventral meatus of a nostril, passed on into the trachea, and positioned 
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within 2 to 3 cm of the tracheal bifurcation. The MH challenge solution was then 
delivered in a way such that the challenge solution would be allowed to enter both lungs. 
No adverse effects of the challenge procedure itself were observed.  
For the next 7 d, calves remained in the stanchions and were monitored several 
times daily. Intensive sampling occurred during this time. After the 7 d intensive 
sampling period, calves were returned to their respective individual 3.05 × 3.66 m slatted 
floor pens for the duration of the experiment. On d 14 and d 28, calves were gathered, 
briefly restrained in a manual squeeze chute, and sampled again. The calves did remain in 
our possession after the experiment was terminated, and an additional sampling occurred 
on d 68. All calves were comingled and received the same diet from d 28 to d 68. 
 
Common diet and feeding  
While on pasture with their dams prior to weaning, cows and calves received no 
mineral supplementation. The only TM calves would have had received would have been 
provided through the milk of their dams or forage consumed on the ranch. Upon arrival to 
the Horse Unit, calves were given ad libitum access to water, Bermuda grass hay, and the 
common receiving ration minus the dry supplement (Table 1). After transportation to the 
NPRC and being placed in stanchions, the Bermuda hay was removed, and the calves 
continued to receive ad libitum access to water and the common receiving ration minus 
the dry supplement. On d -46, a common dry supplement (Table 1) was included in the 
ration. This supplement was formulated to meet or exceed NRC (2000) nutrient 
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requirements except for Cu, Mn, and Zn. The common supplement contained no 
additional Cu, Mn, or Zn from organic or inorganic sources.  
The calves continued to receive ad libitum access to the common receiving ration, 
with supplement now included, and water for the duration of the experiment. Feed was 
delivered twice daily at 0800 h and 1500 h. Bucket feeders were cleaned and orts were 
weighed back weekly. To ensure that the calves still received their respect experimental 
mineral treatments during the 4 d BVDV challenge, calves were gathered each morning 
at 0700 h and sorted into their respective experimental treatments. Each group then 
received 11.3 kg of the common receiving ration and their respective experimental top 
dress. After all 11.3 kg was consumed, all calves were returned to the common pasture 
with the PI animal. Ration samples were collected daily, and dried in a forced air oven for 
48 h at 60ºC to determine dry matter. All daily ration samples were composited 
gravimetrically and analyzed at a commercial laboratory (Servi-Tech Inc., Dodge City, 
KS) for nutrient composition (Table 1). 
 
Experimental mineral treatments 
 Starting on d -46 calves on the MIN experimental treatment received a ground 
corn top dress daily containing 150 mg of Cu, 130 mg of Mn, and 320 mg of Zn in the 
form of Cu methionine, Mn methionine, and Zn methionine, respectively (Mintrex Cu, 
Mn, and Zn; Novus International, Inc., St. Charles, MO). Calves on the CON 
experimental treatment received a top dress daily that only contained ground corn. Top 
dresses were batched daily and weighed out on a gram scale to the nearest 0.01 g. The 
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kitchen mixer was cleaned daily before mixing the CON top dress. The CON top dress 
consisted of 1000 g of ground corn mixed for 5 min and 125 g of the top dress was placed 
in 8 identical plastic color coded containers.  
The mixer was cleaned again prior to making the MIN top dress. The MIN top 
dress consisted of 968 g of ground corn and 32 g of Mintrex mineral (8 g of Mintrex Cu, 
8 g Mintrex Mn, and 16 g Mintrex Zn) on an AF basis. This mixture was mixed for 5 min 
and 125 g of the top dress was placed in 8 identical plastic color coded containers. This 
resulted in 121 g of ground corn with 1 g Mintrex Cu, 1 g of Mintrex Mn, and 2 g of 
Mintrex Zn per MIN container. Top dresses were then delivered to each individual pen or 
stanchion immediately after delivery of the common ration and gently mixed in. All feed 
bunks, pens, stanchions, and containers were color coded to match their respective 
experimental treatment. 
 
Data collection, calculations and statistical analysis 
Unshrunk BW were obtained a d -46, d-4, and d 28. All BW reported were shrunk 
a calculated 2%. Individual BW and experiment DOF was utilized to calculate individual 
ADG. Experimental DOF and total feed consumption on a DM basis were used to 
calculate individual average DMI. Average DMI and ADG were then utilized to calculate 
G:F. 
Data were analyzed using repeated measures analysis with the GLIMMIX 
procedure of SAS 9.3 (SAS Institute Inc., Cary, NC) with steer serving as the 
experimental unit. Various covariance structures within models were compared. The 
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covariance structure that best fit the data in the present experiment was a non-structured 
covariance. In the few instances where model optimization could not be completed, a 
Toeplitz or banded Toeplitz covariance structure was employed. Sampling time served as 
the repeated measure and P-values are reported for the effect of treatment, time, and the 
interaction of time and treatment. If a time × treatment interaction was present, a slice 
output option was used to determine the time points at which treatments were different.  
One animal was excluded from the performance analysis due to decreased 
performance resulting from suffering a mechanical injury prior to the challenge portion of 
the experiment. The calf was able to recover and was not removed from the experiment, 
and thus was included in the remainder of the analysis. For the mineral analysis, extreme 
outliers (samples > 3 SD ± µ) were excluded from the analysis. The removal of any data 
points from the mineral analysis was completed prior to the linking of individual samples 
to experimental treatments to ensure unbiased removal of data points. No other data was 
excluded from the analysis. 
 
Rectal temperatures, respiration rates, and subjective clinical severity scores  
Rectal temperatures (TEMP), respiration rates (RR), and clinical severity score 
(CS) were recorded at h 0, 2, 4, 6, 12, 18, 24, 48, 72, 96, and 168 (d 7). Rectal 
temperatures were recorded using a digital thermometer (GLA M-500; GLA Agricultural 
Electronics, San Luis Obispo, CA). Respiration rates were measured by counting flank 
movements for 30 s while a second person recorded time with a stopwatch. The same 
person counted flank movements at each sampling time. In addition, all steers were 
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monitored by trained personnel throughout the experiment for clinical signs characteristic 
of BRD. The evaluation employed criteria based on the DART™ system (Pharmacia 
Upjohn Animal Health, Kalamazoo, MI) with some modifications as described by Step et 
al. (2008). The subjective criteria utilized for evaluating calves consisted of depression, 
abnormal appetite, and respiratory signs. Signs of depression observed included but were 
not limited to: depressed attitude, lowered head, glazed or sunken eyes, slow or restricted 
movement, arched back, difficulty standing or walking, knuckling of joints or dragging 
toes when walking, and stumbling. Signs of abnormal appetite included: an animal that 
was completely off feed, an animal eating less than expected or eating extremely slow, a 
lack of gut fill or gaunt appearance, and obvious body weight loss. Respiratory signs 
included: labored breathing, extended head and neck (in an attempt to breathe), and 
audible noise when breathing. The evaluators assigned each calf a CS from 0 to 4 based 
on the clinical signs and the severity of those signs. 
A score of 0 was assigned for a clinically normal appearing calf. A score of 1 was 
assigned for mild clinical signs, 2 for moderate clinical signs, 3 for severe clinical signs, 
and 4 for a moribund animal. For a calf to be assigned a score of 4, the calf would not be 
able to rise, or had extreme difficulty standing, walking, or breathing and would have 
required immediate assistance. No calves reached a severity score of 3 or 4 in the present 
experiment.  
 
Tissue sampling for determination of trace mineral status 
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Whole blood was collected via the jugular vein using an 18 gauge needle and 
serum separator tube (Corvac Serum Separator Tube; Tyco Healthcare Group LP, 
Mansfield, MA) at multiple time points throughout the experiment. The whole blood 
samples were allowed to clot for 12 to 24 h at 4°C. After the clotting time, chilled blood 
samples were centrifuged at 2,500 × g for 20 min. Serum was aliquoted to 2 mL 
microcentrifuge tubes and immediately frozen at -20°C until further analyses could be 
completed. Serum samples that were collected on d -70, -4, 7, 14, 28, and 68 relative to 
the MH challenge were used for mineral analysis.  
Muscle and liver biopsy samples were collected from each calf on d -46, d -4, and 
d 28. Muscle and liver biopsy samples were also placed into 2 mL microcentrifuge tubes 
and immediately frozen at -20°C until mineral analyses could be completed. Biopsies 
were collected from the LM and liver using the procedure described by Sexten et al. 
(2012) with slight modifications. To obtain the biopsies, steers were briefly restrained in 
a manual squeeze chute, hair was removed from both biopsy sites using surgical clipper 
blades, and a local anesthetic (lidocaine HCl, 20 mg/mL, 6 mL/biopsy site) was 
administered after a preliminary scrub with iodine. The biopsy sites were then surgically 
scrubbed 3 times with a commercially available iodine scrub followed by rinsing with a 
70% isopropyl alcohol solution. After the third scrub and rinse, commercial iodine 
solution was sprayed on the injection sites.  
After ensuring the biopsy sites were thoroughly anesthetized, a scalpel was 
utilized to make an approximately 1 cm stab incision for the insertion of the biopsy 
needles. For the muscle biopsy, the incision was made between the 12th and 13th ribs 
approximately 5 cm lateral to the vertebrae, and a sterile Bergstrom biopsy needle was 
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used to obtain an approximately 865 mg sample of muscle tissue. For the liver biopsy, the 
incision was made between the 11th and 12th ribs approximately 25 cm lateral to the 
vertebrae, and 2.1 mm × 15.2 cm 14-gauge Tru-cut biopsy needle inserted directed 
cranially and ventrally toward the opposite elbow. The biopsy needle was advanced 
through the peritoneum, through the diaphragm, and into the liver to obtain an 
approximately 85 mg sample of liver tissue. 
 
Trace mineral analysis 
Serum samples were allowed to thaw at 4°C. After thawing, microcentrifuge 
tubes containing serum were vortexed and 1 mL of serum was pipetted into large plastic 
express microwave tubes. One mL of nitric acid was added to each microwave tube, and 
each tube was plugged and capped. Microwave tubes were vortexed and loaded onto the 
microwave rack. Tubes were microwaved on a programed cycle at maximum of 1600 
watts for 15 min. After completion, the microwave tubes were removed and allowed to 
cool. After cooling, the contents of the microwave tubes were triple rinsed with 
milliequivalent water into 5 mL volumetrics. The contents of each volumetric were 
filtered through a syringe filter into screw cap culture tubes. The filtered samples were 
then analyzed for mineral concentration by inductively coupled plasma mass 
spectrometry (ICP-MS) in triplicate (7700 Series ICP-MS; Agilent Technologies, Santa 
Clara, CA). 
Muscle and liver samples were thawed at 4°C. A volume of milliequivalent water 
was used to flush the samples out of the microcentrifuge tubes and transfer them into 
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glass capped test tubes. The samples with added water were placed in a drying oven and 
dried for approximately 24 h at 110°C to obtain an accurate DM for each sample. The 
samples were then placed in a muffle furnace for 6 h to 15 h at 550°C until all samples 
were completely ashed. Two mL of nitric acid was added to each glass test tube and the 
tubes were capped placed in heating racks and heated on hot plates at 260°C until the 
contents became dissolved in solution. The sample contents were triple rinsed with 
milliequivalent water into 10 mL volumetrics. The contents of each volumetric were 
filtered through a syringe filter into screw cap culture tubes. The filtered muscle samples 
were then analyzed for mineral concentration by inductively coupled plasma mass 
spectrometry (ICP-MS) in triplicate (7700 Series ICP-MS; Agilent Technologies, Santa 
Clara, CA). Due to anticipated increased mineral concentrations in the liver, the filtered 
liver samples were analyzed for mineral concentration by inductively coupled plasma 
optical emission spectrometry (ICP-OES) in triplicate (Optima 2100 DV; PerkinElmer, 
Inc., Wellesley, MA). 
 
RESULTS 
Effectiveness of BVDV and MH challenge model 
The immune challenge model described by Burciaga-Robles et al. (2010) was 
validated in this experiment. The BVDV and MH challenges were both proved successful 
via increased antibody titers for BVDV as well as for MH WC and MH LKT. In addition, 
TEMP and CS both significantly increased during the challenge, then returned to normal 
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levels. The responses observed to the immune challenge were consistent with previous 
experiments by Burciaga-Robles et al. (2010) and others using this challenge model.  
 
Calf performance and efficiency 
 Calf performance and efficiency data are presented in Table 2. There was no time 
× treatment interaction (P ≥ 0.82) for any of the performance or efficiency data measured. 
The BW of calves at the initiation of the experiment was not different between the 
experimental mineral treatments. In addition, mineral supplementation did not affect BW 
pre or post challenge (P = 0.78). There were also no differences in the ADG (P = 0.78) or 
DMI (P = 0.48) of calves between the experimental mineral treatments. With ADG and 
DMI both being similar between treatments, there was also no difference in G:F between 
treatments (P = 0.95). Time significantly impacted all performance and efficiency 
variables (P ≤ 0.001).  
 
Subjective clinical severity scores  
 The data for CS are presented in Figures 1a and 1b. For the first 24 h following 
the MH challenge, there was a tendency for a time × treatment interaction (P = 0.09). 
This interaction resulted from calves on the CON treatment having higher (P < 0.05) CS 
at h 12, while calves on the MIN treatment had numerically higher CS at h 18 and h 24. 
While time did significantly impact CS (P < 0.0001) during the first 24 h post MH 
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challenge, treatment did not (P = 0.87). The greatest CS for MIN calves was observed at 
h 18. For CON calves, the greatest CS was observed at h 18 and h 24. 
 When looking at the prolonged (7 d) effect of mineral supplementation on CS 
following an immune challenge, there was no time × treatment interaction (P = 0.15). 
Similar to what was observed with the immediate (24 h) response, time was significant (P 
< 0.0001), but treatment did not have a significant effect on CS (P = 0.53). Most calves 
returned to a CS of 0 (clinically normal) within 48 h of the MH challenge. All calves had 
returned to a CS of 0 by d 7. 
 
Rectal temperatures 
 Calf TEMP is presented in Figures 2a and 2b. For the first 24 h post MH 
challenge, there was no time × treatment interaction (P = 0.16). Mineral treatment did not 
affect TEMP (P = 0.78) during the first 24 h post MH challenge. However, time did 
significantly impact TEMP during this period (P < 0.0001). The greatest TEMP for MIN 
calves occurred at h 6, while the greatest TEMP for CON calves occurred at h 12. By h 
24 TEMP were below 39.5°C for both treatments.  
For the week long effect of mineral supplementation on TEMP following an 
immune challenge, there was no time × treatment interaction (P = 0.12). Similar to the 
immediate (24 h) response, treatment did not significantly impact TEMP (P = 0. 66). 
However, time again was significant (P < 0.0001) during the first 7 d post MH challenge. 
After the initial increase following the MH challenge and falling below 39.5°C at 24 h, 
calves did not exhibit any increase in TEMP from 48 h to 168 h (d 7). 
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Respiration rates  
Calf RR data are presented in Figures 3a and 3b. For the first 24 h after the MH 
challenge, there was no time × treatment interaction (P = 0.65). Mineral supplementation 
did not affect RR (P = 0.35) during the first 24 h post MH challenge. However, time did 
significantly impact RR during this period (P = 0.001). The greatest RR for all calves 
occurred at h 12.  
For the 7 d effect of mineral supplementation on RR following an immune 
challenge, there was no time × treatment interaction (P = 0.31). Similar to the immediate 
(24 h) response, treatment did not significantly impact RR (P = 0. 52). However, time 
was significant (P = 0.0001) during the first 7 d post MH challenge. After the spike in RR 
at 12 h, calves did not exhibit any further increase in RR from 48 h to 168 h (d 7). It 
should be noted that all measurements from 48 h to 168 h were taken at 0700 h. 
 
Serum minerals 
 Serum mineral data are presented in Figures 4a, 4b, 4c, and 4d. There were no 
time × treatment interactions (P ≥ 0.54) for any of the serum mineral concentrations 
examined. Calves on the CON treatment had greater serum Cu concentrations (P = 0.05). 
Serum Cu was also effected by time (P < 0.003) with serum Cu levels for both treatments 
increasing over time. Serum Mn levels were not affected by experimental treatment (P = 
0.21) or time (P = 0.66).  Serum Zn concentrations increased with time (P < 0.003) 
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similarly to serum Cu levels, but were not affected (P = 0.36) by mineral treatment. 
Calves on the CON treatment also had greater serum Fe concentrations (P = 0.04) and 
serum Fe was effected by time (P < 0.005). 
 
Muscle minerals 
 The data for muscle mineral concentrations are presented in Figures 5a, 5b, 5c, 
and 5d. There were no time × treatment interactions (P ≥ 0.57) for any of the muscle 
mineral concentrations examined. In addition, mineral treatment did not impact the 
muscle mineral concentrations for any of the minerals evaluated (P ≥ 0.38). The muscle 
concentrations of Cu (P < 0.001), Mn (P = 0.05), and Zn (P = 0.001) were all effected by 
time, with all 3 of the TM having lower concentrations within the muscle on d 28 
compared to d -46. 
 
Liver minerals 
 The data for muscle mineral concentrations are presented in Figures 6a, 6b, 6c, 
and 6d. There was a significant time × treatment interaction observed (P < 0.0001) for 
liver Cu levels. This resulted from a rapid increase in liver Cu concentrations of MIN 
calves after mineral supplementation began, while calves on the CON treatment had no 
change in liver Cu over time. This resulted in calves on the MIN treatment having 
significantly higher liver Cu concentrations (P = 0.0001) on d -4 and d 28. There were no 
time × treatment interactions (P ≥ 0.31) for Mn, Zn, or Fe liver mineral concentrations. 
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Calves on the MIN treatment had greater liver Mn concentrations (P < 0.008). Liver Mn 
was also effected by time (P < 0.003) with liver Mn levels for both treatments increasing 
from d -46 to d -4 then decreasing from d -4 to d 28. Mineral supplementation did not 
affect liver Zn or Fe concentrations (P ≥ 0.39). However, liver Zn concentrations 
decreased with time (P = 0.01), while liver Fe concentrations increased with time (P < 
0.004). 
 
DISCUSSION 
The supplementation of TM including Cu, Mn, and Zn has been a longstanding 
management practice within the feedlot industry primarily to avoid unwanted deficiencies 
and promote maximum animal performance. While these TM make up a very small 
percentage of a calf’s body mass and are required in extremely small amounts within the 
diet, it has been well established that certain TM are essential for overall performance, 
health, and immune function. In addition to general health and immune function 
mechanisms, the supplementation of TM has been demonstrated to alter specific immune 
function measurements and reduce morbidity associated with BRD in some cases 
(Galyean et al., 1999). However, other experiments have demonstrated no improvements 
in performance or health variables from the supplementation of TM.  
The published research justifying the supplementation of Cu, Mn, or Zn at levels 
greater than published requirements is lacking and has produced inconsistent results to 
date. Regardless, the inclusion of these 3 TM in feedlot diets at concentrations 2 to 3 
times greater than published requirements is common by feedlot nutritionists according to 
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Vasconcelos and Galyean (2007). The role of TM in immune function, combined with 
the unknown TM status of newly received calves, and expectation of depressed DMI 
early in the receiving period may serve as a possible explanation for the reported increase 
in ration TM inclusion.   
The challenge employed in this experiment was the same model described by 
Burciaga-Robles et al. (2010) with slight modifications. This challenge model was 
selected due to the ability of this model to successfully simulate natural BRD 
pathogenesis. Additionally this model is able to induce a controlled, simulated BRD 
event, while simultaneously allowing for accurate determination of antibody responses 
due to the challenge with known viral and bacterial pathogens. The pathogenesis of BRD 
typically involves compromised respiratory immune mechanisms and a primary infection 
with one or more respiratory viruses. The viral infection and the calf's impaired immune 
response to the virus further compromise the immune system and allow for the 
colonization of lung tissues by bacteria (Hodgins et al., 2002). Most of the pathogens 
associated with increased BRD incidence are well documented within the literature. 
However, many of these pathogens are also frequently isolated from the respiratory tract 
of clinically healthy cattle making the analysis of BRD in field studies difficult.  
The decision to use the specific pathogens in this model are justified by the 
published literature and previous experiences. It has been reported that PI BVDV calves 
are a principal source of disease transmission in feedlots (O’Connor et al., 2005). In 
addition, the presence of a PI BVDV animal within a feedlot pen has been reported to 
increase the risk for antimicrobial treatment for clinical BRD by 43% compared to non-
exposed cattle (Loneragan et al., 2005). In multiple experiments, BVDV 1b has been the 
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predominant BVDV subtype isolated from calves diagnosed with BRD (Fulton et al. 
2002a; Fulton et al. 2002b). The most common bacterial pathogen isolated from the 
respiratory tract of calves treated for BRD is MH serotype 1, and this serotype has been 
shown to be responsible for characteristic BRD infection in calves (Hodgins and Shewen, 
2004; Booker et al., 2008; Griffin et al., 2010).  
The objective of this experiment was to determine the influence of Cu, Mn, and 
Zn supplementation on the performance, clinical signs, and mineral balance of calves 
following a BVDV and MH immune challenge. In the current experiment, calves had 
average TEMP of 40.3°C by h 6 and had average CS of 1 by h 18. The CS observed for 
calves in this experiment would have dictated that the calves would have been pulled for 
exhibiting clinical signs of BRD and evaluated for subsequent antimicrobial treatment 
under the standard operating protocols in place at our facility. The TEMP observed in 
these calves would have dictated that the calves would have received an antimicrobial 
treatment for clinical BRD under the same standard operating protocols. At our facility, a 
calf can meet treatment criteria for clinical BRD and receive an antimicrobial via 2 
standard treatment protocols. The first being that an animal can be pulled with a CS of 1 
or 2 and had a TEMP of 40°C or greater. The second being that an animal can be pulled 
with a severe CS (CS = 3 or 4) regardless of TEMP. The increased TEMP and CS of 
calves challenged in combination with increased BVDV antibody titers and MH WC and 
LKT antibody titers validated the immune challenge in the current experiment. The 
increases observed for these 4 response variables would have been similar to those 
observed by Burciaga-Robles et al. (2010) using a similar challenge model.  
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In the present experiment, no measures of calf performance or efficiency were 
affected by the supplementation of additional Cu, Mn, or Zn. A major reason for this 
could be due to the nature of the basal diet feed to all calves. All nutrients aside from Cu, 
Mn, and Zn were formulated to exceed NRC (2000) requirements. While no additional 
Cu, Mn, or Zn were included in the common diet, the analyzed values of the common 
ration indicate that the diet contained more than adequate in Mn and Zn concentrations. 
When samples were analyzed by an independent laboratory, the concentration of Mn in 
the diet was found to be over 2.5 times the NRC (2000) requirement and the 
concentration of Zn in the diet was found to be over 1.5 times the NRC (2000) 
requirement. The only mineral deficiency present in the basal diet was Cu.  
When analyzed, the common ration contained only 60% of Cu recommended by 
the NRC (2000). The reason for the high Mn and Zn levels in the diet result primarily 
from the inclusion of by-product feeds. To accurately reflect production settings, it was 
important to use commercially relevant ingredients rather than feed a semi-purified diet 
to control for mineral concentration. With the diet ingredients at our disposal, it was not 
possible to formulate a Mn or Zn deficient diet. While the diet fed to the calves in this 
experiment was Cu deficient, the calves used in this experiment were not determined to 
be Cu deficient prior to the initiation of the experiment as indicted by liver Cu 
concentrations (Dias et al., 2013). On d -46, prior to any mineral supplementation, liver 
Cu concentrations were 99.1 mg/kg (dry weight basis) across all calves. The lack of an 
induced Mn or Zn deficiency at any time during the experiment, combined with a lack of 
Cu deficiency prior to the initiation of the experiment likely explains the lack of 
performance difference observed between the mineral treatments.  
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Calf performance was severely impacted during the challenge portion of the 
experiment. The ADG of all calves was reduced by approximately 60% from d -4 
through d 28 compared to d -46 through d -4. While a portion of this reduction in 
performance is certainly the result of moving calves from individual pens into 
metabolism stanchions, the calves were only in the stanchions for 7 d during this period. 
If it is assumed that stanchions were solely responsible for this lack of performance, the 
stanchions would have to account for average loss of 20.8 kg of BW over this 7 d period. 
While it is likely that the stanchions did negatively impact performance, they are unlikely 
responsible for the majority of the performance loss. There are several probable reasons 
for this justification. First, the DMI of calves was also depressed during this period, but it 
was only reduced by 7.8%. In addition, calves were adapted to the stanchions for 5 d 
prior to the initiation of the experiment, and as a result the stress of simply being placed 
in a stanchion should have been minimized. Finally, a BW was obtained on d 14 (not 
reported) at the time of sampling. Based on the BW taken on d 14 and d 28, the calves 
only gained an average of 0.37 kg/d for the last 14 d of the experiment. This would have 
allowed the calves 7 d to adjust and pick up any losses in fill that occurred while in the 
stanchions. This amounted to 43% reduction in pre challenge ADG for the calves from d 
14 to d 28. 
Not observing a performance response to TM supplementation is not uncommon 
unless a severe deficiency is induced. In a classical experiment, Ivan and Grieve (1975) 
evaluated the effects of Cu, Mn, and Zn supplementation alone or in all possible 
combination on the performance of Holstein calves. These authors found that the 
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supplementation of the basal ration with the individual TM or combinations had no effect 
on calf performance.  
Some experiments that have induced or attempted to induce TM deficiencies have 
also failed to see a performance response. Genther and Hansen (2014) observed the 
effects of dietary TM supplementation on growth performance. Calves either received a 
control diet supplemented with Cu, Mn, Se, and Zn to meet or exceed NRC (2000) 
recommendations or a mineral depleted diet containing no supplemental Cu, Mn, Se, and 
Zn, but additional Fe (300 mg/kg) and molybdenum (5 mg/kg). The authors found no 
significant differences (P ≥ 0.32) in overall BW, ADG, DMI, or G:F between calves in 
control or mineral depleted treatments during an 84 d period. After the depletion period, 
the calves were finished. No differences (P ≥ 0.13) in live performance existed between 
the dietary treatments for the finishing portion of the experiment as well. 
It is also common to not observe a performance response to TM supplementation 
when a stressor, such a transportation, is applied to calves. Arthington et al. (2014) 
examined the effects of multiple TM injections on the performance and trace mineral 
status of beef calves both before and after weaning. Treated calves were injected with 60 
mg/mL of Zn, 10 mg/mL of Mn, 15 mg/mL Cu, and 5 mg/mL of Se. The control calves 
were administered an equivalent volume of sterile saline solution. The experimental 
treatments were then readministered at 100 and 200 d of age. The TM injection had no 
impact (P ≥ 0.40) on overall pre weaning (birth to d 250) performance. After weaning, a 
subset of heifers were selected and transported 1,600 km. Heifers were administered an 
additional dose of injectable TM or saline following transport. The ADG for heifers 
receiving the TM injection was actually reduced (P = 0.05) compared to control heifers in 
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the first 14 d following transport. In an additional experiment heifers that were not 
previously exposed to TM injection were enrolled in a 177-d heifer development 
experiment. Heifers again received 3 TM injections or 3 injections of sterile saline. The 
final BW of heifers was not different (P = 0.64) between treatments while heifers 
receiving the TM injections had a tendency (P = 0.06) for improved overall ADG. 
In the current experiment, there was a tendency for a time × treatment interaction 
in CS during the first 24 h following the MH challenge. This was a result of CON calves 
having higher CS at h 12, while MIN calves had numerically higher CS at h 18 and h 24. 
The greatest CS for MIN calves was observed at h 18. For CON calves, the greatest 
clinical score was observed at both h 18 and h 24. Based on CS, the majority of these 
calves would have been pulled between 12 and 24 h by a trained evaluator if they were in 
a pen environment. When the extended effect (d 0 to d 7) of mineral supplementation on 
CS following an immune challenge was observed, no interaction or treatment effect was 
observed, but time significantly impacted CS. Most calves appeared clinically normal 
within 48 h of the MH challenge and all calves had returned to a CS of 0 by d 7. No 
calves in the present experiment received a CS of 3 or 4 at any time during the 
experiment. 
In the experiment conducted by Burciaga-Robles et al. (2010), CS were only 
reported for h 72. The values (CS = 0.45) reported for calves exposed to both BVDV and 
MH at this time point in their experiment would be higher than those in the present 
experiment. Corrigan et al. (2007) examined the effects of melengestrol acetate on heifers 
challenged with MH. The subject measure used in this experiment to assess the clinical 
severity of the MH challenge was termed total observational score (TOS). The authors 
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defined TOS as the sum of the clinical scores for respiratory index, activity level, 
hydration index, appetite index, fecal score, nasal discharge, and ocular discharge. This 
value would account for many of the same things as CS in the current experiment, but 
also took RR into account. While a direct comparison between the scores reported in the 
2 experiments cannot be made, there is merit in comparing the time points in which 
calves exhibited elevated CS or TOSs. In the experiment by Corrigan et al. (2007), the 
highest TOS for all calves occurred at 12 h post MH inoculation. This is in agreement 
with the present experiment.  
Theurer et al. (2013) observed the effects of MH pneumonia on the clinical 
behavior and physiologic responses of calves during exposure to high environmental 
temperatures. The authors used a clinical illness score (CIS) using a 1 to 4 scale similar to 
the system used in the present experiment. All calves inoculated with MH had a CIS of 2 
(slight illness, mild depression, and/or cough) at 24 h after MH inoculation. The 
percentage of calves inoculated with MH with a CIS of 2 varied between 10% and 70% 
on subsequent evaluation periods with no calf being classified as greater than CIS 2 
during the experiment. These results would also be similar to the present experiment with 
a slightly longer duration to achieve elevated CIS. 
 These results for CS in the present experiment would be expected for this type of 
challenge model in our experience. The overall challenge is mild by commercial 
production standards as it only consists of the exposure to 1 respiratory virus and a 
controlled dose of 1 bacterial pathogen. The calves in this experiment had previously 
received all standard vaccinations except for the 2 pathogens for which they were 
challenged. In addition, these calves had been weaned for approximately 8 wk prior to the 
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challenge and should not have been experiencing many of the stressors common for 
newly received calves in commercial settings. These calves would have also had positive 
energy balances prior to entering the challenge portion of this experiment, and would not 
have been deficient in any nutrients other than potentially Cu in the case of the CON 
calves.   
In the current experiment, there was no time × treatment interaction or treatment 
effect for TEMP during the first 24 h or over the course of the first wk. However, time 
significantly impacted TEMP during both periods. The greatest TEMP for MIN calves 
occurred at h 6, while the greatest TEMP for CON calves occurred at h 12. By h 24 
TEMP were below 40°C for both treatments. After falling below 40°C by 24 h, calves did 
not exhibit any increase in TEMP from 48 h to 168 h (d 7). 
These results would be similar to those observed by Burciaga-Robles et al. 
(2010). The highest TEMP for calves that were exposed to BVDV and then challenged 
with MH was observed at h 6 in that experiment. The length of time calves demonstrated 
a fever was also similar between the 2 experiments. In their experiment, the average 
TEMP of calves challenged fell below 40°C by 24 h and the calves did not have 
increased TEMP out to 96 h. The last TEMP taken in their experiment were at h 96. The 
TEMP results of the present experiment are also supported by the results of Confer et al. 
(2008), where cattle that were challenged with MH demonstrated an increased TEMP 
compared to control animals. In addition, Corrigan et al. (2007) reported that heifers 
challenged with MH had increased TEMP (> 40°C) between 0 to 12 h post challenge and 
returned to normal TEMP by 24 h. Finally, Theurer et al. (2013) stated that calves 
challenged with MH had greater TEMP compared to unchallenged calves from 6 h 
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through 24 h post MH challenge. The calves challenged with MH in their experiment had 
TEMP above 40°C beginning at h 6 and the average TEMP of challenged calves fell 
below 40°C by 20 h. 
In the current experiment, there was no time × treatment interaction for RR during 
the first 24 h or over the course of the first wk and mineral treatment did not affect RR 
over either interval. However, RR was significantly impacted by time during both 
periods. The greatest RR for all calves occurred at h 12. This increase in RR would 
follow the trend for elevated TEMP in the calves at this time as well. However, it should 
be noted that this time coincided with 1900 h and the environmental temperature and 
humidity were both high at this time. The facility was not environmentally controlled, 
and the majority of this spike in RR is likely a result of the increased environmental stress 
rather than the immune challenge. After the spike in RR at 12 h, the calves did not exhibit 
any further increase in RR from 48 h to 168 h (d 7). Again it should be noted that all 
measurements from 48 h to 168 h were taken at 0700 h. 
In the experiment conducted by Burciaga-Robles et al. (2010), RR were only 
reported for h 72. The values reported for this time point in that experiment would be 
considerable lower than those in our experiment. The authors did state that there was a 
BVDV × MH interaction for RR where calves exposed to BVDV and then challenged 
with MH had greater RR, while calves challenged with MH but not exposed to BVDV 
had lower RR compared to those calves not challenged with MH. Interestingly, Burciaga-
Robles et al. (2010) noted that RR was greatest for the calves that received no exposure 
to BVDV and were not challenged with MH compared to calves exposed to BVDV and 
then challenged with MH or calves challenged with either of the pathogens alone. In 
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addition, the authors noted that a decreased RR was present for all calves that had 
increased TEMP compared the unchallenged calves. Since Corrigan et al. (2007) only 
reported TOS, which would include many measures equivalent to our CS, but also took 
RR into account, we cannot be certain when the highest RR occurred in that experiment. 
However the highest TOS occurred at 12 h post MH inoculation. This would be in 
agreement with the peak CS and RR observed in the present experiment. Theurer et al. 
(2013) found no differences in RR between MH challenged and unchallenged calves. The 
authors noted that the calves were housed in extremely high ambient temperatures 
throughout the experiment and that increases in RRs in response to heat stress potentially 
obscured their ability pick up differences in RR due to the MH challenge. It is believed 
that the much of the elevation in RR observed in the present experiment resulted from 
high ambient temperatures as well. 
There were no time × treatment interactions for any of the serum mineral 
concentrations evaluated in the present experiment. Experimental treatment did not affect 
serum Mn or Zn concentrations. Calves on the CON treatment had greater serum 
concentrations of Cu and Fe. Serum Cu and Zn was effected by time with serum levels 
for both minerals increasing over time for both experimental treatments. Serum Fe was 
also effected by time with serum Fe levels being somewhat erratic over time. The results 
in the literature concerning serum TM concentrations are highly varied, and extremely 
inconsistent from experiment to experiment. Upon reviewing the data, multiple sources 
were found that both agreed and disagreed with the results in the current experiment. 
Mineral metabolism within the body is extremely complex, and changes in mineral stores 
within the body may or may not result in changes in serum mineral concentrations. 
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Orr et al. (1990) evaluated the effects of BRD and infectious bovine 
rhinotracheitis (IBR) on serum Cu and Zn. The authors collected serum samples at 
specific intervals measured serum mineral concentrations for several experiments. Serum 
Zn was decreased by 34%, 57%, 29% and 15% for calves that were morbid or challenged 
with IBR across 4 experiments when measured at peak morbidity. In contrast, serum Cu 
was increased by 5%, 15%, 40%, and 33% for calves that were morbid or challenged 
with IBR when measured across 4 experiments at peak morbidity. These results for Cu 
would be similar to those found for Cu in the current experiment where serum Cu 
increased over time for both experimental treatments. However the results for Zn 
concentrations observed by Orr et al. (1990) would be in stark contrast to what was 
observed in the current experiment where Zn concentrations also increased over time. 
Nockels et al. (1993) examined the effects of induced stress on the Cu and Zn 
balance of calves fed organic and inorganic TM. The authors reported that serum Cu was 
decreased for 4 of the 5 time points sampled and that multiple stress events or mineral 
removals from the diet caused a decrease in serum Cu. In contrast, serum Zn was 
increased for both of the induced stress events within the experiment. These results would 
directly contradict those reported by Orr et al. (1990) and would be similar to the 
response observed with serum Zn over time in the current experiment, but be in stark 
contrast to what was observed in the current experiment for serum Cu. 
Arthington and Havenga (2012) investigated the effects of injectable TM on 
calves receiving a viral vaccination. Serum mineral concentrations were evaluated on d 0 
prior to vaccination and TM administration and on d 14. No differences existed in serum 
Cu, Mn, or Zn between the treatments on d 0. Control steers had decreased serum Zn 
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concentrations on d 14 compared to d 0. This resulted in TM injected steers having 
greater serum Zn concentrations compared with Control steers on d 14. Steers injected 
with TM had an increase in serum Cu levels on d 14 relative to d 0 levels. Serum Cu was 
not different between treatment groups at d 0 or d 14. In addition, serum Mn was not 
effected by time or mineral treatment. The results for Mn presented in this experiment 
would be similar to the results found for serum Mn in the present experiment. The results 
for the other TM would contradict our results except for the time effect on serum Cu 
concentrations. 
Rhodes et al. (2003) studied the effects of TM supplementation level and source 
on plasma Cu and Zn concentrations of steers. There were no differences in plasma Cu or 
Zn due to source or concentration of TM supplementation at the end of the evaluation 
period (d 198). The authors did find that both plasma Cu and Zn concentrations increased 
over time which would support the results observed for serum Cu and Zn in the present 
experiment. Richeson and Kegley (2011) examined the effect of injectable TM on the 
health and performance of highly stressed heifers and found similar results to Rhodes et 
al. (2003). While the authors found no differences in plasma Cu and Zn concentrations 
between treatments, the plasma concentrations of both minerals increased over time. 
These results would be in complete agreement with those in the present experiment. The 
authors reported that plasma Zn was marginal (0.59 mg/L) on d 0, but increased to 
adequate levels (1.72 mg/L) by d 28. Similarly, plasma Cu increased from adequate 
levels on d 0 (0.84 mg/L) to what the authors termed as toxic levels (1.42 mg/L) on d 28. 
No time × treatment interactions were observed for any of the muscle mineral 
concentrations examined in the current experiment. In addition, mineral treatment did not 
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impact muscle mineral concentrations for any of the TM evaluated. The muscle 
concentrations of Cu, Mn, and Zn were all effected by time, with all 3 of the TM having 
lower concentrations within the muscle at the end of the experiment compared to pre 
supplemented levels. The literature concerning the effects of TM supplementation or 
immune challenges on muscle TM concentrations is limited. The values reported in this 
experiment would be similar to those reported by Standish et al. (1971). 
There was a significant time × treatment interaction observed for liver Cu levels 
in the current experiment. This interaction was the result of a rapid increase in liver Cu 
concentrations of MIN calves after TM supplementation began, while CON calves had no 
noticeable change in liver Cu over time. In addition, mineral treatment did effect liver Cu 
levels with calves on the MIN treatment having significantly higher liver Cu 
concentrations on d -4 and d 28. Time also significantly impacted liver Cu when 
averaged across treatments. There were no time × treatment interactions for Mn, Zn, or 
Fe liver mineral concentrations. Mineral supplementation did effect liver Mn 
concentrations with calves on the MIN treatment having greater liver Mn levels. Liver 
Mn was also effected by time with liver Mn levels for both treatments initially increasing 
from d -46 to d -4 then decreasing from d -4 to d 28. Treatment did not affect liver Zn or 
Fe concentrations, however both TM were effected by time. Liver Zn concentrations 
decreased over time. In contrast, liver Fe concentrations increased over time. 
The liver TM concentrations in the current experiment were compared to critical 
values reported by McDowell (1985) and standardized reference values reported by 
Kincaid (1999). According to Kincaid (1999), liver Cu levels for all calves in the current 
experiment would have been categorized as marginally deficient (< 125 mg/kg) on d -46. 
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Without any additional Cu supplementation the calves on the CON treatment continued 
to be considered marginally Cu deficient throughout the experiment. Calves on the MIN 
treatment had increased liver Cu stores by d -4 due to mineral supplementation, and were 
considered to have adequate liver Cu concentrations (125 to 600 mg/kg) on d -4 and d 28. 
Liver Zn concentrations were not affected by mineral supplementation, and were 
considered to be adequate (25 to 200 mg/kg) for all calves throughout the experiment. In 
contrast, liver Mn levels were increased for calves on the MIN treatment, but all calves 
were still considered to be marginally deficient (7 to 13 mg/kg) in liver Mn throughout 
the experiment. While the liver Cu concentrations for CON calves and liver Mn 
concentrations for all calves were classified as marginally deficient, it should be noted 
that the liver concentrations of all 3 TM would not have been considered clinically 
deficient or below critical levels at any time during the experiment (McDowell, 1985; 
Kincaid, 1999). 
Similar to what was found when reviewing the literature for serum and mineral 
TM concentrations, the published results concerning liver TM levels are somewhat varied 
though the results are more consistent than those found for other body TM 
concentrations. There does still seem to be inconsistency from experiment to experiment, 
but the sheer number of studies evaluating liver mineral concentrations allows for 
adequate comparisons to be made. There are multiple experiments evaluation liver TM 
status, but no 2 are exactly alike, and multiple studies can be found that both agree and 
disagree with the results presented in the current experiment. That said, multiple classical 
and recent research experiments support the findings of the current experiment in regard 
to liver TM concentrations. The liver is the primary storage organ for TM within the 
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body, therefore liver TM concentrations give the best indication of the true TM status of 
an animal. 
Arthington et al. (2014) examined the effect TM injections on liver TM 
concentrations when averaged across 3 sampling times. The authors found that the 
administration of injectable TM resulted in greater liver Cu concentrations (34% 
increase) and a decreased liver Fe concentrations (13% decrease). Injectable TM did not 
affect liver Mn or Zn concentrations. After transport stress, a treatment × time interaction 
was found for liver Cu and Zn concentrations. The liver concentrations of Cu and Zn 
increased following the TM injection, and were greater for injected heifers on d 13 
compared to heifers injected with saline. Concentrations of Fe within the liver tended to 
be reduced for TM injected heifers. The results found by Arthington et al. (2014) would 
support our findings for liver Cu in the present experiment where liver Cu increased over 
time for supplemented calves, but remained static for unsupplemented calves. However, 
the results reported for Zn would contradict those in the current experiment.  
Genther and Hansen (2014) examined the effect of previous TM status and TM 
mineral injection on mineral balance in calves. Calves were assigned to either a control 
diet including supplemental Cu, Mn, Se, and Zn or a deficient diet containing no 
supplemental Cu, Mn, Se, or Zn plus additional Fe and Mo as antagonists to the other TM 
for 84 d. After the depletion period, raw liver Cu and concentrations for steers on the 
deficient diet were less than those for steers on the control diet (79.0 ± 11.60 mg/kg DM 
versus 228.8 ± 11.60 mg/kg DM, respectively). In addition, liver Mn concentrations 
tended to be greater for steers on the control diet compared to steers on the deficient diet 
(9.37 ± 0.261 mg/kg DM versus 8.71 ± 0.261 mg/kg DM, respectively. Liver Zn 
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concentrations were not affected by diet TM inclusion. These values reported by Genther 
and Hansen (2014) would support the findings in the current experiment for liver TM. 
Rhodes et al. (2003) did not have any TM deficiencies in their experiment, but 
rather examined organic and inorganic TM supplementation at varying concentrations in 
the diet. For all experimental mineral treatments, liver Cu numerically increased 
throughout the experiment. Similarly, the concentration of Mn within the liver increased 
for all experimental treatments for the duration of the experiment. In contrast, liver Zn 
numerically decreased for all experimental mineral treatments compared to the initial 
levels observed at the beginning of the experiment. These results while not while not 
statistically significant, would support the liver TM data in the current experiment. 
Stabel et al. (1993) examined the effects of a Cu deficiency by feeding a semi-
purified diet (1.5 mg/kg Cu) supplemented with 0 mg/kg or 10 mg/kg of Cu on mineral 
balance and immune function of calves challenged with IBR and MH. The results 
observed in their experiment would be in agreement with our results. The authors found 
that Cu supplementation resulted in increased liver Cu levels. The basal diet contained 
adequate Mn and Zn, and no differences were observed in liver Mn or Zn levels between 
treatments. The experimental treatments in their experiment and the present experiment 
would have been very similar in that the only deficiency present would have been for Cu 
within the unsupplemented diet. 
Finally, Ivan and Grieve (1975) evaluated the effects of supplemental Cu, Mn, 
and Zn on the tissue TM content of calves. Increased dietary Cu inclusion resulted in 
increased liver Cu levels. The inclusion of Cu in the diet did not impact liver Mn or Zn 
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levels. Increased dietary Mn concentration resulted in increased concentrations of all TM 
(Cu, Mn, and Zn) within the liver. Increased dietary Zn concentrations resulted in 
decreased liver Cu concentrations but did not affect liver Mn or Zn concentrations. The 
number of calves used in this experiment was small, but the results demonstrate many 
aspects of classical TM metabolism. In addition, the results help to explain those 
observed in the current experiment. 
Care must be taken in interpreting serum and muscle TM concentrations. The 
most accurate predictor of TM status in calves remains the liver, and the results of liver 
TM concentrations in the current experiment are supported by much of the published 
literature. Within the body the liver is the primary storage organ for TM and it functions 
to maintain appropriate blood concentrations of TM. When a diet deficient in Cu is fed, 
as was the case for calves on the CON treatment in this experiment, Cu will be released 
from the liver in order to maintain proper blood Cu levels. As a result, serum Cu levels 
can be inflated, and may not accurately predict Cu status within the body. This would 
help to explain serum Cu was increased in CON calves compared to MIN calves, even 
though the MIN calves had significantly improved liver Cu stores.  
In addition, when dietary Cu is adequate or excessive, the storage of Cu by the 
liver should exceed the mobilization of Cu resulting in net buildup of liver Cu stores. 
However, since serum Cu concentrations are maintained within such narrow ranges, an 
increase in liver Cu may not be reflected by a representative increase in serum Cu. This 
would help to explain how serum Cu was increased only slightly for MIN calves 
overtime, even though the MIN calves had significantly improved liver Cu stores. 
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Conclusions 
The TM Cu, Mn, and Zn are frequently included at levels well in excess of 
published requirements in feedlot diets. There are certainly multiple reasons for this, but 
the role of TM in immune function, combined with the unknown TM status of newly 
received calves likely serves as a plausible explanation even though documented benefits 
of this practice are lacking. Previous nutrition, stressors, and immune challenge events all 
can certainly impact the TM balance of calves. The immune challenge in this experiment 
impacted the CS, TEMP, and mineral balance of calves. With the increased by-product 
inclusion levels in all feedlot diets, it is unlikely that severe dietary Mn or Zn deficiencies 
exist in practical production settings even if supplemental Mn and Zn are not included in 
the diet. However, most diets will be deficient in Cu if additional Cu is not added to the 
diet. In addition, many regions of the U.S. including the Southern Plains and over 40% of 
the cattle in the country according to USDA reports are at least marginally Cu deficient. 
When Cu is supplemented to calves receiving a marginally Cu deficient diet, Cu status 
within the body can be improved.  
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Table 5-1. Composition of common receiving diet1 
Ingredient (%)1  
Prairie hay  35.0 
Dry-rolled corn  28.0 
Wet corn gluten feed2  15.0 
Dried distillers grains plus solubles  15.0 
Dry supplement B-2783  3.5 
Liquid supplement4  3.5 
Nutrient Composition1,5   
NEm, Mcal/kg  1.62 
NEg, Mcal/kg  1.03 
TDN, %  69.83 
Crude protein, %  16.20 
Crude fat, %  3.13 
NDF, %  44.47 
ADF, %  23.00 
Calcium, %  0.80 
Phosphorus, %  0.51 
Magnesium, %  0.26 
Potassium, %  1.03 
Sulfur, %  0.30 
Copper, mg/kg  6.00 
Manganese, mg/kg  50.33 
Zinc, mg/kg  47.33 
Iron, mg/kg  614.00 
1All ingredient and nutrient values are presented on a 
DM basis. 
2Sweet Bran® (Cargill; Dalhart, Texas).  
3Dry supplement B-278 was formulated to contain: 
38.123% ground corn, 34.705% limestone, 23.477% 
wheat midds, 2.571% salt, 0.224% vitamin A 
(30,000 IU/g), 0.134% vitamin E (500 IU/g), 0.002% 
vitamin D (500,000 IU/g), 0.002% EDDI, 0.496% 
Rumensin 90 (Elanco Animal Health; Indianapolis, 
IN), and 0.266% Tylan 40 (Elanco Animal Health; 
Indianapolis, IN) on a DM basis. 
4Synergy 19-14 (Westway Feed Products; New 
Orleans, LA). 
5Feed samples were analyzed for nutrient 
composition by an independent laboratory (Servi-
Tech Laboratories; Dodge City, KS).
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Table 5-2. Effects of trace mineral supplementation on the performance of calves exposed to 
bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection 
 Experimental treatment1  P-value2 
   Pooled   Time × 
Variable CON MIN SEM Treatment Time treatment 
Body weight3, kg       
d -46  223 225 7.85 0.78 < 0.001 0.95 
d -4  268 272 10.7    
d 28  281 287 13.4    
Average daily gain4, kg       
d -46 to d -4 1.06 1.12 0.12 0.78 < 0.001 0.93 
d -4 to d 28 0.42 0.46 0.12    
Dry matter intake5, kg       
d -46 to d -4 5.88 6.23 0.35 0.48 < 0.001 0.82 
d -4 to d 28 5.45 5.84 0.39    
Gain:Feed6       
d -46 to d -4 0.177 0.176 0.014 0.95 0.001 0.88 
d -4 to d 28 0.117 0.120 0.020    
1Experimental mineral treatments: CON = ground corn only, no additional Cu, Mn, or Zn 
included in the diet; MIN = ground corn containing 150 mg of Cu, 130 mg of Mn, and 320 mg of 
Zn in the form of Cu methionine, Mn methionine, and Zn methionine, respectively (Mintrex Cu, 
Mn, and Zn; Novus International, Inc., St. Charles, MO). 
2P-values are included for the effects of experimental treatment, time, and the time by treatment 
interaction.  
3Treatment BW with a calculated 2% shrink. 
4Treatment ADG was calculated from the shrunk (2%) BW and DOF between the time periods. 
5Treatment DMI was calculated by taking the total DMI in kg for a steer for the period divided 
by the DOF between the time periods. 
6Treatment G:F was calculated by taking the individual ADG in kg divided by the individual 
average DMI in kg for the time periods.
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Figures 
Figure 5-1a. Subjective clinical severity score of calves during the first 24 h following 
exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica 
infection. Subjective clinical severity scores were assigned by trained personnel and 
ranged from 0 to 4: 0 = clinically normal appearing calf, 1 = mild clinical signs, 2 = 
moderate clinical signs, 3 = severe clinical signs, and 4 = extreme clinical signs or a 
moribund animal. There was a tendency for a time × treatment interaction (P = 0.09). 
Treatment was not significant (P = 0.87). However, time was significant (P < 0.0001). 
Values plotted represent least squares means ± SE of the mean, calculated for 8 animals 
per experimental group. Within time points, the slice output option of SAS was used to 
perform mean separations. Means with different superscripts (a,b) differ (P ≤ 0.05). 
Figure 5-1b. Subjective clinical severity score of calves during the first 7 d following 
exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica 
infection. Subjective clinical severity scores were assigned by trained personnel and 
ranged from 0 to 4: 0 = clinically normal appearing calf, 1 = mild clinical signs, 2 = 
moderate clinical signs, 3 = severe clinical signs, and 4 = extreme clinical signs or a 
moribund animal. There was no time × treatment interaction (P = 0.15) and treatment 
was not significant (P = 0.53). However, time was significant (P < 0.0001). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 5-2a. Rectal temperature of calves during the first 24 h following exposure to 
bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection. 
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There was no time × treatment interaction (P = 0.16) and treatment was not significant (P 
= 0.78). However, time was significant (P < 0.0001). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-2b. Rectal temperature of calves during the first 7 d following exposure to 
bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection. 
There was no time × treatment interaction (P = 0.12) and treatment was not significant (P 
= 0.66). However, time was significant (P < 0.0001). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-3a. Respirations per 30 s of calves during the first 24 h following exposure to 
bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection. 
There was no time × treatment interaction (P = 0.65) and treatment was not significant (P 
= 0.35). However, time was significant (P = 0.001). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-3b. Respirations per 30 s of calves during the first 7 d following exposure to 
bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection. 
There was no time × treatment interaction (P = 0.31) and treatment was not significant (P 
= 0.52). However, time was significant (P = 0.0001). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-4a. Serum copper (Cu) concentrations of calves preceding and following 
exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica 
infection. There was no time × treatment interaction (P = 0.83) for serum Cu levels. 
However, treatment did effect serum Cu (P = 0.05). Time was also significant (P < 
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0.003) for serum Cu. Values plotted represent least squares means ± SE of the mean, 
calculated for 8 animals per experimental group.  
Figure 5-4b. Serum manganese (Mn) concentrations of calves preceding and following 
exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica 
infection. There was no time × treatment interaction (P = 0.54) and treatment was not 
significant (P = 0.21) for serum Mn levels. Time also did not significantly impact serum 
Mn (P = 0.66). Values plotted represent least squares means ± SE of the mean, calculated 
for 8 animals per experimental group.  
Figure 5-4c. Serum zinc (Zn) concentrations of calves preceding and following exposure 
to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection. 
There was no time × treatment interaction (P = 0.89) and treatment was not significant (P 
= 0.36) for serum Zn levels. However, time was significant (P < 0.003) for serum Zn 
concentrations. Values plotted represent least squares means ± SE of the mean, calculated 
for 8 animals per experimental group.  
Figure 5-4d. Serum iron (Fe) concentrations of calves preceding and following exposure 
to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica infection. 
There was no time × treatment interaction (P = 0.70) for serum Fe levels. However, 
treatment did effect serum Fe levels (P = 0.04). Time was also significant for serum Fe 
concentrations (P < 0.005). Values plotted represent least squares means ± SE of the 
mean, calculated for 8 animals per experimental group.  
Figure 5-5a. Muscle copper (Cu) concentrations (dry weight basis) of calves preceding 
and following exposure to bovine viral diarrhea virus type 1b and subsequent 
256 
 
Mannheimia haemolytica infection. There was no time × treatment interaction (P = 0.76) 
for muscle Cu levels and treatment did not affect muscle Cu (P = 0.94). However, time 
was significant (P < 0.001) for muscle Cu. Values plotted represent least squares means ± 
SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-5b. Muscle manganese (Mn) concentrations (dry weight basis) of calves 
preceding and following exposure to bovine viral diarrhea virus type 1b and subsequent 
Mannheimia haemolytica infection. There was no time × treatment interaction (P = 0.57) 
and treatment was not significant (P = 0.38) for muscle Mn levels. However, time did 
significantly impact muscle Mn (P = 0.05). Values plotted represent least squares means 
± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-5c. Muscle zinc (Zn) concentrations (dry weight basis) of calves preceding and 
following exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia 
haemolytica infection. There was no time × treatment interaction (P = 0.70) and 
treatment was not significant (P = 0.82) for muscle Zn levels. However, time was 
significant (P = 0.001) for muscle Zn concentrations. Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-5d. Muscle iron (Fe) concentrations (dry weight basis) of calves preceding and 
following exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia 
haemolytica infection. There was no time × treatment interaction (P = 0.61) for muscle 
Fe levels and treatment was not significant for muscle Fe levels (P = 0.58). Time was 
also not significant for muscle Fe concentrations (P = 0.25). Values plotted represent 
least squares means ± SE of the mean, calculated for 8 animals per experimental group.  
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Figure 5-6a. Liver copper (Cu) concentrations (dry weight basis) of calves preceding and 
following exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia 
haemolytica infection. There was a significant time × treatment interaction (P < 0.0001) 
for liver Cu levels. Treatment did effect liver Cu levels (P = 0.0001). Time was also 
significant for liver Cu (P = 0.0001). Values plotted represent least squares means ± SE 
of the mean, calculated for 8 animals per experimental group. Within time points, the 
slice output option of SAS was used to perform mean separations. Means with different 
superscripts (a,b) differ (P ≤ 0.05). 
Figure 5-6b. Liver manganese (Mn) concentrations of calves (dry weight basis) 
preceding and following exposure to bovine viral diarrhea virus type 1b and subsequent 
Mannheimia haemolytica infection. There was no time × treatment interaction (P = 0.89). 
Treatment did effect liver Mn levels (P < 0.008). Time was also significant for liver Mn 
(P < 0.003). Values plotted represent least squares means ± SE of the mean, calculated 
for 8 animals per experimental group.  
Figure 5-6c. Liver zinc (Zn) concentrations (dry weight basis) of calves preceding and 
following exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia 
haemolytica infection. There was no time × treatment interaction (P = 0.53) and 
treatment was not significant (P = 0.39) for liver Zn levels. However, time was 
significant (P = 0.01) for liver Zn concentrations. Values plotted represent least squares 
means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 5-6d. Liver iron (Fe) concentrations (dry weight basis) of calves preceding and following 
exposure to bovine viral diarrhea virus type 1b and subsequent Mannheimia haemolytica 
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infection. There was no time × treatment interaction (P = 0.31) for liver Fe levels and treatment 
did effect liver Fe levels (P = 0.86). Time was significant for liver Fe concentrations (P < 0.004). 
Values plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.
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CHAPTER VI 
 
 
EFFECT OF COPPER, MANGANESE, AND ZINC SUPPLEMENTATION ON 
ANITBODY TITERS AND MULTIPLE IMMUNE RESPONSE VARIABLES OF 
CALVES FOLLOWING EXPOSURE TO BOVINE VIRAL DIARRHEA VIRUS TYPE 
1B AND SUBSEQUENT MANNHEIMIA HAEMOLYTICA INFECTION 
 
ABSTRACT 
Trace mineral (TM) supplementation has been demonstrated to alter immune function in 
some experiments (Galyean et al., 1999). The objective of this experiment was to 
determine the influence of dietary copper (Cu), manganese (Mn), and zinc (Zn) 
supplementation on serum antibody titers and multiple immune response variables of 
calves following a bovine viral diarrhea virus (BVDV) and Mannheimia haemolytica 
(MH) immune challenge. Steers (n = 16; BW = 225 ± 20 kg) from a single ranch were 
processed, weaned, and randomly pairwise assigned to either mineral supplemented 
(MIN) or control (CON) experimental treatments. The MIN calves received 150 mg of 
Cu, 130 mg of Mn, and 320 mg of Zn daily while the CON calves received the basal diet 
with no additional Cu, Mn, or Zn supplementation. The basal diet contained sufficient 
Mn and Zn, but inadequate Cu based on NRC (2000) nutrient requirements. After 46 d on 
the experimental treatments, all calves were naturally exposed to heifer persistently 
infected (PI) with BVDV type 1b for 4 d and then subsequently intratracheally
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challenged with MH. Data were analyzed using the GLIMMIX procedure of SAS with 
sampling time serving as a repeated measure and calf serving as the experimental unit. 
The immune challenge was validated via increased BVDV 1b antibody titers, MH whole 
cell (WC) and leukotoxin (LKT) antibody titers, rectal temperatures (TEMP), and 
subjective clinical scores (CS). A time by treatment interaction was observed for BVDV 
1b antibody titers (P ≤ 0.003). Calves receiving MIN tended to have reduced (P = 0.07) 
BVDV antibody titers, but had increased (P = 0.02) MH WC antibody titers compared to 
CON calves. Mineral supplementation did not impact MH LKT antibody titers (P ≥ 
0.48). Calves on the CON treatment tended (P = 0.09) to have increased serum cortisol 
during the first 24 h following the MH challenge. Total leukocytes counts were not 
different among experimental treatments (P ≥ 0.39). However, CON calves had a higher 
percentage of neutrophils from d -4 to d 28 (P = 0.03). In contrast, MIN calves had a 
higher percentage of lymphocytes over the same interval (P = 0.01). Calves on the MIN 
treatment tended (P ≤ 0.10) to have higher levels of base excess in both blood and 
extracellular fluid. The supplementation of Cu, Mn, and Zn has the potential to impact 
serum antibody titers and multiple immune response variables in calves challenged with 
BVDV and MH. 
 
Key Words: bovine respiratory disease, mineral supplementation, immune challenge, 
copper, manganese, zinc, bovine viral diarrhea virus, Mannheimia haemolytica 
 
INTRODUCTION 
270 
 
Bovine respiratory disease (BRD) is the most significant production problem for 
the feedlot industry, accounting for the majority of morbidity, mortality, and decreased 
production in feedlots with estimated annual economic losses in excess of $2 billion 
(Powell, 2013). The supplementation of trace minerals (TM) has been demonstrated to 
alter immune function and reduce morbidity associated with BRD in some cases 
(Galyean et al., 1999). However, other experiments have shown no improvements in 
performance or health variables from the supplementation of TM. Overall, TM research 
has been very inconsistent when investigating the ideal concentrations and sources of TM 
supplementation needed for optimum results. 
Calves that are persistently infected (PI) with bovine viral diarrhea virus (BVDV) 
have been reported as a principal source of disease transmission in feedlots (O’Connor et 
al., 2005). In addition, the presence of a PI BVDV animal within a feedlot pen has been 
reported to increase the risk for antimicrobial treatment for clinical BRD by 43% 
compared to non-exposed cattle (Loneragan et al., 2005). In multiple experiments, 
BVDV 1b has been the predominant BVDV subtype isolated from calves diagnosed with 
BRD (Fulton et al. 2002a; Fulton et al. 2002b). The initial viral infection combined with a 
calf's previously compromised immune system allows for the rapid colonization of lung 
tissues by bacteria (Hodgins et al., 2002). The most common bacterial pathogen isolated 
from the respiratory tract of calves treated for BRD is Mannheimia haemolytica (MH) 
serotype A1, and this serotype has been shown to be responsible for characteristic BRD 
infection in calves (Hodgins and Shewen, 2004; Booker et al., 2008; Griffin et al., 2010). 
The objective of this experiment was to determine if copper (Cu), manganese (Mn), and 
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zinc (Zn) supplementation effected serum BVDV and MH antibody titers and multiple 
immune response parameters of calves following a BVDV and MH immune challenge. 
 
MATERIALS AND METHODS 
All procedures for the present experiment were approved by the Oklahoma State 
University Institutional Animal Care and Use Committee (Animal Care and Use Protocol 
AG-12-5). 
 
Cattle description and initial processing 
An Angus-based commercial cow herd was identified as a potential source to 
supply calves for this experiment. An initial pool of 18 bull calves were selected from a 
single pasture. Eighty days prior to the initiation of the experiment, all bull calves were 
tagged with an individually numbered tag, given an initial vaccination for clostridial 
pathogens (Covexin 8; Merck Animal Health, Summit, NJ), and surgically castrated at 
the ranch of origin. Blood samples were collected and analyzed as described by Burciaga-
Robles et al. (2010) to ensure calves were seronegative to the pathogens to be used in the 
challenge portion of this experiment. On 24 d prior to initiation of the experiment, a 
second blood sample collected and analyzed to confirm steers remained seronegative to 
the pathogens to be used in the challenge portion of this experiment. Ear notches were 
also obtained and tested via immunohistochemistry (IHC) by a commercial diagnostic lab 
to ensure no calves were persistently infected (PI) with BVDV.  
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Eleven days prior to the experiment, calves received a second vaccination for 
clostridial pathogens (Covexin 8; Merck Animal Health, Summit, NJ), were vaccinated 
for viral pathogens excluding BVDV (Inforce; Zoetis, Florham Park, NJ), received a 
vaccine for infectious bovine keratoconjunctivitis (IBK) (Autogenous Bacterin; Newport 
Laboratories, Worthington, MN), and were treated for the control of internal and external 
parasites (Ivermax Plus; Norbrook Laboratories, Lenexa, KS). Calves also received a 
prophylactic dose of tilmicosin phosphate (300 mg per mL) administered at the rate of 
1.5 mL per 45.4 kg of BW (Micotil; Elanco Animal Health, Indianapolis, IN) and a fly 
tag (Corathon; Bayer, Shawnee Mission, KS). After processing, all steers were 
transported 97 km to the Animal Science Equine Center at Oklahoma State University. 
This facility was chosen to prevent exposure of the recently weaned calves to any other 
cattle at the other University research facilities. Calves remained at the Equine Center for 
a 6 d weaning period. 
 
Challenge model and facility management 
Five days prior to initiation the experiment, the steers were gathered and 
transported 6 km to the Nutrition and Physiology Research Center (NPRC) at Oklahoma 
State University. Calves were weighed, and BW in combination with initial antibody 
titers were used to allocate 16 steers to experimental treatments. Calves were then placed 
in metabolic stanchions with headlocks for a 5 d adaptation period. Each stanchion had 
an individual automatic water bowl and each calf was provided with an individual feed 
trough. Calves were placed in metabolic stanchions prior to the experiment to allow for 
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adaption of calves to the stanchions and automatic water bowls. Metabolic stanchions 
were only used during this experiment during the adaptation period (5 d) and the intense 
sampling period (d 0 through d 7).  
After the adaptation period, the experiment was initiated. All time will be 
referenced in relation to the MH challenge as d 0. All calves were randomly assigned 
individual 3.05 × 3.66 m slatted floor pens on d -46. Each pen had access to 2 automatic 
water bowls and each calf was provided with an individual feed bunk. Calves remained in 
these individual pens for the first 42 d of the experiment.  
The BVDV and MH challenge model described by Burciaga-Robles et al. (2010) 
was utilized in this experiment with slight modifications. Pre BVDV challenge samples 
were collected on d -4. After this sampling, all calves were comingled in a common 
pasture for 4 d with an animal previously confirmed as being PI positive with BVDV1b 
via IHC and genotyping as described by Fulton et al. (2006). During this time, all animals 
shared a single common water tank, and were fed together in 3 portable 3 m feed bunks.  
On d 0, calves were gathered and placed in the metabolic stanchions. Pre-MH 
challenge sampling occurred at h 0. Immediately after h 0 sampling, all steers received 10 
mL of a solution containing 6 × 109 CFU of MH serotype 1 that was reconstituted and 
grown prior to the challenge as described by Mosier et al. (1998). The MH was delivered 
via intratracheal bronchoalveolar lavage by a licensed veterinarian as described by 
Dowling et al. (2002), with slight modifications. Briefly, steers were restrained and a 
broncheoalveolar lavage tube (Bivona Medical Technology, Gary, IN) was gently 
inserted into the ventral meatus of a nostril, passed on into the trachea, and positioned 
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within 2 to 3 cm of the tracheal bifurcation. The MH challenge solution was then 
delivered in a way such that the challenge solution would be allowed to enter both lungs. 
No adverse effects of the challenge procedure itself were observed.  
For the next 7 d, calves remained in the stanchions and were monitored several 
times daily. Intensive sampling occurred during this time. After the 7 d intensive 
sampling period, calves were returned to their respective individual 3.05 × 3.66 m slatted 
floor pens for the duration of the experiment. On d 14 and d 28, calves were gathered, 
briefly restrained in a manual squeeze chute, and sampled again. The calves did remain in 
our possession after the experiment was terminated, and an additional sampling occurred 
on d 68. All calves were comingled and received the same diet from d 28 to d 68. 
 
Common diet and feeding  
While on pasture with their dams prior to weaning, cows and calves received no 
mineral supplementation. The only TM calves would have had received would have been 
provided through the milk of their dams or forage consumed on the ranch. Upon arrival to 
the Horse Unit, calves were given ad libitum access to water, Bermuda grass hay, and the 
common receiving ration minus the dry supplement (Table 1). After transportation to the 
NPRC and being placed in stanchions, the Bermuda hay was removed, and the calves 
continued to receive ad libitum access to water and the common receiving ration minus 
the dry supplement. On d -46, a common dry supplement (Table 1) was included in the 
ration. This supplement was formulated to meet or exceed NRC (2000) nutrient 
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requirements except for Cu, Mn, and Zn. The common supplement contained no 
additional Cu, Mn, or Zn from organic or inorganic sources.  
The calves continued to receive ad libitum access to the common receiving ration, 
with supplement now included, and water for the duration of the experiment. Feed was 
delivered twice daily at 0800 h and 1500 h. Bucket feeders were cleaned and orts were 
weighed back weekly. To ensure that the calves still received their respect experimental 
mineral treatments during the 4 d BVDV challenge, calves were gathered each morning 
at 0700 h and sorted into their respective experimental treatments. Each group then 
received 11.3 kg of the common receiving ration and their respective experimental top 
dress. After all 11.3 kg was consumed, all calves were returned to the common pasture 
with the PI animal. Ration samples were collected daily, and dried in a forced air oven for 
48 h at 60ºC to determine dry matter. All daily ration samples were composited 
gravimetrically and analyzed at a commercial laboratory (Servi-Tech Inc., Dodge City, 
KS) for nutrient composition (Table 1). 
 
Experimental mineral treatments 
 Starting on d -46 calves on the MIN experimental treatment received a ground 
corn top dress daily containing 150 mg of Cu, 130 mg of Mn, and 320 mg of Zn in the 
form of Cu methionine, Mn methionine, and Zn methionine, respectively (Mintrex Cu, 
Mn, and Zn; Novus International, Inc., St. Charles, MO). Calves on the CON 
experimental treatment received a top dress daily that only contained ground corn. Top 
dresses were batched daily and weighed out on a gram scale to the nearest 0.01 g. The 
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kitchen mixer was cleaned daily before mixing the CON top dress. The CON top dress 
consisted of 1000 g of ground corn mixed for 5 min and 125 g of the top dress was placed 
in 8 identical plastic color coded containers.  
The mixer was cleaned again prior to making the MIN top dress. The MIN top 
dress consisted of 968 g of ground corn and 32 g of Mintrex mineral (8 g of Mintrex Cu, 
8 g Mintrex Mn, and 16 g Mintrex Zn) on an AF basis. This mixture was mixed for 5 min 
and 125 g of the top dress was placed in 8 identical plastic color coded containers. This 
resulted in 121 g of ground corn with 1 g Mintrex Cu, 1 g of Mintrex Mn, and 2 g of 
Mintrex Zn per MIN container. Top dresses were then delivered to each individual pen or 
stanchion immediately after delivery of the common ration and gently mixed in. All feed 
bunks, pens, stanchions, and containers were color coded to match their respective 
experimental treatment. 
 
Serum collection and preparation  
Serum was required for multiple analyses in this experiment including: antibody 
titers, cytokines, haptoglobin, and hormones. For all serum analyses conducted, whole 
blood was collected via the jugular vein using an 18 gauge needle and serum separator 
tube (Corvac Serum Separator Tube; Tyco Healthcare Group LP, Mansfield, MA) at 
multiple time points throughout the experiment. The whole blood samples were allowed 
to clot for 12 to 24 h at 4°C. After the clotting time, chilled blood samples were 
centrifuged at 2,500 × g for 20 min. Serum was then aliquoted to multiple 2 mL 
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microcentrifuge tubes and immediately frozen at -20°C until further analyses could be 
completed. 
 
Bovine viral diarrhea virus antibodies 
Serum samples from d -70, -3, 0, 3, 7, 14, and 28 were submitted to a research 
laboratory at Oklahoma State University, Department of Veterinary Pathobiology, for 
BVDV serology using a virus neutralization test in Madin-Darby bovine kidney cell 
monolayers in 96-well microtiter plates as described by Fulton et al. (2002a). The virus 
used as challenge virus in the virus neutralization test were CP BVDV1b (TGAC 8HB). 
A 1:4 dilution was the lowest tested, and titers of less than 1:4 were considered negative 
(0). 
Mannheimia haemolytica antibodies 
Serum samples from d -70, -3, 0, 3, 7, 14, and 28 were submitted to a research 
laboratory at Oklahoma State University, Department of Veterinary Pathobiology, to 
determine MH antibodies to whole bacterial cell (WC) and leukotoxin (LKT). The 
procedure utilized a formalin killed MH S1 by an ELISA test as described by Confer et 
al. (1995; 1996). Antibody responses were expressed as nanograms of immunoglobulin 
binding based on a set of IgG standards on each plate. 
 
Hormones 
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Serum samples from d -4, h 0, h 2, h 4, h 6, h 12, h 18, h 24, d 2, d 3, d 4, d 7, d 
14, d 28 relative to the MH challenge were submitted to a research laboratory at New 
Mexico State University for IGF-I analysis. Serum IGF-I values were determined via a 
double-antibody RIA as described by Berrie et al. (1995) with modifications described by 
Camacho et al. (2012). The detection limit for the IGF-I assay was 4 ng/mL. 
Serum samples from d -4, h 0, h 2, h 4, h 6, h 12, h 18, h 24, d 2, d 3, d 4, d 7, d 
14, d 28 relative to the MH challenge were submitted to a research laboratory at New 
Mexico State University for cortisol analysis. Serum cortisol concentrations were 
quantified by solid-phase RIA using components of a commercial kit (Coat-A-Count, 
Siemens Medical Solutions Diagnostics, Los Angeles, CA) with the modifications 
described by Kiyma et al. (2004). 
 
Hematology  
Whole blood was collected via the jugular vein using an 18 gauge needle and 
EDTA tube (Monject EDTA Tube; Tyco Healthcare Group LP, Mansfield, MA) at 
multiple time points throughout the experiment. Whole blood samples that were collected 
on d -4, h 0, h 2, h 4, h 6, h 12, h 18, h 24, d 2, d 3, d 4, d 7, d 14, d 28 relative to the MH 
challenge were used for hematology analysis. The samples were immediately analyzed 
using an automated hematology analyzer (ProCyte Dx Hematology Analyzer, IDEXX 
Laboratories Inc., Westbrook, ME) for multiple blood cell parameters. Response 
variables measured included: erythrocytes, hemoglobin, hematocrit percentage, mean 
corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin 
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concentration, reticulocytes, platelets, leukocytes, neutrophil percentage, lymphocyte 
percentage, monocyte percentage, eosinophil percentage, and basophil percentage. 
 
Blood gas, pH, and metabolites  
Whole blood was collected via the jugular vein using an 18 gauge needle and 
sodium heparin tube (Monject Sodium Heparin Tube; Tyco Healthcare Group LP, 
Mansfield, MA) at multiple time points throughout the experiment. Whole blood samples 
that were collected on d -4, h 0, h 2, h 4, h 6, h 12, h 18, h 24, d 2, d 3, d 4, d 7, d 14, d 28 
relative to the MH challenge were used for blood gas, pH, glucose, and lactate analysis. 
Samples were immediately analyzed using a blood gas analyzer (GEM Premier 3000; 
Instrumentation Laboratory, Lexington, MA). Response variables measured included: 
pH, partial pressure of carbon dioxide, partial pressure of oxygen, sodium, potassium, 
calcium, glucose, lactate, bicarbonate ion, base excess in extracellular fluid (ECF), base 
excess in blood, and oxygen saturation. 
 
Data collection, calculations, and statistical analysis 
Data were analyzed using repeated measures analysis with the GLIMMIX 
procedure of SAS 9.3 (SAS Institute Inc., Cary, NC) with steer serving as the 
experimental unit. Various covariance structures within models were compared. The 
covariance structure that best fit the data in the present experiment was a non-structured 
covariance. In the few instances where model optimization could not be completed, a 
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Toeplitz or banded Toeplitz covariance structure was employed. Sampling time served as 
the repeated measure and P-values are reported for the effect of treatment, time, and the 
interaction of time and treatment. If a time × treatment interaction was present, a slice 
output option was used to determine the time points at which treatments were different. 
 
RESULTS 
Effectiveness of BVDV and MH challenge model 
The immune challenge model described by Burciaga-Robles et al. (2010) was 
validated in this experiment. The BVDV and MH challenges were both proved successful 
via increased antibody titers for BVDV as well as for MH WC and MH LKT. In addition, 
TEMP and CS (data not presented) both significantly increased during the challenge, then 
returned to normal levels. The responses observed to the immune challenge were 
consistent with previous experiments by Burciaga-Robles et al. (2010) and others using 
this challenge model.  
 
Bovine viral diarrhea virus antibodies 
 Serum BVDV 1b antibody titers are shown in Figure 1. Average BVDV 1b 
antibody titers less than 1:4 were considered negative (0) for all calves prior to the 
initiation of the experiment. No change in BVDV 1b titers was detected for any of the 
calves until d 14 and at d 14, no difference existed between experimental treatments. 
However, by d 28, the BVDV 1b antibody titers of calves receiving no additional TM 
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supplementation (CON) had increased at a more rapid rate than calves receiving MIN. 
This resulted in a time × treatment interaction (P ≤ 0.003) being observed for BVDV 1b 
antibody titers.  
 
Mannheimia haemolytica antibodies 
Serum MH WC and LKT antibody titers are presented in Figure 2a and 2b, 
respectively. Average MH WC and LKT antibody titers were near (0) and considered 
negative for all calves prior to the initiation of the experiment. There were no time × 
treatment interactions (P ≥ 0.27) observed for MH WC or MH LKT antibody titers. Time 
was significant (P < 0.0001) for both MH WC and LKT antibody titers. Serum MH WC 
antibody titers increased slightly during the pre-challenge portion of the experiment and 
then remained fairly static until d 3 post MH challenge. This same pattern was observed 
for serum MH LKT antibody titers. Calves on the MIN treatment exhibited greater (P = 
0.02) MH WC antibody titers compared to calves on the CON treatment, while the MH 
LKT antibodies of MIN calves were numerically increased (P = 0.48) compared to CON 
calves. Serum MH WC and LKT antibodies appeared to plateau by d 28 for both 
treatments.  
  
Hormones 
Serum IGF-I concentrations are presented in Figures 3a and 3b. There were no 
time × treatment interactions (P ≥ 0.15) observed for serum IGF-I concentrations during 
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the first 24 h following the MH challenge or over the length of the experiment. Time was 
significant for serum IGF-I concentrations during the first 24 h following the MH 
challenge (P = 0.02) and over the length of the experiment (P < 0.004). Serum IGF-I 
decreased until 2 d post MH challenge and then slowly increased for the duration of the 
experiment. Mineral supplementation did not affect (P ≥ 0.46) IGF-I concentrations. 
Serum cortisol concentrations are presented in Figures 4a and 4b. There were no 
time × treatment interactions (P ≥ 0.28) observed for serum cortisol concentrations 
during the first 24 h following the MH challenge or over the length of the experiment. 
Time was significant for serum cortisol concentrations during the first 24 h following the 
MH challenge (P = 0.0002) and over the length of the experiment (P = 0.01). Serum 
cortisol decreased until 1 d post MH challenge, was relatively constant from d 1 to d 4, 
and increased again during the latter part of the experiment. During the first 24 h 
following the MH challenge, CON calves tended (P = 0.09) to have elevated serum 
cortisol concentrations compared to MIN calves. Mineral supplementation did not affect 
(P ≥ 0.31) cortisol concentrations over the length of the experiment. 
 
Hematology 
Hematology analysis is presented in Figures 5 through 18. Response variables 
reported include: erythrocytes (Figures 5a and 5b), hemoglobin (Figures 6a and 6b), 
hematocrit percentage (Figures 7a and 7b), mean corpuscular volume (Figures 8a and 
8b), mean corpuscular hemoglobin (Figures 9a and 9b), mean corpuscular hemoglobin 
concentration (Figures 10a and 10b), reticulocytes (Figures 11a and 11b), platelets 
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(Figures 12a and 12b), leukocytes (Figures 13a and 13b), neutrophil percentage (Figures 
14a and 14b), lymphocyte percentage (Figures 15a and 15b), monocyte percentage 
(Figures 16a and 16b), eosinophil percentage (Figures 17a and 17b), and basophil 
percentage (Figures 18a and 18b). Significant time × treatment interactions (P ≤ 0.05) 
were observed for erythrocytes, hemoglobin, hematocrit, and eosinophil percentage 
during the first 24 h following the MH challenge. There was a tendency (P ≤ 0.10) for a 
time × treatment interaction observed for mean corpuscular volume and mean 
corpuscular hemoglobin concentration, over the length of the experiment. 
Time significantly impacted multiple hematology parameters. Time was 
significant (P ≤ 0.05) for erythrocytes, hemoglobin, hematocrit percentage, mean 
corpuscular volume, mean corpuscular hemoglobin concentration, reticulocytes, 
leukocytes, eosinophil percentage, and basophil percentage during the first 24 h 
following the MH challenge. There was also a tendency (P ≤ 0.10) for time to impact 
lymphocyte percentage during the first 24 h following the MH challenge. Time was 
significant (P ≤ 0.05) for erythrocytes, hemoglobin, hematocrit percentage, mean 
corpuscular volume, mean corpuscular hemoglobin concentration, reticulocytes, platelets, 
leukocytes, monocyte percentage, and eosinophil percentage, over the length of the 
experiment. There was also a tendency (P ≤ 0.10) for time to impact mean corpuscular 
hemoglobin, lymphocyte percentage, and basophil percentage over the length of the 
experiment. 
When looking at the general trends for hematology over the length of the 
experiment, both mineral treatments were similarly affected and the results are quite 
variable. However, erythrocytes, hemoglobin, hematocrit percentage, mean corpuscular 
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volume all behaved in a similar fashion. In relation to the MH challenge, these variables 
all decreased from d -4 to d 1, remained fairly constant from d 1 to d 4, and then 
increased from d 4 through the end of the experiment. Mean corpuscular hemoglobin 
concentration followed the exact opposite trend by increasing, leveling off, and then 
decreasing over essentially the same intervals. Reticulocytes were highly variable over 
time, and platelets increased with time. Total leukocytes increased until 18h post 
challenge, decreased until d 4, and then increased again toward the end of the experiment. 
The percentage of lymphocytes decreased until d 1 and then slowly increased prior to 
leveling off later in the experiment. The percentage of monocytes remained relatively 
steady until d 1, increased to d 3 or d 4 and then decreased toward the end of the 
experiment. Eosinophil percentages exhibited multiple peaks, first decreasing until d 1, 
then increasing to d 3, decreasing again until d 7, and finally increasing until the end of 
the experiment. Basophil percentages were effected by time, but were highly variable.  
Mineral supplementation did not affect many of the hematology variables 
examined. However, calves receiving MIN demonstrated greater (P = 0.04) SD of 
platelet distribution widths compared to CON calves during the first 24 h following the 
MH challenge. For the length of the experiment, MIN calves tended (P = 0.07) to have 
increased platelet large cell ratios than CON calves. Calves receiving MIN had an 
increased (P = 0.01) percentage of lymphocytes, while calves receiving CON had an 
increased (P = 0.03) percentage of neutrophils and tended (P = 0.10) to have greater total 
neutrophil numbers. 
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Blood gas, pH, and metabolites 
 Blood gas variables, pH values, and blood metabolites are presented in Figures 19 
through 30. Response variables reported include: pH (Figures 19a and 19b), partial 
pressure of carbon dioxide (Figures 20a and 20b), partial pressure of oxygen (Figures 21a 
and 21b), sodium (Figures 22a and 22b), potassium (Figures 23a and 23b), calcium 
(Figures 24a and 24b), glucose (Figures 25a and 25b), lactate (Figures 26a and 26b), 
bicarbonate ion (Figures 27a and 27b), base excess in ECF (Figures 28a and 28b), base 
excess in blood (Figures 29a and 29b), and oxygen saturation (Figures 30a and 30b). 
There were no time × treatment interactions (P ≥ 0.11) observed for blood gas variables, 
pH values, or blood metabolites during the first 24 h following the MH challenge or over 
the length of the experiment. Time significantly impacted multiple blood gas parameters. 
Time was significant (P ≤ 0.05) for blood pH, partial pressure of oxygen, sodium, 
glucose, lactate, bicarbonate, base excess in ECF, and base excess in blood during the 
first 24 h following the MH challenge. There was also a tendency (P = 0.07) for time to 
impact partial pressure of carbon dioxide during the first 24 h following the MH 
challenge. Time was significant (P ≤ 0.05) for partial pressure of carbon dioxide, partial 
pressure of oxygen, calcium, glucose, lactate, bicarbonate, base excess in ECF, base 
excess in blood, and oxygen saturation over the length of the experiment. There was also 
a tendency (P ≤ 0.08) for time to impact sodium and potassium over the length of the 
experiment.  
When looking at the general trends for blood gas variables, pH, and blood 
metabolites over the length of the experiment, the results are also quite variable. Partial 
pressure of carbon dioxide changed over time, but only fluctuated approximately 5 
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mm/Hg within treatment. Partial pressure of oxygen increased until d 1, decreased until d 
7, and then increased toward the end of the experiment. Calcium within the blood 
increased until d 3, and then decreased for the duration of the experiment. Sodium 
followed an opposite pattern, decreasing until d 4, then increasing for the duration of the 
experiment. Potassium slowly increased through d 14 and then had decreased by d 28. 
Glucose and lactate both initially decreased, leveled off, and then increased until the end 
of the experiment. Bicarbonate and both measurements of base excess were variable, but 
increased approximately to d 0, leveled off for a few days, and then increased to the end 
of the experiment. The oxygen saturation of blood increased until d 1, decreased slightly 
until d 7, and then increased toward the end of the experiment. Mineral supplementation 
did not affect many blood gas parameters. Calves receiving MIN tended (P ≤ 0.10) to 
have greater base excess in ECF and base excess in blood compared to CON calves over 
the length of the experiment. 
 
DISCUSSION 
The role of TM including Cu, Mn, and Zn in immune function has received 
attention from researchers for many years. It is well established that certain TM are 
essential for overall performance, health, and immune function. In addition to general 
health and immune function mechanisms, the supplementation of TM has been 
demonstrated to alter specific immune function measurements and reduce morbidity 
associated with BRD in some cases (Galyean et al., 1999). However, other experiments 
have demonstrated no improvements in performance or health variables from the 
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supplementation of TM. Limited published research justifying the supplementation of Cu, 
Mn, or Zn at levels greater than published requirements has produced inconsistent results. 
However, the role of TM in immune function, combined with the unknown TM status of 
newly received calves and expectation of depressed DMI early in the receiving period 
may serve as a possible explanation for increased TM inclusion even though justification 
of the practice is not necessarily supported by the published literature.   
The pathogenesis of BRD typically involves compromised respiratory immune 
mechanisms and a primary infection with one or more respiratory viruses. The viral 
infection and the calf's impaired immune response to the virus further compromise the 
immune system and allow for the colonization of lung tissues by bacteria (Hodgins et al., 
2002). Most of the pathogens associated with increased BRD incidence are well 
documented within the literature. However, many of these pathogens are also frequently 
isolated from the respiratory tract of clinically healthy cattle making the analysis of BRD 
in field studies incredibly difficult. The challenge employed in this experiment was the 
same model described by Burciaga-Robles et al. (2010) with slight modifications. This 
challenge model was selected due to the ability of this model to successfully simulate 
natural BRD pathogenesis. Additionally, this model is able to induce a controlled, 
simulated BRD event, while simultaneously allowing for accurate determination of 
antibody responses due to the challenge with known viral and bacterial pathogens. 
The decision to use the specific pathogens in this model are justified by the 
published literature and previous experiences. It has been reported that PI BVDV calves 
are a principal source of disease transmission in feedlots (O’Connor et al., 2005). In 
multiple experiments, BVDV 1b has been the predominant BVDV subtype isolated from 
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calves diagnosed with BRD (Fulton et al. 2002a; Fulton et al. 2002b). With great 
repeatability, the most common bacterial pathogen isolated from the respiratory tract of 
calves treated for BRD is MH serotype 1, and this serotype has been shown to be 
responsible for characteristic BRD infection in calves (Hodgins and Shewen, 2004; 
Booker et al., 2008; Griffin et al., 2010).  
The immune challenge model was validated in this experiment. The BVDV and 
MH challenges were both proved successful via increased antibody titers for BVDV as 
well as for MH WC and MH LKT. In addition, TEMP and CS both significantly 
increased during the immune challenge, then returned to normal levels. In the current 
experiment, calves had average TEMPs of 40.3°C by h 6 and had average CS of 1 by h 
18. The CS observed for calves in this experiment would have dictated that the calves 
would have been pulled for exhibiting clinical signs of BRD and evaluated for 
subsequent antimicrobial treatment under the standard operating protocols in place at our 
facility. The TEMP observed in these calves would have dictated that the calves would 
have received an antimicrobial treatment for clinical BRD under the same standard 
operating protocols. At our facility, a calf can meet treatment criteria for clinical BRD 
and receive an antimicrobial via 2 standard treatment protocols. The first being that an 
animal can be pulled with a CS of 1 or 2 and had a TEMP of 40°C or greater. The second 
being that an animal can be pulled with a severe CS (CS = 3 or 4) regardless of TEMP. 
The increased TEMP and CS of calves challenged in combination with increased BVDV 
antibody titers and MH WC and LKT antibody titers validated the immune challenge in 
the current experiment. The increases observed for these response variables would have 
been similar to those observed by Burciaga-Robles et al. (2010) using a similar challenge 
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model. The objective of this experiment was to determine the influence of copper (Cu), 
manganese (Mn), and zinc (Zn) supplementation on serum BVDV and MH antibody 
titers and multiple immune response parameters of calves following a BVDV and MH 
immune challenge. 
In the current experiment, average BVDV 1b antibody titers were less than 1:4 
and were considered negative (0) for all calves prior to the initiation of the experiment. 
Even after exposure to the PI BVDV animal on d -4, no change in BVDV 1b titers was 
detected for any of the calves until d 14 (18 d after BVDV exposure). This time interval 
was longer than that reported by Burciaga-Robles et al. (2010). In that experiment, an 
increase in BVDV 1b antibody titers was observed on d 7 (10 d after BVDV exposure). 
In addition, Burciaga-Robles et al. (2010) observed exponentially greater BVDV 1b titers 
on d 14 and d 28 compared to those observed on d 14 and d 28 in the present experiment. 
The reasons for the longer delay lower levels observed for BVDV antibody titer response 
in the present experiment, could result from the calves in the current experiment being 
more naïve. It could also be a result of other experimental conditions, or a less severe 
challenge in the current experiment.  
Arthington and Havenga (2012) did not challenge calves directly, but examined 
the effects of injectable TM on the humoral immune response to multivalent vaccine 
administration in seronegative calves. The authors found that neutralizing BVDV 
antibody titers increased following vaccination and were greater than baseline antibody 
titers on d 14. In addition, the most rapid increase in BVDV antibody titers was observed 
from d 14 through d 30. These results would closely resemble those of the current 
experiment. Kegley et al. (2012) found similar results when investigating supplemental 
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Cu, Mn, Zn, and cobalt (Co) fed in organic or inorganic from to stressed calves. When 
only observing naïve calves, the authors found an initial increase in BVDV antibody 
titers by d 14 and then a rapid increase in BVDV antibody titers until d 42. 
In the present experiment, no differences existed among experimental treatments 
until d 28. By d 28, the BVDV 1b antibody titers of CON calves had increased at a more 
rapid rate than calves receiving MIN. This resulted in a time × treatment interaction being 
observed for BVDV 1b antibody titers. This rapid increase in the BVDV 1b antibody 
titers of CON calves resulted in CON calves having greater BVDV 1b antibody titers on 
d 28 and a tendency for CON calves to have increased BVDV 1b antibody titers for the 
duration of the experiment. These results unfortunately cannot be compared to the 
findings of Arthington and Havenga (2012) who only reported pooled treatment means 
for BVDV antibody titers. In addition the results in the present experiment could not be 
compared to the results from Kegley et al. (2012) who did not utilize a non-supplemented 
control group.  
Stabel et al. (1993) challenged Cu deficient and Cu supplemented calves with 
Infectious Bovine Rhinotracheitis (IBR) and MH (formally known as Pasteurella 
hemolytica). While the authors used a different viral challenge than we used in the 
current experiment, they noticed similar responses in viral antibody titers for calves that 
received adequate dietary Cu and calves that were fed a Cu deficient diet. The authors 
found no difference in serum IBR antibody titers from d 0 to d 7 among Cu supplemented 
or Cu deficient calves. However, those calves that were Cu deficient had significantly 
higher IBR antibody titers by d 10 and numerically higher IBR antibody titers on d 14 
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and d 21 compared to Cu supplemented calves. Time significantly impacted BVDV 1b 
antibody titers in the present experiment and all other experiments discussed.  
In the current experiment, average MH WC and LKT antibody titers were near (0) 
and considered negative for all calves prior to the experiment initiation. In addition, there 
were no time × treatment interactions observed for either MH WC or MH LKT antibody 
titers. Time was significant for both MH WC and LKT antibody titers. Serum MH WC 
and LKT antibody titers increased slightly during the pre-challenge portion of the 
experiment and then remained fairly static until d 3 post MH challenge. This response 
would be consistent with that found by Burciaga-Robles et al. (2010) who also found no 
significant increase in MH WC or LKT antibody titers from d -3 to d 3 post MH 
challenge. However in contrast to what was observed for BVDV 1b antibody titers, the 
calves in the current experiment exhibited greater MH WC and LKT antibody titers on d 
7, d 14, and d 28 compared to the calves challenged with MH in the experiment by 
Burciaga-Robles et al. (2010). 
The results in the present experiment for MH WC and LKT antibody titers would 
also be supported by those found by Confer et al. (1997). The authors found that 
vaccination with 50 or 100 µg of LKT or a challenge with live MH stimulated significant 
increases in LKT neutralizing antibody titers between d 7 and d 14. The vaccination with 
100 µg of LKT or a challenge with live MH stimulated also resulted in significant 
increases in MH WC antibody titers to by d 14. For calves challenged with MH, the 
antibody responses remained significantly greater than the d 0 values for the duration of 
the experiment. 
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Calves on the MIN treatment exhibited greater MH WC antibody titers compared 
to CON calves. A similar pattern was also observed in the MH LKT antibodies of calves, 
however there was no statistical difference among experimental mineral treatments. 
Serum MH WC and LKT antibodies appeared to plateau by d 28 for both treatments. 
Stabel et al. (1993) noticed similar responses in MH antibody titers for calves that 
received adequate dietary Cu and calves that were fed a Cu deficient diet. The authors 
noted that measurable increases in MH antibody titers were observed by 14 d after 
inoculation. By 23 d post MH challenge, Cu supplemented calves had numerically higher 
MH antibody titers than Cu deficient calves (85.1 versus 37.3, respectively). The authors 
noted that there was a large amount of variation within the Cu supplemented group, 
which caused them to not detect a significant difference in MH antibody titers among the 
treatments. 
Burciaga-Robles et al. (2010) reported a BVDV × MH × time interaction for MH 
LKT antibodies and suggested that calves exposed to PI BVDV steers had decreased 
production of MH LKT antibodies. These results are similar to those reported by Zhang 
et al. (1997) in which calves that were challenged with bovine immunodeficiency virus 
(BIV) had decreased and delayed BVDV antibody production after vaccination. In 
addition, calves in that experiment challenged with BIV also had decreased BHV1 
antibody production after inoculation with the virus compared to calves that were not 
previously challenged with BIV. These data would suggest that the exposure of healthy 
calves to an initial viral challenge results in a suppression of the immune system thus 
predisposing calves to a secondary infection due to decreased antibody production toward 
the secondary pathogen. In addition, these data could explain the antibody titer 
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differences between the two experimental treatments in the current experiment. The 
decrease in MH WC antibody titers observed in the CON calves in the current experiment 
is likely the result of increased BVDV antibody titers in the same calves indicating a 
more severe immune suppression resulting from the BVDV challenge in those calves.  
In the present experiment there were no time × treatment interactions observed for 
serum IGF-I or cortisol concentrations and mineral supplementation did not affect serum 
concentrations of either hormone over the length of the experiment. However, CON 
calves had elevated serum cortisol concentrations at h 12 and tended to have elevated 
serum cortisol concentrations at h 18. This resulted in CON calves tending to have 
elevated serum cortisol concentrations compared to MIN calves during the first 24 h 
following the MH challenge. Time affected both hormones during the first 24 h following 
the MH challenge and over the course of the experiment.  
Serum IGF-I decreased rapidly from pre BVDV challenge sampling until post 
MH challenge then increased slowly from 2 d post MH challenge until the end of the 
experiment. Numerous studies have demonstrated reduced IGF-I concentrations 
independent of animal DMI during an immune challenge (Elsasser et al., 1987; Elsasser, 
1988; Spurlock, 1997). These reduced concentrations of blood IGF-I associated with 
immune challenge events probably are the result of decreased IGF-I synthesis in multiple 
tissues (Spurlock, 1997). An endotoxin challenge administered to rats by Fan et al. (1994) 
caused a decrease in plasma, liver, skeletal muscle, and pituitary IGF-I, and liver and 
skeletal muscle IGF-I compared to control animals. Spurlock (1997) stated that the 
reduction of circulating IGF-I seemed to be an important part of necessary bodily 
function to support an immune response. Elsasser et al. (2008) reported decreased plasma 
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IGF-I concentrations for 24 h following a LPS challenge. The authors stated that the 
reduction in plasma IGF-I likely reflects a mechanism to spare nutrients necessary for 
immune defense and that the metabolic functions of IGF-I must be redirected. Elsasser et 
al. (2008) stated that this was not only true for IGF-I message transcription and tissue and 
plasma IGF-I concentrations but also through the redistribution IGF-I to tissues affected 
by the pro-inflammatory response. 
Serum cortisol also decreased rapidly from pre BVDV challenge until post MH 
challenge. Serum cortisol increased slightly at d 7 and was then highly elevated on d 14 
and d 28. Cortisol response to an immune challenge have proven somewhat inconsistent, 
and are potential influenced by multiple variables unrelated to the actual immune 
challenge. Arthington et al. (1997) found that supplemental chromium and a bovine 
herpesvirus-1 (BHV1) immune challenge did not influence cortisol levels of calves. In 
another chromium supplementation experiment by Burdick et al. (2011), a cortisol 
response was detected in calves subjected to a LPS challenge. Peak cortisol 
concentrations were measured at 1 h post challenge and returned to baseline levels within 
4 h. It should be noted that this was an acute LPS challenge, where 0.5 mg/kg body 
weight of Escherichia coli O111:B4 was administered intravenously.  
The highest measurements for serum cortisol in the present experiment coincided 
with sampling periods where calves were gathered, handled and briefly restrained in a 
manual squeeze chute. When calves were maintained in stanchions during the intensive 
sampling portion of the experiment (d 0 through d 7) serum cortisol levels remained 
relatively constant after the first 12 h. There was a slight increase in serum cortisol from 
h 0 until h 6, but it is impossible to determine if that slight increase is due to the immune 
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challenge, or initial brief restraint and being placed in the stanchions. When the data are 
examined closely, it would seem that the spikes in cortisol observed in the present 
experiment are related to periods of animal handling and restraint rather than to the 
BVDV and MH immune challenge. Experiments by Lay et al. (1992), Wohlt et al. 
(1994), and Apple et al. (2005) have all demonstrated similar increases cortisol responses 
to physical restraint and handling. 
With the multitude of hematology variables examined in the current experiment, 
multiple time × treatment interactions and tendencies were observed. Time × treatment 
interactions existed for erythrocytes, hemoglobin, hematocrit, the SD of platelet 
distribution width, eosinophils, and eosinophil percentage during the first 24 h following 
the MH challenge and for the SD of erythrocyte distribution width over the duration of 
the experiment. There was also a tendency for a time × treatment interaction observed for 
the CV of erythrocyte distribution width during the first 24 h following the MH challenge 
and for mean corpuscular volume and mean corpuscular hemoglobin concentration over 
the length of the experiment.  
The effect of the challenge was significant with multiple hematology parameters 
being significantly impacted by time. This was true both for the 24 h period following the 
MH challenge and for the duration of the experiment. These results were similar to those 
found by Burciaga-Robles et al. (2010). The authors in that experiment found multiple 
hematology parameters that were affected by either the exposure to PI animals, the MH 
challenge, or both. Burciaga-Robles et al. (2010) noticed that haptoglobin concentrations 
were increased for steers challenged with MH from h 18 to h 96 following the MH 
challenge. Interestingly, Burciaga-Robles et al. (2010) found that the exposure of steers 
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to a PI BVDV animal resulted in less total leukocytes, while the MH challenge resulted in 
greater total leukocytes. Neutrophils were also increased in steers challenged with MH. 
The exposure of calves to both a PI animal and the MH challenge resulted in decreased 
lymphocytes. Similar to what was observed with total leukocytes, the authors found that 
PI BVDV exposure resulted in decreased eosinophils while the MH challenge resulted in 
increased eosinophils. Basophils followed the same pattern with PI exposure reducing 
basophil numbers while a challenge with MH increased basophil counts. Hematocrits 
tended to be decreased and hemoglobin was decreased for steers challenged with MH in 
their experiment. Mean corpuscular volume and mean corpuscular hemoglobin 
concentration were reduced for steers challenged with MH. Total erythrocytes were also 
reduced for steers challenged with MH. 
Other researchers have demonstrated the effects of an immune challenge of 
various hematology parameters or demonstrated differences in hematology variables for 
sick versus healthy calves. Martin and Lumsden (1987) sampled calves entering 
Canadian feedlots and monitored them for subsequent BRD incidence. The hematology 
values reported in this experiment would also be similar to those found in the current 
experiment. The authors found that those calves subsequently treated for BRD had 
significantly lower hematocrits, fewer platelets, and more band cells at arrival compared 
to calves that did not get sick.  
When comparing our hematology results to standard reference ranges for reported 
for cattle, most erythrocyte parameters fell within normal ranges (Radostits et al., 2000; 
Merck, 2012). The one exception would be mean corpuscular volume, which was slightly 
lower at multiple time points than the reference values reported. However, the mean 
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corpuscular volumes in the current experiment would be similar to those reported by 
Burciaga-Robles et al. (2010) and Martin and Lumsden (1987). Most leukocyte variables 
in the current experiment would also fall within normal reference ranges if averaged 
across all sampling times. However, multiple leukocyte variables peaked outside the 
standard reference ranges (Radostits et al., 2000; and Merck, 2012). 
Total peak leukocytes (CON = 11.7 × 103/µL; MIN = 13.6 × 103/µL) and 
lymphocytes (CON = 7.12 × 103/µL; MIN = 9.32 × 103/µL) both occurred at 18 h post 
MH challenge. Peak neutrophils (CON = 6.13 × 103/µL; MIN = 5.61 × 103/µL) occurred 
slightly later at 24 h post MH challenge. Monocytes were highly variable and exhibited 
multiple peaks thought the experiment. While they occurred on different days, the 
maximum monocyte values observed for CON and MIN calves were 1.17 × 103/µL and 
1.10 × 103/µL, respectively. All of these peak values for leukocytes, lymphocytes, 
neutrophils, and monocytes exceed the standard reference ranges for cattle. The values 
for lymphocytes also exceed those reported by Burciaga-Robles et al. (2010). Eosinophils 
and Basophils both were within the same standard reference ranges for cattle throughout 
the experiment. 
Mineral supplementation only affected limited hematology variables examined. 
Calves receiving MIN demonstrated greater SD of platelet distribution widths during the 
first 24 h following the MH challenge and tended to have increased platelet large cell 
ratios for the duration of the experiment compared to CON calves (data not shown). 
Interestingly, while total leukocytes were not different among the TM treatments, there 
were some differences in specific leukocyte percentages. Calves receiving MIN had an 
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increased percentage of lymphocytes, while calves receiving CON had an increased 
percentage of neutrophils. 
The increased neutrophil percentages observed in the CON calves in the current 
experiment are in conflict with those commonly found in both rats and humans. 
Typically, circulating neutrophils are reduced in the blood of humans or rats in cases of 
Cu deficiency (Percival, 1998). In addition to being reduced in number, the ability of 
neutrophils to generate superoxide anion and kill ingested bacteria is also decreased in 
cases of even marginal Cu deficiency (Percival, 1998). Boyne and Arthur (1986) and Xin 
et al. (1991) have reported similar decreases in neutrophil function in cattle where Cu 
deficient diets were fed. In contrast, Arthington et al. (1995) found that Cu depletion or 
repletion did not affect neutrophil function in beef heifers. We did not examine neutrophil 
function the current experiment. 
The decreased lymphocyte percentages observed in the non-supplemented calves 
in our experiment would be supported by previous research. Multiple researchers have 
demonstrated that a Cu deficiency is associated with reduced lymphocyte counts. Blakley 
and Hamilton (1987), Koller et al. (1987), and Bala et al. (1991) demonstrated that a 
lower Cu levels are associated with a reduced T lymphocytes in rodents. Cerone et al. 
(1998) found that the number of B lymphocytes was significantly decreased by about 
40% in the Cu deficient calves. However, Cerone et al. (1998) reported only a 7% 
reduction in T lymphocytes in Cu deficient calves. Total lymphocytes were reduced in 
the Cu deficient calves in that experiment, but the difference was not statistically 
significant. 
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In the current experiment, there were no time × treatment interactions observed 
for blood gas variables, pH values, or blood metabolites during the first 24 h following 
the MH challenge or over the length of the experiment. Similar to what was observed 
with the hematology variables, the effect of the challenge was significant and time 
impacted multiple blood gas variables, pH values, and blood metabolites for the 24 h 
period following the MH challenge and for the duration of the experiment. These results 
were also similar to those found by Burciaga-Robles et al. (2010). The authors in that 
experiment found multiple blood gas variables, pH values, and blood metabolites 
parameters that were affected by either the exposure to PI animals, the MH challenge, or 
both. The concentration of certain metabolites, namely glucose, and lactate were higher 
in the present experiment when compared to the results reported by Burciaga-Robles et 
al. (2010).  
In the current experiment, Ca slowly increased until 72 h following the MH 
challenge, then slowly decreased for the remainder of the experiment returning to 
baseline levels by d 14. These results are similar to those reported by Orr et al. (1990). 
The authors evaluated the effects of BRD and IBR on serum Ca levels of calves. In that 
experiment, serum Ca increased for the first 4 d following the IBR challenge, then 
decreased prior to returning to baseline levels for the remainder of the experiment. Orr et 
al. (1990) stated that the increases in serum Ca were not due to a decrease in DMI, and 
that they must be a result of market-transit stress and BRD or the IBR infection. In the 
current experiment, glucose and lactate both sharply decreased early in the challenge 
period, leveled out during the first wk after the MH challenge, and then increased through 
the end of the experiment.  
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Stress associated with transportation and disease has been shown to impact blood 
metabolite concentrations of calves (Galyean et al., 1981; Montgomery et al., 2009). 
Mitchell et al. (1988) reported increased plasma lactate concentrations for cattle that were 
handled and subjected to transport stress compared to cattle that were not handled and 
transported. Montgomery et al. (2009) took samples at the time of initial processing and 
then monitored heifers for the incidence of BRD. The authors observed a linear decrease 
in both plasma glucose and lactate concentrations as the number of BRD treatments 
increased. The authors attributed the decrease in plasma glucose concentrations for those 
heifers subsequently treated for BRD to a possible disease challenge prior to processing. 
Steiger et al. (1999) and Kushibik et al. (2000) both observed biphasic responses in 
plasma glucose in calves infused bacterial lipopolysaccharides or injected recombinant 
tumor necrosis factor-α (TNF-α), respectively. These data would indicate that an immune 
challenge causes an initial period of hyperglycemia followed by a subsequent period of 
hypoglycemia and may explain some of the changes in glucose concentrations observed 
in the steers in the present experiment.  
It should be noted that these studies are observing glucose concentrations at a 
single time point or over a duration of a few hours, where we observed glucose 
concentrations across larger intervals of time. Glucose concentrations are highly variable 
and fluctuate rapidly with metabolism and after biological events. We attempted to 
control for as much variation as possible for all blood variables and metabolites in the 
current experiment by maintaining a tight sampling schedule. Samples on d -4 and d 28 
would have been taken over a window of several hours as calves were biopsied on those 
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days as well. However, sampling at all other time points for the daily values occurred at 
0700 h and would have been completed for all claves within a 15 to 30 min span of time.  
It should also be noted that while the challenge did effect multiple blood gas 
variables, pH values, and blood metabolites, it did not necessarily cause them to be 
abnormal. When comparing our results to standard reference ranges for reported for 
cattle, most blood gas variables, pH values, and blood metabolites fell completely within 
normal ranges (Gokce et al., 2004; Cornell, 2012). Mineral supplementation had a 
minimal affect blood gas parameters and blood metabolites. Calves receiving MIN tended 
to have greater base excess in ECF and base excess in blood compared to CON calves 
over the length of the experiment. These differences are likely the result of numerical 
increases in bicarbonate at the beginning and end of the challenge period for calves on 
the MIN treatment.  
 
Conclusions 
The supplementation of TM has been shown to alter immune function in some 
experiments, however, the effects on specific immune responses in cattle have been 
somewhat minimal and highly variable except in cases of extreme TM deficiency. The 
BVDV and MH immune challenge employed in this experiment impacted antibody titers, 
and multiple hematology, blood gas, and blood metabolite variables. However, most of 
the hematology, blood gas, and blood metabolite variables measured remained within 
normal ranges, so the clinical relevance of most of these changes is likely minimal except 
as validation of a successful immune challenge. The supplementation of Cu, Mn, and Zn 
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has the potential to impact serum antibody titers and leukocyte populations in calves fed a 
Cu deficient diet and experiencing a controlled short term immune challenge. These 
results would serve as evidence of an important role for TM, especially Cu, in the normal 
immune function of calves. 
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Table 6-1. Composition of common receiving diet1 
Ingredient (%)1  
Prairie hay  35.0 
Dry-rolled corn  28.0 
Wet corn gluten feed2  15.0 
Dried distillers grains plus solubles  15.0 
Dry supplement B-2783  3.5 
Liquid supplement4  3.5 
Nutrient Composition1,5   
NEm, Mcal/kg  1.62 
NEg, Mcal/kg  1.03 
TDN, %  69.83 
Crude protein, %  16.20 
Crude fat, %  3.13 
NDF, %  44.47 
ADF, %  23.00 
Calcium, %  0.80 
Phosphorus, %  0.51 
Magnesium, %  0.26 
Potassium, %  1.03 
Sulfur, %  0.30 
Copper, mg/kg  6.00 
Manganese, mg/kg  50.33 
Zinc, mg/kg  47.33 
Iron, mg/kg  614.00 
1All ingredient and nutrient values are presented on a 
DM basis. 
2Sweet Bran® (Cargill; Dalhart, Texas).  
3Dry supplement B-278 was formulated to contain: 
38.123% ground corn, 34.705% limestone, 23.477% 
wheat midds, 2.571% salt, 0.224% vitamin A 
(30,000 IU/g), 0.134% vitamin E (500 IU/g), 0.002% 
vitamin D (500,000 IU/g), 0.002% EDDI, 0.496% 
Rumensin 90 (Elanco Animal Health; Indianapolis, 
IN), and 0.266% Tylan 40 (Elanco Animal Health; 
Indianapolis, IN) on a DM basis. 
4Synergy 19-14 (Westway Feed Products; New 
Orleans, LA). 
5Feed samples were analyzed for nutrient 
composition by an independent laboratory (Servi-
Tech Laboratories; Dodge City, KS).
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Figures 
Figure 6-1. Serum bovine viral diarrhea virus (BVDV) type 1b neutralization antibody 
titers of calves following exposure to BVDV 1b and subsequent Mannheimia 
haemolytica (MH) infection. Treatment tended to be significant (P = 0.07) and time was 
significant (P < 0.0001). Values plotted represent least squares means ± SE of the mean, 
calculated for 8 animals per experimental group. There was a time × treatment interaction 
(P < 0.003). A slice output option of SAS was used to perform mean separations within 
time points. Means with different superscripts (a,b) differ (P ≤ 0.05).  
Figure 6-2a. Serum Mannheimia haemolytica (MH) whole cell (WC) antibody titers of 
calves following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
MH infection. There was no time × treatment interaction (P = 0.48). Treatment (P = 0.02) 
and time (P < 0.0001) effects were significant. Values plotted represent least squares 
means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-2b. Serum Mannheimia haemolytica (MH) leukotoxin (LKT) antibody titers of 
calves following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
MH infection. There was no time × treatment interaction (P = 0.27) or treatment effect (P 
= 0.48). However, time was significant (P < 0.0001). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-3a. Serum IGF-I concentrations of calves during the first 24 h following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.43) or 
treatment effect (P = 0.46). However, time was significant (P = 0.02). Values plotted 
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represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-3b. Serum IGF-I concentrations of calves during the first 28 d following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.15) or 
treatment effect (P = 0.99). However, time was significant (P < 0.004). Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-4a. Serum cortisol concentrations of calves during the first 24 h following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.28). 
Treatment tended to be significant (P = 0.09) and time was significant (P = 0.0002). 
Values plotted represent least squares means ± SE of the mean, calculated for 8 animals 
per experimental group.  
Figure 6-4b. Serum cortisol concentrations of calves during the first 28 d following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.87) or 
treatment effect (P = 0.31). However, time was significant (P = 0.01). Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-5a. Total erythrocyte counts of calves during the first 24 h following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
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(MH) infection. Treatment was not significant (P = 0.49). However, time was significant 
(P < 0.008). Values plotted represent least squares means ± SE of the mean, calculated 
for 8 animals per experimental group. There was a time × treatment interaction (P = 
0.03). A slice output option of SAS was used to perform mean separations within time 
points. Means with different superscripts (a,b) differ (P ≤ 0.05). 
Figure 6-5b. Total erythrocyte counts of calves during the first 28 d following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.64) or treatment effect 
(P = 0.30). However, time was significant (P < 0.0001). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-6a. Hemoglobin concentrations of calves during the first 24 h following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. Treatment was not significant (P = 0.54). However, time 
was significant (P < 0.007). Values plotted represent least squares means ± SE of the 
mean, calculated for 8 animals per experimental group. There was a time × treatment 
interaction (P = 0.05). A slice output option of SAS was used to perform mean 
separations within time points. Means with different superscripts (a,b) differ (P ≤ 0.05). 
Figure 6-6b. Hemoglobin concentrations of calves during the first 28 d following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.48) or 
treatment effect (P = 0.40). However, time was significant (P = 0.0004). Values plotted 
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represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-7a. Hematocrit percentages of calves during the first 24 h following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. Treatment was not significant (P = 0.60). However, time was significant 
(P < 0.006). Values plotted represent least squares means ± SE of the mean, calculated 
for 8 animals per experimental group. There was a time × treatment interaction (P = 
0.04). A slice output option of SAS was used to perform mean separations within time 
points. Means with different superscripts (a,b) differ (P ≤ 0.05). 
Figure 6-7b. Hematocrit percentages of calves during the first 28 d following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.56) or treatment effect 
(P = 0.44). However, time was significant (P = 0.0004). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-8a. Mean corpuscular volumes of calves during the first 24 h following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.17) or 
treatment effect (P = 0.84). However, time was significant (P = 0.0009). Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-8b. Mean corpuscular volumes of calves during the first 28 d following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
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haemolytica (MH) infection. Treatment was not significant (P = 0.85). However, time 
was significant (P < 0.007). Values plotted represent least squares means ± SE of the 
mean, calculated for 8 animals per experimental group. There tended to be a time × 
treatment interaction (P < 0.08). A slice output option of SAS was used to perform mean 
separations within time points. Means with different superscripts (a,b) differ (P ≤ 0.05). 
Figure 6-9a. Mean corpuscular hemoglobin amounts of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.14). Treatment (P = 0.87) and time (P = 0.29) were also not significant. Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-9b. Mean corpuscular hemoglobin amounts of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.12) or treatment effect (P = 0.77). However, time tended to be significant (P = 0.07). 
Values plotted represent least squares means ± SE of the mean, calculated for 8 animals 
per experimental group.  
Figure 6-10a. Mean corpuscular hemoglobin concentrations of calves during the first 24 
h following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.17) or treatment effect (P = 0.84). However, time was significant (P < 0.005). Values 
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plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-10b. Mean corpuscular hemoglobin concentrations of calves during the first 28 
d following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. Treatment was not significant (P = 0.99). 
However, time was significant (P < 0.003). Values plotted represent least squares means 
± SE of the mean, calculated for 8 animals per experimental group. There tended to be a 
time × treatment interaction (P = 0.10). A slice output option of SAS was used to perform 
mean separations within time points. Means with different superscripts (a,b) differ (P ≤ 
0.05). 
Figure 6-11a. Total reticulocyte counts of calves during the first 24 h following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.55) or treatment effect 
(P = 0.99). However, time was significant (P = 0.05). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 11b. Total reticulocyte counts of calves during the first 28 d following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.47) or treatment effect 
(P = 0.81). However, time was significant (P = 0.05). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-12a. Total platelet counts of calves during the first 24 h following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
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(MH) infection. There was no time × treatment interaction (P = 0.82). Treatment (P = 
0.91) and time (P = 0.16) were also not significant. Values plotted represent least squares 
means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-12b. Total platelet counts of calves during the first 28 d following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.24) or treatment effect 
(P = 0.98). However, time tended to be significant (P = 0.06). Values plotted represent 
least squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-13a. Total leukocyte counts of calves during the first 24 h following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.66) or treatment effect 
(P = 0.78). However, time was significant (P < 0.002). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-13b. Total leukocyte counts of calves during the first 28 d following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.12) or treatment effect 
(P = 0.39). However, time was significant (P < 0.002). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-14a. Neutrophil percentages of calves during the first 24 h following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.98). Treatment (P = 
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0.38) and time (P = 0.12) were also not significant. Values plotted represent least squares 
means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-14b. Neutrophil percentages of calves during the first 28 d following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.93). Treatment was 
significant (P = 0.03). Time was not significant (P = 0.35). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-15a. Lymphocyte percentages of calves during the first 24 h following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.98) or treatment effect 
(P = 0.25). However, time tended to be significant (P = 0.07). Values plotted represent 
least squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-15b. Lymphocyte percentages of calves during the first 28 d following 
exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia 
haemolytica (MH) infection. There was no time × treatment interaction (P = 0.94). 
Treatment was significant (P = 0.01) and time tended to be significant (P = 0.07). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-16a. Monocyte percentages of calves during the first 24 h following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.61). Treatment (P = 
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0.49) and time (P = 0.34) were also not significant. Values plotted represent least squares 
means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-16b. Monocyte percentages of calves during the first 28 d following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.46) or treatment effect 
(P = 0.51). However, time was significant (P < 0.005). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-17a. Eosinophil percentages of calves during the first 24 h following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. Treatment was not significant (P = 0.41). However, time was significant 
(P < 0.0001). Values plotted represent least squares means ± SE of the mean, calculated 
for 8 animals per experimental group. There was a time × treatment interaction (P = 
0.01). A slice output option of SAS was used to perform mean separations within time 
points. Means with different superscripts (a,b) differ (P ≤ 0.05). 
Figure 6-17b. Eosinophil percentages of calves during the first 28 d following exposure 
to bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.40) or treatment effect 
(P = 0.94). However, time was significant (P < 0.002). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group. 
Figure 6-18a. Basophil percentages of calves during the first 24 h following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.17) or treatment effect 
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(P = 0.86). However, time was significant (P = 0.01). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-18b. Basophil percentages of calves during the first 28 d following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.84) or treatment effect 
(P = 0.76). However, time tended to be significant (P = 0.08). Values plotted represent 
least squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-19a. Blood pH of calves during the first 24 h following exposure to bovine viral 
diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica (MH) infection. 
There was no time × treatment interaction (P = 0.25) or treatment effect (P = 0.36). 
However, time was significant (P < 0.006). Values plotted represent least squares means 
± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-19b. Blood pH of calves during the first 28 d following exposure to bovine viral 
diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica (MH) infection. 
There was no time × treatment interaction (P = 0.40). Treatment (P = 0.27) and time (P = 
0.13) were also not significant. Values plotted represent least squares means ± SE of the 
mean, calculated for 8 animals per experimental group.  
Figure 6-20a. Partial pressure of carbon dioxide within the blood of calves during the 
first 24 h following exposure to bovine viral diarrhea virus (BVDV) type 1b and 
subsequent Mannheimia haemolytica (MH) infection. There was no time × treatment 
interaction (P = 0.33) or treatment effect (P = 0.22). However, time tended to be 
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significant (P = 0.07). Values plotted represent least squares means ± SE of the mean, 
calculated for 8 animals per experimental group.  
Figure 6-20b. Partial pressure of carbon dioxide within the blood of calves during the 
first 28 d following exposure to bovine viral diarrhea virus (BVDV) type 1b and 
subsequent Mannheimia haemolytica (MH) infection. There was no time × treatment 
interaction (P = 0.45) or treatment effect (P = 0.14). However, time was significant (P = 
0.02). Values plotted represent least squares means ± SE of the mean, calculated for 8 
animals per experimental group.  
Figure 6-21a. Partial pressure of oxygen within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.88) or treatment effect (P = 0.34). However, time was significant (P = 0.02). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-21b. Partial pressure of oxygen within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.81) or treatment effect (P = 0.67). However, time was significant (P < 0.005). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-22a. Sodium concentration within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
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Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.57) or treatment effect (P = 0.93). However, time was significant (P = 0.05). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-22b. Sodium concentration within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.41) or treatment effect (P = 0.38). However, time tended to be significant (P = 0.08). 
Values plotted represent least squares means ± SE of the mean, calculated for 8 animals 
per experimental group.  
Figure 6-23a. Potassium concentration within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.26). Treatment (P = 0.96) and time (P = 0.77) were also not significant. Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-23b. Potassium concentration within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.92) or treatment effect (P = 0.78). However, time tended to be significant (P = 0.08). 
Values plotted represent least squares means ± SE of the mean, calculated for 8 animals 
per experimental group.  
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Figure 6-24a. Calcium concentration within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.33). Treatment (P = 0.72) and time (P = 0.16) were also not significant. Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-24b. Calcium concentration within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.62) or treatment effect (P = 0.57). However, time was significant (P = 0.0005). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-25a. Glucose concentration within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.11) or treatment effect (P = 0.46). However, time was significant (P < 0.003). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-25b. Glucose concentration within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.50) or treatment effect (P = 0.20). However, time was significant (P < 0.002). Values 
322 
 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-26a. Lactate concentration within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.14) or treatment effect (P = 0.33). However, time was significant (P = 0.03). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-26b. Lactate concentration within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.71) or treatment effect (P = 0.17). However, time was significant (P = 0.0006). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-27a. Bicarbonate concentration within the blood of calves during the first 24 h 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.24) or treatment effect (P = 0.15). However, time was significant (P = 0.05). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-27b. Bicarbonate concentration within the blood of calves during the first 28 d 
following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
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Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.14) or treatment effect (P = 0.11). However, time was significant (P = 0.003). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-28a. Base excess in extracellular fluid (ECF) within the blood of calves during 
the first 24 h following exposure to bovine viral diarrhea virus (BVDV) type 1b and 
subsequent Mannheimia haemolytica (MH) infection. There was no time × treatment 
interaction (P = 0.44) or treatment effect (P = 0.20). However, time was significant (P < 
0.008). Values plotted represent least squares means ± SE of the mean, calculated for 8 
animals per experimental group.  
Figure 6-28b. Base excess in extracellular fluid (ECF) within the blood of calves during 
the first 28 d following exposure to bovine viral diarrhea virus (BVDV) type 1b and 
subsequent Mannheimia haemolytica (MH) infection. There was no time × treatment 
interaction (P = 0.34). Treatment tended to be significant (P = 0.10) and time was 
significant (P < 0.005). Values plotted represent least squares means ± SE of the mean, 
calculated for 8 animals per experimental group.  
Figure 6-29a. Base excess in blood of calves during the first 24 h following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.41) or treatment effect 
(P = 0.20). However, time was significant (P = 0.01). Values plotted represent least 
squares means ± SE of the mean, calculated for 8 animals per experimental group.  
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Figure 6-29b. Base excess in blood of calves during the first 28 d following exposure to 
bovine viral diarrhea virus (BVDV) type 1b and subsequent Mannheimia haemolytica 
(MH) infection. There was no time × treatment interaction (P = 0.11). Treatment tended 
to be significant (P = 0.09) and time was significant (P = 0.002). Values plotted represent 
least squares means ± SE of the mean, calculated for 8 animals per experimental group.  
Figure 6-30a. Oxygen saturation percentage within the blood of calves during the first 24 
h following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.64). Treatment (P = 0.56) and time (P = 0.12) were also not significant. Values plotted 
represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.  
Figure 6-30b. Oxygen saturation percentage within the blood of calves during the first 28 
d following exposure to bovine viral diarrhea virus (BVDV) type 1b and subsequent 
Mannheimia haemolytica (MH) infection. There was no time × treatment interaction (P = 
0.73) or treatment effect (P = 0.92). However, time was significant (P < 0.004). Values 
plotted represent least squares means ± SE of the mean, calculated for 8 animals per 
experimental group.
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All procedures for the experiments presented in this dissertation were approved by the 
Oklahoma State University Institutional Animal Care and Use Committee. 
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